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Biocatalysis is the use of biological materials, such as whole cells or enzymes, to perform chemical 
transformations. One of the major obstacles limiting the widespread adoption of biocatalytic 
methodologies in organic synthesis is the restricted number of chemical transformations enzymes are 
capable of performing. To address this, the field of rational design utilises the techniques of molecule 
biology, such as mutagenesis, molecular cloning, and recombinant protein technology, to engineer 
novel enzymes with abiological activity. Rational design can be split into two complementary fields: 
protein redesign and de novo design. Protein redesign involves identifying a suitable, naturally 
occurring protein scaffold to function as a molecular blueprint into which desired functionality can be 
engineered. De novo design is a bottom-up approach, in which novel proteins are designed from 
scratch using first principles. 
The recent success in engineering carbene transferases using artificial cytochrome P450 and globin 
scaffolds has expanded the repertoire of biocatalysis into carbene transfer chemistry. The reactive 
intermediate in all the reported artificial carbene transferases is a heme-localised electrophilic 
metallocarbenoid intermediate. C45 is a tetra-α-helical c-type heme-containing de novo protein which 
functions as a proficient oxidoreductase. The first question raised is whether C45 is capable of forming 
a metallocarbenoid intermediate, and, if it can, can C45 catalyst carbene transfer reactions with an 
assortment of suitable substrates, such as olefins (cyclopropanation), X-H α-bonds (X-H insertions), 
aldehydes (carbonyl olefinations), and nitrogen-containing heteroaromatics (homologous ring 
expansions)?  
C45 was screened for metallocarbenoid formation activity using spectroscopic techniques and mass 
spectrometry, and its reactivity was quantified using a variety of small molecule analytical techniques. 
In addition, the inherent simplicity and evolvability of C45 rendered the protein scaffold a perfect 
blueprint for direct evolution, and novel stereocomplementary tetra-α-helical c-type heme-containing 
maquettes were developed, biophysically characterised, and enzymatically evaluated. Another 
significant obstacle hindering the widespread adopting of biocatalytic methodologies in organic 
synthesis is the limited number of operating conditions hospitable to enzymes. In particular, the 
presence of organic solvents is often completely detrimental to enzymatic function. The stability of 
C45 encapsulated inside an organic-solvent resistance hydrogel allowed for the development of a 
novel heterogeneous biocatalyst that remains catalytically active towards peroxidase and carbene 





Overall, a de novo c-type heme-containing protein proficient at i) forming a number of stable, 
spectroscopically distinctive bioorganometallic intermediates, ii) catalysing a wide range of abiological 
chemical reactions via a metallocarbenoid intermediate, and iii) performing biocatalytic conversions 
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CHAPTER 1: INTRODUCTION TO CARBENE CHEMISTRY   
1.1 INTRODUCTION TO CARBENE CHEMISTRY  
A carbene is a divalent carbon atom, with six valence electrons and two unpaired electrons, and can 
be represented by the general formula :CR1R2, where R1 and R2 represent the substituents.1 The 
existence of carbenes was first theorized, in 1855, by Geuther and Hermann who identified 
dichlorocarbene as a possible reaction intermediate in the hydrolysis of chloroform.2,3 
Dichloromethane was mentioned again, by Nef in 1897, as a possible mechanistic intermediate in the 
Reimer-Tiemann reaction.3,4 In 1912, Staudinger isolated cyclopropane-containing products when 
investigating reactions between alkenes and diazomethane, and methylene, :CH2, a carbene 
generated by the elimination of molecular nitrogen from diazomethane, was postulated to be the 
reactive species.3,5 Interest in carbenes was rejuvenated in 1953 when Doering and Knox 
demonstrated their synthetic versatility after photochemically decomposing diazomethane as a key 
step in the synthesis of substituted tropolones.6 In 1954, Hofmann and Doering further demonstrated 
the utility of carbenes by synthesising an assortment of cyclopropane-containing products from 
alkenes using dichlorocarbene (CCl2)7 in addition to providing evidence for the existence of a 
dibromocarbene species in the reaction between cyclohexene and bromoform under basic 
conditions.3,7 In 1959, DeMore attempted to isolate methylene spectroscopically via photolysis of 
diazomethane in a nitrogen matrix at 20 K; although the authors reported IR and UV spectra consistent 
with methylene, it was stated the species itself could not be identified and could only be inferred from 
the assortment of reaction products obtained from the experiment.8 In 1964, Fischer isolated and 
reported a tungsten carbene complex, although the existence of transition metal carbenes had been 
considered as early as 1925.9,10 
In 1992, Goddard provided a theoretical framework to predict the ground-state configuration for an 
assortment of carbenes.11 The electronic configuration of a carbene, which regulates its stability and 
reactivity, is a function of the geometry of the X-C-X bond, and the chemical properties of the 
substituents, X, bonded to the divalent carbon.11–16 The geometry of the carbene determines the 
nature of the frontier orbitals. Linear carbenes have two degenerate p orbitals (px and py) and are 
characterised by sp hybridisation.1 Linear carbenes are relatively rare, and the vast majority exist in a 
bent confirmation1 where the deviation away from linearity lifts the degeneracy of the system. The py 
orbital remains generally unaffected by the deviation from linearity and is denoted as the pπ orbital. 
The px orbital, however, acquires a small degree of s-like character and is denoted the σ-orbital.1 Bent 
carbenes are characterised by sp2 hybridisation and two non-degenerate orbitals, pπ and σ.1 The 





of the substituents neighbouring the carbene carbon. The electronic configuration of the carbene, 
which has pronounced effects on its properties and reactivity, is determined by the energy gap 
between the pπ and σ orbitals. 1,3,11 If the energy difference is sufficiently large it becomes energetically 
favourable to pair the two electrons together in the lower energy σ orbital, resulting in an electronic 
configuration of σ2 and a spin multiplicity of one; these systems are called singlet carbenes (another 
possible singlet configuration is pπ2) (figure 1).1,3,8-13 Alternatively, if the pairing of the two electrons 
comes at an energetic penalty greater than the difference between the pπ and σ orbitals, one electron 
occupies the vacant pπ and the other occupies the vacant σ orbital; this results in an electronic 
configuration of σ1pπ1 and a spin multiplicity of three, and hence these systems are called triplet 
carbenes (an alternative configuration σ1pπ1 with differing spin states is also possible, resulting in a 
singlet carbene) (figure 1).1,3,8-13 How the multiplicity manifests as differences in the reactivity of 
singlet and triplet carbenes will be discussed in detail shortly.  
 
Figure 1: The electronic configuration of singlet and triplet carbenes (adapted from de Frémont et al).3 
1.1.1 Electronic effects of the –R substituents 
The nature of the substituents neighbouring the divalent carbon influences the multiplicity of the 
carbene via induction and mesomeric effects.1,13 For induction, electron-withdrawing groups stabilise 
the singlet state by withdrawing electron density away from the σ orbital, increasing the s-like 
character of the σ orbital and lowering its energy while leaving the pπ unaffected. The increase in the 
σ-pπ energy gap therefore favours a singlet configuration. Electron-donating groups have the inverse 
effect, by donating electron density into the σ orbital the σ-pπ energy gap is decreased and hence the 
system favours a triplet configuration.1,3 This principle is conveniently demonstrated by the 






Figure 2: Inductive effects of EWG and EDG substituents on the singlet-triplet energy gap in free 
carbenes (adapted from Bourissou et al).1 
Although inductive effects play a critical role in determining the ground state multiplicity of a carbene, 
mesomeric effects are often more significant.1,12 There are three systems worth considering: CX2, CY2 
and CXY carbenes were X = π-electron-donating substituents and Y = π-electron-withdrawing 
substituents (figure 3). In CX2 carbenes, a lone pair of electrons on the substituent interact with the 
pπ orbital while leaving the σ largely unchanged. The increased electron density in the pπ orbital results 
in an elevated σ-pπ energy gap and hence CX2 carbenes are normally bent singlet carbenes. The 
donation of electron density into the pπ orbital also results in the C-X bonds acquiring a degree of π-
character and can cause a build-up of negative charge on the central carbon. CX2 carbenes are 
common when X = NR2, OR, F, Cl, Br, I, PR2 or SR(1-3).1,3,12,14,15  In CY2 carbenes the dominant interaction 
is between vacant orbitals on the substituent and the carbene py orbital. The px orbital is unaffected 
and the removal of electron density from the py orbital lifts the degeneracy of the system resulting in 
a py-px energy gap. The py-px energy gap means CY2 carbenes are usually linear species with a py2 singlet 
configuration. Analogous to CX2 systems, the interaction between the vacant orbitals of the 
substituent and the carbene py orbital imparts a degree of π-character into the C-Y bonds, but a 
positive charge develops on the carbene carbon on account of the electron-withdrawing nature of the 
substituents. CY2 carbenes are common when Y = COR, CN, CF3, BR2 and SiR3.1,11 Lastly, in the case of 
mixed carbenes, CXY, the X substituent interacts with the py orbital while the Y substituent interacts 
with the px orbital. The net result is a destabilisation of the py orbital and a stabilisation of the px 
orbital, which results in a singlet configuration being favoured with π-like character associated with 
both the C-X and C-Y bond, with negative charge localised on the Y substituent and positive charge 






Figure 3:  Mesomeric effects of EDG (X) and EWG (Y) substituents on the singlet-triplet energy gap in 
free carbenes (adapted from Bourissou et al).1 
1.2 TRANSITION METAL CARBENE COMPLEXES 
The majority of free carbenes are too reactive to be conveniently isolated (unless sterically bulky 
substituents are employed to kinetically stabilise the carbene). A common method of stabilising (and 
hence isolating) a carbene species is via complexation with a transition metal. The d-orbitals of a 
transition metal can provide stabilising interactions with the carbene’s pπ and σ orbitals to form a 
stable transition metal carbene complex with the carbene functioning as a ligand.1,3,18–22 The additional 
ligands in the coordination sphere of the metal determine the nature of the metal-carbene bond and 
reactivity of the carbene ligand. The two major types of transition metal carbene complexes are the 
Fischer complexes and the Schrock complexes, which are distinguished by the oxidation state of the 
metal, oxidation state of the carbene ligand, and the properties of the metal-carbene bond.3,21,23,24 
The distinctions between the two types of carbene complexes will be outlined below, followed by a 
brief account of ‘’intermediate’’ transition metal carbene complexes known as radical carbenes. N-
heterocyclic carbenes have been omitted from the discussion on account of irrelevancy.  
1.2.1 Fischer Carbenes 
Fischer carbene complexes are transition metal-carbene complexes formed by low oxidation state 
middle-to-late transition metals (i.e. Fe(0), Mn(0), Ni(0)). The other ligands coordinated to the 
transition metal are often strong-field π-acceptor ligands (i.e. CO, NO, CN, PR3). A distinctive 





-NR, -OR). The π-donating interaction from the substituent lone pair into the vacant p-orbital of the 
carbene provides additional stabilisation to the Fischer complex.3,21,23,24 A few examples of Fischer 
complexes include (CO)5Cr=C(NR2)Me, (CO)5Cr=C(OR)Ph, (CO)5W=C(OR)Me, and 
(CO)4(PPh3)Mo=C(OEt)Ph (figure 4).  
 
Figure 4: The molecular structures of some typical Fischer carbene complexes. 
The π-donating interaction between the carbene and a heteroatom stabilises the carbene, with the 
increased electron density in the p-orbital elevating the singlet-triplet barrier in favour of a singlet 
complex. Fischer carbene complexes often adopt a σ2pπ0 singlet electronic configuration, and this is 
reflected in the nature of the M=C bond. The M=C bond in Fischer complexes are characterised by a 
strong σ-donation from the lone pair situated in the filled carbene σ-orbital into a vacant metal d-
orbital and a reciprocal π-back bonding from a filled d-orbital into the vacant p-orbital on the carbene. 
The M=C bond in Fischer complexes is shorter than a typical M-C bonds but longer than a typical M=C 
bond. In addition, the M=C bond length is inversely related to the strength of C-X interaction between 
the carbene carbon and the alpha-heteroatom (X), resulting in an elongation (and hence weakening) 
of the M=C bond as the C-X bond strength increases. The overall net result of the metal-carbene bond 
is a flow of electron density onto the metal from the carbene carbon, resulting in an electron-rich, 
nucleophilic metal centre and an electron deficient, electrophilic carbene centre. The electrophilic 
nature of the carbene imparts reactivity analogous to a ketone carbonyl, and therefore Fischer 
carbenes can function as intermediates and/or catalysts in nucleophilic substitutions, aldol reactions, 
Diels-Alder reactions, and Michael additions. The most noteworthy reaction involving Fischer 
carbenes is the Wulff-Dötz benzannulation, where aromatic/vinylic alkoxy pentacarbonyl chromium 
carbene complexes (figure 4, far right) are employed in the synthesis of Cr(CO)3-coordinated 
substituted phenols from a terminal alkyne and CO.25,26  
1.2.2 Schrock Carbenes 
Schrock complexes are transition metal-carbene complexes formed by high oxidation state early 





typically π-donor ligands (i.e. NR2, -NR, -OR,).3,21,24 The substituents on the carbene are hydrogen 
and/or alkyl groups, and, therefore, unlike in Fischer complexes, Schrock carbenes lack the stabilising 
π-donating interaction provided by a neighbouring heteroatom. The lack of electron donation into the 
vacant p-orbital means the σ-pπ energy gap is smaller relative to Fischer carbenes, and therefore 
Schrock carbenes often adopt σ1pπ1 electronic configurations which is reflected in the nature of the 
M=C bond. The M=C bond in Schrock complexes is characterised by a σ-bond resulting from the 
coupling between an unpaired electron situated in the carbene σ-orbital and an unpaired electron 
situated in the metal d-orbital. This interaction is complemented by a reciprocal π-bond formed by 
the coupling between an unpaired electron in the d-orbital of the metal with an unpaired electron in 
the p-orbital on the carbene. A few examples of Shrock complexes include Cl2CpTa=C(H)tBu, 
Cp2Ti=CMe2, Cp2HTa=CH2, and Cl2(P(Cy)3)2Ru=C(H)Ph. The M=C bond in Schrock complexes is shorter 
and stronger than the M=C bond in Fischer complexes on account of the triplet coupling between the 
carbene and the metal. The overall net result of the metal-carbene bond is a flow of electron density 
from the metal to the carbene carbon, resulting in an electron-deficient metal centre and an electron-
rich carbene centre. The polarisation of the M=C bond towards the carbon renders the carbene a 
nucleophilic species, and Schrock complexes have been employed as synthetic reagents in carbonyl 
olefinations, alkene metathesis reactions, ring opening metathesis polymerisations (ROMP) and ring 
closing metathesis (RCM) reactions. One Schrock carbene of interest is the dimetal-containing 
organometallic compound Tebbe’s reagent (figure 5).27 Tebbe’s reagent is a titanium tetrahedral 
complex coordinated to two cyclopentadienyl (C5H5)- ligands and bridged with a dimethyl aluminium 
fragment via a chlorine ligand and a methylene (carbene) ligand, to yield a complex with a molecular 
formula of (C5H5)2TiCH2ClAl(CH3)2. Tebbe’s reagent is employed as a catalyst in carbonyl methylenation 
reactions of aldehydes, esters, lactones, and amides.27,28 A chlorinated analogue of Tebbe’s reagent 
has been successfully employed to convert carbonyls into cyclopropanes, and the reaction mechanism 
is hypothesised to proceed via a TiCl2(=CH2) carbene intermediate.28    
 





1.2.3 Radical Carbenes 
Radical carbenes are a unique class of organometallic carbenes formed when a carbene ligand is 
coordinated to an open-shell metal. Radical carbenes can be prepared by the one-electron reduction 
of a Fischer complex or by the direct coordination of a carbene to an open-shell metal.29 In radical 
carbenes, the carbene carbon have radical-like properties and exhibit features intermediate between 
Shrock and Fischer carbenes. Radical-carbene complexes are common when a carbene is coordinated 
to a low-spin group 9 transition metal.  In particular radical-carbene complexes with cobalt (Co3+)29 are 
very stable and generate long-lived intermediates.26–30 Radical carbene complexes with other metals, 
such as ferrous iron (Fe2+), have also been reported,34 although these complexes are shorter-lived and 
less stable relative to the analogous Co3+ complexes. The mechanism behind radical carbene formation 
is analogous to Fischer carbene formation, with the formation of a σ-bond between the carbene 
carbon and the metal accompanied by π back-bonding from the metal to the carbene π* orbital.29,35 
The nature of the M=C bond imparts significant electron density to the carbene carbon, predominantly 
localised in the pz. The complex is further stabilised by a back bonding interaction from the carbene pz 
orbital into an adjacent substituent’s π*-orbital; this interaction is critical for stabilising the overall 
complex.29,35 Tetrapyrrole ligands, especially porphyrin-derived macrocycles, are renowned for their 
ability to stabilise a carbene radical complex by functioning as an ‘’electron buffer’’. The porphyrin 
macrocycle donates electron density into the π d-orbitals of the metal, stabilising the metal and 
localising the radical-like electron density on the carbene carbon.29,35 
1.3 METALLOCARBENOIDS 
Carbenoids is the name assigned to a class of compounds that possess a complete valency but exhibit 
properties similar to free carbenes.1,18,20 The most common precursors for carbenoids are diazo 
compounds (C-N2).36,37 The reactivity of diazo compounds is determined by the nature of the 
substituents neighbouring the carbenoid carbon. In the presence of a suitable metal (Cu, Rh, Pt), a 
diazo compound will decompose to release a molecule of N2 and form a metal-carbon double bond.37 
The bonding to the metal stabilises the carbenoid and allows the reactivity to be controlled. The 
bonding consists of a strong σ-bond between the metal and carbon formed by the donation of a lone 
pair of electrons localised on the carbon to the metal.38–41 The metal donates electron density from a 
d-orbital into the carbon p-orbital, affording a stable bond with a degree of π-character. The 
metallocarbenoid is an electrophilic species as a consequence of the strong σ-bond, with the 
electrophilicity controlled by the neighbouring substituents of the carbenoid carbon and the strength 
of the π-donation from the metal. 38–41 Metallocarbenoids have reactivity similar to singlet carbenes, 





A notable metallocarbenoid is the organozinc carbenoid IZnCH2I (generated from CH2I2) which is 
employed in the stereospecific cyclopropanation of alkenes in a reaction called the Simmons-Smith 
reaction (discussed below in section 2.2.4).42 Many transition metal complexes of carbenes can be 
classified as metallocarbenoids. 
1.4 REACTIONS OF FREE CARBENES AND METALLOCARBENOIDS 
1.4.1 [2+1] cycloaddition reactions 
The most important reactions involving carbenes and metallocarbenoids are the [2+1] 
cycloadditions.37,42,43 [2+1] cycloadditions are cheletropic, with both new σ-bonds being formed on the 
carbene(oid) carbon to give a three-carbon ring. The substrates are most commonly alkenes which 
yield cyclopropanes products (cyclopropanation), but alkynes can also be employed to yield 
cyclopropene products (cyclopropenation).37,42,43 Although the majority of cyclopropanation reactions 
involve a transition-metal stabilised carbenoid, free carbenes can also be employed as reagents in 
cycloaddition reactions, although the variable electronic configurations of free carbenes has 
important implications on the reaction stereoselectivity. 
1.4.1.1 Carbene multiplicity and cyclopropanation stereochemistry 
Singlet carbenes, characterised by a σ2 electronic configuration, behave as electrophiles, and react 
with alkenes in a concerted single step cheletropic reaction which proceeds via a four-electron-three-
centred transition state. The bonding in the transition-state involves the donation of the σ2 electrons 
into the vacant π* orbital of the alkene with a weak back-donation from the alkene p-orbitals into the 
vacant carbene pz orbital. The diastereoselectivity of the alkene substrate is preserved in the 
cyclopropane-product because both new σ-bonds form simultaneously; singlet carbene [2+1] 
cycloaddition reactions are therefore stereospecific (figure 6). 
Triplet carbenes, characterised by a σ1pπ1 electronic configuration, behave as diradicals, and react with 
alkenes in a stepwise radical addition reaction which proceeds via a diradical intermediate. The first 
step involves a reaction between the carbene σ electron and the alkene π-bond to produce a diradical 
species with the two lone electrons separated by a tetrahedral bridge. The second step involves 
coupling of the two lone electrons to form a new σ-bond and generate the final cyclopropane product. 
The diastereoselectivity of the alkene substrate is not preserved in the cyclopropane-product because 
the two new σ-bonds form separately; triplet carbene [2+1] cycloaddition reactions are therefore not 





allows for free rotation around the newly formed tetrahedral carbon and the two neighbouring carbon 
radicals (figure 6).   
 
Figure 6: The selectivity of triplet (A) vs singlet (B) free carbene cyclopropanation. Triplet carbenes 
react with olefins in a step-wise mechanism, proceeding via a diradical intermediate which affords 
free rotation around the newly formed sp3-sp3 C-C bond; the reaction is not stereospecific. Singlet 
carbenes react with olefins in a concerted manner and are stereospecific.  
1.4.1.2 Cyclopropanation using free carbenes 
The [2+1] cycloaddition of a carbene across an alkene C=C double bond can be readily achieved by 
generating a reactive carbene intermediate in situ via thermolysis, photolysis, dihalogen reduction, or 
base hydrolysis.3 A major limitation with free carbene reagents is the lack of chemo-, regio- and stereo- 
control because of the highly reactive nature of free carbenes and the singlet/triplet multiplicity. 
Nonetheless, several important cyclopropanation reactions proceed via the generation and 
subsequent consumption of a reactive carbene in the presence of olefins. Treating chloroform with 
alkoxides (i.e. (tBu)3ONa, EtONa, tBuOK, NaOH etc) generates the common carbene dichlorocarbene 
(Cl2C:).7 Cl2C: is a bent singlet carbene which reacts with alkenes to yield geminal 
dichlorocyclopropanes. Analogous geminal dibromocyclopropanes can be readily obtained by treating 
CHBr3 with an alkoxide to generate dibromocarbene (Br2C:) in the presence of a suitable olefin. The 
cyclopropantion of alkenes with dihalocarbenes is a stereospecific process because the singlet 





The resulting geminal dihalocyclopropanes can be subsequently treated with an organolithium base 
in a reductive dehalogenation reaction to yield a cyclopropane-carbene intermediate. The 
cyclopropane-carbene intermediate is incredibly unstable, and spontaneously rearranges to yield an 
allene product. This reaction is called the Skattebøl reaction (figure 7).44 An analogous reaction, the 
Doering–LaFlamme allene synthesis, also involves the in-situ generation of a dihalocarbene which 
reacts (with an olefin) to form a geminal dihalocyclopropane. The dihalocyclopropane is subsequently 
reduced in the presence of magnesium or sodium metal to generate the cyclopropane-carbene 
intermediate which spontaneously rearranges to the final allene product (figure 7).45 Another 
modification of the Skattebøl/Doering–LaFlamme allene synthesis involves the reductive 
dehalogenation of a 1,1-dihalo-2-vinylcyclopropane to yield a 2-vinylcyclopropane carbene, which 
spontaneously rearranges to yield a cyclopentadiene product; this modified reaction is known as the 
vinylcyclopropane rearrangement. 
 
Figure 7: Allene synthesis via dihalocyclopropanes: Skattebøl rearrangement (top) and Doering-
LaFlamme synthesis (bottom). In both reactions, the first step involves the generation of a 
dihalocyclopropane moiety, which is reduced in a second step to yield a reactive cyclopropane 
carbene. The highly reactiove cyclopropane carbon is susceptible to spontaneously rearrangement to 
yield an allene (C=C=C proudct). 
Fluorenylidene is a carbene derived from the photolysis of 9-diazofluorene, with the carbene carbon 
localised on the bridging methylene connecting the two aryl groups (figure 8). The most distinctive 
property of fluorenylidene is the remarkably low energy gap between the singlet and triplet states 
(approximately 4.5 KJ mol-1).46,47 Flash photolysis of 9-diazofluorene results in a high population of 
singlet fluorenylidene molecules which gradually relax down to triplet fluorenylidene via intersystem 
crossing. The rate of intersystem crossing is dependent on temperature and the physical properties of 





fluorenylidene and a suitable olefin. If the rate of intersystem crossing greatly exceeds the rate of 
singlet fluorenylidene cyclopropanation, the system equilibrates to the triplet state and the 
cyclopropanation proceeds in a non-stereospecific, stepwise fashion resulting in a mixture of 
stereoisomers. However, the presence of halogenated solvents was found to decelerate the rate of 
intersystem crossing. In particular, hexafluorobenzene (C6F6) was reported to significantly reduce the 
rate of intersystem crossing and the reported rate of reaction with a triplet-quenching molecule such 
as MeOH. The authors conjectured that a halogen lone pair from the solvent interacts with the vacant 
fluorenylidene orbital and stabilises the singlet state, and subsequent cyclopropanation with 
fluorenylidene in the presence of a suitable olefin and C6F6 resulted in a stereospecific reaction, 
indicative of a singlet fluorenylidene carbene species.46–48     
 
Figure 8: Fluorenylidene synthesis via flash photolysis of 9-diazofluorene. 
1.4.1.3 Metallocarbenoid-catalysed cyclopropanation 
Although free carbenes can be employed as reagents in cyclopropanation, problems associated with 
their inherent instability, selectivity, and side-reactions (i.e. carbene dimerization) limit their scope 
and applications. Transition-metal stabilised carbenoids, synthesised from diazo compounds, present 
a safer and more reliable methodology for intra- and intermolecular cyclopropanation.42 The 
stereoselectivity of transition metal catalysed carbene transfer reactions can also be finely tuned by 
coordinating select chiral ligands to the transition metal.49–53 Metallocarbenoid catalysed 
cyclopropanations are well established and have been readily employed as key steps in the 
enantioselective synthesis of important molecules, such as the pyrethroid precursor chrysanthemic 
acid.54 
A very common reaction is the Simmons-Smith cyclopropanation (figure 9),42,55 a cheletropic [2+1] 
cycloaddition between an alkene and an organozinc metallocarbenoid species: iodomethylzinc iodine 
(IZnCH2I). Iodomethylzinc iodine is the active reagent in the Simmons-Smith reaction, and is generated 
in-situ by reacting diiodomethane (CH2I2) with a zinc-copper alloy, Zn(Cu). In the presence of a suitable 
olefin, iodomethylzinc iodine transfers a methylene group to the alkene C=C bond via a concerted 





stereochemistry of the alkene substrate being preserved in the cyclopropane product. The reaction is 
subject to steric effects, with the methylene adding to the least-hindered face of the alkene.42,55 The 
reactivity of the Simmons-Smith reaction can be significantly enhanced by the Furukawa modification, 
which involves substituting the Zn(Cu) alloy for diethylzinc, Et2Zn.56 The Furukawa modification, like 
the original Simmons-Smith reaction, is also stereospecific and the methylene groups adds across the 
least hindered face of the alkene. A notable exception occurs for alkenes situated in close proximity 
to hydroxyl groups; the hydroxyl group coordinates to the zinc and positions the metallocarbenoid in 
the same plane of the hydroxyl prior to the methylene transfer step, meaning the methylene transfer 
step proceeds via a syn-addition relative to the hydroxy group irrespective of any steric 
considerations.42,57  
 
Figure 9: The Simmons-Smith cyclopropanation. The reaction proceeds via an organozinc 
metallocarbenoid intermediate. The reaction is stereospecific.  
The Simmons-Smith reaction is one of the most popular reactions for synthesising cyclopropanes, but 
limitations concerning the expense of the reagents, unwanted side-reactions occurring because of 
ZnI2, and the requirement for a stoichiometric quantity of ICH2ZnI means alternative methodologies 
have been explored. An alternative cyclopropanation methodology is the transition metal catalysed 
decomposition of a diazo compound to form a metallocarbenoid complex followed by a subsequent 
carbene transfer step to a suitable substrate.42,49–53  The mechanism involves the initial attack of the 
diazo compound on the metal centre to yield a tetrahedral zwitterion alkyl-metal complex. Rapid 
expulsion of a N2 molecule thermodynamically drives the formation of the π-bond between the metal 
and carbon to yield the metallocarbenoid complex. The metallocarbenoid complex is electrophilic, and 
reacts with an alkene via a concerted, cheletropic mechanism to afford a cyclopropane product.42,58 
1.4.2 X-H insertion reactions 
An insertion reaction occurs when a reagent inserts into a pre-existing σ-bond on another substrate, 
resulting in the formation of a new σ-bond. Insertion reactions are often limited because of the 
strength of C-X σ-bonds, but the extraordinarily high reactivity of carbenes renders them useful 
reagents for insertions into X-C σ-bonds (where X = C, N, S, Si, H).37,59,60 In the absence of a stabilising 
metal, carbene insertion reactions tend to be non-regioselective, but the selectivity can be improved 





There are two plausible mechanisms for carbene X-H insertion reactions,39,61 although at present it is 
unclear which mechanism is accurate. The first is a concerted formation of a tricyclic C-X-H 
intermediate state which is characterised by the concurrent formation of the C-X σ-bond, breaking of 
the X-H σ-bond and transfer of the H to form a X-H σ-bond. The second involves the nucleophilic 
addition of the X-H substrate to the electrophilic metallocarbenoid followed by the subsequent 
dissociation of the resultant ylide. A 1,2-hydrogen shift from the X-group to the carbene carbon  
completes the reaction. The two plausible mechanistic pathways are illustrated in figure 10 for the 
reaction between aniline and methylene.    
 
Figure 10: The two possible mechanisms for the carbene N-H insertion reaction between aniline and 
methylene. The first pathway involves the formation of three-membered cyclic intermediate; the 
second pathway involves the initial formation of an ylide species followed by the 1,2-hydrogen shift. 
1.4.2.1 C-H insertion reactions 
The synthesis of C-C σ-bonds is one of the most important reactions in organic chemistry because it 
affords the possibility of synthesising large and complex molecules from smaller starting materials.62,63 
The problem with such reactions concerns the strong bong energy of C-H bonds, which needs to be 
compensated for.62–64 The common methodologies involve an initial C-H activation/substitution step 
to lower the energetic barrier to C-C σ-bond formation, but this is unfavourable because it adds 
additional steps to a synthesis.62,63 Carbenes can form new C-C σ-bonds without the need for C-H 
activation, which renders them useful reagents.37,59,64 In the absence of a catalyst, carbene C-H 
insertion reactions proceed without selectivity and yield a mixture of different possible insertion 
products. The employment of a suitable transition metal catalyst can circumvent the selectivity issues.  
Dirhodium polycarboxylate catalysts are the most commonly employed class of catalysts for this type 
of chemistry, with Rh(II)2(AcO)4, which exhibits high promiscuity towards regioselective intermolecular 





utilised.65–67 An assortment of dirhodium complexes with bulky chiral ligands have been reported for 
asymmetric intermolecular and intramolecular C-H carbene insertion reactions.66  
1.4.2.2 N-H insertion reactions 
In addition to C-H insertion reactions, carbene intermediates have been utilised in the synthesis of C-
X σ-bonds (X = O, N, S, Si).37 Amine insertions, the insertion of a carbene into a N-H σ-bond to form a 
novel C-N σ-bond,65 is a valuable synthetic reaction because it affords the ability to synthesise complex 
important molecules under mild reaction conditions. The N-H insertion reaction is catalysed by a 
variety of transition metals, including Cu, Pd, Ru, which affords a degree of chemo-, regio- and 
stereoselectivity to the reactions.65 For example, a Cu(I) derived catalyst afforded the chemoselectivity 
insertion of reactive carbenes into N-H in the presence of O-H groups. In another study, an iridium-
derived catalyst demonstrated a remarkable catalytic turnover towards the mono-insertion of a 
carbene for aromatic-NH2 functional group containing molecules in water.68  
The importance of N-H insertion reactions in forming novel C-N σ-bonds is of special interest in amino 
acid chemistry and peptide synthesis.69 The current synthetic methods employed in peptide synthesis 
involves multiple protection/deprotection steps, adding additional reactions and purifications to the 
overall synthesis which can negatively affect reaction yields. The chemo-, regio- and stereoselectivity 
of transition metal catalysed carbene insertion reactions offers a new and easier methodology in the 
controlled synthesis of peptides and non-natural amino acid derivatives.  
1.4.3 Homologation reactions 
The simplest free carbene is the compound methylene (H2C:) generated in situ by the photolysis of 
diazomethane (CH2N2).6,37 A colourless gas detectable at low temperatures and pressures, methylene 
is a highly reactive species only isolatable in solution an adduct or coordinated to a suitable metal. In 
organic chemistry, methylene is synthesised and immediately consumed in situ as a reactive 
intermediate. A good example of methylene in synthesis is the Arndt–Eistert reaction,59,70 the one 
carbon homologation reaction of carboxylic acids to yield the homologue carboxylic acid. In the 
reaction, the nucleophilic methylene, generated by photolysis of diazomethane, attacks an acyl 
chloride to yield a tetrahedral intermediate. The carbonyl group reforms, expelling HCl, and yields a 
α-diazo carbonyl; the subsequent rearrangement of the α-diazo carbonyl (via a Wolff rearrangement) 
expels N2 and results in a ketene species, which is subsequently hydrolysed to yield the homologation 
product.59,70 Diazomethane is also a crucial reagent in the synthesis of substituted tropolones, in which 





with substituted benzene to yield a substituted 7-membered cycloheptatriene ring, which is further 
oxidised to the tropolone product.6  
1.4.4 Carbene dimerization reactions 
The reactions discussed above involve a carbene or carbenoid reacting with a non-carbene(oid) 
substrate in a biomolecular reaction. Another organic reaction observed is a carbene dimerization, a 
biomolecular reaction where a carbene(oid) reacts with another carbene(oid) to yield a homodimer 
(when the two carbene(oids) are identical) or a heterodimer (when the two carbene(oids) are not 
identical) alkene product. Although carbene dimerization reactions are usually undesirable side- 
reaction (carbene dimerization reactions are particularly problematic when α-carbonyl diazo 
compounds are employed as carbene precursors), carbene dimerizations have attracted some 
attention in the synthesis of symmetrical alkene products. A good example is the dimerization of ethyl 
diazoacetate (EDA) to the symmetrical cis-alkene ethyl maleate which is catalysed by the 
organoruthenium complex RuCl(PPh3)2(C5H5).71  
1.4.4.1 The Wanzlick Equilibrium  
The most famous and well documented carbene dimerization reaction is the Wanzlick dimerization,72–
77 a reaction characterised by a chemical equilibrium between a stable carbene and its dimer product 
(figure 11). In the 1960s, Wanzlick and Schikora studied the vacuum pyrolysis of 2-trichloromethyl 
dihydroimidazole substrates and hypothesised the elevated temperatures encouraged the thermal 
decomposition of 2-trichloromethyl dihydroimidazole to afford dihydroimidazol-2-ylidene substrates 
via the elimination of chloroform (figure 11).78,79 It was proposed that dihydroimidazol-2-ylidene 
derivatives would exist in an unfavourable equilibrium with the corresponding dimer.72 Investigations 
using bis-(1,3,-diphenyl-2-imidazolidinylidene), generated from the elimination of chloroform, 
resulted in a colourless crystal which exhibited a strong band in the Raman spectrum at 1640 cm-1 
(C=C bond).72 The thermal decomposition of bis-(1,3,-diphenyl-2-imidazolidinylidene) in the presence 
of tetracyanoethylene resulted in the isolation of a cyclopropane product. The authors demonstrated 
the dimerization product was chemically inactive towards a selection of electrophiles, and postulated 
that bis-(1,3,-diphenyl-2-imidazolidinylidene), which reacted with the selected electrophiles, was the 






Figure 11: An illustration of the Wanzlick equilibrium. Flash photolysis yields a carbene intermediate 
which exists in equilibrium with its dimer. 
The carbene-dimer equilibrium conjecture presented by Wanzlick and Schikora was challenged by a 
series of experiments conducted in the mid-60s. In 1964, Lemal and co-workers investigated the 
dissociation of two tetraaminoethylenes substrates, the N-Ph (1) and the N-p-tolyl derivative (2).80 It 
was claimed that if Wanzlick’s hypothesis was correct a cross over-species between the two 
tetraaminoethylenes derivatives would be expected. After refluxing equimolar quantities of 
substrates (1) and (2), under anaerobic conditions, the product mixture was collected, purified, and 
analysed by NMR spectroscopy. The authors reported that ‘’no absorption attributable to the crossed 
ethylene was present’’ in the NMR spectrum and concluded that the carbene-dimer equilibrium 
proposed by Wanzlick was incorrect; a new reaction mechanism for the reactivity observed by 
Wanzlick was subsequently proposed.80 In 1965, the Wanzlick equilibrium was also criticised by 
Winberg and co-workers, after reporting that no cross-over products could be detected by gas 
chromatography after refluxing equimolar volumes of tetrakis(dialkylamino)ethylene derivatives, 
corroborating the arguments of Lemal and co-workers.81 
The Wanzlick carbene-dimer equilibrium was revisited in 1999 by Denk and co-workers who reported 
the synthesis and isolation of metal carbene complexes from electron-rich tetraaminoethylenes 
precursors.75 Denk and co-workers reported a statistical mixture of A=A, A=B and B=B products in the 
ration 1:2:1 in the free metathesis reaction of all tetraaminoethylenes explored; the only mixture were 
no mixed product (A=B) could be detected was the mixture employed by Lemal in 1964. The authors 
claimed the experiments supported the existence of the Wanzlick equilibrium but commented that 
the results did not irrefutably prove it; the authors highlighted that a [2+2]-cycloaddition/[2+2] 
cycloreversion could account for the reported statistical mixture of alkene products.75 In 2000, Hahn 
and co-workers provided further evidence for the existence of the Wanzlick equilibrium after 
detecting a free N-heterocyclic carbene, via NMR spectroscopy, in solution (prepared from its 
corresponding pure entetramine) after 24 hours.76 The simultaneous detection of the free carbene 
and the dimer also provided convincing evidence for the dissociation mechanism proposed by 





supported by Lemal after observing the dissociation of methyl-/ethyl-functionalised entetramine via 
NMR spectroscopy.73,82   
1.5 CONCLUSION 
Carbenes are highly reactive and electron deficient species that can be employed as useful 
intermediates in a number of important reactions, including [2+1] cycloadditions, X-H insertions, 
homologation reactions and dimerization reactions. The stability and reactivity of a carbene species is 
a function of the electronic and spatial properties of the substituents bonded to the carbene carbon. 
A few classes of carbene species can be established from the disinvite differences in the electronic 
nature and reactivity. For example, singlet carbenes react in a concerted fashion whereas triplet 
carbenes react in a two-step stepwise fashion. The differences in reactivity can also afford control over 
the selectivity in syntheses employing carbenes. A common methodology for stabilising a carbene 
intermediate is by decomposing a carbene intermediate, such as a diazo compound, in the presence 
of a suitable transition metal to form a metallocarbenoid complex. The nature of the substituents 
coordinated to the transition metal can be finely tuned to generate three classes of metallocarbenoid 
complexes: Fischer, Shrock and radical complexes. The different natures of the complexes result in 
different reactivity with a variety of substituents. Once a metallocarbenoid complex has been 
prepared, the complex is then free to react with a variety of functional groups to construct larger 







CHAPTER 2: A HISTORY OF CARBENE TRANSFERASES: FROM RATIONALLY DESIGNED 
ARTIFICIAL METALLOENZYMES TO DE NOVO MAQUETTES.   
2.1 A BRIEF HISTORY OF THE MAJOR DEVELOPMENTS IN MOLECULAR BIOLOGY 
Biocatalysis is the use of biological material, such as an enzyme or whole cell, to catalyse a chemical 
transformation.83–85 The ability to isolate, clone and express a specific protein has rejuvenated interest 
in biocatalysis. The non-toxicity, biodegradability, remarkable selectivity, and specificity of enzymes 
underlines them as promising alternatives to the hazardous organometallic catalysts ubiquitously used 
in synthesis. However, three historical obstacles continue to hinder the widespread adoption of 
enzymes: i) the difficulty in isolating a sufficient quantity of a desired enzyme,  ii) the limited number 
of chemical transformations enzymes can perform, and iii) the limited operating conditions of 
enzymes. The revolutionary developments in molecular biology and biotechnology have allowed these 
limitations to be addressed. Three of the most important developments are i) DNA sequencing 
technology, ii) the polymerase chain reaction (PCR), and iii) DNA/protein recombinant technology. 
Each of these developments shall be briefly discussed below. 
A major breakthrough came from the development of DNA sequencing technology. The first method 
introduced for DNA sequencing, by Wu, involved the binding of location-specific primers to a DNA 
sequence followed by an extension reaction catalysed by DNA polymerase.86 Wu and colleagues used 
this methodology to sequence the lysozyme gene of bacteriophage T4.86 In 1977, Sanger adopted the 
principle of the primer-extension strategy to develop faster DNA sequencing techniques.87 In Sanger 
sequencing, the four necessary canonical bases deoxynucleosidetriphosphates (dNTPs), a DNA primer, 
a single-stranded DNA template, and DNA polymerase are present, in addition to one of four modified 
dNTPs called deoxynucleotide triphosphates (ddNTPs).87 The importance of the ddNTPs in the Sanger 
sequencing is a due to the absence of a 3’-hydroxyl group which is required for the formation of the 
phosphodiester bond between two nucleotides which form the backbone of a DNA strand. The 
random incorporation of ddNTPs into a sequence of DNA inhibits further elongation of the strand and 
terminates the reaction. The random nature of ddNTP addition means after the reaction the mixture 
will contain an ensemble of different-length single-stranded DNA strands, each containing a terminal 
ddNTP. The ddNTPs can be radioactively or fluorescently tagged for detection and, thus, repeating the 
experiment in the presence of all four ddNTPs separately allows the sequence of a DNA strand to be 
accurately determined by corresponding the positions of the terminal ddNTPs to the original 
sequence.87 The first complete genome of an organism, of the bacterium Haemophilus influenzae, was 





Another crucial development was the polymerase chain reaction (PCR). In PCR, an infinitesimal 
quantity of a specific DNA sequence is amplified by repeated cycles of thermally denaturation of the 
double-stranded DNA, the annealing of specifically designed primers to the single strands of DNA , and 
the subsequent replication of the gene by DNA polymerases. The key component behind the 
development of PCR was the isolation of taq DNA polymerase from the thermophilic bacterium 
Thermus aquaticus.89 The protein taq DNA polymerase is thermally-stable (up to 80 OC) and can 
tolerate the higher temperatures required for denaturing double-stranded DNA without any loss of 
functionality or specificity. Through repeated cycles of denaturation, annealing and replication, PCR 
allows a sufficient quantity of a desired gene to be acquired.   
The techniques of molecular cloning and the introduction of recombinant DNA and protein technology 
was the final development.90 Molecular cloning introduced a facile way of acquiring large quantities 
of a desired biomolecule, such as a protein. Molecular cloning involves the introduction of laboratory 
prepared recombinant DNA into a host organism and directing its expression. A large variety of host 
organisms and cloning vectors have been developed, but the majority of applications involve E. coli as 
the host organism and a plasmid expression vector as the cloning vector.90 A plasmid is a small, circular 
fragment of extrachromosomal DNA, commonly found in bacteria cells, that is capable of autonomous 
replication within its host. Plasmids can be introduced into competent cells via transformation and 
can be passed on to future generations during cell division. These biochemical properties highlighted 
plasmids as perfect tools for molecular cloning. A plasmid cloning vector must contain several 
important genes in order to function adequately: i) an origin of replication, ii) a minimum of one 
selective marker, and iii) a minimum of one unique restriction endonuclease recognition site. The 
origin of replication allows for the plasmid to be expressed inside the host organisms. The selective 
marker is a gene that encodes for antibiotic resistance towards a specific antibiotic (e.g. ampicillin, 
tetracycline, etc) and ensures only cells possessing the plasmid will survive in the presence of the 
specific antibiotic. The restriction endonuclease recognition sites allow for endonucleases to cut the 
plasmid DNA and so a gene encoding the desired gene product (i.e. protein) can be inserted into the 
plasmid prior to transformation. The inserted DNA is appended to the plasmid via DNA ligases. In 
enzymology, the recombinant DNA contains a gene encoding for a desired enzyme, which can be over-
expressed once transformed into the host organisms.90  
The three techniques above allow sufficient quantities of a desired protein to be collected and also 
provide an easy methodology for introducing modifications into a sequence of DNA, which is 
translated into modifications to a gene target’s (protein) structure and function. This has afforded the 





towards novel functionality and chemistry. The design of novel proteins is sometimes called rational 
design.83,91–93 Rational design is divided into two complementary approaches: protein redesign and de 
novo design.94 Protein redesign is a top-down approach in which a natural protein is selected as the 
blueprint from which new proteins can be engineered. De novo design is a bottom-up approach in 
which non-naturally occurring proteins are designed from scratch.95,96 The application of rational 
design has afforded valuable insights into complex phenomena such as protein folding, protein 
structure, protein dynamics, and mechanistic enzymology. In addition, rational design has resulted in 
an explosion of new functional enzymes with abiological activity. A testament to the success of 
rational protein design is the recent work achieved in oxidoreductase (re)design.94,97–99 The 
oxidoreductase class is an enormous group of ubiquitously distributed enzymes that are responsible 
for catalysing redox biochemistry.100 The biological importance of oxidoreductases makes them 
attractive targets for protein (re)design. One major class of enzymes in the oxidoreductase class are 
the hemoproteins, a group of metalloenzymes with a range of biological roles including small molecule 
transportation, electron transfer chemistry, biosynthesis, and xenobiotic detoxification.101 The 
hemoproteins have been subjected to protein redesign in attempts to unlock abiological chemistry 
intrinsic to the heme cofactor while de novo design has focused on accomplishing the same objective 
by manufacturing simplified heme-containing protein scaffolds. Before a discussion on the rational 
design of hemoproteins is presented, it is first necessary to provide an overview of the structure, 
biological function, and biochemistry of naturally occurring hemoproteins.    
2.2. AN INTRODUCTION TO HEMOPROTEINS  
Hemoproteins are a large and diverse class of metalloproteins characterised by the integration of a 
heme prosthetic group/cofactor into the protein structure.100–103  Abundant in nature, hemoproteins 
are involved in an assortment of vital biological processes, including small molecule binding and 
transportation, oxygen reduction, peroxidase/monooxygenase chemistry, and electron transport 
processes.100,101 The incorporation of a heme group allows the hemoproteins to perform biological 
functions that would be otherwise inaccessible via the twenty canonical amino acids.  
2.2.1 The heme group – the molecular structure and electronic spectral classification 
The heme group is a family of tetrapyrrole macrocycles derived from the simplest tetrapyrrole, 
porphine. The porphine scaffold consists of four pyrrole heterocycles connected via methylene 
bridges (-CH2=) to afford a planar macrocyclic molecule. The carbon backbone is divided into three 
positions: i) the meso-carbons forming the methylene bridges, ii) the α (connected to the meso-





a total of 26 π-electrons, with 18 π-electrons forming a continuous, conjugated system connecting all 
four pyrrole subunits, rending porphyrin an aromatic compound. In solution, porphin can exist in three 
protonated states, depending on the pH of the system, on account of the four pyrrolic nitrogen: 
PorH42+ ↔ PorH2 ↔ Por2-. In the fully deprotonated state, porphin can function as a tetradentate 
coordination ligand and can form complexes with a variety of different transition metals.  
The heme groups are iron-containing porphine derivatives and are distinguished by the various 
functionalisations at the β-position of the pyrrole subunits (figure 12). The four planar pyrrolic 
nitrogens of the porphine ring coordinate to the iron and the axial sites of the iron are occupied by 
one or two coordinating amino acids to generate pentacoordinate or hexacoordinate complexes 
respectively.100,101 The iron has two accessible oxidation states, the ferric (Fe3+) and ferrous (Fe2+) 
states, with the redox potential of the Fe(III)/Fe(II) transition often being finely tuned by the primary 
and secondary coordination spheres of proteins and the functionalisation of the tetrapyrrole ring. In 
addition, a change in oxidation state of the heme iron results in a conformational change to the heme 
and to the surrounding protein on account of the axial ligand and other interaction residues provided 
from the protein backbone.100,101  
 
Figure 12: The molecular structure of the most common and biologically relevant heme cofactors 





The heme cofactors can be divided into distinct groups based on the substituents at the β-position of 
the pyrrolic subunits constituting the porphin ring (figure 12). The most important heme types are 
heme A, heme B, heme C and heme O. Heme A and heme O are characterised by an isoprenoid 
hydroxyethylfarnesyl substituent at the 2nd position of the porphyrin ring; heme A also possess a 
formyl group at the 8th position of the porphyrin ring, which distinguishes it from heme O, which 
contains a methyl side chain at the 8th position. Heme A plays an important role in the conversion of 
energy from oxygen reduction in mammalian cells, often acting as terminal oxidases, and heme O 
performs a similar role in E. coli, on account of the much higher redox potentials of heme A and heme 
O relative to heme B and heme C. 
Heme B and heme C are the most common and biologically relevant of the heme cofactors. The 
structure of heme B and heme C is illustrated in (figure 12).  Heme B is the most abundant of the heme 
cofactors and is important in biological roles such as small-molecule binding and electron transfer 
processes; for example, heme B is the cofactor found in the oxygen-binding hemoproteins myoglobin 
and haemoglobin (discussed below) and the ubiquitous oxidoreductase hemoprotein cytochrome 
b5.100,101 Heme B is bound to the protein by one or two coordinating amino acids, typically histidine, 
cysteine, and methionine, but is not covalently attached to the protein scaffold itself. Heme C differs 
from heme B in that the two vinyl groups (attached to positions 2 and 4 (figure 12)) are modified to 
covalent thioether bonds, formed by the reaction with the thiol groups of two cysteine residues 
provided from the protein backbone. The tethering of heme C to the protein backbone via the 
thioether linkages is suspected to provide a greater degree of functional flexibility, allowing the 
Fe(III)/Fe(II) redox potential to be finely tuned across a far greater range than is possible with heme B 
(-400 to +450 mV (vs SHE) for heme C vs -400 to 180 mV (vs SHE) for heme B). Like heme B, the axial 
positions of heme C are often occupied by one or two coordinating amino acids, typically histidine, 
cysteine and/or methionine.100    
One defining characteristic of the heme cofactors are the distinctive, and diagnostic, UV-VIS spectra 
of each heme originating from the allowed π-π* electronic transitions of the porphyrin ring.100,104 The 
π-π* electronic transition gives an intense peak, called the Soret peak, in the 400-430 nm range and 
is accompanied by two weaker peaks, called the α and β peaks (collectively called the Q-band region), 
in the 500-600 nm range (figure 13); the Q-band originates from vibrational coupling to the electronic 
transitions (addressed in more detail in chapter 3 section 3.4). The positions, and intensities, of the 
Soret peak and the Q-band are highly sensitive to the oxidation state of iron, the coordination state 
of iron, the chemophysical properties of the coordinating ligands, and the substituents on the 





electronic absorption profiles when coordinated to a pyridine ligand in its ferrous state (called the 
pyridine hemochrome); the letters assigned to each heme are associated with the distinctive 
electronic spectrum for the pyridine-Fe(II)-heme complex. The heme groups can be further divided 
based on the distinctive UV-VIS spectra arising from variable coordinate states and axial ligands; for 
example, mono- or bis-histidine ligation or type I/type II cysteine ligation produce distinctive 
electronic absorption spectra.100,101,104  
 
Figure 13: The UV-VIS spectrum of cytochrome c, (left) the UV-VIS spectrum of ferrous cytochrome c 
displaying the characteristic Soret peak (415 nm) and the Q-band (500-551 nm), and (right) the 
structure of horse heart cytochrome c showing the histidine/methionine bis-ligation to a c-type heme 
(heme is shown in yellow, PDB: 1HRC). 
The unique and diagnostic electronic spectra of heme cofactors has proved indispensable for studying 
hemoprotein function, allowing for facile detection of electron transfer reactions (Fe3+ ↔ Fe2+ 
transitions), small molecule binding (penta- ↔ hexa- coordinate and/or Fe3+ ↔ Fe2 transitions) and 
the formation of reaction intermediates. In all situations, the function exhibited by the hemoprotein 
is a consequence of the intrinsic nature of the heme-cofactor itself, with the protein scaffold usually 
establishing key interactions with the heme-cofactor to finely tune parameters such as the oxidation 
state, standard electrode potential and/or reactivity of the iron.101 These interactions between the 
protein and the heme-cofactor are often critical for the specific function of a specific hemoprotein. 
This versatility of the heme cofactor accounts for the ubiquitous distribution of, and the vast array of 





2.2.2 Hemoprotein function – dioxygen binding, peroxidation and monooxygenation enzymology   
2.2.2.1 Oxygen-binding and transporting hemoproteins 
The electron-transport chain is a complex sequence of electron transfer reactions, where electrons 
descend an energy pathway from donor to acceptors.105 The flow of electrons is coupled to the flow 
of protons across the cellular membrane which generates an electrochemical gradient. The 
electrochemical gradient drives the synthesis of ATP.105 ATP functions as an energy reserve in the cell, 
preserving energy in highly strained triphosphate bonds which can later be released to provide the 
necessary energy for important cellular processes, such as biosynthesis.105 The electron-transport 
chain requires a ‘’terminating acceptor’’, the final step in the sequence of electron transport steps. In 
aerobic respiration the final step is the reduction of molecular oxygen to water – hence, molecular 
oxygen serves as the ‘’terminating acceptor’’ in aerobic respiration.105,106  Aerobic respiration is an 
immensely important biological process because it is the pathway responsible for the majority of ATP 
synthesised (in vertebrates).107 It is therefore imperative that molecular oxygen is efficiency 
transported throughout the organism in order for the electron-transport chain to function properly. 
The electron transport chain itself involves several key hemoproteins, but the oxygen-binding and 
transportation process itself (in vertebrates) is the responsibility of two extremely important 
hemoproteins, myoglobin, and haemoglobin. 
2.2.2.1.1 Myoglobin 
Myoglobin, the first protein for which the three-dimensional tertiary structure was solved using X-ray 
crystallography, is a small hemoprotein. The structure of myoglobin consists of eight α-helices which 
adopt a tertiary structure called the ‘globin fold’ – a fold common to globins (figure 14). Myoglobin 
binds a single pentacoordinate, monohistidine-ligated b-type heme. The distal coordination site of the 
heme remains vacant and functions as the site of oxygen binding. Myoglobin can bind many small 
molecules other than oxygen (CO, CN-, N3-), but its primary biological role is oxygen binding. The 







Figure 14: WT sperm whale deoxymyoglobin (heme group is shown in yellow; PDB: 1VXA). 
The heme in deoxymyoglobin is a pentacoordinate mono-histidine ligated complex. The EPR spectra 
of ferrous deoxymyoglobin indicates the d6 iron has a high-spin electronic structure with an electronic 
configuration of (dxz)2(dyz)1(dxy)1(dz2)1(dx2-y2)1 (figure 15).110 The electron density situated in the dx2-
y2 orbital means ferrous iron has an ionic radius too large to be accommodated inside the porphyrin 
cavity, and so ferrous iron deviates away from the xy-plane of the porphyrin ring towards the 
coordinating histidine situated along the z-axis. However, the high spin state of ferrous iron is 
imperative for deoxymyoglobin to bind molecular oxygen, as the ground state of molecular oxygen is 
a high spin triplet species (figure 15) meaning interactions between ground state molecular oxygen 
and a low spin complexes is strictly spin forbidden.111 The binding of oxygen to deoxymyoglobin 
produces oxymyoglobin, a hexacoordinate, diamagnetic low-spin d6 ferrous iron complex with a 
ground state electronic configuration of (dxz)2(dyz)2(dxy)2(dz2)2(dx2-y2)0 (figure 15).110 One key 
structural difference between deoxy- and oxymyoglobin is the decreased ionic radius of iron in 
oxymyoglobin renders the iron small enough to be comfortably accommodated in the centre of the 
porphyrin ring. This structural change is a consequence of spin-pairing between the d-electrons of iron 
and the π* electrons of oxygen which results in a destabilisation, and hence removal of electron 
density, from the dx2-y2 orbital (figure 15).110 The active site of myoglobin also contains a histidine 
residue, uncoordinated to the iron, at the distal face of the heme. The histidine residue provides a 
stabilising interaction with molecular oxygen in the oxymyoglobin state, and is a key residue behind 
the preferential binding of molecular oxygen over the binding of competitive small molecules such as 
CO. It has been shown that mutating this key histidine residue generates a mutant myoglobin capable 





situated chiefly in muscle tissue. The transportation (and delivery) of oxygen around (and to) the body, 
via the bloodstream, is the function of another hemoprotein called haemoglobin.   
 
Figure 15: The electronic configuration of deoxy- and oxy- myoglobin.110 
2.2.2.1.2 Haemoglobin 
Haemoglobin is an oxygen-binding hemoprotein responsible for the transportation of oxygen around 
an organism.101,107,114 Haemoglobin consists of two nearly identical all-α-helical subunits, the α and β 
units, which non-covalently assemble to yield a tetrameric quarternary α2β2 structure in an 
approximate tetrahedral arrangement. The subunits α and β adopt the globin fold motif, and create a 
tight binding pocket for heme-binding similarly to myoglobin. The four subunits are assembled 
through a combination of non-covalent interactions, predominantly salt bridge formation and 
hydrogen bonding. Each subunit can bind a single heme, meaning haemoglobin is a tetrameric 
tetraheme-containing protein (figure 16). Each subunit provides a histidine ligand which coordinates 
to the iron in the proximal position to give a pentacoordinate heme with a vacancy in the axial position 
for oxygen binding. The iron can exist in two oxidation states, ferric (Fe3+) and ferrous (Fe2+); however, 
ferric-haemoglobin is incapable of binding molecular oxygen, and so ferric-haemoglobin must be 
reduced to ferrous-haemoglobin prior to oxygen binding. Ferrous-deoxyhaemoglobin is a high-spin 





the structural changes in the heme group after molecular oxygen binds to deoxyhaemoglobin parallels 
the changes observed in myoglobin.101,107,110,91 
 
Figure 16: WT human deoxyhaemoglobin (the four heme groups are shown in yellow; PDB: 1A3N) 
The presence of four hemes in the final structure of haemoglobin results in a more complex oxygen 
binding process than for myoglobin. This is best illustrated by comparing oxygen-binding curves for 
haemoglobin and myoglobin.108,115 Myoglobin exhibits the distinctive hyperbolic curve for small 
molecule binding, showing initial binding of molecular oxygen followed by saturation once all 
deoxymyoglobin has been exhausted. Haemoglobin deviates away from the hyperbolic curve and 
exhibits a sigmoidal relation with respect to oxygen binding.108,115,116 The plot indicates that, for 
haemoglobin, the binding of a second molecule of oxygen is facilitated by the first oxygen binding 
event, which in turn facilitates the binding of a third oxygen molecule and so on.114,115,117–119 The 
phenomenon of the first ligand binding event enhancing successive ligand binding is called 
cooperativity and can be quantified by the Hill equation (which was first postulated to account for the 
O2-sigmodial binding cure exhibited by haemoglobin).117,118,120,121 The structural rationale behind 
cooperative binding suggests that the four subunits of haemoglobin exist in two interconverting 
states: the ‘T’-state (tense-state) and the ‘R’-state (relaxed state).115,116,118,119,122,123 A subunit of 
deoxyhaemoglobin exists predominantly in the T-state which possesses a lower binding affinity for 
molecular oxygen relative to the R-state. The T-state and R-state are in equilibrium, and the binding 





induces a confirmation transition within the subunit. The conformational change is intramolecularly 
transmitted through the remaining deoxygenated subunits to shift the equilibrium in favour of the R-
state which facilitates the binding of a second molecule of molecular oxygen because of the higher 
binding affinity in the R-state. The process repeats until saturation.115,118,119,122,123 The two models 
postulated to structurally account for cooperative binding are the concerted124 and sequential125 
models. In the concerted model, all four subunits of haemoglobin interconvert between the R and T 
states simultaneously, with each molecular oxygen binding event stabilising the R-state until 
saturation.118,121,124 In the sequential model, the four subunits are in the R-T equilibrium 
independently, and the binding of molecular oxygen stabilises the R-state of an individual subunit 
only; however, the stabilisation of the R-state in a single subunit translates through the remaining 
domains to shift the equilibrium in the remaining deoxygenated subunits towards the R-state which 
facilitates additional oxygen binding events.121,125  
Haemoglobin transports oxygen through the bloodstream before transferring oxygen to myoglobin, 
which possess a higher affinity of oxygen relative to haemoglobin.107 The remarkable system 
established by these two hemoproteins beautifully highlights how the protein structure can modify 
and finely tune the functionality of a cofactor. Hemoproteins are not limited to small-molecular 
binding, and other hemoproteins exhibit catalytic activity with the protein scaffolding serving to finely 
tune the heme cofactor towards a particular type of chemistry.       
2.2.2.2 Catalase and peroxidase hemoproteins  
The peroxidases are a large group of heme-containing enzymes that catalyse the peroxide-dependent 
oxidation of an assortment of substrates.101,126,127 The common feature of all heme-peroxidases is the 
use of hydrogen peroxide or organic hydroperoxides to catalyse a range of oxidation reactions via a 
reactive intermediate called compound I, a heme-localised cationic-radical oxene complex (figure 17). 
The formation of compound I allows peroxidase enzymes to perform important biological roles, 
including reactive-oxygen-species scavenging, providing protection from oxidative stress, and 
biopolymer degradation. Unlike oxygen-binding hemoproteins, the binding of hydrogen peroxide to 
heme is not spin-forbidden111, and an iron-localised peroxide complex forms rapidly without the need 
for prior reduction from the ferric to the ferrous state.101  
The catalytically cycle of a heme peroxidase is illustrated in (figure 17).101-104 The initial step involves 
the formation of a ferrous-heme-peroxide complex. The second step involves the heterolytic cleavage 
of hydrogen peroxide to eliminate water. In this step, the ferric iron is oxidised by oxygen to generate 





suitable amino acid side chain, such as tryptophan. After the heterolytic elimination of water, the 
resultant complex is a highly reactive ferryl cationic radical intermediate called compound I.101 In the 
third step, the substrate is oxidised by compound I, resulting in the reduction of the cationic radical to 
a ferryl complex called compound II.101 In the final step, a second substrate is oxidised which completes 
the catalytic cycle by regenerating the initial ferric-heme. A distal histidine in the active site of many 
peroxidases facilitates the heterolytic cleavage of peroxide by facilitating the initial deprotonation of 
the oxene oxygen and the transfer of the proton to the departing hydroxyl group. The distal histidine 
functions as an acid-base catalysis during the catalytic cycle.101   
 
Figure 17: A general reaction cycle for heme peroxidase chemistry. The reaction of ferric heme with 
hydrogen peroxide results in the heme-peroxide complex. A proton transfer and loss of water results 
in the formation of the highly reactive cationic-radical species compound I. A proton-coupled 
reduction of compound I yields compound II, and a second proton-coupled reduction produces water 
and regenerates the starting ferric enzyme. 
The heme peroxidases are split into three distinctive class, intercellular (class I), fungal extracellular 
(class II) and plant extracellular (class III).101,129,130 The class I peroxidases are intercellular enzymes 
which function as biological scavengers for reactive oxygen species. Although the class I peroxidases 
share a similar biological function, the enzymology of each specific heme peroxidase can vary greatly 
in terms of the enzyme’s active site, heme axial ligand, quarternary structure, necessary redox 
partners, substrates employed in the oxidative mechanism and the localisation of the cationic radical 
in compound I.101,129,130  These variances are amply highlight by considering the distinctive differences 







The first enzyme to break down peroxides was reported in 1818 to account for an unidentified 
biological substance that catalysed the disproportionation of cellular hydrogen peroxide to molecule 
oxygen and water.131 The unknown biological substance was later deciphered to be a tetraheme 
containing metalloenzyme. The metalloprotein was named catalase and it was purported to have a 
tetrameric quarternary structure formed by the assembly of four single heme-containing domains 
(figure 18).131–134 The four hemes are penta-coordinate, with a tyrosine residue coordinated at the 
axial position. The main biological function of catalase is to protect cells from oxidative damage caused 
by reactive oxygen species, and as such catalase has one of the largest turnovers reported for an 
enzyme. Although technically not a peroxidase, as catalase catalyses the disproportionation of 
peroxide instead of generating an activate substrate, catalase and peroxidases provide similar 
biological roles, and both proceed via the active cationic radical intermediate compound I. 
 
Figure 18: (left) Human erythrocyte catalase (hemes shown in yellow; PDB: 1QQW), and (right) active 
site of human catalase (figure taken from Putnam et al).133 
The catalytic cycle for catalase epitomises the aforementioned peroxidase catalytic cycle (despite 
being distinguished from peroxidases). The active site of wild-type catalase is illustrated in figure 18 
with the key amino acids involved in the peroxidase cycle highlighted.133,135 The initial diffusion of 
hydrogen peroxide into the active site is facilitated by an asparagine (Asp148) which favourably 
interacts with hydrogen peroxide.106 The histidine (His75) functions as an acid-base catalyst and 
facilitates the heterolytic cleave of the O-O peroxide σ-bond; the whole process is mediated by a water 
molecule.101,106 The tyrosine axial ligand (Tyr358) promotes the oxidation of Fe(III) to Fe(IV) and is 





radical of compound I is suspected to be localised on the porphyrin ring there is evidence to indicate 
the formation of a tyrosyl radical on the axial tyrosine.101,136–138 A second hydrogen peroxide molecule 
is deprotonated by compound I, forming compound II, and is concurrently deprotonated by His75 to 
release molecular oxygen. The final stage involves the transfer of the proton from His75 to compound 
II, liberating a water molecule and completing the catalytic cycle.106  
2.2.2.2.2 Cytochrome c peroxidase 
Cytochrome c peroxidase (CcP) is a small water-soluble hemoprotein first reported in 1939.139 The 
structure of yeast CcP is highly α-helical, with a single b-type heme bound within a hydrophobic pocket 
in the active site.101,140 The heme is bound to CcP via monohistidine ligation (in contrast to mono-
tyrosine ligation in catalase), resulting in a pentacoordinate, high-spin, ferric complex resting state. 
The distal side of the heme is vacant (often coordinated by a liable water molecule) and therefore 
available for catalysis (figure 19). 
 
Figure 19: (left) Crystal structure of yeast cytochrome c peroxidase (CcP) (heme is shown in yellow; 
PBD: 2CYP), and (right) the active site of yeast cytochrome c peroxidase (figure taken from Poulos)101 
CcP, similar to catalase, catalytically degrades hydrogen peroxide (or alkyl hydroperoxides) to two 
equivalents of water; however, unlike catalase, CcP requires an additional enzyme, the heme-
containing metalloenzyme cytochrome c, in order to adequately function.141 Cytochrome c (Cc) is a 
small c-type hemoprotein structurally consisting of 5 α-helices and a β-sheet.142 The axial ligands for 
Cc are provided by a histidine and methionine residue, resulting in a hexacoordinate, low spin, 
paramagnetic ferric complex.101,141–143 Cc functions as an electron-transfer protein, readily converting 
between ferric and ferrous oxidation states. The main biological role of Cc is to function as a redox 





precedes peroxidase activity, and the catalytic cycle includes the breakdown of hydrogen peroxide 
and the concurrent oxidation of two ferrous cytochrome c enzymes.101,141 
 
Figure 20: The crystal structure of the 1:1 complex formed between cytochrome c peroxidase (CcP, 
white) and yeast cytochrome c (Cc, iso-1, blue) (hemes are shown in yellow; PDB: 2PCB) 
The first step of the Cc-CcP catalytic cycle (figure 21) is the formation of compound I from the 
heterolytic cleavage of hydrogen peroxide, accompanied by binding of one equivalent of ferrous 
cytochrome c.101,141 An electron transfer from Cc to CcP reduces compound I to compound II, which is 
followed by the disassociation of ferric-cytochrome c and binding of a second equivalent of ferrous 
cytochrome c. Another electron transfer step occurs, followed by disassociation of the second ferric 
cytochrome c to yield the starting ferric CcP. The active site of CcP resembles that of catalase, with an 
acid-base histidine residue (His-52) and a stabilising arginine residue (Arg-48); however, the presence 
of a tryptophan residue (Trp-191) further distinguishes CcP from catalase. The Trp-191 residue is 
critical for the two electron transfer steps.101,141 In the formation of compound I (first electron transfer 
step) tryptophan provides the necessary reducing electron resulting in a Fe(IV) Trp●+ intermediate; 
therefore, unlike catalase, the formation of compound I results in a low-spin ferryl complex with the 
cationic radical localised on the tryptophan (unlike in catalase, where the cationic radical is suspected 
to be a porphyrin/tyrosyl species). Following the reduction of compound I to compound II, via one 
reducing equivalent of Cc, an equilibrium exists between the Fe(IV)-Trp and Fe(III)-Trp●+ species, and, 
in addition to providing extra stabilisation to the intermediate, Fe(III)-Trp●+ behaves as an electron 






Figure 21: (left) The cytochrome c peroxidase catalytic cycle (CcP = cytochrome c peroxidase, Cc = 
cytochrome c, CpI = compound I, CpII = compound II, ET = electron transfer; figure adapted from 
Volkov et al),141 and (right) structure of compound I in yeast cytochrome c peroxidase (figure taken 
from Poulos).101 
A small distinct group of cytochrome c peroxidases are the diheme-containing cytochrome 
peroxidases, which containing two distinctive c-type heme containing domains.144–147 The two hemes 
have drastically different redox potentials, with a high-potential heme acting as the reducing 
equivalent for a low-potential heme.144,146,147 The high-potential heme is first reduced by redox 
partners, and transports electrons to the low-potential heme which functions as the site of peroxide 
reduction in a fashion analogous to catalase.     
2.2.2.2.3 Ascorbate peroxidase 
A final peroxidase worth mentioning is ascorbate peroxidase (APX). APX was first identified in 1979148 
as the metalloenzyme responsible for the peroxide-dependent oxidation of ascorbate in plants.149 APX 
is notable for its high-sequence identity to CcP.129,130,150 The heme-group in APX is a pentacoordinate, 
b-type heme with the proximal site coordinated to a histidine and a tryptophan residue (Trp-179) 
situated in the active site.101,151–153 Unlike CcP, however, APX possess a monovalent cation in close 






Figure 22: (left) Crystal structure of soybean ascorbate peroxidase (heme is shown in yellow; PDB: 
1OAG), and (right) the active site of ascorbate peroxidase, showing the binding site of the monovalent 
cation (figure taken from Poulos).101 
Although APX exhibits a general peroxidase catalytic cycle, the presence of a monovalent cation 
disfavours the formation of a tryptophan radical and so the structure of compound I is accounted for 
as a Fe(IV)-por●+ species, with the cationic radical localised on the porphyrin ring of the heme 
group.101,153 The catalytic cycle of APX is distinguished from the cycle observed for catalase and CcP 
because the reduction of compound I and compound II is achieved by a single substrate molecule, 
ascorbate, in two sequential electron transfer steps (figure 23).101,151,152 The reaction cycle involves 
the formation of compound I from hydrogen peroxide, followed by the subsequent oxidation of 
ascorbate to yield compound II and the anionic radical monodehydroascorbate. A subsequent electron 
transfer step reduces compound II, completing the catalytic cycle and yielding the oxidative product 
dehydroascorbate and the original ferric-APX complex.101,151,152  
 






2.2.2.3 Monooxygenase hemoproteins 
The class I heme peroxidases are distinctive in their ability to utilise hydrogen peroxide to oxidase 
substrates. The monooxygenases are another group of heme-containing metalloenzymes that reduce 
molecular oxygen in the oxidation of substrates.101,154–157 The typical catalytic cycle (figure 24) involves 
the reduction of molecular oxygen to water and the concurrent oxidation of an organic substrate by 
the insertion of a single oxygen to form a hydroxyl or epoxide group.101 One of the most important 
groups of monooxygenases are the cytochrome P450s, a superfamily of thiolate-ligated heme-
containing monooxygenases involved in an assortment of important biological processes including 
steroidogenesis, aerobic respiration, xenobiotic detoxification and secondary metabolite 
biosynthesis.101,104,157 The ‘P450’ classification arises from the characteristic maximum absorbance 
peak at 450 nm observed in the electronic spectra for ferrous-P450-CO complexes.101,104   
 





2.2.2.3.1 Monooxygenase catalytic cycle 
In addition to the initial reduction, the formation of additional intermediates in the catalytic cycle prior 
to the formation of compound I further distinguishes monooxygenases from peroxidases.101,158,159 The 
general catalytic cycle of a cytochrome P450 is illustrated in (figure 24). The resting state of 
cytochrome P450s is typically a low-spin thiolate-ligated ferric complex with a Fe(II)/Fe(III) reduction 
potential lower than the reduction potential of NAD(P)H/NADH. As a consequence, NAD(P)H/NADH 
cannot reduce a P450 in its resting state. The binding of a substrate to the complex displaces a liable 
water ligand and converts the complex into a high-spin state, which also elevates the Fe(II)/Fe(III) 
reduction potential above the lower limit for NAD(P)H/NADH reduction, rendering the P450 
susceptible to reduction by NAD(P)H/NADH. After reduction, molecular oxygen binds to P450 to 
generate a ferric-O2● superoxide complex. A second electron transfer step results in the ferric-OO- 
peroxy complex which, upon protonation, heterolytically cleaves to release a molecule of water and 
form the ferryl Fe(IV)=O●+ cationic radical intermediate compound I.101,158,159 The thiol ligand 
coordinated to the heme iron in the proximal position (provided by a backbone cysteine residue) is 
thought to facilitate the heterolytic cleavage of the peroxy intermediate through increased electron 
donation from the sulphur onto iron, which increases the electron density on iron and enhances 
backbonding into the O-O pπ* orbital, weakening the O-O bond and therefore facilitating its 
heterolytic cleavage.160–162 The substrate is subsequently deprotonated by compound I to yield 
compound II which functions as an ‘activated hydroxyl group’ and is readily transferred to the 
deprotonated/oxidised substrate to complete the catalytic cycle, yielding the monooxygenated 
product and the original low-spin hexacoordinate ferric-P450.101,158,159 
Although the reactivity of cytochrome P450 monooxygenases proceeds via the same highly reactive 
intermediate as the peroxidases (compound I), there are key differences in the overall catalytic cycle. 
The first major difference is that, unlike peroxidases which are active in the ferric form, the P450s 
required a reduction to the ferrous state prior to binding and activating molecular oxygen. To achieve 
reduction, the P450s are often associated with a redox-partner which transports electrons from 
common biological reductants, such as NADPH, to the heme iron of the P450.101,163,164 The need for 
reduction is a consequence of the spin-forbidden interaction between high-spin molecular oxygen and 
the low-spin ferric resting state of cytochrome P450s; a one-electron reduction of the low-spin ferric 
heme results in a high-spin ferrous heme complex which can freely interact with molecular oxygen 





2.2.2.3.2 A case study: the heme-domain and chemistry of cytochrome P450BM3  
Cytochrome P450BM3 is one the best studied of the cytochrome P450 superfamily. P450BM3 was first 
isolated from the soil bacterium Bacillus mageterium by Miura and Fulco in 1974.165 P450BM3 functions 
as a cell-free NAD(P)H and O2 dependent monooxygenase and catalyses the regio- and stereoselective 
hydroxylation of numerous long-chain fatty acids, alcohols, and amides, typically hydroxylating at the 
ω1-3 positions.165,166 It was also demonstrated that P450BM3 can catalyse the regio- and stereoselective 
epoxidation of unsaturated substrates.167 P450BM3 reached great popularity as a model P450 on 
account of its self-sufficiency: its electron-donating redox partner, a FAD/FMN reductase domain 
(cytochrome P450 reductase (CPR)), is covalently fused to the C-terminal end of the heme-containing 
domain, circumventing the need for co-expressing and binding any necessary redox partners.101 In 
light of its popularity, P450BM3 has also received a great deal of attention from the rational design 
community as a model hemoprotein for introducing novel functionality. It is therefore prudent to give 
a comprehensive description of the structural, functional, and catalytic properties of P450BM3 before 
introducing its applications in protein design. 
The structure of the heme-domain of P450BM3 has been determined crystallographically (figure 25) 
and its biophysical properties have been exceptionally well characterised. The heme-domain of 
P450BM3 consists of an α and a β domain.168,169 The α-domain accounts for 70% of the overall structure 
and is mostly α-helical,168 with the 12 α-helices labelled A-L.168,170–172 The main structural feature of 
the α-domain is a right-handed four-α-helix bundle formed through the parallel arrangement of 
helices D, I and L which are anti-parallel to helix E.145 The β-domain constitutes 22% of the overall 
structure and consists of two β-sheets blanketed by three α-helices and two 310 helices.145 The active 
site of the heme is accessible through a channel formed mostly from nonaromatic hydrophobic 
residues in the β domain.168–171 The heme cofactor is situated between helices I and L of the α-domain 
which shields the heme from the solvent.168–171 P450BM3 is classified as a low-spin, pentacoordinate, 
type I thiolate-ligated hemoprotein,169 and a liable water molecule occupies the trans-axial position 
relative to the cysteine thiolate.169 A phenylalanine protrudes into the active site and is orientated 
perpendicular to the heme,168,171 and four solvent exposed hydrophobic residues constitute the 
solvent docking site.145 It was demonstrated that P450BM3 possesses one of the highest known catalytic 
efficiencies for P450s, turning over arachidonate with an activity of 15,000-17,000 min-1.169,173 The 
structural study of the P450BM3 heme domain complexed with the fatty acid substrate palmitoleic acid 
revealed significant conformational differences between the free-form and the complexed domain.171 
Analysis of the substrate-free and substrate-bound structures revealed the most important 





hydrophobic substrate access channel, and upon substrate binding a conformational change in the 
F/G loops results in a narrowing of the access tunnel.171 The narrowing of the access channel allows 
for new hydrophobic and hydrogen-bonding interactions to form between various amino acid 
residues, which augments the rigidification of the F/G loop region.171   
 
Figure 25: The atomic structure of the P450-BM3 heme domain (heme shown in yellow; PBD: 2IJ2). 
P450-BM3 catalyses the monooxygenation of saturated and mono-unsaturated substrates, including 
fatty acids, alcohols, and amides.154,166,167,174 The reactions are typically regio- and stereoselective, 
occurring at the  ω-1, ω-2, and ω-3 positions.166 The mechanism of monooxygenation epitomises the 
classical oxygenase catalytic cycle.101 The reactivity and selectivity of P450-BM3 catalysed 
monooxygenation is governed by an intricate network of interactions between key amino acids and 
the substrate in the active site. In the resting state, the ferric iron is a low-spin, six-coordinate complex 
(a liable water molecule occupies the proximal site) and therefore the resting state is spin-forbidden 
from interacting with triplet molecular oxygen.101,175 The first step of the catalytic cycle involves the 
binding of the substrate, which displaces the liable water molecule and yields a ferric high-spin iron; 
the interaction between a high spin heme and triplet oxygen is not spin forbidden, and so the binding 
of the substrate converts the catalytically inactive resting state to the catalytically active state.101,175 
The binding of two substrates, sodium laurate and 12-bromo-laurate, to the ferric heme domain was 
studied using paramagnetic relaxation techniques and revealed the substrates bind in an extended 
conformation, with the reactive ω-1, ω-2, and ω-3 positions situated too far from the iron for 
hydroxylation to proceed.175 After binding of a substrate, ferric iron is reduced to ferrous iron and the 
reduction is accompanied by a 6 Å displacement of the substrate towards the catalytic iron.175 It was 
reported the ω-1 and ω-2 positions are situated 3 Å from iron in the ferrous state, as opposed to 9 Å 





bound P450-BM3 heme domain when ferrous P450-BM3 is bound to the inhibiting substrate 
omeprazole (figure 26) and illustrates the significant conformational changes accompanying a 




Figure 26: (top) The overlapping crystal structure of the substrate-free (blue, heme is shown in orange; 
PDB: 2IJ2) and substrate-bound P450-BM3 (white, heme is shown in yellow, omeprazole is shown in 
purple; PDB: 4KEW) heme domain when ferrous P450-BM3 is bound to the inhibiting substrate 
omeprazole. (middle) The active site crystal structure of the omeprazole-bound P450-BM3 heme 
domain (white, heme is shown in yellow, omeprazole is shown in purple; PDB: 4KEW), and (bottom) 
the molecular structure of omeprazole. 
It appears binding of the substrate raises the redox potential of the iron sufficiently to allow for 
reduction by NAD(P)H.101,175 The reduction results in a significant conformational change which 





site amino acids, Phe-42, Arg-47, Tyr-51, and Phe-87, have been identified as critical residues involved 
in substrate binding in the active site (figure 27).176 Arg-47 is proposed to establish favourable 
interactions with the carboxylate terminal of fatty acids through the formation of an electrostatic 
guanidinium-carboxylate pair.176 A kinetic study of P450-BM3 mutants containing Arg-47 mutations 
revealed higher KM and reduced kcat values for laurate and arachidonate, indicating the guanidinium-
carboxylate interaction is key in the initial substrate binding step and in stabilising the transition 
state.176 A BM3 mutant containing a Y51F mutation exhibited increased KM values, but the kcat was 
practically unaffected, indicating Tyr-51 plays a key role in the initial substrate binding step, probably 
through establishing a hydrogen-bond with the carboxylate group of the fatty acid.176 The residue Phe-
42 resides close to the entrance of the active site on the protein surface. After binding of the substrate, 
Phe-42 is re-orientated and provides a ‘’cap’’ over the binding site which is postulated to protect the 
hydrophobic substrate and increase the hydrophobicity by excluding the diffusion of solvent 
molecules into the active site. It is also postulated that Phe-42 constitutes a fraction of the 
hydrophobic docking site of the substrate, which is supported by observations that a P450 variant 
containing a F42A mutant exhibited a 7-fold increase in KM.176 The re-orientation of P450-BM3 upon 
substrate binding displaces the residue Phe-87 from a plane perpendicular to the heme cofactor to a 
conformation parallel with the bound substrate. Phe-87 is orientated in close proximity to the heme 
cofactor and has been demonstrated to govern the regiospecificity to monooxygenation reactions.176  
 
Figure 27: The active site crystal structure of the omeprazole-bound P450-BM3 heme domain (white, 
heme is shown in yellow, omeprazole is shown in purple; PDB: 4KEW) displaying key amino acids 
involved in substrate binding (note the two distinctive rotamers of Phe87) from (A) a side-on and (B) 





The highly conserved residue Phe-393 in P450-BM3 resides close to the Cys400 thiolate ligand in the 
active site and has been demonstrated to regulate the redox potential of P450-BM3.177–179 In 
regulating the redox potential of the heme, Phe-393 plays a critical role in the FMN-to-heme electron 
transfer step, the binding of molecular oxygen, and its subsequent reduction.177 The kinetic analysis 
for the turnover of laurate and arachidonate by a series of BM3 variants containing mutations 
targeting Phe-393 displayed the trend WT > F393Y > F393H > F393A.178 Interestingly, the kinetic 
analysis of the FMN-to-heme transfer revealed the exact opposite trend.178 The trend supports the 
notion that an increase in free and substrate-bound redox potential favours the stabilisation of the 
ferrous complex relative to WT. Increasing the redox potential facilitates electron transfer but also 
hinders the rate of oxygen reduction, resulting in a decreased turnover rate. In a follow-up study, the 
spectroscopic and structural comparisons between WT-BM3 and the F393H mutant revealed a 
number of factors governing the redox potential.179 No reported differences in the oxidation products 
produced by each variant were identified, indicating Phe-393, although critical for catalysis, exerts 
little influence over the selectivity of the monooxygenation reaction.179 This was supported as the 
crystal structures of both WT-BM3 and the F393H mutant exhibited minimal conformational 
deviations. The authors could not conclude how the phenylalanine to histidine mutation resulted in 
such a drastic change in redox potential but conjectured that the histidine exists in a protonated state 
which alters the dielectric constant of the microenvironment surrounding the heme and the cysteine 
thiolate.179 In an additional study, Raman spectroscopy was employed to study the Fe-S stretching 
frequency (νFe-S) in a series of Phe-393 mutants. The authors surprisingly reported that the Fe-S bond 
is largely unaffected by a Phe-393 mutation.177 The authors discovered the extent of conformational 
changes to the heme cofactor upon reduction correlated reasonably well with the steric bulk of the 
Phe393 mutants and the heme redox potential.177  
A final residue important in governing the catalytic properties of P450-BM3 is Thr-268.180 The Thr-268 
residue is conserved in many P450s and is located in the distal side of the heme cofactor on the I-helix. 
Thr-268 has been accredited with playing critical roles in protonation, oxygen activation, and substrate 
binding.180 In P450-CAM a similar residue, Thr-252, has been identified as critical for dioxygen 
activation.181 The introduction of a T252A mutation engendered a P450-CAM mutant with little 
hydroxylation activity towards P450-CAM’s natural substrate, camphor. It was reported that the 
T252A mutation increased solvent accessibility into the active site which is suspected to destabilise 
dioxygen binding, promoting hydrogen peroxide and water production instead of hydroxylation.181 
Thr-268 in P450-BM3 performs the same role as Thr-252 in P450-CAM, behaving as a proton-shuffling 
residue, controlling solvent diffusion and activating dioxygen.180 It was demonstrated that Thr-268 is 





P450-BM3 was revealed to be governed through a substrate recognition pathway that is mediated by 
residues Thr-268 and Phe-87.182  
An understanding of the key roles of individual amino acids, and the intricate network of molecular 
interactions between the protein and the substrate, is paramount for understanding enzymatic 
function. However, the problem of clarifying the interdependency of single amino acids, on account 
of the evolutionary history of the enzyme, drastically obscures the precise interconnectivity between 
the biophysical, kinetic, thermodynamic, and structural properties of an enzyme. This principle was 
illustrated, for example, by the difficulty associated with unravelling the relationship between the 
highly conserved Phe-393 residue and the redox potential in P450-BM3. Nonetheless, a structural 
understanding of the key components governing an enzyme’s function provides a platform from which 
novel functionality can be engineered through the introduction of intelligent modifications. 
2.3 REDESIGN OF NATURALLY OCCURRING HEMOPROTEINS TOWARDS CARBENE TRANSFERASE 
ACTIVITY 
2.3.1 Rational design of enzymes towards carbene transferase chemistry via directed evolution 
In protein redesign, a naturally occurring protein provides a blueprint for engineering a novel protein 
with desired functionality, usually by varying rounds of mutagenesis.183,184 The introduction of 
mutations into a gene, via mutagenesis, can be done randomly or selectively, depending on the nature 
of the desired gene product and the information known about the blueprint protein’s structure. In 
random mutagenesis (figure 28) the mutations are completely random and are introduced to a gene 
via mutagenic chemicals, exposure to UV/X-ray radiation, or by error-prone PCE in which the 
conditions employed reduce the fidelity of the DNA-polymerase.185 The variants generated from 
random mutagenesis are then cloned into an expression vector, expressed and characterised. The 
advantage of random mutagenesis is that it requires little-to-no structural knowledge of the blueprint 
protein. If structural knowledge of the protein is known, selective mutagenesis can be performed to i) 
target key residues responsible for the undesired functionality, and/or ii) introduce key mutations at 
certain residues to enhance desired functionality. A technique called site-directed mutagenesis can be 
employed to introduce specific changes into a DNA sequence, allowing control over where and which 
changes are introduced (figure 28). Site-direct mutagenesis is often used to investigate how a key 
residue, usually in the active site, participates in the functionality of the protein.185 Another technique, 
called saturation mutagenesis, also targets a specific residue in the DNA sequence, but outputs a 





Saturation mutagenesis can be used to identify optimal residues, at key positions, for desired 
functionality.  
In protein engineering, a technique called direct evolution (DE) is used to generate large numbers of 
mutant libraries (figure 28).83,93,187,188 DE is a process that mimics natural evolution, with the selective 
pressure being defined by the desired functionality. DE involves iterative rounds of mutagenesis to 
create mutant libraries that are screened to identify variants that exhibit the desired functionality. 
The best variant(s) are then amplified to serve as a/the template(s) in subsequent rounds of 
mutagenesis.83,93,187,188 The isolation of iron-porphyrin carbene complexes,189 and the analogous 
nature between porphyrin metallocarbenoids and the intermediate compound I in 
peroxidases/monooxygenases, provoked the question of whether hemoproteins that are proficient 
towards the formation of compound I could be selectively fine-tuned towards metallocarbenoid 
formation instead via DE.190 If at all possible, another question concerning whether such an 
intermediate would be catalytically active towards carbene transfer chemistry, as has been reported 
for iron-porphyrin carbenes in the literature, would be raised.190 The first experiments involved 
subjecting the hemoprotein, P450BM3, to DE in attempts to generate the first heme-containing carbene 
transferase, with the selective pressure being activity towards a cyclopropanation reaction.190 
 
Figure 28: Schematic illustration of the different approaches to enzyme design (figure taken from 






The most common reactions involving carbene reagents are [2+1] cycloadditions to unsaturated C-C 
bonds.42 [2+1] cycloadditions are cheletropic, with two new σ-bonds being formed on the carbene 
carbon, across a C-C π-bond, to yield a three-carbon ring. The substrates are most commonly alkenes 
which yield cyclopropane products, and hence [2+1] cycloadditions involving alkenes are commonly 
called cyclopropanations.42 As discussed in section 1.4.1 of chapter 1 the vast majority of 
cyclopropanation reactions involving a carbene intermediate require a stabilising agent, such as an 
organometallic complex, to circumvent the lack of chemo-, regio- and stereoselectivity exhibited by 
free carbene reagents. 
 
Figure 29: The cyclopropanation reaction between ethyl diazoacetate (blue) and styrene used for 
detecting the carbene transferase activity and of hemoproteins. The four possible stereoisomers of 
the reaction are also presented. 
In January 2013, Coelho and Arnold reported the activity of a selection of mutant cytochrome P450s 
engineered (via DE) towards the cyclopropanation reaction between styrene and ethyl diazoacetate 
(EDA) (figure 29).190 Ninety-two variants of P450BM3 were screened for cyclopropanation activity, with 
the ten best variants being taken forward for subsequent rounds of evolution. Interestingly, a single 
mutation (T268A) generated a highly active and stereoselective mutant, with product yields and 
cis:trans ratios of 65% and 1:99 (the (S,S)-product was favoured).190 Another mutant, BM3-CIS, 13 
mutations away from WT-P450BM3, demonstrated reasonable activity towards cyclopropantion (with 
product yields of 40%), but with inverted stereoselectivity, exhibiting a cis:trans ratio of 71:29. The 
introduction of an additional mutation to generate the variant BM3-CIS-(T438S) elevated the product 
yield to 59% and the cis:trans ratio to 92:8. Interestingly, the variant BM3-CIS-(Q263A) afforded a 
cis:trans ratio of 9:91, demonstrating succinctly the sensitive relationship between the enzyme’s 





electron-donating olefins, as well as α-methyl styrene. Furthermore, in the presence of CO all the 
variants were inhibited and were characterised by the presence of an intense absorption in the UV-
VIS spectra (λMAX) at 450 nm, a diagnostic feature of cytochrome P450 FeII-CO complexes. The 
importance of this observation is it demonstrated the discerned carbene transferase activity was 
ceased once the vacant site of the heme was occupied, signalling that the iron-porphyrin cofactor is 
critical for carbene transferase activity.190  
 
Figure 30: (left) The crystal structure of the P450-BM3 carbene transferase mutant P411-CIS (white, 
heme is show in yellow, PDB: 4H23), and (right) the overall of the crystal structures for P411-CIS 
(white, heme is show in yellow, PDB: 4H23) and P450-BM3 (blue, heme is show in orange, PDB: 2IJ2) 
The generation of P450s active towards cyclopropanation (after a single mutation) demonstrated the 
powerful methodological approaches available for unlocking the intrinsic, but unexplored in nature, 
chemistry of heme cofactors. Another report by Coelho et al, published in August 2013,191 investigated 
the nature of the axial ligand coordinating to the heme cofactor, and demonstrated its importance in 
governing heme functionality. A cysteine to serine mutation (C400S) generated a library of 
cytochrome mutants characterised by a blue shifted FeII-CO peak in the electronic spectra from 450 
to 411 nm; the C400S mutant were therefore named the cytochrome P411s.191 The P411s possessed 
an increased resting state FeII/FeIII reduction potential and a distinctive lack of monooxygenation 
activity. Introducing the C400S mutant to BM3-CIS resulted in the cis-selective P411-CIS (figure 30), a 
variant proficient in catalysing the cyclopropanation reaction between styrene and EDA with reported 
product yields and enantioselectivities of 74% and 99% respectively.191 In October 2014, Heel et al 
introduced the Cys→Ser mutation to four other hemoproteins, CYP119-(C316S), CYP153A6-(C363S), 
TxtE-(C356S) and P450CAM-(C357S), and created a new library of four serine-ligated but structurally 
distinctive hemoproteins.192 The authors reported the Cys→Ser mutation resulted in elevated 
cyclopropanation activity for all four mutants under anaerobic and whole E. coli cell conditions (except 





different, reflecting the author’s hypothesis that the different active site volumes and topologies for 
each parent mutant would influence the stereochemical distribution of the resultant products.192    
A critical step in P450 monooxygenation chemistry is the cessation of the molecular oxygen bond, 
which is facilitated by the weakening of the O=O bond through the donation of electron density from 
the iron into the π*p orbitals of molecular oxygen.104,161 The observed diminishment in 
monooxygenation chemistry accompanying the Cys→Ser mutation was therefore attributed to the 
differing electronic properties of a thiol group relative to a hydroxyl group. The SH group of cysteine 
is more polarisable and therefore a stronger electron-donating group, compared to the OH group of 
serine.104,161 The SH group provides more electron density to the iron, providing more electron density 
to be donated to dioxygen’s π*p orbitals.104,161 The OH group of serine, being a weaker electron-
donating group, provides less electron density to iron and consequently hinders the cessation of the 
O=O bond. As monooxygenation chemistry competes with carbene transfer chemistry, it was further 
theorized that mutating the serine in the P411 mutant library to an even less electron-donating group 
would further diminish monooxygenation activity while concurrently enhancing carbene transfer 
chemistry. In 2014, Wang et al investigated the influence of multiple axial ligands on the functionality 
and catalytic activity of P450BM3.193 The amino acids screened were alanine, histidine, methionine, 
tyrosine and serine, in addition to another mutation, T268A (a mutation previously found to be highly 
beneficial for cyclopropanation), to generate five mutants called T268A-axX. After examining all 
mutants for cyclopropanation activity, the histidine-ligated P450BM3-(T268A-axH) mutant was 
reported to be the best variant, catalysing the reaction between N,N-diethyl-2-phenylacrylamide and 
EDA, in whole E. coli cells, with a product yield, enantioselectivity and cis:trans ratio of 81%, 42% and, 
94:6 respectively.193 Additional rounds of directed evolution resulted in the identification of two other 
variants that showed improved enantioselectivity without loss of reactivity. The most influential 
mutations were subsequently combined to produce a final variant, T268A-axH-L437W-V78M-L181V 
(named “BM3-Hstar”).193  
 
Figure 31: The cyclopropanation of acrylamides by the P450-BM3 mutant HStar; the reaction was used 





BM3-Hstar exhibited substantially enhanced carbene transferase activity, with reaction yields of the 
desired product exceeding 92%, alongside reported values of 92% and 2:98 for the reaction 
enantioselectivity and diastereoselectivity respectively.193 In a later study, published in June 2014 by 
Renata et al, BM3-Hstar was demonstrated to be an extremely proficient carbene transferase, 
catalysing the cyclopropanation of numerous acrylamide substrates (figure 31), with product yields, 
enantioselectivities and diastereoselectivities of 75-90%, 60-99%, and 97:3 respectively.194 The 
substrate scope of BM3-Hstar was also expanded to acrylamides functionalised at either the aryl or 
amine moiety of the molecule and was later employed in the gram-scale synthesis of levomilnacipran 
(figure 31).194 
The successful engineering of carbene transferases by utilising cytochrome P450 scaffolds raised the 
question of whether other hemoproteins could be utilized, and in December 2014 Bordeaux et al 
reported a library of myoglobin variants engineered towards carbene transferase activity.195 One 
variant, Mb(H64V,V68A) (figure 32), was reported to catalyse the cyclopropanation of aryl-olefins with 
yields, enantioselectivities and diastereoselectivities of up 99% respectively for the trans-(S,S) 
product. Mb(H64V,V68A) also exhibited good substrate scope, displaying catalytic proficiency towards 
several ortho-, meta-, and para- functionalised styrene substrates. Interestingly, a Hammett plot of 
para-functionalised styrenes revealed a positive relationship between the electron-donating ability of 
the para-substituent and the rate of the cyclopropanation reaction (p+ = -0.34 ± 0.07).195 This 
observation is consistent with the suggestion that cyclopropanation reactions proceed through an 
electrophilic, iron localised metallocarbenoid intermediate.  
 
Figure 32: The crystal structure of the sperm-whale myoglobin mutant Mb(H64V,V68A) (white, the 





In April 2017, Tinoco et al expanded the substrate scope of Mb(H64V,V68A) to include new carbene 
precursors.196 The carbene precursor 2-diazo-1,1,1-trifluoroethane (CF3CHN2) was prepared in situ 
from CF3CH2NH2.HCl and NaNO2 and was utilised in the synthesis of trifluoromethyl-substituted 
cyclopropanes (figure 33). The reaction was catalysed by isolated Mb(H64V,V68A), with product 
yields, enantioselectivities and diastereoselectivies of 22%, >99.9% and 98.5% respectively. When the 
reaction was conducted in whole E. coli cells overexpressing Mb(H64V,V68A), product yields, 
enantioselectivities and diastereoselectivies between 43-82%, 97-99.9% and >99.9% were reported 
for an assortment of functionalised styrene substrates.196  
 
Figure 33: The Mb(H64,V68A)-catalysed cyclopropanation of styrene by in situ generated aliphatic 
diazo compounds (left) diazoacetonitrile197 and  (right) 2-diazo-1,1,1-trifluoroethane.196 
Later that year, in October 2018, the substrate scope of Mb(H64V,V68A) was further expanded, by 
Fasan et al, to include the synthesis of nitrile-functionalised cyclopropanes using in situ generated 
diazoacetonitrle as the carbene precursor (figure 33).197 A range of nitrile-functionalised cyclopropane 
products were obtained using E. coli overexpressing Mb(H64V,V68A), with product yields ranging from 
50-99%, and enantioselectivities and diastereoselectivities being consistently >99.9% for the trans-
(S,S)-product. The nitrile-functionalised cyclopropanes are of particular interest as synthetic targets 
because of the reaction scope of nitrile groups.197 
In May 2018, Villarino et al developed an artificial hemoprotein using the lactococcal multidrug 
resistance regulator (LmrR) protein as the metalloenzyme scaffold.198 Incorporation of the heme B 
cofactor (followed by UV-VIS spectroscopy) afforded a modestly proficient metalloenzyme capable of 
catalysing cyclopropanation reactions (products yields of up to 25%), but with low enantioselectivity 
(17% for the trans-(R,R) product). Introducing a single mutation, M8A, afforded the variant LmrR-
(M8A), which, despite only showing a moderate increase in product yield relative to WT-LmrR (45% vs 
25% respectively), enhanced the enantioselectivity relative to WT-LmrR (51% vs 17% for the trans-





In November 2016, Bajaj et al explored the relationship between the stereoselectivity of 
cyclopropanation reactions and an enzyme’s structure by engineering a library of myoglobin variants 
with stereoselectivities complementary to Mb(H64V, V68A).199 The authors had previously recognized 
five key amino acids in the distal pocket of myoglobin that influenced the activity and selectivity of 
myoglobin in carbene transfer reactions, namely Leu29, Phe43, His64, Val68, and Ile107.199 The 
mutation of a distal histidine residue to a valine (H64V) was demonstrated to significantly enhance 
the cyclopropanation activity of myoglobin, which the authors attributed to an increased accessibility 
of the heme pocket to the reactants.199 The authors generated ten notable myoglobin mutants, 
including two trans-(S,S) selective variants and eight trans-(R,R)-selective variants. The substrate 
scope was subsequently screened for the (R,R)-selective myoglobin variants, against ortho-, meta-, 
and para- functionalised styrenes, with reported product yields, enantioselectivities and 
diastereoselectivies of >95% (excluding p-CF3; 45%), 45-99% and 92-99% respectively.199   
In February 2018, Knight et al further explored the relationship between the stereoselectivity of 
biocatalytic cyclopropanation reactions by screening a diverse range of native and engineered 
hemoproteins.200 The authors investigated the cyclopropanation of unactivated terminal alkene 
substrates catalysed by variants isolated from distinctive organisms. Two naturally occurring enzymes, 
WT-Aeropyrum pernix protoglobin (ApePgb) and WT-Rhodothermus marinus nitric oxide dioxygenase 
(RmaNOD), were identified as suitable candidates for engineering as both WT-enzymes exhibited low 
but measurable cyclopropanation activity towards 1-octene, catalysing the reaction with TTNs of 18 
and 27 respectively.200 Notably, WT-ApePgb and WT-RmaNOD displayed complementary 
diastereoselectivity, preferentially producing cis-(1R,2S) and trans-(1S,2S)-products respectively 
(figure 34). After subjecting RmaNOD and ApePgb to directed evolution, the two variants RmaNOD-
(Q52V) and ApePgb-(W59A,Y60G,F145W) showed drastically improved activity towards the 
cyclopropanation of 1-octene. Two addition mutants, P411-UA-(V87C) and P411-UA-(V87F) (derived 
from a previous variant P411-CIS-(L437F,T438Q,L75Y,L181I), called P411-UA) were identified as 
proficient catalysts towards the cyclopropanation of 1-octene, affording the separate cis-(1S,2R) and 
trans-(1R,2R) stereoisomers (figure 34). Overall, the authors reported four mutant hemoproteins 
proficient towards the cyclopropanation of 1-octene with complementary stereoselectivities (figure 
34). The  enantioselectivities and diastereoselectivities of the four mutants were: 97% and 95:5 for 
cis-(1S,2R), P411-UA-(V87C); 99% and 89:11 for cis-(1R,2S), ApePgb-(W59A,Y60G,F145W); 96% and 






Figure 34: Stereoselective whole cell catalysed cyclopropanation of the aliphatic alkene 1-octene and 
EDA to obtain each of four stereoisomers of the cyclopropane product, two serine-ligated cytochrome 
P450-BM3 variants (P411-UA-V87C and P411-UA-V87F), Aeropyrum pernix protoglobin-(W59A Y60G 
F145W) (ApePgb AGW), and Rhodothermus marinus nitric oxide dioxygenase-(Q52V) (RmaNOD 
Q52V); reactions were contrasted against a racemic mixture synthesised using a rhodium acetate 
dimer (Rh2(OAc)4) catalyst (figure taken from Knight et al).200 
In addition to the axial ligand and the first-coordination sphere, the identity of the metal and its 
coordinating ligand(s) also govern the functionality and catalytic activity of a metalloenzyme. As a 
variety of non-iron metalloporphyrin catalysts are well-established abiological catalysts, a 
considerable amount of research has been devoted to incorporating non-natural and/or semi-
synthetic cofactors into metalloenzymes in efforts to enhance reactivity and selectivity.201–208 In June 
2016, Key and Hartwig209 generated an eight variant library of apo-mOCR-Myo-H93X, with each variant 
characterised by a distinctive axial ligand (H93X) coordinating to the heme metal. Each variant was 
reconstituted with nine different porphyrin cofactors which differed by the coordinated metal, 
including Fe, Co, Cu, Mn, Rh, Ir(Cl), Ir(Me), Ru, and Ag.209 The authors rapidly screened the 72 artificial 
metalloenzymes and reported activity profiles distinct from wild-type myoglobin. The variants were 
screened for cyclopropanation activity, employing β-methylstyrene and EDA as substrates. The 
authors reported that the variants reconstituted with Fe-PPIX exhibited negligible activity, in contrast 
to the Rh-, Ru-, and Ir-PPIX reconstituted variants. The variants reconstituted with Ir(Me)-PPIX were 
the most active, exhibiting TONs of >20 with enantioselectivity and diastereoselectivity ratios, for the 
trans-isomer, of 70:30 and 33:1 respectively.209 The authors then expanded the substrate scope of the 
Ir(Me)-PPIX-reconstituted variants by investigating the cyclopropanation of 1-octene. Although 





cyclopropanation reaction between EDA and 1-octene with TONs of >40 and enantioselectivity and 
diastereoselectivity ratios of 91:9 and 40:1, for the trans-isomer, respectively.209  
In April 2017, Key et al continued investigated how incorporating an iridium containing analogue of 
heme B, Ir(Me)-protoporphyrin IX, into a hemoprotein scaffold influenced the catalytic activity.210 The 
authors derived a library of iridium-containing P450 variants form the parent WT-CYP119 
hemoprotein and screened for cyclopropanation activity. A double mutant, CYP119(+), was reported 
to yield the cis-cyclopropane product with an enantioselectivity of 73%, while a triple mutant, 
CYP119(-), afforded the trans-cyclopropane product with an enantioselectivity of 74%.210 The authors 
utilised CYP119(+) and CYP119(-) to generate another library of 100+ variants and reported one 
variant, CYP119(+)-(L155W), that catalysed the reaction between to give the (1S,2R)-cis cyclopropane 
product with a yield, enantioselectivity, and diastereoselectivity of 80%, 98%, and 90:1 respectively. 
The same reaction catalysed by of another variant, CYP119(-)-(V254L) gave a product yield, 
enantioselectivity and diastereoselectivity of 74%, 98%, and 73:1%, respectively. Perhaps more 
importantly, the Ir(Me)-PPIX containing CYP119 variants catalysed the cyclopropanation of a large 
variety of alkenes, displaying catalytic activity towards terminal and internal, activated and 
unactivated, electron-rich and electron-deficient, conjugated and nonconjugated alkenes as well as 
1,2-disubstituted styrenes.210 
Also, in April 2017, Wolf and co-workers reported several sperm whale myoglobin variants 
reconstituted with ruthenium mesoporphyrin IX (RuMPPIX) (mesoporphyrin differs from 
protoporphyrin IX by the complete saturation of the vinyl groups).211 Reconstituted WT-Mb and the 
three variants containing the H64X mutation, with X equalling aspartic acid (D), aniline (A) and valine 
(V) were demonstrated to be very weakly active towards the cyclopropanation of  styrene and EDA 
with reaction yields from 0.6 - 3.9 % compared to 26% for free RuMPPIX respectively (the Mb catalysts 
were, however, moderately proficient at N-H insertion [see below]).211 The reaction between para-
methoxystyrene and EDA, catalysed by RuH64AMb, was moderately proficient, however, with a 
reported reaction yield of 36%. The authors did report an ESI-MS for the RuMb prior to and after the 
addition of EDA, with dominant peaks present at 17995.4 and 18081.4 m/z respectively corresponding 
to a mass difference of 86 m/z, the anticipated mass change expected to be observed upon the 
addition of EDA; however, the authors were not capable of discerning whether EDA was localised on 
the metal or whether the carbene had inserted into the porphyrin/protein.211     
At the same time, Sreenilayam et al investigated the influence of the metal on the catalytic activity of 
the previously reported Mb(H64V,V68A) mutant.212 Apo-Mb(H64V,V68A) was reconstituted with a 





generating a series of five reconstituted holoenzymes (all four metal substitutions were referenced 
against Fe(PPIX)). In addition, three M(PPIX)-Mb(H64V,V68A,H93F) (where M = Fe, Mn, Ir) variants 
were also prepared and characterised. The authors reported that the variant Fe(PPIX)-Mb(H64V,V68A) 
remained the best biocatalyst for the cyclopropanation reaction between EDA and styrene, with 
neither the metal substitution nor the introduction of the additional H93F mutation producing any 
appreciable improvements in product yield or stereoselectivity.212 The authors did, however, discover 
some interesting functionality with other variants towards X-H insertion chemistry (discussed below). 
In September 2017, the same authors reported a variant of Mb(H64V,V68A) reconstituted with iron-
chlorin e6 (Fe(Ce6) (figure 35)) was highly proficient towards carbene transferase activity, catalysing 
the reaction between styrene and EDA with a reported product yield, enantioselectivity and 
diastereoselectivity of >99% for all values respectively.213 Importantly, although Fe(Ce6)-
Mb(H64V,V68A) was less thermally stable than its Fe(PPIX) analogue, unlike the vast majority of 
metalloenzyme variants proficient towards cyclopropanation chemistry the Fe(Ce6)-Mb(H64V,V68A) 
variant is highly proficient under aerobic conditions and is capable of catalysing the cyclopropanation 
reaction of a diverse collection of functionalised styrenes with reported product yields, 
enantioselectivities and diastereoselectivities of 70->99%, 92-98% and 93-99% for all values 
respectively.213  
 
Figure 35: The chemical structure of the tetrapyrrole derivatives porphycene (left) and chlorin e6 
(right). 
The above work highlighted that for inorganic cofactors both the metal and the coordinating ligand(s) 
are important in catalysis. This principle was wonderfully demonstrated by Oohora et al, in November 
2017, who reported that WT-myoglobin reconstituted with iron porphycene (rMb (figure 35)) afforded 





proficient cyclopropanation biocatalyst, affording the trans-(R,R)-product at 99% with no 
modifications introduced into the WT scaffold. The authors also reported kinetic parameters for the 
reaction and concluded that rMb presented a 26-fold enhanced catalytic efficiency (kcat/KM) relative 
to WT-Mb.214  
2.3.3 X-H insertions 
2.3.3.1 X-H insertions where X = N, S, Si, B 
 As discussed in section chapter 1, an X-H (X = C, N, B, Si) insertion reaction is the insertion of a chemical 
species (R) into a pre-existing σ-bond (X-H), resulting in the formation of a new σ-bond (X-R). Carbenes 
are good reagents for insertion reactions (and are particularly useful for C-H bond), but require a 
stabilising agent, such as an organometallic complex, to overcome problems associated with the lack 
of chemo-, regio- and stereo- selectivity. Having engineered myoglobin and P450s variants towards 
cyclopropanation activity, the question of whether reactivity and specificity towards X-H σ-bonds 
instead of olefin π-bonds was raised.  
 
Figure 36: The general reaction scheme for an enzymatic catalysed carbene insertion reaction 
between an N-H σ-bond and a diazo compound (blue). 
The first carbenes insertion reactions reported concerned insertions into N-H σ-bonds (figure 36). N-
H insertion reactions are important in organic synthesis because the reactions can divide complex 
synthetic pathways into multiple pathways and allow for a non-linear synthetic approach for complex 
molecules. In early 2014, Wang et al reported a cytochrome P450 variant proficient towards N-H 
insertion chemistry.215 The variant H2-5-F10 (15 mutations away from WT-P450BM3) was thermally 
stable and catalysed the N-H insertion reaction between aniline and EDA under anaerobic conditions 
and when expressed in whole E. coli cells (47% and 38%). H2-5-F10 is tolerant to primary and 
secondary anilines, and anilines with either ortho- or para- substitutions.215 H2-5-F10 is also chemo- 
and regioselective towards N-H insertion: in the presence of aniline and styrene N-H 
insertion/cyclopropanation yields were 63% to 9% respectively, and when para-vinylaniline was 
employed as the substrate a 32% yield for the N-H insertion product was accompanied by only trace 
amounts of the cyclopropanation product.215 The authors reported that the introduction of a C400S 





mutation enhances cyclopropanation activity. In addition, only single-insertion products were 
detected in reactions catalysed by H2-5-F10, circumventing a common problem in amine chemistry 
(single:double insertion ration is 3:1 when the same reaction is catalysed by hemin).215   
In early 2015, the Fasan group engineered myoglobin variants towards N-H insertion.17 The same 
variant reported for cyclopropanation, Mb(H64V,V68A), demonstrated a 61% reaction yield for the 
reaction between aniline and EDA. For comparison, WT-Mb exhibited a product yield of 21% for the 
same reaction. Mb(H64V,V68A) also exhibited good substrate scope, reacting with a variety of ortho-
, meta-, and para- functionalised anilines with yields and TTNs between 67-99% and 540-7000 
respectively.17 Another variant, Mb(L29A, H64V), tolerated the N-H insertion using both EDA and 
tBuDA, with a TTN of 4000 and for the reaction between EDA and N-methylaniline and  8000 for the 
reaction between tBuDA and aniline. As mentioned above, Wolf and co-workers reported several 
sperm whale myoglobin variants reconstituted with ruthenium mesoporphyrin IX (RuMPPIX). 
Although the reconstituted WT-Mb and the three variants containing the H64X mutation (X = D, A and 
V) were very weakly active towards cyclopropanation (especially when compared to free RuMPPIX), 
the RuMb variants demonstrated moderate catalytic proficiency towards the N-H insertion of aniline, 
with reaction yields between 32-52% observed.211 The variant RuH64AMb was a good improvement 
relative to WT-Mb and RuMb (52% vs 21 and 36% respectively), but only provided a marginal 
improvement over free RuMPPIX (52% vs 48% respectively). The variant RuH64AMb is also capable of 
catalysing several para-functionalised anilines, but with decreased reactivity (product yields ranged 
from 2.9 – 45 %).211 
Having demonstrated that hemoproteins can be engineered towards N-H insertion chemistry, the 
question of what other X-H functional groups could be targeted as potential substrates was raised. In 
February 2015, Tyagi et al reported the first example of a biocatalytic methodology for the synthesis 
of thioethers via an intermolecular carbene insertion into a thiol S-H bond (figure 37).216 Employing 
the sperm whale myoglobin scaffold previously used for engineering, a library of mutants were 
generated via site-directed mutagenesis and screened for reactivity using thiophenol and EDA as 
substrates. The previously reported variant, Mb(H64V,V68A),17,195 catalysed the reaction but with 
modest activity compared to the cyclopropanation and N-H insertion activity previously reported. 
Screening the initial library, two single point mutations, L29A and F43W, resulted in an elevated S-H 
insertion activity relative to WT-Mb. Subsequent mutations resulted in a second generation of 
variants, with one mutant, Mb(L29A,H64V), eclipsing all the other variants with regards to S-H 
insertion activity (TTN = 2750).216 Mb(L29A,H64V) was screened for its substrate scope, and reaction 





Three additional α-diazo precursors, tert-butyl diazoacetate, cyclohexyl diazoacetate, and benzyl 
diazoacetate, were screened using Mb(L29A,H64V) and product yields of 95, 95 and 75% were 
reported respectively (figure 37).216 The authors considered the effect of the two mutations on the 
observed catalytic activity of Mb(L29A,H64V). The mutation L29A is postulated to facilitate the 
approach of the thiol nucleophile to the iron-bound metallocarbenoid, and the mutation H64V is 
postulated to enhance the catalytic activity by increasing the accessibility of the heme active site to 
both the thiol and α-diazo ester substrate. These propositions are supported by the observation that 
introducing both mutations to WT-Mb enhanced its catalytic activity towards S-H insertion. The same 
mutations also activate WT-Mb towards N-H insertion reactions, suggesting N-H and S-H insertion 
reactions proceed via a similar reaction mechanism.216  
 
Figure 37: The general reaction scheme for the thiol insertion reaction catalysed by Mb(L29A,H64V).216  
The successful  development of biocatalytic methodologies to synthesize novel N-C and S-C σ-bonds 
raised the exciting question of whether more exotic X-H groups could be targeted. This question was 
answered in November 2016 by Kan et al, who reported an engineered enzyme capable of converting 
Si-H σ-bonds to Si-C σ-bonds, via a carbene insertion mechanism.217 Initially, free hemin and a 
selection of cytochrome c variants were screened for Si-H insertion activity using phenyldimethylsilane 
and ethyl 2-diazopropanoate as substrates (figure 38). A wild-type cytochrome c isolated from 
Rhodothermus marinus (Rma cyto c) exhibited low activity but remarkable enantioselectivity (97%).  
For this reason, Rma cyto c was subjected to directed evolution to enhance its catalytic activity 
towards Si-H insertion.217 A first-generation Rma cyto c mutant, containing a M100D mutation, 
displayed a 12-fold improvement in activity compared to the WT-enzyme. The Rma(M100D) variant 
was then selected as the enzyme scaffold for subsequent directed evolution.217 Two amino acids in 
close proximity to the iron heme centre, Val-75 and Met-103, were identified as possible candidates 
for mutation, and sequential site-saturation mutagenesis at these positions resulted in the triple 
mutant Rma-(V75T,M100D,M103E) (called Rma-TDE (figure 38)). Rma-TDE showed drastically 
improved catalytic activity towards Si-H carbene insertion while retaining the high enantioselectivity 





and M103E, were proved to activate WT-Rma cyt c towards Si-H insertion individually, but provided a 
synergistic effect when combined in the triple-mutant. Rma-TDE was then investigated for Si-H 
substrate scope, and was demonstrated to turnover a diverse variety of aryl-silane substrates when 
E. coli cells over-expressing Rma-TDE were employed as catalyts. Although the TTNs for some aryl-




Figure 38: (top left) The crystal structure of the Rhodothermus marinus cytochrome c variant Rma-
TDE (white, heme is shown in yellow; PDB: 6CUK), (top right) structure of the active site of Rma-TDE 
(picture taken from Kan et al) and (bottom) the general reaction scheme for the Rma-TDE catalysed 
Si-H insertion reaction.217  
An interesting question concerning chemoselectivity arises when a molecule containing two differing 
X-H groups in its structure is employed as a substrate. As carbene transferases have previously shown 
proficiency towards N-H (and S-H) insertions, the chemoselectivity of Rma cyto c mutants was 
investigated using 4-(dimethylsilyl)aniline, a Si-H and N-H containing compound (figure 39).217 WT-
Rma exhibited no chemoselectivity towards N/Si-H insertion, affording the Si-C and N-C containing 
products in equal quantities.217 The introduction of the M100D mutation to WT-Rma, yielding 
Rma(M100D), introduced a minor preference for Si-H insertion, affording the Si-C and N-C containing 





the final triple-mutant variant, Rma-TDE, exhibited a high chemoselectivity in favour of Si-H insertion, 
with a reported Si-C/N-C ratio of 29:1, a >30 fold increase relative to WT-Rma.217 The authors later 
demonstrated, through MD and QM/MM simulations, that the three mutations (V75T, M100D, 
M103E) affect the flexibility of the T98-E103 loop on the pro-R-face of the protein.218,219 The 
surrounding protein residues on the pro-S-face are rigidified by an extensive network of hydrophobic 
contacts which blocks the channel between the substrate and heme active site. Silane binding is more 
favourable in the Rma-TDE triple mutant compared to WT-Rma because of the increased flexibility at 
the front of the T98-E103 loop.218,219 The authors performed DFT calculations on the geometries of the 
insertion transition states in WT-Rma and Rma-TDE for both N-H and Si-H insertions, and discovered 
that the N-H and Si-H insertions proceed via geometrically distinct transition states on account of the 
differences associated with accommodating the substrate’s approach towards the carbene.218,219 It 
was noted that N-H carbene insertion has a lower energy barrier than Si–H carbene insertion when 
catalysed by free hemin, and therefore the authors concluded the observed chemoselectivity for Si-H 
carbene insertion was a result of the conformational changes in the front T98-E103 loop, which 
lowered the energy barriers of silane binding and the Si-H insertion transition state relative to WT-
Rma cyto c.218,219 The authors provided evidence for this conclusion by engineering another variant 
that is chemoselective towards N-H insertion.218 The group rationalised that Si-H insertion could be 
disfavoured by carefully introducing key mutations to alter the conformation of the front loop and 
ultimately the binding of the silane. A novel mutant Rma(V75T,M100D,N80F,M99P,E103I) 
(abbreviated as Rma-TDFPI) was engineered and catalysted the N-H insertion reaction between 4-
(dimethylsilane)-aniline and ethyl 2-diazopropanoate chemoselectively with product yields of 90% 
(figure 39).218 The IPC of Rma-TDFPI was analysed using MD simulations and revealed a significant 
change in the front loop conformation in Rma-TDFPI compared to Rma-TDE. It was also emphasised 
that the mutations M99P and E103I work synergistically to disfavor the Si-H insertion reaction 
transition state by changing the conformational of the front loop and blocking the preferred binding 






Figure 39: The possible mono-insertion products of the X-H carbene insertion when employing 4-
(dimethylsilyl)aniline as the substrate and a Rma cyto c variant as the catalyst. 
In December 2017, the Arnold group expanded the scope of biocatalytic X-H insertion methodologies 
to include B-H carbene insertion reactions (figure 40).220 Employing the Rma-cytochrome c scaffold 
acquired from Rhodothermus marinus, and subjecting the wild type to directed evolution, the group 
engineered an enzyme proficient at catalysing B-C σ-bond formation when overexpressed in E. coli 
cells. Initial screenings using either free hemin or WT-Rma (named BORWT) incubated with an N-
heterocyclic carbene borane (NHC-borane) and ethyl 2-diazopropanoate (Me-EDA) resulted in low-
activities (TTNs = 80 and 120 respectively), but reasonable enantioselectivity for BORWT ([R]/[S] = 6).220  
 
Figure 40: The in vivo borylation reaction between an N-heterocyclic carbene borane and ethyl-2-
diazopropanoate catalysed by E. coli overexpressing Rma cyto c variants.  
The introduction of the previously reported activating mutation, M100D, engendered the first 
generation BOR(M100D) variants that exhibited a drastic improvement in catalytic activity. The 
M100D mutation is known to increase the flexibility of the pro-R-face loop of BORWT (while 
simultaneously blocking the pro-S-face) and was demonstrated to be an important mutation in 
stabilising silane substrate.218 The introduction of two additional mutations, V75R and M103T, 
resulted in the triple-mutant BORR1 which catalysed the B-H insertion reaction with a reported TTN of 
2,500 and a significant improvement in enantioselectivity ([R]/[S] = 39) (figure 41).220 The increase in 
catalytic activity and R-stereoselectivity parallels the observations reported for Rma-TDE and Si-H 





of the heme active site plays an important role in binding boranes and stabilising the B-H carbene 
insertion transition state.217,218,220 The substrate scope and whole cell compatibility of BORR1 
overexpressed in E. coli cells was explored, with TTNs and (R)-enantioselectivities ranging from 890-
2760 and 92->99 across 16 different borane substrates.220 Further mutagenesis studies engendered 
another variant, BORWT(V75R,M100D,M103D) (called BORP2) which catalysed the B-H insertion of 
borane-NHC and benzyl 2-diazopropanoate with a TTN and (R)-enantioselectivity of 4,200 and 92% 
respectively. Interestingly, E.coli cells harbouring BORP2 also catalysed the B-H insertion of an NHC-
borane substrate when (1-diazo-2,2,2-trifluoroethyl)benzene was employed as the carbene precursor 
substrate, opening up the potential towards highly coveted organofluoride synthesis (figure 41).220  
 
Figure 41: The expansion of the substrate scope of in vivo borylation reactions catalysed by various 
Rma cyto c variants accessed via direct evolution and the amino acid residues targeted during directed 
evolution (figure adapted from Kan et al).220 
In 2019, Huang et al reported a novel variant, BOR-CF3, five mutations away from WT-Rma cyto c 
(Y44I,V75S,M99A M100L,M103D) which catalysed the borylation reaction between (3-diazo-4,4,4-
trifluorobutyl)benzene and an NHC-borane substrate (figure 42), affording the chiral α-
trifluoromethylated organoborane product with a TTN of 2460 and an enantioselectivity of >95% (R-
stereoisomer). The substrate scope was enlarged to include 12 α-CF3-diazo precursors, producing TTNs 
and (R)-enantioselectivities ranging from 730-2900 and >96% respectively.221 As with Rma-TDE,218 the 





dynamic flexibility of the protein caused by the introduction of key mutations in the surface loop.221 
This postulation was later corroborated by the computational studies of Alonso-Cotchico and 
Roelfes.222 
 
Figure 42: The general in vivo enantioselective borylation reaction between (3-diazo-4,4,4-
trifluorobutyl)benzene and an NHC-borane substrate catalysed by E. coli overexpressing the Rma cyto 
c variant BOR-CF3. 
2.3.3.2 C-H insertions 
One of the most challenging reactions in organic chemistry is the conversion of C-H σ-bonds to C-C σ-
bonds. The functionalisation of C-H σ-bonds to C-X σ-bonds usually involve an intermediate step, 
called C-H activation, to active the C-H bond towards reactivity. The activation step usually involves a 
transition metal and the formation of a M-C organometallic intermediate. The direct conversion of C-
H σ-bonds to C-C σ-bonds is one of the most highly coveted transformations, as direct functionalisation 
circumvents the C-H activation step. In 1981, Teyssié reported the rhodium-catalysed carbene 
insertion into the C-H σ-bonds of several paraffins.67 The reaction mechanism involves the metal-
catalysed decomposition of a diazo compound to yield a metallocarbenoid intermediate which then 
reacts with a C-H σ-bond in a concerted manner, proceeding via a three-membered cyclic transition 
state.223 In 1993, Doyle demonstrated that dirhodium(II) carboxylates and carboxamides are 
extremely proficient catalysts for the intramolecular C-H insertion reaction of diazoacetoacetates.223 
Since the seminal paper in 1981, several copper, dirhodium and metalloporphyrin complexes have 
been established as proficient catalysts for numerous intra- and intermolecular C-H carbene insertion 
reactions.64  
Having demonstrated that engineered carbene transferases are proficient catalysts for X-H carbene 
insertion reactions (X = N, S, B, and Si), the question of whether a carbene transferase capable of direct 
carbene insertion into C-H bonds was raised. It was mentioned above that in June 2016 Key et al209 
generated a library of apo- Myo-H93X variants each characterised by a distinctive mutation to the axial 
ligand (H93X) coordinating to the heme iron. Each variant was reconstituted with nine different 
porphyrin cofactors which differed by the coordinated metal, and included Fe, Co, Cu, Mn, Rh, Ir(Cl), 





cyclopropanation activity profiles that are distinct from wild-type myoglobin, as mentioned above. In 
addition to cyclopropanation activity, the authors screened the variants for intramolecular C-H 
insertion activity, employing methyl 2-diazo-2-(2-methoxyphenyl)acetate as both the substrate and 
the diazo compound (figure 43). Several variants reconstituted with Ir(Me)-PPIX exhibited remarkable 
C-H insertion activity (TONs of >60). The authors generated a novel library of Ir(Me)-mOCR-Myo 
mutants and screened across 7 substrates to access the activity and selectivities towards 
intramolecular C-H carbene insertion. It can be seen from figure 43 that both the activity and 
selectivity of C-H carbene insertion towards distinctive substrates can be finely tuned by introducing 
key mutations into Ir(Me)-mOCR-Myo.209  
 
Figure 43: The directed evolution strategy used by Hartwig to obtain Ir(Me)-mOCR-Myo mutants 
capable of producing either enantiomer of the intramolecular C–H carbene insertion reactions of 
varied substrates. Inner sphere (red), middle sphere (blue), and outer sphere (yellow) residues are 
highlighted in the depiction of the active site (bottom left) and in the evolutionary tree (figure adapted 
from Key and Dyido et al).209 
In October of the same year, Dyido et al re-examined the intramolecular C-H carbene insertion 
reaction used previously but using iridium-reconstituted-CYP119 variants to catalyse the reaction.224 
A variant called Ir(Me)-CYP-Max was reported to catalyse the intramolecular C-H insertion of methyl 
2-diazo-2-(2-methoxyphenyl)acetate with a reaction yield and enantioselectivity of >95% 
respectively.224 The authors reported remarkable kinetic values for Ir(Me)-CYP-Max, with KM, kcat and 
kcat/KM values of 170 mM, 45.8 min-1 and 269 min-1 mM-1 for the intramolecular C-H carbene insertion 
reaction respectively. The authors also reported other Ir(Me)-CYP119 variants proficient towards 





secondary sp3 C-H bonds (TON = 402-414), unactivated primary sp3 C-H bonds (TON = 31), sterically 
hindered sp3 C-H bonds (TON 107-582), and intermolecular C-H carbene insertions into activated 
primary sp3 C-H binds (55% yield).224 
In 2018, Vargas et al reported the myoglobin-catalysed carbene insertion into sp2 C-H bonds in 
indole.225 The myoglobin variant, Mb(H64V,V68A), previously reported as a proficient 
cyclopropanation catalyst was employed to catalyse the C-H carbene insertion reaction between 
unprotected indole and EDA (figure 44). The reaction was conducted using free enzyme and in whole 
cells, and reaction yields of 85 and >99% were reported respectively.225 The remarkably high yields for 
the whole cell catalysed biotransformations encouraged the authors to explore the substrate 
promiscuity, and reported Mb(H64V,V68A) could catalyse the C-H carbene insertion of a variety of 
functionalized indoles and reported yields of >99% all substrates. Interestingly, another variant, 
Mb(L29F,H64V), exhibited a preference for bulkier indole substrates relative to Mb(H64V,V68A), 
catalysing the C-H insertion of a variety of bulky indoles with reaction yields of 40-80%225 The authors 
rationalised the enhanced activity of Mb(L29F,H64V) (relative to Mb(H64V,V68A)) by suggesting the 
phenylalanine, situated close to the heme cofactor, can establish favourable π-π interactions with the 
indole ring, unlike the H64V mutation which sterically clashes with bulkier substrates. Furthermore, 
the authors postulated a possible reaction mechanism for indole C-H insertion (figure 44). The C3 
atom of indole behaves as a nucleophile and attacks the electrophilic carbon in the metallocarbenoid 
intermediate. The resultant complex possesses a formal negative charge on the carbene carbon 
(distributed with iron) and a formal positive charge on the nitrogen in the indole fragment. At this 
point, either a [1,2]-proton shift from the C3 carbon of indole to the α-carbonyl ester or dissociation 
of the ylide complex and protonation of the fragment by the solvent (accompanying an elimination of 
the C3 hydrogen) are both plausible mechanisms. To confirm the mechanism, the authors repeated 
the assays with 1-methyl-3-deutero-indole. The product obtained did not retain deuterium which 
indicates the reaction proceeds via the solvent-mediated protonation pathway. If this is the case, the 
mechanism cannot be classified as a C-H insertion reaction; instead, the mechanism would be better 
described as resembling a regioselective electrophilic aromatic substitution reaction (figure 44).225 The 






Figure 44: The general reaction and mechanism of the Mb(H64,V68A) catalysed regioselective and 
chemoselective electrophilic aromatic substitution reaction between EDA and indole. 
In 2019, Zhang et al reported the first sp3 C-H functionalisation reaction catalysed by a heme-
containing protein.226 A selection of P450, globin and cytochrome c variants were screened for C-H 
functionalisation activity to identify the blueprint protein for DE. The reaction between 1-methoxy-4-
(methoxymethyl)benzene and EDA was employed as the selective pressure. One variant, P411-P-
4(A82L) (18 mutations from WT-P450BM3), gave the product with a TTN of 13, and was subsequently 
subjected to DE.226 After multiple rounds of mutagenesis, one novel variant, P411-CHF, exhibited a 
140-fold improvement in activity relative to P411-P-4(A82L). Furthermore, P411-CHF catalysed the 
reaction with an enantioselectivity of 97%. P411-CHF was active towards an assortment of substrates, 
exhibiting TTNs and enantioselectivities of 50-2150 and 69-99%.226 P411-CHF was also remarkably 
chemoselective, catalysing sp3 C-H functionalisation over cyclopropanation in a ratio of 25:1 when 1-
allyl-4-methoxybenzene was employed as the substrate (figure 45).226 E. coli overexpressing P411-CHF 
was also proficient at chemo-, regio-, and stereoselectively catalysing sp3 C-H functionalisations (when 
the C-H group was alpha to an sp2 carbon or  nitrogen), successfully converting several products with 






Figure 45: The possible reaction products from the P411-variant catalysed reaction between EDA and 
1-allyl-4-methoxybenzene. The reaction catalysed by the variant P411-CHF exhibited a 25:1 ratio for 
the formation of the sp3 C-H insertion product.226 
In May 2019, Brandenberg et al re-explored the regioselective sp2 C-H functionalisation of the C3 C-H 
bond in indole substrates.227 Several P411 variants were initially screened in whole-cell 
biotransformation assays, with the variant P411-HF emerging as the best enzyme, catalysing the 
reaction between 1-methylindole and EDA with a TTN of up to 5350 (83% yield).227 The substrate scope 
of P411-HF extended to 10 functionalised 1-methylindole substrates, affording TTNs and yields of 700-
3380 and 17-74% respectively.227 The authors also demonstrated P411-HF could be engineered 
towards either chemoselective C-H functionalisation or cyclopropanation by the introduction of key 
mutations. It was also shown that key mutations afforded control over the regioselectivity of a 
reaction, by engineering two distinctive P411-HF variants that catalysed the C-H functionalisation of 
methylpyrrole at the C2 and C3 positions, with ratios of 9:91 and 98:2, respectively,.227  
In June of the same year, Zhang et al reported another P411 variant, P411-PFA, that was proficient at 
the fluoroalkylation of α-amino sp3 C-H bonds.228 P411-PFA catalysed the C-H functionalisation 
reaction between phenylpyrrolidine and 2,2,2-trifluoro-1-diazoethane with a TTN and 
enantioselectivity (for the (R)-product) of 4000 and 98% respectively.228 The substrate scope of P411-
PFA extended to 10 phenyl-functionalised phenylpyrrolidine substrates, affording TTNs and 
enantioselectivities of 120-2100 and 84->99%. The authors also engineered another variant, P411-
PFA-(S) (8 mutations away from P411-PFA), which catalysed the C-H trifluoroalkylation of 
phenylpyrrolidine in favour of the (S)-product (94% enantioselectivity), demonstrating the evolvability 
of the P411 scaffold towards enantiodivergent biocatalysis in the synthesis of chiral organofluoride 






Figure 46: Enantiodivergent C-H sp3 trifluoroalkylation using the P411 variant P411-PFA (figure taken 
from Zhang et al).228  
2.3.4 Carbonyl Olefination 
In 2015, the Fasan group demonstrated a few key mutations to sperm-whale myoglobin afforded a 
carbene transferase proficient towards cyclopropanation.195 In 2016, the same group postulated that 
an electrophilic metallocarbenoid intermediate could react with tertiary phosphine nucleophiles to 
engender a phosphonium ylide.229 The resultant intermediate, a heme localised phosphonium ylide, 
could further react with electrophilic carbonyl groups in a fashion analogous to the Wittig reaction, 
but with the protein scaffolding providing an asymmetric environment to govern the stereoselectivity. 
After screening several conditions and mutants, a myoglobin variant, Mb(F43V,V68F), proved the most 
efficient, with a reported TON and E/Z diastereoselectivity of 34 and 64 respectively in the synthesis 
of ethyl cinnamate from benzaldehyde and EDA in the presence of triphenylphosphine.229 Repeating 
the assays with triphenyl arsine resulted in a TON and dE of 92 and >99.9% respectively. The same 
mutant in later screens (with lower catalytic loading) exhibited good substrate specificity for carbonyls 
when AsPh3 and EDA/cyclohexyl-diazoacetate were employed, with reported TONs and cis:trans 





In the same year, Weissenborn  et al published a report on the carbonyl olefination reaction catalysed 
by the hemoprotein YfeX, isolated from E. coli.230 YfeX was reported to catalyse the carbonyl 
olefination reaction between EDA and benzaldehyde under aerobic conditions and in the absence of 
phosphines. The group started by screening for carbonyl olefination activity in E. coli lysate, and 
identified four active hemoproteins, flavohemoprotein (Hmp), bacterioferritin (Bfr), hydroperoxidase 
II (KatE), and YfeX, via fast-protein-liquid-chromatography (FPLC). All four proteins, once identified, 
were overexpressed, purified and screened for carbonyl olefination activity; of the four candidates, 
YfeX catalysed the reaction with a TTN of 2.9 and a trans:cis selectivity of 60%.230 The introduction of 
PPh3 to the reaction mixture elevated the TTN to 16, and the introduction of various mutations into 
YfeX engendered a variant, YfeX(S234A), with an increased TTN of 17.3.230 The authors presented two 
differing mechanisms to account for the reactivity observed in the presence and absence of phosphine 
additives (figure 47). 
 
Figure 47: Proposed mechanistic differences for the hemoprotein catalysed carbonyl olefination of 
aldehydes in the presence (electrophilic carbene) and absence (nucleophilic carbene) of phosphine 
reagents (figure taken from Weissenborn et al).230 
2.4 INTRODUCTION TO DE NOVO PROTEINS 
The ability to introduce novel functionality into naturally occurring protein scaffolds ignited interest 
in engineering new enzymes towards abiological chemistry. However, one problem with natural 
proteins is their long, complex evolutionary history.95 The interdependency of amino acids, a 
consequence of natural evolution, means simple mutations can unpredictably impair the function of 
a protein, sometimes in an untraceable way. Unravelling the intricate relationship between amino 





insurmountable task. This problem with natural protein scaffolds demanded a novel approach to 
protein design: de novo design.95,96 The basic premise underpinning de novo protein design is 
simplistic, small protein scaffolds, inspired by nature, can be created to mimic the functionality of 
natural proteins without harbouring any evolutionary baggage. In addition, the chemistry exhibited 
by many enzymes is a consequence of the intrinsic chemistry of an incorporated cofactor, such as a 
heme group. De novo design asserts the functionality of hemoproteins, for example, can be replicated 
by incorporating heme cofactors into simple, engineerable protein scaffolds and utilising the protein 
scaffold to fine-tune the functionality by introducing conformational restraints, facilitating 
substrate/cofactor binding, and/or tuning redox potentials.231–233  
There are three prominent approaches to designing de novo proteins: i) the maquette approach, ii) 
computational design, and iii) combinatorial assembly.233 In practice a combinational of al the 
approaches is used. The three methodologies are founded on basic principles. The maquette approach 
is a non-computational method which employs an evolutionary naïve protein scaffold as a starting 
template.98,231,233 The protein scaffold is designed to fold into a particular stable confirmation and 
provides a blueprint for functional design (figure 48). The intrinsic stability and mutability of 
maquettes facilitates enzyme design, with simple point mutations in the protein scaffold often proving 
sufficient for acquiring the desired functionality.98,231,233 Furthermore, multiple cofactors, such as 
hemes,234–238 flavins,97,239 small metals ions (such as Zn2+, Co2+),94,231 iron-sulphur clusters240–242 and 
other tetrapyrrole cofactors97,241,243,244 can be readily incorporated into a maquette backbone by 
introducing a known sequence motif (i.e. heme c-type C-X-X-C-H motif) or binding pocket without 
disrupting the protein scaffolding or suppressing the desired functionality (figure 48). The 
computational design of de novo proteins utilises computational methods (such as Rosetta software 
for protein design, coupled with QM/MM and MD to analyse Rosetta outputs) to design suitable 
protein scaffolds optimised towards a particular function, protein fold, or theozyme.95,245–250 Iterative 
simulations can be performed to determine the optimal geometric conditions for cofactor binding and 
small metal binding, and for tuning redox potentials by optimising the amino acids in the active site 
and/or secondary sphere. Computational design is frequently utilised alongside the maquette 
approach to assist in designing new catalysts, for example in the development of maquettes with 
oxidoreductase activity.232,251,252 The combinatorial approach employs a small, monomeric protein 
scaffold to be redesigned, and generates large libraries of mutants which are subject to high-
throughput screening methods to assess function; iterative rounds of diversification can be performed 






Figure 48: (left) the pattern, sequence and common topologies of maquette protein scaffolds, and 
(right) common redox cofactors that can be readily incorporated into maquette scaffolds (figure taken 
from Lichtenstein et al).253 
The oxidoreductase class of proteins encompasses an enormous set of functionally diverse and 
biologically important enzyme families.99,143,254 Oxidoreductase enzymes are involved in redox 
chemistry and find critical roles in several biological processes including aerobic/anaerobic respiration, 
secondary metabolite biosynthesis, xenobiotic detoxification and energy/light harvesting.99,143,254 The 
design of small, simplistic enzymes capable of replicating oxidoreductase activity is a very attractive 
endeavour, owing to the immense biological importance of oxidoreductases, and has been the subject 
of a wealth of research in the protein design community. 
2.4.1 Historical development of α-helical b-type heme-containing maquettes 
The redox chemistry performed by oxidoreductases is achieved through the employment of various 
redox active cofactors. 99,143,254 One of the most important classes are the heme cofactors, which 
facilitate redox chemistry via FeII/FeIII redox transitions.143 For example, the hemoproteins (heme-
containing proteins) catalyse electron transfer reactions in a variety of biological processes, including 
anaerobic/aerobic respiration, sulphate, nitrate and carbon fixation, biosynthesis and small-molecular 
transportation, all processes governed by the FeII/FeIII redox potential.143 The ubiquitous distribution 





The transmembrane respiratory complex cytochrome bc1 contains a four α-helical subunit capable of 
binding two bis-histidine coordinated b-type heme cofactors (figure 49).255–257 The structure of the 
respective active sites neighbouring each heme finely tunes the FeII/FeIII redox potential of each heme, 
resulting in a low- and high-potential heme which facilitates electron transfer.255–257 The sequence of 
the tetra-α-helix bundle was recognized to be comprised of a certain pattern of hydrophobic and 
hydrophilic amino acid residues situated at particular positions to facilitate protein folding, stability 
and heme binding. The four helices are connected by three disordered helix-loop-helix domains to 
yield the monomeric tetra-α-helix di-heme containing subunit of the enzyme complex cytochrome 
bc1.255–257 The chemical principles underlining the tetra-α-helix bundle served as inspiration for the 
design of simplified protein scaffolds for heme-containing oxidoreductase de novo design. 
 
Figure 49: (left) The crystal structure of the yeast cytochrome bc1 complex (white, hemes are shown 
in yellow; PDB: 1KB9), and (top left and top right) close of views of the di-heme tetra-α-helix bundle 
in the core of yeast cytochrome bc1, the bottom panel shows the bis-histidine ligation of each heme 
cofactor (white, hemes are shown in yellow; PDB: 1KB9). 
In 1987, Degrado and co-workers reported the design of monomeric amphiphilic 16-residue synthetic 
peptides, α1A and α1B, designed to tetramerise into 4-helix bundles (figure 50, A).258 Each peptide was 
confirmed to form stable helices by circular dichroism (in the presence and absence of a denaturant). 
The peptide α1B was subjected to further design and two peptides, α1B-Pro-α1B and α1B-Pro-Arg-Arg-
α1B, were reported, with the -Pro- and -Pro-Arg-Arg- links incorporated into the scaffold to covalently 
link two α1B peptides. The α1B-Pro-α1B peptide was reported to trimerise in solution to give a hexa-α-
helix protein, while the α1B-Pro-Arg-Arg-α1B was reported to form stable helical dimers (figure 50, B). 
The difference between the two is attributed to the inclusion of the two Arg residues in the connecting 
loop, which reportedly destabilises the trimeric structure of α1B-Pro-α1B. This work demonstrated the 






Figure 50: The design of tetra-α-helical bundles, from A) the self-assembly of monomeric peptides into 
a tetramer, B) the self-assembly of a helix-loop-helix monomeric unit into a dimer, and C) a monomeric 
four-helix bundle formed by connecting loops 
In 1988, Degrado and co-workers extended their designs to include monomeric tetra-α-helix bundles 
(figure 50, C).259 A series of proteins, named α1, α2, and α4, were designed to emphasize how simple 
point mutations in the helical backbone can finely tune the dynamics, folding and stability of simple 
tetra-α-helix maquettes. The general ‘helix’ sequence, employed for all three maquettes, was 
intentionally selected to favour 4-helix bundle formation. Hydrophobic leucine residues were 
introduced at certain positions to enhance the hydrophobic interactions in the core of the maquette. 
Likewise, glutamic acid and lysine residues were introduced at certain positions to facilitate the 
formation of ion pairs between the helices and provide additional stabilisation to the final 4-helix 
structure.259 The α1 protein consisted of a single helix monomeric unit which tetramerised in solution; 
the α2 protein consisted of a helix-loop-helix monomeric structure which favourably dimerised into a 
tetra-α-helix protein.259 The α4 protein was a monomeric, single polypeptide chain that folded into a 
tetra-α-helix confirmation, could be expressed in E.coli, and possessed considerable stability towards 
denaturants (such as GuHCl) relative to small hemoproteins (ΔGα4 = -22.5 kcal mol-1 vs -7.6 kcal mol-1 
for myoglobin).259  
In 1994, DeGrado and Dutton reported a library of synthetic 62-residue di-α-helical peptides that, 
through self-assembly into tetra-helical bundles, were capable of accommodating two bis-histidine 
ligated heme B cofactors (figure 51, C).260 A series of four dimeric maquettes, collectively named IIa2, 
IIb2, IIc2, and IId2 respectively, were designed based on two differing di-α-helical monomers (the two 





structural difference between the four maquettes was the number and position of histidine residues 
(H10 and H24) in each helix respectively.260 The IIa2 and IId2 maquettes both contained a H10-H10 and 
H24-H24 histidine pair, rendering them tetraheme-containing dimeric bundles, while the IIb2 (H10-
H10) and IIc2 (H24-H24) maquettes yielded dimers possessing only two bis-histidine ligated hemes (at 
H10-H10 and H24-H24) respectively (figure 51, A/B).260 Importantly, all four maquettes possessed 
biophysical characteristics similar to natural heme-containing proteins, displayed sub-micromolar 
heme dissociation constants and exhibiting characteristic spectroscopic profiles for bis-histidine 
ligataion.260 These maquettes are collectively named the H10H24 maquettes, and beautifully illustrate 
how simple, mutable protein scaffolds can be readily engineered to accommodate biologically 
important cofactors. In 1996, Dutton and co-workers incorporated a [4Fe-4S]2+/1+ cluster into the loop 
domain of H10H24 maquettes, further illustrating the facile nature at with tetra-α-helix bundles can 
be engineered towards desired functionality.240    
 
Figure 51: The incorporation of bis-histidine ligated b-type heme cofactors into tetra-α-helical 
maquette. A and B) incorporation of a single b-type heme, and C) incorporation of two b-type hemes. 
In 1996, DeGrado et al reported a di-α-helical maquette, α2, which upon dimerization assembled into 
a parallel configuration with two-fold symmetry to engender the tetra-α-helix maquette, [α2]2.261 All 
four α-helices of the bundle had a common sequence, containing two histidine residues to function as 
heme binding sites. Coproporphyrin I (CP) was selected to represent chlorophyll. A parent chain of α 
was derivatised with CP to yield CP-α, which heterodimerised with another α chain to yield the CP-α2 
which, like the parent chain, self-assembles to give the dimeric maquette [CP-α2]2. The CP monomer-
to-dimer equilibrium (KD < 10-8) indicated that [CP-α2]2 stabilises and promotes CP dimerization; the 
authors reported up to four CP cofactors could be incorporated into the maquette without any 
detectable disruption to the CP monomer-to-dimer spectra.261 The postulation was further support 
after examining the monomer-to-dimer equilibrium in the presence of 2,2,2-trifluoroethanol (TFE), a 
solvent known to disrupt the tertiary and quaternary structure of a protein without disrupting the 





transition, caused by the dissociation of the [CP-α2]2 into monomeric CP-α2 molecules. The ability of 
[CP-α2]2 to stabilise the dimerization of CP by >1000-fold lead the authors to postulate that [CP-α2]2 
could function as a primitive, simplified structure in future efforts towards the design of photoactive 
redox centres.261  
In 1997, Dutton et al explored the biophysics of the H10H24 maquette by substituting the hydrophobic 
leucine residues for β-branched and/or aromatic amino acids.262 Initial studies introduced isoleucine 
mutations at L6 and phenylalanine mutations at L13 to yield three mutant maquettes, H10H24-(L6I), 
H10H24-(L13F), and H10H24-(L6I, L13F).262 The CD spectrum for each mutant had 222nm/208nm 
ratios >1, the hallmark for α-helicity. The authors also reported NMR data for each mutant, with each 
exhibiting enhanced chemical shift dispersions relative to the parent H10H24 maquette.262 The 
enhanced chemical shift dispersion is a result of a more native-like, stable tertiary structure for the 
mutant maquettes provided by the increased side-chain packing specificity in the maquette core. 
Furthermore, each mutant maquette exhibited heme-binding dissociation constants in the 10-20 nM 
range for the binding of the initial pair of hemes, followed by dissociation constants in the 5-15 µM 
range for the second pair of hemes. The EPR spectra indicating the resting state of each maquette is a 
low-spin ferric complex.262 The importance of this work is it demonstrates how introducing key 
substitutions into the maquette scaffold (leucine for isoleucine/phenylaniline) can result in the 
emergence of native-like structures for the simple maquette proteins.  
In the following year, Dutton and co-workers further examined the nature of the double variant 
H10H24-(L6I, L13F) in contrast to parent maquette H10H24.263 It was reported that apo-H10H24 has 
a defined secondary structure, but exists as an ensemble of slowly interconverting confirmations in 
solution. The authors utilised 15N-HSQC and NOSY NMR to investigate the structure of apo-H10H24-
(L6I, L13F), which was characterised by a single set of narrow NMR resonances and a chemical shift 
dispersion characteristic of a native protein. It was reported that apo-H10H24-(L6I, L13F) exists, in 
solution, as a four-α-helix bundle comprised of two asymmetric (α-SS- α)2 helices with a well-defined 
tertiary structure. The authors indicated the maquette apo-H10H24-(L6I, L13F) would be employed in 
future investigations to better understand the dynamics of protein stability and folding.263  
In 1999, two papers using NMR spectroscopy to study the solution structure and dynamics of de novo 
helical-bundles were reported: a de novo three-helix bundle by Walsh, Degrado and co-workers264 and 
a de novo four-helix bundle by Skalicky et al.265 In the Degrado report, the NMR solution structure of 
a non-native three-α-helix bundle, α3D, was resolved. Although α3D  is not based on any native protein, 
its biophysical characterisation revealed its thermodynamic and spectroscopic properties paralleled 





(HNMD-NMR) spectroscopy which revealed the helices adopt a counterclockwise topology, in 
agreement with computational predictions. The structure acquired from HNMD-NMR spectroscopy 
also confirmed the presence of a well-defined and tight hydrophobic core.264 In the Dutton report, the 
NMR solution structure of a non-native, two-fold symmetrical four-α-helix bundle, (α’-SS-α’)2, was 
resolved.265 It was observed that α’-SS-α’ (figure 52) dimerises and adopts a parallel configuration 
which is stabilised by the formation of a well-ordered hydrophobic core. One particular feature of (α’-
SS-α’)2 is its lack of any heme-binding pocket because of the tight hydrophobic packing in its core. 
Despite this, (α’-SS-α’)2 is still capable of binding four heme cofactors with Kd values of 10-20 nM (for 
the first two hemes) and 5-15 µM (for the last two hemes). The authors note the binding of four hemes 
causes the reorganisation in the hydrophobic core, resulting in a disorder mutli-heme containing 
protein with a well-defined helical structure.265  
 
Figure 52: (left) the three-dimensional superposition of 25 (α’-SS-α’) structures and (right) the 1H/13C 
HSQC NMR spectrum for α’-SS-α’ (figures taken from Dutton et al).265  
The establishment of well-defined α-helical scaffolds provided a platform to begin investigating how 
oxidoreductase functionality could be engineered into maquettes. In 2000, Shifman et al explored 
how varying the structure of a co-factor, changing the pH and introducing key mutations in the heme-
binding site affected the heme-redox potential when the cofactor was bound to a tetra-α-helical 
maquette.244 A combination of all possible approaches allowed the authors to obtain a library of bis-
histidine ligated heme-containing maquettes possessing redox potentials across a 435 mV range.244 





maquettes can be finely tailored towards a particular application, highlighting the fact that de novo 
maquettes are more than mere laboratory curiosities.    
In 2003, to corroborate the NMR structures of α-helical maquettes reported by the Degrado264 and 
Dutton265 labs in 1999, Dutton reported the X-ray crystal structure of the maquette [I6F13M31]2 (called 
L31M), a third-generation H10H24 maquette (H10H24-(L6I, L13F, L31M)).266 The X-ray structure, 
resolved to 2.8 Å, of L31M revealed the maquette is a tetra-α-helical bundle, formed by the 
dimerization of two (α-SS-α) monomers, and adopts an anti-topology confirmation.266 In 2004, Dutton 
and co-workers expanded on the L31M maquette.267 It was reported that both [I6F13] (the predecessor 
to L31M) and L31M were conformationally specific in the apo-state, but binding of a ferric heme 
engendered molten globular maquettes with poorly defined tertiary structures.267 The L31M 
maquette scaffold was subsequently subjected to seven additional mutations to yield a novel, fourth 
generational maquette named HP-1.267 HP-1 was reported to be a molten globule in the apo-state, in 
direct contrast to [I6F13] and L31M maquettes.267 HP-1 was, however, reported to bind ferric heme 
tightly, with reported dissociation constants in the nM range (< 20 nM). Halo-HP-1 exhibited UV-VIS 
absorption spectra consistent with bis-histidine ligation for both the ferric and ferrous states, and the 
EPR spectra indicated the ground electronic state of di-heme HP-1 to be two identical low-spin bis-
histidine ligated ferric hemes.267 Unlike apo-HP1, halo-HP-1 possess a defined tertiary structure in 
solution (determined by NMR spectroscopy), in direct contrast to [I6F13] and L31M.266,267 Interestingly, 
HP-1 binds zinc-protoporphyrin IX with high affinity, in a similar fashion to iron-protoporphyrin IX; 
however, the resulting complex is a pentacoordinate ligated complex and the NMR chemical shift 
dispersions indicate Zn-PPIX-HP-1 has no definitive tertiary structure in. This observation indicated 
that bis-histidine ligation is necessary for HP-1 to adopt a stable, defined tertiary structure.267 
The maquette approach began using simple repeating monomeric structures that self-assemble into 
small tetrameric bundles in solution. Over the course of two decades, the maquette approach 
matured and ultimately afforded small, stable well-defined tetra-α-helical heme-containing protein 
scaffolds. The next question concerned whether tetra-α-helical heme-containing maquettes could 
mimic hemoprotein function. In 2009, Dutton and co-workers reported a tetra-α-helical heme-
maquette capable of binding oxygen with affinities similar to natural histidine-ligated globins (figure 
53).268 The evolutional history of the oxygen-binding maquette starts with a simplified scaffold 
consisting of three amino acids (glutamate, lysine, and leucine) arranged in an almost repeating 
heptad structure. The monomers generated were observed to spontaneously assemble into four-helix 
bundles in solution, with the polar residues (glutamate and lysine) exposed to the solvent and the 





histidine ligated di-heme maquette was engineered. The maquette consisted of two di-helical 
containing identical sequences fused together by a single disulphide linked bridge to yield a 
monomeric di-heme-containing tetra-α-helical maquette (figure 53).268 The maquette bound heme B 
tightly (Kd < 1 nM) and exhibited UV-VIS spectra consistent with bis-histidine coordinated ferric and 
ferrous heme. The ferrous maquette displayed UV-VIS spectra consistent with the formation of an 
oxy-ferrous complex, with spectra remarkably similar to that of neuroglobin (figure 53).268 It was 
reported the oxy-ferrous was stable for approximately 10 seconds before superoxide is released. The 
authors reported an apparent KdO2/KdCO of 0.1, a ratio significantly larger than that observed for other 
distal histidine oxygen binding hemoproteins.268 Although the rate of formation of the oxy-complex, 
(konO2 ; 0.017 µM-1 s-1) was lower than for natural hemoproteins, the rate of oxygen dissociation (koffO2) 
was drastically lower. The stability of the oxy-complex is attributed to a stabilising interactions 
between a histidine residue and the oxygen ligand.268 The importance of the work is two-fold. Firstly, 
it demonstrates that de novo protein scaffolds are functional proteins capable of replicating naturally 
occurring enzymes. Secondly. It highlighted the underlining principle of de novo design that the 
complex structures found in nature (such as the globin fold in oxygen-binding proteins) are 
unnecessary to achieve functionality. 
 
Figure 53: The design of an artificial oxygen binding protein (left) the design pathway from a simple 
self-assembling monomeric peptides into a 4-helix bundle (1) to the di-b-type heme containing 
monomeric 4-helix bundle (6) and (right) the UV-VIS spectra for the ferric, ferrous, carboxy-ferrous 
and oxy-ferrous of the maquette 6 with either heme B (a) or heme A (b). The spectra c and d show the 
stopped-flow spectral changes after rapid mixing of ferrous heme B containing 6 with oxygen (figure 





A seminal paper in de novo protein design came in 2013, when Dutton and co-workers reported a 
series of non-symmetrical monomeric tetra-α-helical maquettes.269 The homodimeric maquette 
structure was redesigned to engender a series of monomeric maquettes structurally consisting of four 
helices connected by three loops. The elementary scaffold design was engineered to afford a 
minimalist interior that allowed for the functionalisation with a range of light- and redox- active 
cofactors, including hemes, zinc porphyrins, zinc chlorins, and flavins.269 The non-symmetrical 
sequence of the principle maquette scaffold allowed more sophisticated functionalisations to be 
accessed.269 A monoheme-containing maquette was reportedly efficient at oxygen-binding, producing 
spectra consistent with the formation of a ferrous-oxy complex. The absorbance in the spectra 
doubled when the same maquette scaffold containing two hemes was mixed with an oxygen saturated 
buffer.269 The same diheme-containing reduced maquette was reported to catalyst an inter-protein 
reduction, transferring an electron to cytochrome c with a remarkable bimolecular rate constant of 2 
x 107 M-1 s-1. The mutation of three glutamates to alanines in each helix afforded a new di-heme 
containing maquette that demonstrated proficiency at superoxide formation, with a half-life of 
approximately 0.15 seconds observed for the formation of the oxy-ferrous complex and the 
subsequent generation of superoxide. Finally, functionalising mono-heme scaffolds with either zinc 
porphyrin, zinc chlorin or flavin engendered a series of maquettes with photoinducible intraprotein 
electron transfer capabilities.269 
2.4.2 The emergence of the tetra-α-helical c-type heme-containing maquettes 
There are two primary objectives of de novo protein design. The first is the ability to engineer simple, 
protein scaffolds capable of mimicking the biological function. The second is the ability to incorporate 
de novo proteins into cellular environments for in vivo function. The development of the heme-
containing maquettes utilised non-covalently bound heme cofactors (heme A and heme B), with the 
heme cofactor being introduced to the protein scaffold post-purification. In nature, many 
hemoproteins are functionalised with c-type heme cofactors, in which the heme is post-translationally 
appended to the protein via the formation of  covalent thioether bonds with cysteine residues.100 The 
covalent attachment of a c-type heme to apo-c-type proteins is catalysed by a large membrane-
localised protein complex called the cytochrome c maturation (ccm) apparatus.270,271 The attachment 
of c-type hemes to apo-c-type proteins requires three things: i) the translocation of the biosynthesised 
heme cofactor from the cytoplasm to the periplasm, ii) the translocation of the polypeptide sequence 
from the cytoplasm to the periplasm, and iii) the reduction of any disulphide bridges to thiols to allow 
covalent attachment.270 In bacterial c-type hemoproteins, the ccm apparatus perform all three crucial 





considered essential for translocation across the lipid bilayer and post-translational modification.271 In 
particular, the histidine residue which provides the axial ligand post-functionalisation is considered 
absolutely vital for the functioning of the ccm apparatus, as mutations of the histidine residue in c-
type hemoproteins result in only small quantities of the apoprotein being formed.271  
 
Figure 54: The cytochrome c maturation (ccm) pathway (taken from Watkins et al)272 
The success of engineering b-type maquettes raised the question of whether the ccm apparatus could 
be utilised in vivo to post-translationally modify an apo-maquette (containing the crucial CαX1X2CβH 
sequence motif) into a c-type maquette. The hijacking of the bacterial ccm machinery had already 
been demonstrated in 2004 when Braun and Thӧny-Meyer utilised the ccm machinery of E. coli to 
produce a library of c-type functionalised artificial microperoxidases in vivo.273 In 2014, Anderson and 
co-workers reported a fully functional, monomeric tetra-α-helical c-type maquette (CTM), possessing 
the necessary consensus sequence, that was successfully constructed in vivo when co-expressed with 
a pEC86 expression vector harbouring the ccm apparatus.251 After 15 hours of co-expression with the 
pEC86 vector the authors reported up to 90% c-type heme incorporation into the maquette scaffold. 
The incorporation of a c-type heme was verified by MALDI-TOF mass spectrometry and UV/VIS 





was identical to the Q-band exhibited by bovine cytochrome c, and treating the c-type maquette with 
acidified 2-butanone resulting in no heme partitioning into the organic phase.211  
Anderson and co-workers had demonstrated that de novo maquettes can be engineered and 
expressed, without disruption of functionality, in cellular environments. In 2015, Watkins et al 
extended their work by exploring the engineering tolerance of the ccm machinery and the c-type 
maquette prototype.234 The authors generated a diverse library of c-type maquettes (CTMs) including 
C1, C2, C3, and C4 respectively, distinguished by the helix the c-type heme is covalently appended to 
(figure 55).234  In addition, a suite of diheme containing maquettes, functionalised with ether two c-
type hemes (cCTMs) or a c-type and b-type heme (bCTMs), named C1C2, C1C4, C2C4, and C3C4 
respectively, were also created.234   
 
Figure 55: 1 µs molecular dynamic simulations of CTMs. (top row) side views of C1 (red), C2 (blue), C3 
(pink), and C4 (green), and (bottom row) zoomed in view of the heme c active site in C1 (red), C2 
(blue), C3 (pink), and C4 (green). Figures taken from Watkins et al.234 
The CTM and C1C4 and CC2C3 cCTM variants exhibited UV-VIS spectra consistent with ferric and 
ferrous c-type hemoproteins.234  The redox properties of the mono-heme CTMs, bCTMs and C1C4 was 
also investigated. The mono-heme CTMs exhibited midpoint potentials across a range of 39 mV, from 
-181 mV for C3 to -220 mV (vs NHE) for C4. The bCTMs had two distinctive redox events separated by 
a midpoint potential difference of 40 mV, 49 mV and 62 mV (vs NHE) for BC1, BC3 and BC4, 
respectively. In addition, the cCTM C1C4 maquette also recorded two separate redox events, at -154 
mV and -207 mV (vs NHE).234  The thermal stability of the CTMs, bCTMs and C1C4 was also investigated 
by circular dichroism. The CTMs exhibited thermal melting temperatures (Tm) across a 24OC range; 





range.234  For the CTMs, the authors report the differences in the orientation of heme at the binding 
site plays a critical role in the observed TM. The heme propionates are either positioned towards the 
solvent (C3 and C4) or towards the hydrophobic core (C1 and C2); the displacement of the charged 
propionates from the hydrophobic core engenders a more stable conformation, which is reflected in 
the respective Tm values (C3 > C4 > C1 > C2). It was also suggested, via MD simulations, that the charged 
propionates of the C3 and C4 heme formed stabilizing salt bridges with lysine residues from the 
hydrophilic helix regions.234 In the bCTM maquettes, the orientation of the b-type heme is not 
restricted by covalent attachment to the protein scaffold, and therefore adopts an orientation that 
positions the propionates towards bulk solvent thus facilitating the formation of electrostatic 
interactions with surface lysines, accounting for the elevated Tm values for bCTMs vs CTMs.234  Finally, 
the oxygen binding and autoxidation of the CTM variants was examined. The oxygen binding affinity 
for all CTMs was determined under anaerobic conditions by mixing the maquette with oxygenated 
buffer and monitoring the binding event spectroscopically. The observed first-order rates for dioxygen 
binding (kobs; s-1) indicated the CTM variants retained the ability to bind oxygen despite changes in the 
heme C binding site.234  The formation of an oxy-ferrous complex has also previously been 
demonstrated to be succeeded by an autoxidation event, resulting in the generation of superoxide. 
The observed rates of autooxidation (kobs; s-1) for C1-4 were 0.25, 0.27, 0.46, and 0.27 respectively.234  
The work demonstrated, again, the flexibility and plasticity of the maquette approach, and 
demonstrated that the biophysical properties of CTMs could be fine-tuned towards a desired 
oxidoreductase function. 
In 2017, Watkins et al extended the maquette approach towards the design of an in vivo constructed 
CTM with proficient peroxidase activity.235 The maquette was designed from the C4 CTM by 
introducing three key histidine to phenylalanine mutations: mutating the two histidines that 
coordinate to the iron and form the heme b binding site (on helices 1 and 3) and the histidine that 
provides the sixth ligand to the iron at the c-type active site (on helix 2) (figure 56).235 The result was 
a pentacoordinate CTM called C45 (C = c-type, 4 = helix the axial histidine residues on, 5 = the 






Figure 56: (a) The engineering of the monohistidine ligated CTM C45 from C4 via the intermediary bis-
histidine CTM C46, (b) CD spectra of C45 across an 80OC temperature range, (c) denaturation and 
refolding of C45 measured at 222 nm, (d) the UV-VIS spectra of ferric C46 (red) and C45 (blue), (e) UV-
VIS spectra of ferrous C46 (red), C45 (blue), and C45 in excess imidazole (magenta). Figure taken from 
Watkins et al235 
The UV-VIS spectra of ferric and ferrous C45 resembled the electronic spectra recorded for the other 
monohistidine-ligated cytochrome c variants. The electronic spectra of ferric C45 is pH-dependent, 
indicting the vacant sixth coordinate site in C45 is occupied by a titratable water molecule (in the 
resting state).235 The presence of a labile water molecule is also indicated from the pH-dependence of 
the heme redox potential, which varies from -208 mV (pH = 10) to -174 mV (pH = 8.6), indicative of a 
water/hydroxide equilibrium.235 The UV-VIS spectra of C45 in excess imidazole reproduces the spectra 
of C4 and C46 (a bis-histidine-ligated CTM resulting from two histidine to phenylalanine mutations on 
helices 1 and 3 respectively). The three histidine to phenylalanine mutations afford remarkable 
thermostability, with a Tm of 86OC reported for C45. C45 was also proficient at binding O2, exhibiting a 
10-fold increase in binding affinity relative to C4. The presence of a liable water axially coordinated to 
the histidine residue opens up the possibility that C45 could be employed for catalysis.235  
The enzymology of peroxidases was introduced in section 2.2.2.2. The catalytic cycle of peroxidases, 
irrespective of structural differences, are characterised by the formation of an active intermediate 
called compound I. A common assay for measuring peroxidase activity is mixing an enzyme and 
hydrogen peroxide together in the presence of 2,2′-azino-bis(3-ethylbenzothiazoline 6-sulfonic acid 
(ABTS).274 In the presence of an active peroxidase, ABTS is converted into a green cationic radical, 
allowing for peroxidase activity to be detected spectroscopically (figure 57). Mixing ABTS with ferric 





The steady-state kinetics of C45-catalysed ABTS turnover, as a function of peroxide concentration, 
were determined and displayed classic Michaelis-Menten behaviour (figure 57).  
 
Figure 57: The steady-state of ABTS and hydrogen peroxide turnover by C45. (a) The reaction between 
peroxide-activated C45 and ABTS generates a green cationic radical, (b) Steady-state kinetics plot for 
ABTS turnover by C45 at varying [ABTS] and [H2O2], (c) The thermal stability of C45 enables classical 
Michaelis-Menten kinetics to be determined up to 70OC. Figure taken from Watkins et al235 
The kinetic behaviour was fitted to a ping-pong mechanism, characteristic of peroxidases, and allowed 
the kinetic parameters for i) the activation of peroxide by C45, and ii) the electron transfer between 
peroxide-activated C45 and ABTS to be quantified. The Michaelis-Menten parameters reported for the 
electron transfer step afforded a catalytic efficiency of kcat/KM = 3.2 x 106 M-1 s-1, which is close to the 
catalytic efficiency reported for the naturally occurring peroxidase horseradish peroxidase (HRP; 
kcat/KM = 5.13 x 106 M-1 s-1).235 In contrast to the electron transfer step, C45 is less adept at the peroxide 
activation step (kcat/KM = 1.3 x 104 M-1 s-1 for C45; kcat/KM = 4.6 x 106 M-1 s-1 for HRP), which the authors 
attribute to a lack of peroxidase-activating residues in the active site of C45. C45 was also 
demonstrated to function as an efficient artificial cytochrome c peroxidase (kcat/KM = 4.3 x 105 M-1 s-1  
for C45; kcat/KM = 1.62 x 107 M-1 s-1 for yeast cytochrome c peroxidase).235 C45 exhibits significant 
substrate promiscuity, catalysing the oxidation of guaiacol, p-anisidine,  o-phenylenediamine, 5-
aminosalicylic acid, luminol, reactive blue 4, reactive black 5, and the oxidative dehalogenation of 
halogenated phenols such as 2,4,6-trifluorophenol, 2,4,6-trichlorophenol, and 2,4,6-tribromophenol, 
and 4-bromophenol.235 The reactive intermediate in all the aforementioned reactions was 
investigated via UV-VIS and EPR spectroscopy. The UV-VIS spectrum of C45 in the presence of 





reported for compound I in cytochrome c peroxidase; in addition, the EPR spectrum indicated the 
formation of a tryptophan radical species (the residue W43 residues close to the active site heme) also 
resembling the EPR spectra recorded for compound I in cytochrome c peroxidase.235 
2.5 CONCLUSION: IS C45 A POSSIBLE CARBENE TRANSFERASE? 
Hemoproteins are an extensive class of metalloenzymes characterised by the incorporation of a redox-
active iron-metallated tetrapyrrole cofactor (heme) into the protein backbone. The incorporation of 
the heme cofactor allows hemoproteins to perform biological functions that would otherwise be 
inaccessible via the twenty canonical amino acids. These functions include electron transport, small 
ligand sensing, small molecule transportation, peroxidase chemistry, and monooxygenase chemistry. 
The catalytic cycle exhibited by peroxidase and monooxygenase enzymes all proceed via a universal, 
heme-localised cationic radical reactive intermediate called compound I. The intrinsic chemistry of the 
heme cofactor is, however, a lot richer than is otherwise observed in nature. The developments in 
molecular biology have afforded novel methodologies for the re-engineering of proteins towards 
abiological functionality, with the introduction of key mutations and modifications allowing for novel, 
abiological chemistry to be unlocked.  It was demonstrated that cytochrome P450 monooxygenases 
and globins were identified as suitable candidates for designing artificial hemoproteins proficient 
towards carbene transferase chemistry on account of the analogous nature of compound I and 
isolated iron-tetrapyrrole metallocarbenoids. Through iterative rounds of directed evolution naturally 
occurring hemoproteins could be engineered towards metallocarbenoid formation and subsequently 
demonstrated proficient chemo-, regio-, and stereoselective carbene transferase activity towards a 
host of suitable substrates, including olefins (cyclopropanation), thiols, amines, phosphines, borides, 
C-H bonds (X-H insertion) and carbonyls (carbonyl olefinations).   
C45 (figure 58) is a thermostable pentacoordinate, c-type tetra-α-helical maquette capable of being 
assembled in vivo and functions as a promiscuous and proficient de novo peroxidase. The UV-VIS and 
EPR spectrum acquired for C45 in the presence of peroxides indicates its catalytic activity is a 
consequence of its ability to form a heme-localised reactive intermediate called compound I, with the 
EPR spectra suggesting the cationic radical is localised on an active site tryptophan residue, 
analogously to compound I in cytochrome c peroxidase. The similarities between the carbene 
transferases engineered from naturally occurring hemoprotein scaffolds (P450s and globins) and C45 
engendered two simple questions: i) can a heme-localised metallocarbenoid intermediate by isolated 
and characterised with C45, and ii) if it can, is it possible to use C45 as a de novo carbene transferase 












CHAPTER 3: SPECTROSCOPIC CHARACTERISATION AND MASS SPECTROMETRY OF 
BIOORGANOMETALLIC METALLOCARBENOID COMPLEXES IN HEMOPROTEINS AND DE 
NOVO MAQUETTES  
3.1 A BRIEF HISTORY OF IRON PORPHYRIN CARBENES (IPCS) 
An iron-bound tetrapyrrole metallocarbenoid (IPC) was first hypothesised in 1974 by Mansuy and 
Ulrich in attempts to explain the metabolism of halothane in the body.275 It was postulated that 
halothane is broken down by a microsomal cytochrome P450 and its anabolism proceeds via a 
metallocarbenoid intermediate. The UV-VIS spectrum obtained for P450 in the presence of halothane 
produces a distinctive spectrum characterised by a shift in the Soret peak.275 It was shown the UV-VIS 
spectrum for P450 in the presence of halothane could be reproduced when a known carbene 
precursor, trifluorodiazoethane, was added to a solution of P450 under reducing conditions. 
Furthermore, trifluoroacetic acid was obtained under aerobic conditions, which hinted at the 
formation, and subsequent hydrolysis, of trifluorodiazoethane via a carbene intermediate.275  
In 1977 it was demonstrated that cytochrome P450s (isolated from liver) could reduce tri- and tetra- 
halogenated methanes (i.e. CBr4, CCl4, CCl3F, CCl3Br, CCl3CN, CHI3, CHBr3, and CHCl3).276 Under 
anaerobic conditions NADPH was oxidised and the production of CO was detected via IR-spectroscopy; 
the production of CO supports the formation of a metallocarbenoid intermediate (figure 59), as it had 
previously been isolated as a breakdown product of Cr(III)-halogenated-carbene complexes.276 A 
crystal structure for the carbene complex, Fe(TPP)(CCl2)(H2O), was reported in 1978 (figure 59), and 
confirmed the hypothesis that a metallocarbenoid intermediate was responsible for the reduction of 
halothane and polyhalogenated methanes.189 In addition, the IR-spectrum of the complex exhibited a 
band at 872 cm-1 which was assigned to a C-Cl stretching vibration (the band is absent in Fe(TPP)(py)2 
and Fe(TPP)(py)(CO) complexes) and shifts to 841 cm-1 in the IR-spectrum for Fe(TPP)(13CCl2).189 
Interestingly, the crystal structure revealed the carbene bound to the metal in the terminal mode, as 
opposed to the possible bridging mode (a result of insertion into a Fe-N bond). It was later 
demonstrated, in 1978, that cytochrome P450s metabolise DDT via a vinylidene complex,277 and in 
1979 a metallocarbenoid intermediate was attributed to the potency of the 1,3-benzodioxole series 
of insecticide synergists, suggesting metallocarbenoid formation irreversible inhibits P450 and thus 






Figure 59: A) The general reaction scheme for the cytochrome P450 catalysed dehalogenation of 
polyhalogenated methanes, B) the crystal structure of the carbene complex Fe(TPP)(CCl2)(H2O) (figure 
taken from Mansuy et al),189 and C) the rate of carbon monoxide production following the addition of 
various polyhalogenated methanes to reduced rate liver cytochrome P450 (figure taken from Wolf et 
al).276 
Iron tetraporphyrins are well established catalysts in hydroxylation and epoxidation chemistry.279–282 
In nature, the cytochromes P450 are a superfamily of hemoproteins that perform monooxygenation 
reactions using molecular oxygen or hydrogen peroxide.101,283,284 P450s are found ubiquitously in 
biology, with roles ranging from the synthesis of biomolecules (i.e. steroidogenesis) to the metabolism 
of xenobiotics. All P450s capable of performing monooxygenation reactions proceed via a ubiquitous 
intermediate called compound I – a radical cation iron(IV)-oxene species.101,126,283–285 In 1995 Robbins 
Wolf and Woo employed ferrous tetraphenylporphyrin (FeII(TPP)) as a catalyst in the stereoselective 
cyclopropanation of alkenes.286 The active intermediate was postulated to be an iron-localised 
metallocarbenoid, a postulation that was supported by secondary kinetic isotope effects using 
styrene-d8.286 Interestingly, an iron-localised-metallocarbenoid intermediate is analogous to 
compound I, the active intermediate in monooxygenases.101,285 As carbene transfer chemistry and 
monooxygenation chemistry are both catalysed by an iron-tetrapyrrole catalyst, and the mechanism 
proceeds via analogous intermediates, the question of whether hemoproteins could catalyse carbene 






3.2 ARTIFICIAL CARBENE TRANSFERASES 
The successful employment of iron tetrapyrrole complexes as catalysts in abiological reactions, such 
as carbene transfer chemistry, prompted the question of whether hemoproteins could be altered 
towards abiological chemistry. The rationale was that key mutations to an enzyme’s sequence, for 
example via iterative rounds of directed evolution, could supress its natural functionality while 
concurrently unlocking novel functionality undocumented in nature.91,94,287 Through directed 
evolution, engineered hemoproteins (starting from myoglobin and cytochrome P450 blueprints) have 
been successfully utilised as biocatalysts in cyclopropanation,192,195,199,209,210 intra- and intermolecular 
X-H insertion (where X = C, N, S, Si, B)17,210,215–217,220,221,288 and carbonyl olefination reactions.229,230  
The mechanism of biocatalytic carbene transfer reactions is hypothesised to proceed via a heme-
localised metallocarbenoid intermediate.187,289 Computational analysis has indicated a 
metallocarbenoid complex in a tetrapyrrole-ligated iron would afford an electrophilic carbene as 
electron density is donated from the carbene orbitals into the vacant orbitals of iron (discussed in 
detail below).38,39,290,291 These predictions are consistent with two pieces of empirical evidence. Firstly, 
a mutation of the axial ligand that coordinates to the heme iron, and trans to the reactive intermediate 
(oxene, carbene etc), to a less-efficient electron donor (i.e. cystine to serine) results in diminished 
monooxygenation activity and improved carbene transfer activity.192,193,292,293 This is rationalised on 
account of electronics. In the case of monooxygenation, as less electron-donation from the occupied 
axial ligand orbitals to the unoccupied iron orbitals results in less electron density being available in 
the iron orbitals for donating into the π* orbital of O2, a crucial step in the heterolytic cleavage of O2 
leading to the formation of compound I. In the case of the metallocarbenoid intermediate, the 
decreased electron donation from the occupied orbitals of the axial ligand to the unoccupied orbitals 
of iron results in a greater degree electron donation from the occupied carbene orbitals to the empty 
iron orbitals, meaning electron density is shifted away from the carbene carbon and results in 
increased electrophilicity. Secondly, the improved reaction efficiency observed in cyclopropanation/X-
H insertion reactions catalysed by engineered hemoproteins, where an olefin/X-H group (NH, SH etc) 
serves as the nucleophile in the reaction. This is corroborated by the Hammett plots and Hammett 
constants reported in the literature for various functionalised styrenes: electron-donating groups in 
the para-position of the styrene aromatic ring increase the nucleophilicity of the olefin nucleophile 
and result in an increased reaction efficiency, whereas electron-withdrawing groups decrease the 
nucleophilicity and consequently decrease the reaction efficiency.52  
In 2018 the Arnold group reported the first crystal structure of an iron-localised metallocarbenoid 





60).219 The importance of the crystal structure is two-fold. Firstly, the crystal structure provided the 
first direct evidence for the existence of an enzymatic metallocarbenoid intermediate, and confirmed 
that a bioorganometallic intermediate, previously undocumented in nature, was involved in the 
abiological chemistry exhibited by modified hemoproteins.219 Secondly, the crystal structure allowed 
for the key interactions between amino acids in the protein’s primary/secondary spheres and the 
metallocarbenoid intermediate to be elucidated, affording an insight into how further modifications 
of the protein structure could be introduced to stabilise the formation of the metallocarbenoid 
intermediate, improve the rate of carbene transfer kinetics, and increase the stereoselectivity of 
carbene transfer reactions.218,219,294 
 
Figure 60: The crystal structure of the metallocarbenoid complex formed between ethyl diazoacetate 
(EDA) and the Rhodothermus mainus cytochrome c variant Rma-TDE (figure taken from Lewis et al).219 
3.3 COMPUTATIONAL STUDIES OF IRON PORPHYRIN METALLOCARBENOID (IPCS): THEORETICAL 
EXAMINATION OF IPC FORMATION AND ELECTRONIC STRUCTURE 
The isolation of metallocarbenoid intermediates in crystal structures of iron-porphyrins189 and 
cytochrome c219 validated the role of metallocarbenoid intermediates in carbene transferase activity 
previously reported in the literature by Arnold,184,187 Fasan,195,199,213,216,288,291 Brustad,289,295–297 
Coelho.190,191,298 However, further questions concerning i) the reaction mechanism for the formation 
of IPCs from diazo compounds, ii) the electronics governing IPC formation, and iii) the electronic 
structure of IPCs needed to be addressed. To date, several computational studies have been reported 
and have provided valuable insights into the aforementioned questions and have made predictions 





3.3.1 Iron porphyrin carbenes (IPCs): formation pathway and complex electronics 
The theoretical reaction mechanism for iron-porphyrin carbenoid formation from diazo compounds is 
illustrated in figure 61. The proposed pathway starts with a tetrahedral intermediate following the 
formation of a σ-bond between iron and the carbenoid carbon. A concerted elimination ensues where 
a π-bond between the iron and the carbenoid forms at the expense of N2, which is eliminated to yield 
the iron-porphyrin carbenoid.61,291 The loss of entropy following conversion of the carbenoid carbon 
from a sp3 hybridisation state in the tetrahedral intermediate to a sp2 hybridisation state in the IPC is 
compensated by the significant increase in entropy accompanying the expulsion of N2, and likely acts 
as the thermodynamic driving force of the reaction.  
 
Figure 61: The formation of an iron porphyrin metallocarbenoid (IPC) from a diazo compound 
proceeding via a tetrahedral transition state (TS).38,40,290 
3.3.1.1 Formation of IPCs via a tetrahedral intermediate 
Zhang and co-workers studied the IPC formation pathway computationally and provided some key 
insights into the nature of the initial tetrahedral intermediate.38,40,290 It was reported that the largest 
bond change accompanying tetrahedral formation is the C-N bond on the diazo compound, with an 
elongation of approximately 0.5 Ӓ.40 The elongation of the C-N bond is accompanied by an increase in 
the bond angles around the carbon substituents as a consequence of a deviation away from the planar 
conformation of the diazo compound.40 
It was noted that a large charge transfer from the N2 substituent to the carbene carbon is a crucial 
electronic step governing the rate of formation of the tetrahedral intermediate. A subsequent charge 
donation from the carbene to the iron in the transition state results in an increase in negative charge 
on the iron which is accompanied by an increase in positive charge on the carbene carbon.40 This is 
corroborated by considering the influence the electronic nature of the carbene substituents have on 
the rate of IPC formation: electron-donating groups (EDG) facilitate the formation of the IPC because 





result in an elevated reaction barrier to IPC formation by destabilising the carbene carbon in the 
transition state. It was concluded from the computational experiments that the carbene-to-iron 
charge transfer is the dominant step governing the formation of IPCs 
3.3.1.2 Electronic structure of IPCs 
An important question concerns the electronic structure of a ground-state iron-porphyrin-carbene 
complex. An understanding of the frontier orbitals, electronic configuration, nature of the iron-
carbene bond, and oxidation state of the iron are important parameters that need to be properly 
understood to improve the stability and reactivity of IPCs. Zhang and co-workers initially addressed 
the nature of the iron-carbene bond and the Fe(II)/Fe(IV) problem using Mossbauer, NMR, and 
computational simulations.38,290 Zhang and co-workers were particularly interested in addressing 
whether the bonding in IPCs is best described as a Fe(II)[:C(X)(Y)] or Fe(IV)=[C(X)(Y)]2- resonance 
structure.  The calculations performed using geometrically optimised structures of IPCs indicated the 
ground-state of IPCs are best described as diamagnetic low-spin complexes.35 The Fe(II)[:C(X)(Y)] 
resonance structure results from a dominant carbene-to-iron charge transfer which renders a positive 
charge on the carbene carbon and is consistent with the reported chemical shifts of IPCs in NMR 
spectroscopy. The Fe(IV)=[C(X)(Y)]2- resonance structure is characterised by π-back donation from the 
iron to the carbene which would result in the build-up of a negative charge on the carbene carbon; an 
electronic structure inconsistent with the NMR data and the observed electrophilicity of IPCs.35  
The next question concerned the electronic configuration of the frontier molecular orbitals in IPCs. 
Shaik and co-workers expanded upon the work of Zhang by calculating the molecular orbital 
configurations for both penta- and hexa- coordinated IPCs for both Fe(II) and Fe(IV) complexes, and 
demonstrated that in the d6 Fe(II) complexes the orbital configuration is (dxy)2(dxz)2(dyz)2(dz2)0(dx2-
y2)0, consistent with the proposed low-spin ground state.39 In d4 Fe(IV) complexes the orbital 
configuration is (dxy)2(dxz)2(dyz)0(dz2)0(dx2-y2)0, also consistent with a low-spin ground state.39 Shaik 
and co-workers also investigated the electron distribution in Fe(II) d6 ground-state IPCs.39 The three 
possible electron configurations that are possible in a Fe(II) d6 IPC are closed-shell-singlet (CSS), open-






Figure 62: IPC orbitals (figure taken from Sharon et al)39 
The model presented by Zhang operated under the assumption that a CSS was the energetically 
favourable configuration of IPCs, but the calculations performed by Shaik and co-workers rendered 
the OSS electronic configuration as the energetically favourable electron distribution (figure 62, C).39 
It was rationalised that an OSS electronic state occurs from the nature of the interacting orbitals on 
the iron and carbene in IPCs. A carbene sp2 orbital with the correct symmetry overlaps with the dz2 
orbital of iron, donating its electron pair, to form the initial Fe-C σ-bond.39 Additionally, the doubly 
occupied dxz orbital on iron, which possesses π-symmetry, weakly interacts with the vacant carbene 
px-orbital. This configuration can be best described as generating an iron-localised dxz orbital and a 
carbene localised px orbital, with one electron occupying each. This results in an electronic 
configuration of (dxy)2(dyz)2(dxz)1(Cpx)1(dz2)0(dx2-y2)0, with the lone-electrons in dxz and Cpxz anti-
ferromagnetically coupled, giving a diamagnetic open-shell low-spin configuration.39 The question 
concerning ground-state IPCs has yet to be completely answered, but what can be deduced is that i) 
carbene-to-metal charge transfer is the dominant process governing IPC formation, and ii) IPCs are 
low-spin singlet, diamagnetic complexes possessing a Fe(II) metal.38,290 The singlet nature of IPCs could 
also partially account for the observed stereoselectivity observed with iron-tetrapyrrole catalysts and 
the reported hemoprotein carbene transferases.  
One last consideration investigated by Zhang and co-workers explored the energetic differences 
between terminal- and bridging- carbene complexes.40 Bridging carbene complexes have been 





IPCs is significantly higher than in Co(II) carbene complexes (13.17 kcal/mol higher).40 This suggests 
the terminal-binding mode in IPCs is the dominant interaction, a conclusion consistent with the 
reported crystal structures of IPCs and the IPC in the cytochrome c crystal structure reported by Lewis 
et al.219 It was further reported that the preference in terminal binding in IPCs is a consequence of the 
ordering of the d-orbitals in IPCs relative to Co(II)-carbene complexes.40 In terminal binding IPCs, the 
dz2 is unoccupied on account of the greater repulsion between the carbene and the dz2 orbital, while 
the dyz orbital, less-aligned with the carbene, is occupied. In the bridging mode, the electron density 
on the carbene is shifted away from the dz2 axis and is more aligned with the dyz orbital, resulting in 
greater repulsion between the carbene and the dyz orbital in the bridging mode. This results in the 
dz2 and dyz orbitals being energetically reversed in the bridging mode relative to the terminal mode 
and as a consequence the dz2 is occupied while the dyz orbital is unoccupied.40  
3.4 UV-VIS SPECTROSCOPY OF HEME-CONTAINING PROTEINS – APPLICATIONS TO STUDY 
METALLOCARBENOID FORMATION IN NATURAL HEMOPROTEINS AND DE NOVO HEME-
CONTAINING MAQUETTES 
Although crystal structures provide the most reliable and direct evidence for enzymatic reaction 
intermediates, not all proteins are capable of being crystallised. The de novo tetra-α-helix c-type 
maquettes are a class of proteins that have proved notoriously difficult to crystallise. Therefore, an 
alternative methodology for studying the formation and characteristics of a metallocarbenoid 
intermediate needs to be employed.  
Heme-containing proteins are characterised by distinctive UV-VIS spectroscopic profiles as a 
consequence of the π-conjugation of the porphyrin cofactor.143,299,300 The UV-VIS profiles of porphyrins 
are a consequence of electronic transitions between two occupied (HOMO) ground state (S0) π 
orbitals, a1u and a2u, and two unoccupied (LUMO) degenerate (S1 and S2) π* orbitals, egx and egy (figure 
63).104,143,300 Electronic transitions between these orbitals results in an intense Soret peak around 400-
430 nm and a region of multiple, less intense peaks in the 500-650 nm range called the Q-band.299,300 
The Soret peak arises from an S0 → S2 electronic transition from the heme πa1u to π* orbitals, with the 
intensity arising from the transition being spin and symmetry allowed. The Q band arises from an S0 
→ S1 electronic transition from the π to π* orbitals, with the splitting of the Q-band a consequence of 
vibrational coupling with the S0 → S1 electronic transition, resulting in two possible transitions, 
Q0,0(v=0) and Q1,0,(v=1) from the ground electronic state, S0 (S0v0 → S1 and S0v1 → S1).299–301  (In free 
base porphyrins, the presence of two NH groups breaks the symmetry of the porphyrin macrocycle 
and further splits the two Q-band peaks resulting in four peaks (QX0,0, QY0,0, QX1,0 and QY1,0) in the Q-






Figure 63: The UV-VIS spectra of free-base and metalled porphyrins. (top) the relative molecular 
orbitals of tetraphenylporphyrin (TPP, black) Zn-TPP (red) and Pd-TPP (blue), (bottom left) the general 
molecular structure of a metalloporphyrin, and (bottom right) the UV-VIS spectra for TPP (black), Zn-
TPP (red) and Pd-TPP (blue) with the Q-bands magnified (figure taken from Dabrowski et al).301  
The spectroscopic profiles of heme-containing proteins are sensitive to the oxidation state of the 
metal, the coordination state of the central metal, and the properties of the coordinating ligands (i.e. 
electronics).104,143 Any changes in these parameters, caused by a chemical transformation, would alter 
the frontier orbitals of the system and would engender pronounced changes in a hemeprotein’s 
electronic spectrum. The formation of a metallocarbenoid intermediate, and hence a shift from a 
pentacoordinate to a hexacoordinate complex, should, therefore, have a traceable effect on the 
absorbance profile of the UV-VIS spectrum.104,143 In the presence of a suitable carbene precursor (i.e. 
diazo compounds) three scenarios are possible: (i) no chemical reaction between the protein and the 
carbene precursor, (ii) the formation of a ferrous hexacoordinate metallocarbenoid intermediate 
terminally bound at the iron, and (iii) an insertion reaction where a carbene inserts into a Fe-N bond 
of the porphyrin ring to yield a Fe-C-N bridged complex. Scenario (i) would result in no observable 
changes in the UV-VIS spectrum, whereas scenarios (ii) and (iii) would produce clear and distinctive 
changes. The bridged complex would result in modification of a porphyrin nitrogen and would result 





intermediate would not disrupt the porphyrin, resulting in only noticeable shifts in the Soret peak and 
Q-band profile respectively. Therefore, UV-VIS spectroscopy is a suitable technique for investigating 
the formation, and possible subsequent decay, of a metallocarbenoid intermediate in the 
absence/presence of a reactive substrate (i.e. styrene). Initial investigations into metallocarbenoid 
formation (using ethyl diazoacetate (EDA) as the carbene precursor) employed several naturally 
occurring heme protein scaffolds, including myoglobin, zinc-chlorin-e6 reconstituted myoglobin, 
haemoglobin, horseradish peroxidase, cytochrome c, and the cytochrome c digestion product 
microperoxidase-11, before extending the methodology to examine metallocarbenoid formation in 
the de novo tetra-α-helix c-type maquettes C45 and JR1. The cytochrome c variant reported by Arnold 
et al219 and a myoglobin variant ((Mb(H64V,V68A)) reported by Fasan et al195 were also examined for 
comparative purposes.  
3.5 RESULTS AND DISCUSSION 
3.5.1 Stopped-Flow Kinetics and UV/VIS Spectroscopy  
3.5.1.1 Spectroscopic characterisation of metallocarbenoid formation for naturally occurring 
hemoproteins 
The formation of a metallocarbenoid intermediate was investigated by monitoring changes in the 
distinctive spectroscopic profile of heme-containing proteins. To avoid the rapid decay of a 
metallocarbenoid intermediate, single-mixing stopped-flow techniques were employed. A solution 
containing the ferrous enzyme of interest (15 µM protein, 10 mM Na2S2O4, CHES buffer, pH 8.6) and a 
solution containing ethyl diazoacetate (EDA) (100 µM-10 mM, 20-100% EtOH) were isolated in 
separate compartments (syringes) before a small volume (2x20 µl) of each were injected concurrently 
into a mixing chamber. The mixing chamber was monitored by UV-VIS spectroscopy over several 
timescales to monitor any reactions occurring in the mixing chamber. Final concentrations were 7.5 
µM enzyme, 50 µM-5 mM EDA, 5mM Na2S2O4, and 10-50% EtOH.  The spectra acquired for myoglobin, 
zinc-chlorin-e6 reconstituted myoglobin, haemoglobin, horseradish peroxidase, and cytochrome c are 






Figure 64: The stopped-flow UV-VIS spectra for metallocarbenoid formation in the presence of ethyl 
diazoacetate (EDA) at 0 seconds (red) and 60 seconds (blue) for the ferrous hemoproteins (top left) 
horseradish peroxidase, (top middle) cytochrome c, (top right) haemoglobin, (bottom left) 
myoglobin, (bottom middle) zinc chlorin-e6 reconstituted myoglobin, and (bottom right) 
microperoxidase-11. All spectra were recorded at 5OC using stopped-flow spectroscopy; final 
concentrations were 1 mM EDA, 10 µM protein, 1 mM Na2S2O4 and 20% (v/v) ethanol.   
Horseradish peroxidase is a predominately α-helical protein that coordinates a b-type heme cofactor 
via a backbone histidine ligand to yield a pentacoordinate iron.101 The UV-VIS spectrum (figure 64, top 
left) for ferrous horseradish peroxidase is dominated by the ferrous Soret peak and a small less-
intense Q-band at 500-650 nm. After 60 seconds of mixing with EDA, the UV-VIS spectrum for ferrous 
HRP displayed a minor shift in the Soret peak and a decrease in intensity of the Q-band. The UV-VIS 
indicates no metallocarbenoid formation/Fe-N insertion has occurred and the changes are probably 
associated with degradation. Cytochrome c (equine heart) is a small, soluble c-type hemoprotein.110 
The heme is covalently bound to the protein backbone via the sequence motif C-X-X-C-H and two axial 
ligands are provided from a histidine and a methionine, resulting in a hexacoordinate iron.110  The UV-
VIS spectrum for cytochrome c (figure 64, top middle) is dominated by the ferrous Soret peak and is 
accompanied by two, sharp and well resolved peaks in the Q-bands at 525 nm and 551 nm 
respectively. After 60 seconds of mixing with EDA the UV-VIS spectrum displayed no major differences, 





the heme is hexacoordinate, meaning there is no vacant site for the carbene ligand. Haemoglobin is 
an all α-helix protein structurally consisting of two α and two β sub-units that form a tetrameric 
quarternary structure (αβ)2 in aqueous solution.101 Each subunit possesses one b-type heme group 
tethered to the protein backbone via a coordinating histidine, meaning haemoglobin is a tetraheme 
containing protein.101 The UV-VIS spectrum for haemoglobin (figure 64, top right) is dominated by the 
ferrous Soret peak and is accompanied by a poorly resolved Q-band in the range 500-600 nm. After 
60 seconds of mixing with EDA, the UV-VIS spectrum for ferrous haemoglobin displayed only a 
decrease in absorbance, indicative of possible heme degradation. Myoglobin is a small, α-helical 
protein that possesses a pentacoordinate Fe3+/2+ b-type heme cofactor.101 A backbone histidine 
provides the coordinating ligand that binds the cofactor, leaving a vacant site at the trans position for 
catalysis/binding in the holoprotein (usually occupied by a liable water molecule in the resting state 
in solution). Myoglobin is structurally characterised by the globin fold, with the heme group 
sandwiched between two α-helices.101 The ferrous UV-VIS spectrum for myoglobin (figure 64, bottom 
left) is dominated by the ferrous Soret peak and is accompanied by a less-intense, poorly resolved Q-
band in the range 500-600 nm. The UV-VIS spectrum for ferrous-myoglobin parallels the spectra 
acquired for HRP and haemoglobin: after 60 seconds of mixing with EDA the Soret peak and Q-bands 
are retained, but there is a general decrease in absorbance, indicative of possible heme degradation 
instead of formation of a metallocarbenoid intermediate. Zinc-chlorin-e6 reconstituted myoglobin is 
the myoglobin scaffold with the b-type heme group substituted for Zn-chlorin-e6. Like myoglobin, a 
backbone histidine coordinates to the zinc to yield a pentacoordinate Zn2+ complex. Zinc reconstituted 
hemoproteins have similar UV-VIS spectra to iron-containing hemoproteins, but the Q-band is red-
shifted to 600-700 nm. Unlike iron, zinc can only occur in a M2+ oxidation state, but computational 
analysis of heme-localised metallocarbenoids indicate the metal adopts a M2+ oxidation state 
rendering it possible for a zinc-metallocarbenoid intermediate to form; however, after 60 seconds of 
mixing with EDA, the UV-VIS spectrum (figure 64, bottom middle) was significantly disrupted, 
probably caused by cofactor degradation, indicating no metallocarbenoid formation/Zn-N insertion 
had occurred. 
Microperoxidase oligopeptides are the proteolysis products of cytochrome c enzymes and consist of 
a c-type heme pentacoordinated to an oligopeptide via a backbone histidine ligand. For 
microperoxidase-11, the oligopeptide is 11 amino acids long and contains the conserved C-X-X-C-H c-
type heme binding sequence motif.302,303 As free heme has been demonstrated to form 
metallocarbenoid complexes in solution, it is reasonable to expect microperoxidase oligopeptides to 
display similar chemistry because the heme cofactor is considerably solvent exposed. The UV-VIS 





with two peaks in the Q-bands at 525 nm and 551 nm respectively (like cytochrome c). After 60 
seconds of mixing with EDA the UV-VIS spectrum displayed a distinctive red shift in the Soret peak, 
from 415 nm to 427 nm, which is accompanied by pronounced changes in the Q-band profile (figure 
64, bottom right). These shifts can be accounted for by two possible explanations: (i) 
metallocarbenoid formation, or (ii) carbene insertion into a N-Fe bond, disrupting the iron 
coordination state. Carbene insertion into a N-Fe bond, to form a bridged Fe-C-N complex, would 
modify a porphyrin nitrogen sufficiently to alter the Q-band profile and produce a spectrum 
completely uncharacteristic of a six-coordinate heme-containing protein. The formation of a 
metallocarbenoid would be characterised by concurrent shifts in the Soret peak and Q-band region 
consistent with the diagnostic spectroscopic features of a hexacoordinate heme-containing protein. 
The UV-spectra recorded in the stopped-flow experiment for microperoxidase-11 indicates the species 
formed after rapid mixing is the terminally-bound metallocarbenoid complex, consistent with the 
crystal structure reported by Arnold.219 
3.5.1.2 Spectroscopic characterisation of C45 metallocarbenoid formation  
Having observed a spectrum consistent with terminal metallocarbenoid formation for the cytochrome 
c derived heme-containing oligopeptide microperoxidase-11, stopped-flow spectroscopy was 
extended to investigate metallocarbenoid formation in the de novo hemoprotein C45. Identical 
experimental conditions to those outlined above were employed for C45.  
A time course stopped-flow UV-VIS spectrum acquired for C45 in the presence of EDA (at 40% EtOH) 
is presented in figure 65. The spectrum of C45 parallels the UV-VIS obtained for microperoxidase-11 
(figure 10) under identical conditions. After 60 seconds, a significant red shift in the Soret peak, from 
417 nm to 428 m, was observed and is accompanied by a concurrent red-shift and broadening of the 
Q-band profile. The formation of the metallocarbenoid is visible in the spectrum after 60 seconds. 
Figure 66 displays a time-dependent profile of the spectroscopic changes at wavelengths 417 and 433 
nm, corresponding to ferrous C45 and the C45-metallocarbenoid complex, respectively. The time-
dependent plots show an initial increase in absorbance at 433 nm, accompanied by a paralleled 
decrease in absorbance at 417 nm, with both traces plateauing after approximately 12 seconds 
indicating saturation has been established. The spectroscopic data is consistent with the formation of 
a terminal metallocarbenoid intermediate; however, the rate of formation of the metallocarbenoid 
intermediate is initially slow. This is probably a consequence of the low temperature and ethanol 
concentration of the experimental. The spectroscopic data indicates metallocarbenoid intermediate, 
once formed, is stable and persistent (no appreciable decay over 1000 seconds) and does not react 





the C45-metallocarbenoid intermediate was unaffected by changes in the ethanol concentration from 
10% to 50%, with an observable increase in the initial rate of formation being the only appreciable 
difference. Tetra-α-helix maquettes, in particular C45, have previously demonstrated good tolerance 
to high ethanol concentrations235 without any disruption to their structure or function, and therefore 
it is unsurprising that the profile of the obtained spectra is unaffected in 40-50% ethanol (figure 65). 
 
Figure 65: A) The UV-VIS spectra of C45 (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) after 0 (red) 
and 60 (blue) seconds following rapid mixing of ferrous C45 with 500 μM ethyl diazoacetate at 5OC, 
and B) The UV-VIS spectra of C45 (7.5 µM, CHES buffer, pH 8.6i) n the presence of EDA (1 mM) after 
60 seconds in 10% (red) and 50% (blue) EtOH. 
 
Figure 66: (Left) Metallocarbenoid formation and stability. The UV-VIS spectra of C45 (7.5 µM, CHES 
buffer, pH 8.6, 40% (v/v) EtOH) after 0 (red) and 60 (blue) seconds following rapid mixing of ferrous 
C45 with 500 μM ethyl diazoacetate (EDA) at 5oC. (Right) Single wavelength traces represent the time 
course of ferrous C45 (417 nm, red, 7.5 μM protein, 10% EtOH) and metallocarbenoid:C45 adduct (433 
nm, blue) following rapid mixing of ferrous C45 with 500 μM EDA at 5OC. Once formed, the 





Having demonstrated the formation of an iron-bound C45-metallocarbenoid intermediate using EDA 
as the carbene precursor, the versatility of the carbene precursor was next investigated using two 
different diazo compounds: tert-butyl diazoacetate (tBuDA) and benzyl diazoacetate (BnDA). These 
two carbene precursors were selected because of the increased sterics of the ester substituents. 
 
Figure 67: (Left) The UV-VIS spectra of C45 (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) after 0 (red) 
and 60 (blue) seconds following rapid mixing of ferrous C45 with 500 μM tert-butyl diazoacetate at 
5oC. (Right) Single wavelength traces represent the time course of ferrous C45 (417 nm, red, 7.5 μM 
protein, 10% EtOH) and metallocarbenoid:C45 adduct (433 nm, blue) following rapid mixing of ferrous 
C45 with 500 μM tert-butyl diazoacetate at 5OC. 
Figure 67 shows the UV-VIS spectrum acquired for ferrous C45 in the presence of tBuDA. Analogous 
to figures 65-66 for EDA, figure 67 exhibits a pronounced red-shift in the Soret peak from 417 nm 
(ferrous C45) to the metallocarbenoid intermediate (430 nm), which is accompanied by a concurrent 
red shift and subtle diminishment in the Q-band region. Figure 67 displays a time-dependent trace of 
the reaction at 417 and 433 nm, and demonstrates that, analogous to the C45-EDA intermediate, the 
C45-tBuDA intermediate is stable and persists after initial formation. In comparison to EDA the 
duration required to reach saturation, indicated by the plateauing of the 417 and 433 nm absorbance 
profiles respectively, is approximately 80 s, approximately seven-times greater than the duration 
required for EDA to reach saturation under identical conditions. Although the electron-donating 
properties of the tBu substituent would stabilise the electrophilic metallocarbenoid intermediate, the 
increased steric bulk of the tBu, relative to the small and linear Et substituent, would hinder the 
accessibility of tBuDA into the active site and would be subject to enhanced steric clashes once situated 
near the heme. The unfavourable steric clashes of tBu therefore likely account for the observed seven-






Figure 68: (Left) The UV-VIS spectra of C45 (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) after 0 (red) 
and 60 (blue) seconds following rapid mixing of ferrous C45 with 500 μM benzyl diazoacetate at 5oC. 
(Right) Single wavelength traces represent the time course of ferrous C45 (417 nm, red, 7.5 μM 
protein, 10% EtOH) and metallocarbenoid:C45 adduct (433 nm, blue) following rapid mixing of ferrous 
C45 with 500 μM benzyl diazoacetate at 5OC.  
Figure 68 shows the UV-VIS spectrum acquired for ferrous C45 in the presence of BnDA. Analogous to 
Figure 65-67 for EDA and tBuDA, figure 68 exhibits a pronounced red-shift in the Soret peak from 417 
nm (ferrous C45) to the metallocarbenoid intermediate (428 nm), which is accompanied by a 
concurrent red shift and subtle diminishment in the Q-band region. Figure 68 displays the time-
dependent trace of the reaction at 417 nm and 433 nm, respectively. Interestingly, the time-
dependent trace for the formation of the C45-BnDA complex demonstrates that a similar duration, 
approximately 12 seconds, is required for saturation to occur, indicated by the plateauing of the 417 
and 433 nm absorbance changes. The spectroscopic data for BnDA parallels the spectroscopic profile 
exhibited by EDA. The similarity between BnDA and EDA is difficult to completely account for by taking 
the electronics and sterics of the benzyl substituent into account. The increased sterics of the Bz 
substituent should parallel the decrease in rate formation exhibited by tBu if sterics alone was 
responsible for governing the formation of a metallocarbenoid intermediate. However, the phenyl 
group of the benzyl substituent is an aromatic species and can potentially establish stabilising π-π 
interactions with other aromatic species in the active site, such as the porphyrin on the heme cofactor 
or backbone residues such as Phe46 or Trp43. Any stabilising π-π interactions would compensate for 
the increased and unfavourable steric clashes between Bz and residues in the active site, facilitating 






3.5.1.3 Kinetic characterisation of C45 metallocarbenoid formation  
In order to understand the nature of the metallocarbenoid complex the kinetic parameters for each 
diazo compound were determined. Repeating the stopped-flow experiments using varying 
concentrations of EDA, tBuDA and BnDA allowed the single turnover kinetic parameters, K1 and kobs, 
for the formation of the C45-metallocarbenoid intermediates to be determined (table 1). Figure 69 
exhibits the calculated curves acquired for each diazo compound, respectively. The analysis of the 
single turnover formation of a metallocarbenoid involves three distinct identities: i) free enzyme and 
substrate, ii) a tetrahedral transition state, and iii) the metallocarbenoid intermediate.40 There are 
three underlining assumptions that have been made to assist in the analysis: i) the rate of 
decomposition of the tetrahedral transition state to the metallocarbenoid intermediate (k2) is first 
order, ii) the reaction is irreversible (k2 >>> k-2) and iii) a steady-state equilibrium is established 
between the free enzyme and the tetrahedral transition state (k1 = k-1). The overall process, with 
associated rate constants, is illustrated in figure 69 (bottom).   
 
 
Figure 69: (top) The concentration-dependent single turnover kinetics of C45-metallocarbenoid 
formation (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) with the diazo precursors EDA (left), BnDA 
(middle) and tBuDA (right). Initial rates were determined from the rate of change in absorbance for 
the C45:metallocarbenoid adduct at 5oC. (bottom) the mechanism of metallocarbenoid formation 
showing the respective rate constants. The existence of the tetrahedral transition state has been 





Table 1: The single turnover kinetic parameters for C45-metallocarbenoid formation for diazo 
precursors EDA, BnDA, and tBuDA. 
 
The K1 values represent the affinity of C45 for the binding of a carbene precursor, with lower K1 values 
reflecting a higher affinity for binding. The K1 values do not contain any information on the 
thermodynamic stability of a resultant metallocarbenoid intermediate, but it does provide insight into 
the relative energy barriers to formation from the tetrahedral transition state. The calculated K1 values 
for EDA, tBuDA and BnDA are 74.36, 219.43 and 113.16 µM, respectively. The K1 values are consistent 
with the computational reports on the relative activation energies for metallocarbenoid intermediate 
formation as a function of carbene substituents.40 EDA contains a small, linear ethyl substituent which 
can be readily accommodated in the active site of C45 without disrupting the local organisation. BnDA, 
which possess a benzyl substituent, has a larger K1 relative to EDA, but the phenyl group can establish 
favourable π-π interactions with the heme group and/or nearby aromatic residues in the active site 
which can provide some energetic compensation for any necessary reorganisation required in the 
active site to accommodate the bulkier ligand. tBuDA has a K1 two times that of BnDA and three times 
that of EDA respectively, and this is accounted for by the steric bulk of the tert-butyl group which 
would need to be accommodated in the active site, but unlike BnDA cannot establish any 
compensatory interactions with local residues. The relationship between carbene substituent and 
formation energy is further corroborated by the kobs values, 0.498, 0.349 and 0.195 s-1 for EDA, tBuDA 
and BnDA respectively, which represent the relative rates for the formation of the metallocarbenoid 
intermediate from the tetrahedral transition state. The ratio kobs/K1 for EDA, tBuDA and BnDA are 
reported in table 1 and demonstrate the C45 preferentially binds to EDA with an efficiency twice that 
of BnDA and 7.5 times that of tBuDA. This is reflected in the time-course stopped-flow spectroscopic 
data reported above, which demonstrated C45 reaches saturation with EDA and BnDA relatively 
quickly (12 and 20 seconds respectively) but requires approximately 80 seconds to reach saturation 
with tBuDA.  
Although the kinetic parameters for C45 against EDA, tBuDA and BnDA demonstrate a kinetic 





thermodynamic stability of the resultant metallocarbenoid complexes. It was reported above that 
although bulkier ligands elevate the activation energy of formation the resultant complexes tend to 
be more thermodynamically stable.40 If this observation is correct it should be reflected in the 
reactivity of the metallocarbenoid intermediates when presented with suitable substrates. The kinetic 
analysis of C45 metallocarbenoid formation with EDA, tBuDA and BnDA also suggests the steric bulk 
of the diazo substituent influences the reaction. This will be explored further in chapter 4.  
3.5.1.4 Spectroscopic characterisation of metallocarbenoid formation in mutant cytochrome c and 
myoglobin carbene transferases 
Several carbene transferases engineered through the directed evolution of naturally occurring 
hemoproteins, such as cytochrome P450s, cytochrome c, and myoglobin, have been reported in the 
literature. The most successful variants have demonstrated product yields, diastereoselectivies and 
enantioselectivities of >99.9%. In all the reported cases, the reactive intermediate is postulated to be 
a terminally bound, iron-localised electrophilic metallocarbenoid complex. In 2018 the Arnold lab 
published a crystal structure of a c-type hemoprotein cytochrome c Rhodothermus mainus (Rma) 
mutant with a bound IPC.75 The enzyme was initially generated after three rounds of mutagenesis and 
was demonstrated to be highly efficient at catalysing carbene insertion reactions into Si-H σ-bonds. 
The three mutations discovered to enhance its reactivity where V75T, M100D, and M103E, and hence 
the mutant enzyme was named Rma-TDE. Rma-TDE was subsequently selected as a suitable candidate 
for capturing and characterising an IPC. In December of the same year, the Hilvert lab published a 
crystal structure of an IPC in a sperm-whale myoglobin mutant called Mb(H64V,V68A).304 
Mb(H64V,V68A), two mutations from WT-sperm whale myoglobin, was previously demonstrated to 
be an efficient and highly stereoselective carbene transferase in the cyclopropanation of vinylarenes.  
The IPC crystal structures for Rma-TDE and Mb(H64V,V68A) provided key insights into the nature of 
IPCs, and into the phenomena governing metallocarbenoid formation and stability. Despite these 
insights a thorough spectroscopic investigation of the enzymatic IPCs has yet to be conducted. As the 
methodology for investigating metallocarbenoid formation had been established using C45 and 
microperoxidase-11, Rma-TDE and Mb(H64V,V68A) were selected for spectroscopic investigation and 
comparison to C45. Identical experimental conditions used to investigate metallocarbenoid formation 
with C45 were employed for each characterisation.  
3.5.1.4.1 Rma-TDE 
The UV-VIS spectra for the ferric and ferrous states of Rma-TDE are presented in figure 70. As is 





Soret peak at 410 nm followed by a less-intense Q-band region split into two peaks, α and β, with α > 
β in relative intensity. The UV-VIS spectrum for ferrous Rma-TDE, acquired by the addition of sodium 
dithionite, is characterised by a pronounce red-shift in the Soret peak, from 410 nm to 419 nm, 
alongside a concurrent modification of the Q-band region; in particular, both the α and β peaks 
comprising the Q-band are slightly blue-shifted and are accompanied with a reversal in the relative 
intensities of each respective peak, such that α < β. 
 
Figure 70: The UV-VIS spectrum for ferric (red) and ferrous (blue) Rma-TDE. 
The acquired UV-VIS spectra for Rma-TDE is consistent with the UV-VIS spectra reported in the 
literature for cytochrome c.143,219 Rma-TDE was subsequently investigated for metallocarbenoid 
activity using stopped-flow spectroscopy. The UV-VIS spectra acquired for ferrous Rma-TDE in the 






Figure 71: (Left) The UV-VIS spectra of Rma-TDE (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) after 
0 (red) and 60 (blue) seconds following rapid mixing of ferrous C45 with 500 μM ethyl diazoacetate at 
5oC. (Right) Single wavelength traces represent the time course of ferrous Rma-TDE (417 nm, red, 7.5 
μM protein, 10% EtOH) and metallocarbenoid:Rma-TDE adduct (433 nm, blue) following rapid mixing 
of ferrous Rma-TDE with 500 μM ethyl diazoacetate at 5OC. 
The UV-VIS spectrum is characterised by a significantly red-shifted Soret peak, from 418 to 430 nm, 
which is accompanied by a red-shifted and broadened Q-band. The time-dependent plots presented 
in figure 71 show the time-varying absorbance changes at 417 and 433 nm, corresponding to the 
ferrous species and metallocarbenoid complex, respectively. The decrease in absorbance at 417 nm is 
accompanied by a paralleled increase in absorbance at 433 nm, with a 40 second duration required 
before saturation is established. The spectroscopic data acquired for Rma-TDE metallocarbenoid 
formation in the presence of EDA is analogous to the spectroscopic data acquired for C45 
metallocarbenoid formation. The two data sets are characterised by a significant red-shift in the Soret 
peak, a red-shift and broadening of the Q-band profile, and the eventual attainment of saturation. In 
comparison to C45, Rma-TDE takes approximately 3.5 times longer to reach saturation. The ferrous 
Rma-TDE UV-VIS spectrum is identical to the spectrum reported by Lewis et al;219 however, the 
spectrum acquired for the metallocarbenoid intermediate contrasts the spectrum reported by Lewis 
et al, which is characterised by a Soret peak at 416 nm and two Q-band peaks at 529 and 561 nm.219 
The spectrum reported here has a similar profile but with the Soret peak and Q-band peaks red-
shifted. There are, however, several notable differences between the spectrum reported here and by 
Lewis et al:219 the spectrum reported by Lewis et al was acquired using ethyl 2-diazopropanoate (Me-
EDA), at room temperature under aerobic conditions,219 while the spectrum reported here was 
acquired using EDA, at 5OC, under anaerobic conditions and 10% (v/v) EtOH. As the spectrum 





anaerobic conditions ([O2] < 5 ppm) it is postulated that the species reasonable for the spectrum 
reported by Lewis et al is an alternative, unidentified species. 
3.5.1.4.2 Mb(H64V,V68A) 
The UV-VIS spectra for ferric and ferrous Mb(H64V,V68A) are presented in figure 72. The spectrum 
for ferric Mb(H64V,V68A) is dominated by an intense Soret peak at 410 nm, with a significantly less-
intense and broad Q-band region between 500-600 nm. Addition of sodium dithionite yields the 
spectrum for ferrous Mb(H64V,V68A) which is characterised by a pronounced red-shift in the Soret 
peak, from 410 nm to 435 nm. The Q-band is characterised by a narrowing of the observed range, to 
550-600 nm, but remains low in intensity and poorly resolved. Mb(H64V,V68A) was subsequently 
investigated for metallocarbenoid activity using stopped-flow spectroscopy.  
 
Figure 72: The UV-VIS spectrum for ferric (red) and ferrous (blue) Mb(H64V,V68A). 
Figure 73 is the UV-VIS spectra acquired for ferrous Mb(H64V,V68A) in the presence of EDA. The 
spectra is characterised by a significantly blue-shifted Soret peak, from 435 to 424 nm, which is 
accompanied by the emergence of a blue-shifted but well-resolved Q-band profile, with α and β peaks 
at 525 and 555 nm respectively, with α < β in relative intensity. The time-dependent plots presented 
in figure 73 show the changes in absorbance at 435 and 424 nm over time, corresponding to the 
ferrous species and metallocarbenoid complex, respectively. The decrease in absorbance at 435 nm is 





before saturation is established. The time-dependent spectra for Mb(H64V,V68A) in the presence of 
EDA is distinctive from the spectra acquired for C45 and Rma-TDE as the initial changes in absorbance 
are fast, with a drastic change occurring in the initial 20 seconds, followed by a considerable lag phase 
before saturation is established (80 seconds). The time-dependent spectra acquired for 
Mb(H64V,V68A) in the presence of EDA resembles the time-dependent spectra acquired for C45 in 
the presence of tBuDA, but is nonetheless consistent with the formation of a metallocarbenoid 
complex.   
 
Figure 73: The UV-VIS spectra of Mb(H64V,V68A) (7.5 µM, 0.1 M KPi, pH 7, 40% (v/v) EtOH) after 0 
(red) and 60 (blue) seconds following rapid mixing of ferrous Mb(H64V,V68A) with 500 μM ethyl 
diazoacetate at 5oC. (Right) Single wavelength traces represent the time course of ferrous 
Mb(H64V,V68A) (435 nm, red, 7.5 μM protein, 10% EtOH) and metallocarbenoid:Mb(H64V,V68A) 
adduct (424 nm, blue) following rapid mixing of ferrous Mb(H64V,V68A) with 500 μM ethyl 
diazoacetate at 5OC. 
3.5.1.5 Kinetic characterisation of metallocarbenoid formation in Rma-TDE and Mb(H64V,V68A) 
carbene transferases 
The initial experiments using Rma-TDE and Mb(H64V,V68A) exhibited UV-VIS spectra consistent with 
the formation of an iron-localised, terminally bound metallocarbenoid intermediate and are 
consistent with the crystal structures of these complexes. The next step was to employ the stopped-
flow methodology used to determine the single turnover kinetic parameters, K1 and kobs, for 
metallocarbenoid formation using Rma-TDE and Mb(H64V,V68A) respectively. The single turnover 
kinetic parameters for Rma-TDE and Mb(H64V,V68A) could then compared to the single turnover 
kinetic parameters obtained for C45 (table 2). As in the C45 experiments, varying concentrations of 
EDA were used and the formation of the metallocarbenoid intermediate was followed 





Table 2: The kinetic parameters for the metallocarbenoid formation between EDA and the de novo 
heme-containing maquette C45, and the rationally designed heme-containing proteins 
Mb(H64V,V68A), and Rma-TDE. 
 
 
Figure 74: The concentration-dependent kinetics of metallocarbenoid formation of (left) 
Mb(H64V,V68A) (7.5 µM, 0.1M KPi buffer, pH 7.1, 40% (v/v) EtOH) and of (right) Rma-TDE (7.5 µM, 
CHES buffer, pH 8.6, 40% (v/v) EtOH) with varying concentration of EDA. Initial rates were determined 
from the rate of change in absorbance for the enzyme:metallocarbenoid adduct at 5oC 
The calculated curves for Rma-TDE and Mb(H64V,V68A) are presented in figure 74 for EDA. As with 
C45 the analysis of the formation of a metallocarbenoid involves three distinct identities: i) free 
enzyme and substrate, ii) a tetrahedral transition state, and iii) the metallocarbenoid intermediate. 
There are three underlining assumptions that have been made to assist in the analysis: i) the rate of 
decomposition of the tetrahedral transition state to the metallocarbenoid intermediate (k2) is first-
order, ii) the reaction is irreversible (k2 >>> k-2) and iii) a steady-state equilibrium is established 
between the free enzyme and the tetrahedral transition state. The K1 values represent the affinity of 
an enzyme for the binding of a carbene precursor, with lower K1 values reflecting a higher affinity for 
binding. The calculated K1 values for Rma-TDE and Mb(H64V,V68A) are 487.94 and 15.05 µM, 
respectively. The calculated K1 for EDA/C45 is 74.36 µM, rendering K1 for Mb(H64V,V68A) 5 times 
smaller, but for Rma-TDE K1 is approximately 6 times larger, relative to C45. In order to comprehend 





differences between the three enzymes, with particular attention dedicated to the active-site and 
first-coordination sphere. 
The crystal structure of Rma-TDE (1.3 Å resolution, figure 75) reveals the introduction of the three 
mutations results in significant changes to the loop distal to the heme.218,219 Three amino acids in the 
loop region of IPC-bound Rma-TDE, Asp-100, Thr-101, and Asp-102, were unresolved in the crystal 
structure (figure 75). The authors suggested the mutations introduced significant flexibility into the 
loop region, opening up the active site and increasing solvent accessibility.218,219 It was also suggested 
the topological changes in the loop region preorganised Rma-TDE towards substrate binding and 
metallocarbenoid formation. In addition to increased loop flexibility and solvent accessibility, the 
crystal structure revealed five short-range non-polar interactions between amino acid residues and 
the iron-carbene. The five residues where identified as Thr-75, Met-76, Pro-79, Ile-83, and Met-89, 
with average interaction distances in the range 3.5-4.3 Å, suggesting a strongly hydrophobic active 
site despite the increased solvent accessibility (figure 75).218,219  
 
Figure 75: The crystal structure Rma-TDE bound to the carbene generated from ethyl 2-
diazopropanoate (1.29 Å; PDB ID code 6CUN). The residues Asp-100, Thr-101, and Asp-102 are 
unresolved. Interactions between the carbene and amino acid residues are shown with yellow lines. 
(i) Thr-75, 3.7 Å. (ii) Met-76, 4.3 Å. (iii) Pro-79, 3.5 Å. (iv) Ile-83, 3.6 Å. (v) Met-89, 3.5 Å (figure taken 
from Lewis et al).219 
The computational analysis of the electronic structures of IPCs in model complexes reported in the 
literature indicate the lowest energy state for an IPC is an open shell singlet (OSS) with an 
antiferromagnetic coupling between the iron and the carbene.39 In contrast, the authors reported a 
water molecule in the active-site of Rma-TDE stabilises the carbene complex through hydrogen-





significantly more substantial in a closed shell singlet (CSS) IPC, and suggested this stabilising 
interaction contributed to the formation of a single conformation.218,219 The authors reported the 
observed electron density of the IPC crystal structure supports the proposition of a singlet carbene 
complex adopting a single conformation, corroborating the suggestion the dominant species in 
solution is a CSS carbene complex.218,219  
The crystal structure of Mb(H64V,V68A) (1.1 Å resolution) revealed the introduction of the two 
mutations did not disrupt the three-dimensional fold of the protein relative to wild-type sperm whale 
myoglobin.304 In addition, the residues participating in hydrogen-bonding with the heme cofactor, and 
the distances of such interactions, were also unaffected by the two mutations relative to the wild-
type. The most drastic structural change occurring as a consequence of the introduction of the two 
mutations was an enlargement of the heme distal pocket volume from approximately 125 Å3 in the 
wild-type to 243 Å3 in Mb(H64V,V68A) respectively.304 The authors noted the expansion was most 
pronounced on the solvent-exposed face of the heme cofactor, which should enhance substrate 
accessibility into the active site.304  
The H64V mutation was reported to enhance the cyclopropanation activity relative to WT-myoglobin, 
and it is postulated this is accomplished via increased hydrophobicity of the active site.304 In addition, 
analysis of the crystal structure allowed four key residues occupying the area above the heme cofactor 
to be identified – Val-64, Ala-68, Phe-43, and Ile-107.304 Fasan and co-workers subsequently utilised 
the structural information obtained from crystallography to perform an extensive conformational 
analysis of the IPC. DFT calculations were performed to identify the energetically favourable 
conformations and to elucidate the stabilise factors.305 Initially, the number of conformations was 
established to be 8, with four conformations corresponding to the orientation of the carbene plane 
along a Fe-N axis and four corresponding to an orientation in-between two Fe-N axes. The σ-bond 
connecting the ester moiety to the carbene carbon can freely rotate, and two particular 
conformations, labelled (+) and (-), were identified for this C-C σ-bond, resulting in a total of 16 
possible conformations to be explored.305 The conformations could be conveniently divided into four 
spatial groups of four conformations, with each spatial region defined as the inter-residue space 
between the four primary amino acids above the plane of the porphyrin; therefore, the four spatial 






Figure 76: (left) The arrangement of amino acids surrounding the heme cofactor in Mb(H64V,V68A), 
and (right) view of the bound heme and nearby amino acid residues, along with the labels for pyrrole 
N atoms, porphyrin rings and the four spatial regions utilised in the DFT calculations (picture adapted 
from Tinoco et al).305 
The DFT calculations indicated that conformer 2(+), a conformer in the Ala-64-Ile-107 spatial group, 
was the most energetically favourable by approximately 3-10 kcal mol-1 relative to the remaining 
fifteen conformers.305 The results of the calculations indicated that steric effects play a dominant role 
in the conformational stability of the heme-bound carbene, as conformer 2(+) is situated in a region 
with the second biggest inter-residual volume. Further examination of the remaining fifteen 
conformers reveals that two additional conformers, 3(+) and 6(+) were only slightly higher in energy 
relative to 2(+) (3.2 and 3.4 kcal mol-1 respectively) despite 3(+) occupying the least hindered region, 
Ile-107-Phe-43. It was evident from the crystal structure, and corroborated by the DFT simulations, 
that the stability of a heme-bound carbene was mediated by van der Walls interactions between 
protein residues and the carbene-bound ester moiety. In 2(+), a total of four short interactions (~2.5 
Å) between the oxygen atoms in the ester moiety (O1 and O2) and neighbouring C-H bonds were 
present, in comparison to only 2 short-distance bonds in the 3(+) and 6(+) conformations.305  
The analysis of the IPCs in Rma-TDE and Mb(H64V,V68A) revealed two factors governing the Gibbs 
energy of formation and resultant conformational stability of a metallocarbenoid species: i) sterics, 
and ii) protein-carbene non-covalent interactions. A discussion on the importance of protein-carbene 
non-covalent interactions has already been presented above, in particular with regard to Rma-TDE 
and Mb(H64V,V68A). For C45, an account of important carbene-protein interactions is difficult to 
provide because of a lack of structural information; although it is likely that a tryptophan residue in 
close proximity to the active site may provide stabilising π-π interaction with the benzyl group in BnDA. 





relationship between the rate of metallocarbenoid formation and the steric bulk of the diazo 
precursor. It is abundantly clear that more structural information is required before any atomistic 
account of metallocarbenoid formation can be presented. Analysing the formation of the 
metallocarbenoid:C45 adduct with a variety of other functionalised diazo precursors, Raman 
spectroscopy, NMR spectroscopy, and computational simulations (DFT), could collectively provide key 
insights into the protein-carbene interactions governing the binding of the diazo precursor, and 
stabilisation of the tetrahedral intermediate and the resultant metallocarbenoid complex. 
3.5.2 Electron spray ionisation mass spectrometry of C45 and C45-metallocarbenoid complexes 
The difficulty associated with crystallising tetra-α-helix maquettes rendered the crystallisation of a 
heme-localised metallocarbenoid intermediate, like the crystal structure reported by Arnold using 
cytochrome c, unfeasible. Electron-spray-ionisation mass spectrometry (ESI-MS), a soft ionisation 
technique, has been previously employed to characterise the binding of myoglobin and haemoglobin 
to small molecules such as O2, CO and CN-. It was therefore rationalised that ESI-MS could be a good 
technique for isolating a heme-bound maquette metallocarbenoid intermediate.  
An initial ESI-MS experiment was conducted using only C45 (350 µM, 100 mM KCl, 20 mM CHES, pH 
8.6) in the absence of any carbene precursor. Injections were inserted immediately into the ionisation 
chamber without an initial chromatographic purification step. The injections into the ionisation 
chamber were monitored at 280 and 407 nm (the Soret peak for ferric C45) respectively. The acquired 
mass spectrum exhibited a dominant peak at 1974.36 Da, with smaller significant peaks at 1755.18 Da 
and 2256 Da respectively (figure 77). The peak at 1974.36 Da was calculated to correspond to the M8+ 
species, with the peaks at 1755.18 Da and 2256 Da corresponding to the M9+ and M7+ species, 
respectively. The clear resolution of these peaks indicated that any change in mass of the species, 







Figure 77: ESI mass spectrometry of C45 metallocarbenoid complexes. A. Mass spectrum of C45 (350 
μM) in buffer. The three dominant peaks occur at m/z values of 1755.13, 1974.36, and 2256.1 Da, 
respectively. These fragments correspond to a charged species of (from left to right) 9+, 8+, and 7+, as 
determined by the atomic mass of C45 (15789.17 Da). B. Mass spectrum for C45 after the addition of 
50 μl of ethyl diazoacetate (EDA, 20 mM, 5% ethanol). The three dominant peaks in the spectrum have 
shifted, relative to the peaks exhibited in the C45 spectrum, to 1764.76, 1985.14, and 2268.46 Da for 
the M9+, M8+ and M7+ species, respectively. The spectrum indicates an average mass increase of 86.52 
Da, which corresponds approximately with the predicted molecular weight of an ethyl diazoacetate 
carbene (-N2) species (86.09 Da). C. Mass spectrum for C45 after the addition of 50 μl of tert-butyl 
diazoacetate (tBuDA, 20 mM, 5 % ethanol). The dominant peak corresponding to the M8+ species has 
shifted to an m/z value 1988.68, indicating an increase in mass of 114.56 Da, which corresponds with 
the predicted molecular weight of a tert-butyl diazoacetate carbene (-N2) species (114.14 Da). D. Mass 
spectrum for C45 after the addition of 50 μl of benzyl diazoacetate (BnDA, 20 mM, 5% ethanol). The 
dominant peak corresponding to the M8+ species has shifted to an m/z value 1992.81, indicating an 
increase in mass of 148.08 Da, which corresponds with the predicted molecular with of a benzyl 
diazoacetate carbene (-N2) species (148.05 Da). All spectra were recorded in ES+ mode and monitored 
at 280 and 430 nm. The samples were injected directly into the ionisation chamber, with no LC 





A solution containing ferrous C45 (350 µM, 100 mM KCl, 20mM CHES, pH 8.6, 10 mM Na2S2O4) was 
prepared, under nitrogen, and cooled to 5 OC. Ethyl diazoacetate (EDA, 400 mM stock in EtOH) was 
prepared under nitrogen, cooled, and 20 µl was transferred into the sealed-vial containing ferrous C45 
using an air-tight syringe. The vial was left to mix for one minute, on ice, after which effervescence 
was visible (which was attributed to the expulsion of N2 following the formation of the 
metallocarbenoid intermediate). After one minute, the vial was transported to the mass spectrometer 
loading bay and immediately injected into the ionisation chamber. The injected sample passed 
through a UV-VIS detector prior to entering the ionisation chamber, which was set at 428 nm (the 
Soret peak for the maquette-metallocarbenoid complex). The spectrum acquired exhibited the 
following shifted peaks, 1764.82 Da, 1985.1 Da, and 2268 Da, corresponding to the M7+, M8+ and M9+ 
species respectively (the M8+ peak, at 1985.1 Da, was the dominant peak) (figure 77). The shift in each 
respective peak was calculated via subtraction and subsequent multiplication by the respective charge 
and resulted in an average m/z shift of 86 Da, which corresponds very well with the expected mass of 
an EDA carbene adduct after the loss of N2. As the injection of the species into the ionisation chamber 
was monitored at 428 nm, the Soret peak for the maquette-metallocarbenoid intermediate, this rules 
out the possibility that EDA is reacting with an amino acid in the protein backbone or inserting into a 
Fe-N bound of the heme cofactor, as these chemical transformations would not result in detectable 
species at 428 nm, as had been previously established spectroscopically. The mass spectrum obtained 
therefore corroborates the spectroscopic results, indicating that a heme-localised metallocarbenoid 
complex is readily formed and persistent. 
The spectroscopic profiles for metallocarbenoid formation employing tBuDA and BnDA as the carbene 
precursors paralleled the spectra obtained for EDA and literature reports for metallocarbenoid 
complexes. As the maquette-metallocarbenoid intermediate had been successfully detected for EDA 
using ESI-MS, the experiments were repeated, under identical conditions, for tBuDA and BnDA. The 
mass spectrum obtained for C45 in the presence of tBuDA resulted in a dominant peak at 1988.7 Da, 
corresponding to the M8+ species (figure 77). The mass shift calculated via subtraction and subsequent 
multiplication by the respective charge resulted and produced an m/z shift of 114.1 Da, corresponding 
to the mass difference expected for the formation of a tBuDA:M8+ species. Similarly, the mass 
spectrum for C45 in the presence of BnDA resulted in a dominant peak at 1992.8 Da, corresponding 
to the M8+ species and a m/z difference of 148.1 Da, the mass difference expected for the formation 






The carbene transfer activity exhibited by numerous carbene transferases in the literature are 
postulated to proceed via a heme-localised electrophilic metallocarbenoid intermediate. 
Computational studies have revealed the most energetically favourable state of a heme-localised 
metallocarbenoid intermediate would be a closed-shell-singlet electronic configuration with a ferrous 
iron. C45 is a pentacoordinate, histidine ligated heme-containing four-helix bundle which exhibits 
oxygen binding, electron transfer and peroxidase functionality. In the literature, it was reported an 
axial histidine ligation enhances carbene transferase activity for select hemeproteins. Given the 
similarities between C45 and the reported engineered carbene transferases, the question of whether 
a metallocarbenoid intermediate could be detected using C45 was raised. A combination of stopped-
flow spectroscopy, single turnover experiments, and ESI-MS conducted with three diazo precursors 
(EDA, tBuDA and BnDA) revealed C45 forms a stable, spectroscopically distinct intermediate with each 
precursor, with ESI-MS spectrum revealing the new intermediates each have an exact mass 
corresponding to the loss of molecular nitrogen. A relationship between the steric bulk of the diazo 
ester and the kinetic parameters has also been suggested. A comparison of the spectroscopic profiles 
and kinetics of the metallocarbenoid complex formed by EDA with two engineered carbene 
transferases, Rma-TDE and Mb(H64V,V68A), was reported. The metallocarbenoid intermediate of 
Rma-TDE and Mb(H64V,V68A) has been isolated and successfully crystallised, and the strong 
similarities between the spectroscopic profile of the EDA adducts of Rma-TDE and Mb(H64V,V68A) 
and the EDA, tBuDA and BnDA adducts of C45 strongly corroborates the existence of a terminal-bound 






CHAPTER 4: CYCLOPROPANATION CATALYSED BY A DE NOVO CARBENE TRANSFERASE  
4.1 INTRODUCTION TO THE CYCLOPROPANYL GROUP  
The cyclopropyl group is a three-membered carbon ring consisting of three sp3 hybridised carbons 
arranged in a planar ring via three C-C σ-bonds.306 The carbon-carbon bond angles are 60O, a significant 
deviation away from the ideal 109.5O adopted in linear sp3 carbons (figure 78, left). The three sp3 
carbon atoms align in the same plane, forming a planar ring structure, which forces the hydrogen 
atoms into an eclipsed conformation (figure 78). As a consequence of the C-C and C-H bond angles a 
cyclopropyl fragment is a highly strained fragment, which is manifested in its interesting properties 
and unique reactivity.42,306 This is reflected in the reported C-C and C-H bond dissociation energies for 
cyclopropane compared to propane, which are 238 and 456 KJ mol-1 for cyclopropane and 335 and 
413 KJ mol-1 for propane respectively.307–309 The high ring strain in cyclopropane is also reflected in the 
C-C bond dissociation energies for the homologous cycloalkane series, which follows the trend C3 < C4 
< C5, C6, C7, C8.307 Interestingly, the C-H bond in a cyclopropane is stronger than the C-H bond in 
propane, and this observation is accounted for by the hybridisation of the relative orbitals involved in 
cyclopropane bonding.42,306 
 
Figure 78: The cyclopropyl fragment. (left) the C-C-C and H-C-H bond angles, and (right) the 
orientation of the carbon sp3 orbitals.  
The C-C bonds in cyclopropanes are best described as ‘’bent’’ or ‘’banana’’ bonds (figure 78, right). In 
bent bonds, the density distribution function describing the electron density of the C-C bond is 
deviated away from the planar cyclopropane ring. This arrangement increases the orbital angles and 
compensates for some of the ring strain.42,306 In this arrangement, the hybridisation of the carbon is 
better described as an sp5 hybridisation state. A consequence of sp5 hybridisation is that the C-C bonds 
possess significant π-character and are shorter in length relative to alkanes.42,306 Furthermore, the sp5 
hybridisation results in a significant s-character in the C-H bonds which renders the C-H bonds in 
cyclopropanes shorter and stronger than C-H bonds in ethane.42,306 A consequence of the stronger C-





property, in addition to the increased hydrophobicity, has seen the widespread incorporation of 
cyclopropyl-fragments into an assortment of pharmaceuticals.42,306–161   
4.1.2 Synthesis of cyclopropane functional groups – a general overview 
In general, the synthesis of cyclopropanes falls into six categories: i) carbene based reactions, ii) ylide 
reactions, iii) cyclisation reactions, iv) nucleophilic displacement reactions, vi) cyclisation reactions, 
and vi) miscellaneous reactions.42,306 The carbene based syntheses can be further subdivided into i) 
free carbene reactions, ii) metallocarbenoid catalysed reactions, and iii) enzymatic cyclopropanation 
catalysed by a designed carbene transferase. The traditional synthetic approaches to the synthesis of 
cyclopropanes involving carbene reagents were briefly discussed in chapter 1 section 1.4.1. Chapter 2 
section 2.3.2 was dedicated to the recent advances in enzyme engineering and the successful 
development of carbene transferases, especially from P450s and myoglobin scaffolds, for 
cyclopropane synthesis. Having successfully demonstrated the proficiency of C45 towards the 
formation of a stable metallocarbenoid intermediate, the next question concerned whether C45 could 
be utilised as a carbene transferase, thus introduction a novel methodology to the synthesis of 
cyclopropanes from carbene reagents: enzymatic cyclopropanation catalysed by a de novo carbene 
transferase. 
4.2 RESULTS AND DISCUSSION 
4.2.1 Spectroscopic characterisation of C45 metallocarbenoid formation in the presence of receptive 
olefins 
In chapter 3, the spectroscopic characterisation of C45 metallocarbenoid formation was reported with 
three distinct carbene precursors. The single turnover kinetic parameters for the formation of 
metallocarbenoids from EDA, BnDA and tBuDA for C45 were also determined. It was observed that the 
K1 values for C45-metallocarbenoid formation followed the order EDA < BnDA < tBuDA. The three 
examined C45-metallocarbenoid intermediates were demonstrated to be stable complexes, with no 
observable degradation detectable in the UV-VIS spectra over a 1000 second period. This affords the 
possibility that C45 could be readily utilised as a carbene transfer catalyst via the reaction of the 
metallocarbenoid intermediate with a suitable substrate. Initial experiments were conducted using 
stopped-flow spectroscopy to examine the carbene transfer activity of the C45-EDA complex. 
The experimental conditions employed to investigate carbene transfer activity paralleled the 
conditions initially used to investigate metallocarbenoid formation, with a single modification being 





protein, stochiometric Na2S2O4, CHES buffer, pH 8.6) and a solution containing ethyl diazoacetate 
(EDA) and styrene (100 µM -10 mM and 200 µM - 3mM respectively, 20%:80% CHES:EtOH) were 
prepared in separate compartments (syringes) before a small volume (2x20 µl) of each were injected 
concurrently into a mixing chamber. The mixing chamber was monitored by UV-VIS spectroscopy over 
several timescales to monitor any reactions occurring over the duration of the experiment. Final 
concentrations were 7.5 µM enzyme, stochiometric Na2S2O4, 50 µM - 5 mM EDA, 100 µM - 1.5 mM 
styrene, and 40% EtOH. 
Figure 79 displays the time-course spectra (obtained from the stopped-flow experiments) for C45 in 
the presence of EDA and styrene at wavelengths 417 and 433 nm. 417 nm corresponds to the ferrous 
C45 species and 433 nm corresponds to the C45-EDA metallocarbenoid complex, respectively. The 
data indicates that in the initial 20 seconds post-mixing there is a gradual decrease in the 417 nm 
absorbance and a concurrent increase in the 433 nm absorbance – corresponding to the formation of 
the C45-EDA metallocarbenoid complex from the ferrous species. It was demonstrated  that once 
formed the C45-EDA metallocarbenoid complex is stable and persists over a duration of 1000 seconds 
without any appreciable decay (chapter 3, section 3.5.1.4; figure 75). In the presence of styrene, the 
spectra initially resemble the spectra acquired in the absence of styrene, corresponding to the 
formation of the metallocarbenoid intermediate. After approximately 30 seconds, however, the 
absorbance at 433 nm starts linearly decreasing and is accompanied by a concurrent linear increase 
in absorbance at 417 nm – indicating the decay of the metallocarbenoid species and the return to the 
starting ferrous complex. The differences between the time-dependent traces in the presence and 
absence of styrene at 417 and 433 nm respectively are presented in figure 79. Figure 79 clearly 
demonstrates the plateauing of the absorbance changes at 417 and 433 nm in the absence of styrene, 
corresponding to saturation, is never accomplished in the presence of styrene. UV-VIS traces captured 
at numerous timepoints over 120 seconds is also presented in figure 79. In the initial stages of the 
reaction (1-20 seconds) the UV-VIS exhibits the red-shift corresponding to the formation of the 
metallocarbenoid intermediate, alongside the concurrent shift and broadening of the Q-band profile. 
The spectra acquired in the absence of styrene is characterised by the disappearance of the sharp 
Soret peak at 417 nm and the emergence of a new Soret peak at 428-433 nm, corresponding to the 
formation of the metallocarbenoid intermediate from the starting ferrous complex. In the presence 
of styrene, the emergence of the 433 nm peak appears as a shoulder alongside the 417 nm, resulting 
in a broad, split Soret peak, without either the 417 nm or 433 nm peak dominating the spectra. After 
20 seconds, the maximum absorbance begins to shift towards the 417 nm peak and is accompanied 






Figure 79: (left) Single wavelength traces representing the time course absorbance of ferrous C45 (417 
nm, 7.5 μM protein, 10% EtOH) and the metallocarbenoid:C45 complex (433 nm) following rapid 
mixing of ferrous C45 with 500 μM ethyl diazoacetate at 5OC in the absence (black traces) and presence 
(red trace for 417 nm; blue trace for 433 nm) of 3 mM styrene. (right) UV-VIS traces recorded at 
various time intervals following the rapid mixing of ferrous C45 with 500 μM ethyl diazoacetate at 5OC 
in the presence of 3 mM styrene. 
The spectroscopic data acquired from these initial experiments provides two observations: i) the 
presence of styrene results in the decay of a C45-metallocarbenoid complex, and ii) the decay of a 
metallocarbenoid complex results in the re-emergence of the initial C45 ferrous complex. It cannot, 
however, be concluded whether the metallocarbenoid is i) reacting with styrene to form a 
cyclopropane product, or ii) the presence of styrene destabilises a metallocarbenoid and causes its 
decomposition, possibly via displacement or dimerization. Additional experiments that address 
product identification and characterisation need to be conducted to assign a dynamic explanation to 
the above UV-VIS spectra.       
4.2.3 C45 catalysed cyclopropanation assays 
The spectroscopic information acquired for C45-metallocarbenoid formation in the presence of 
styrene indicates that some reactivity is taking place. In order to quantify the reactivity, it is necessary 
to identify the resultant products. In the literature, it has been well established that hemoproteins 
(such as P450, cytochrome c, and myoglobin) engineered towards metallocarbenoid formation are 
also capable of subsequently reacting with olefins to yield cyclopropane-containing products via a 
concerted carbene transfer reaction.187 The typical substrates employed in the screening of carbene 
transferase activity are ethyl diazoacetate (EDA) and styrene (figure 80). The reaction between these 
two species results in a cyclopropane-containing product and is further distinguished by the 





four possible stereoisomers can be obtained from the reaction; therefore, in addition to carbene 
transfer activity, the assay can provide information on the stereoselectivity of the reaction.  
 
Figure 80: The general cyclopropanation reaction between styrene and EDA catalysed by C45. 
A well-established protocol from the literature for screening for carbene transferase activity was 
employed to screen for C45 activity.190 The protocol involves a small-scale (400 µl) reaction between 
EDA and styrene which is catalysed by the enzyme of interest (C45) under anaerobic conditions. The 
reaction is left to mix for 2 hours at room temperature before the reaction is quenched and the 
product is extracted into an organic solvent and analysed. The product mixture is analysed by HPLC, 
and a chiral column is employed as the stationary phase; chiral-HPLC affords the quantification of the 
stereoselectivity, in addition to product identification and reaction yields. LC-MS was subsequently 
used post-HPLC to corroborate product identification. Initial carbene transfer assays were conducted 
i) in the absence of any catalyst, ii) in the presence of free hemin, and iii) the heme-containing proteins 
myoglobin, haemoglobin, catalase, and horseradish peroxidase. The assays were performed in 1.5 mL 
seal-top reaction vials and the vials were purged with nitrogen prior to conducting the assays. The 
final reaction volumes were 400 µl, and consisted of 30 mM styrene, 10mM EDA, 10 mM sodium 
dithionite and 10 µM of the appropriate catalyst in CHES buffer (100 mM KCl, 20mM CHES, pH 8.6). 
The reactions were stirred for 2 hours, at room temperature, before being quenched with 3M HCl and 
the products extracted with ethyl acetate for analysis. The chromatograms for the six initial assays 
performed are presented in figure 81. It can be seen in figure 81 that no product was identified in any 







Figure 81: Chiral-HPLC chromatograms for the cyclopropanation assays between styrene (30 mM) and 
EDA (10 mM) (CHES buffer, pH 8.6, 254 nm) catalysed (10 μM, 0.1 % catalyst loading) by (top left) no 
catalyst, (top middle) hemin, (top right) myoglobin, (bottom left) haemoglobin, (bottom middle) 
catalase, and (bottom right) horseradish peroxidase (HRP). A polar organic mobile phase (100% 
MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and injection volumes were 2 μl. 
The expected cyclopropane product following the reaction between styrene and EDA is ethyl 2-
phenylcyclopropane-1-carboxylate. A chromatogram of a commercial racemic sample of trans-ethyl 
2-phenylcyclopropane-1-carboxylate was acquired; the chromatogram contained two peaks with 
retention time ranges 7.1-7.3 and 8.9-9.5 seconds, respectively. A commercial sample of 
enantiomerically pure trans-ethyl (1R,2R)-2-phenylcyclopropane-1-carboxylate was subsequently 
analysed, using chiral-HPLC and LC-MS, to identify which peak corresponded to which enantiomer, 
and to facilitate subsequent product analysis. The chiral-HPLC chromatogram of the commercial (R,R)- 
and (S,S)- products is presented in figure 82 (top), and exhibits a symmetrical peak, characteristic of 
the classic Gaussian distribution, at a retention time of 7.1-7.3 seconds; by deduction, the 7.1-7.3 
retention time corresponds to the (R,R)-enantiomer and the 8.9-9.5 retention time to the (S,S)-
enantiomer. The enantiomerically-pure (R,R)-enantiomer was analysed via LC-MS, and the spectrum 
is displayed in figure 83 (bottom). The spectrum is dominated by a peak at 145 m/z, corresponding to 
a stable carbonyl ion following the loss of EtOH from the parent [M-H]+ via fragmentation. The 
spectrum also possess a [M-H]+ parent ion at 191 m/z, corresponding to the exact mass of the 
protonated (R,R)-product.  
The assay was then repeated, under identical conditions employed in the controls, in the presence of 
C45. The chromatogram acquired for the C45-cataysed assay is presented in figure 82 against the 





possesses a dominant peak at 7.1 minutes shortly followed by a few minor peaks in the 8.5-9.1 minutes 
region. The comparison between the normalised average chromatograms for the C45-catalsyed 
carbene transferase assay, obtained from triplicate repeats, against the normalised chromatogram for 
the commercial (R,R)-sample reveals a very clear overlap between the two chromatograms, indicating 
the peak at 7.1-7.3 in the C45-catalysed carbene transfer assay can be assigned as the (R,R)-product.  
 
 
Figure 82: Chiral-HPLC chromatograms for the cyclopropanation assays. A polar organic mobile phase 
(100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and injection volumes were 2 μl. (top) 
normalised chiral-HPLC chromatograms for commercial (R,R)-ethyl 2-phenylcyclopropane-1-
carboxylate (254 nm, EtOH, blue) and (S,S)-ethyl 2-phenylcyclopropane-1-carboxylate (254 nm, EtOH, 
red). (bottom) Averaged chromatogram from the C45 (10 μM, 0.1 % catalyst loading) catalyzed 
cyclopropanation assay between styrene (30 mM) and EDA (10 mM) (CHES buffer, pH 8.6, 254 nm).  
In order to confirm the identity of the 7.1-7.3 peak, the C45-catalysed assay mixture was analysed by 
LC-MS, and the acquired spectrum is displayed in figure 83. The mass spectrum possesses the 
dominant 145 m/z peak and the parent [M-H]+ at 191 m/z, and excluding relevant intensities is 







Figure 83: LC-MS spectra of C45 catalyzed cyclopropanation assay products. Commercial ethyl 2- 
phenylcyclopropane-1-carboxylate (in EtOH) exhibiting the dominant oxonium ion fragment at 145 
m/z (top MS) and C45 catalyzed cyclopropanation assay between styrene (30 mM) and EDA (10 mM) 
(bottom MS). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 column 
was employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v 
water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. (bottom) 
Fragmentation pathway leading to the dominant oxonium ion at 145 m/z from the elimination of EtOH 
from the parent [M+H]+ ion. 
The spectroscopic data obtained for C45 metallocarbenoid formation in the presence of EDA and 
styrene indicated that the presence of styrene disrupts the formation of the metallocarbenoid, which 
was concluded from the simultaneous changes in the metallocarbenoid (433 nm) and ferrous species 
absorbance (417 nm) respectively. It could not be concluded, however, whether the disruption was a 





complex. The chiral-HPLC and LC-MS data obtained from the C45-catalysed assay is consistent with 
the postulation that C45 is catalysing the carbene transfer reaction between styrene and EDA to yield 
a cyclopropane-product; therefore, the absorbance differences in the time-dependent spectra of 
C45/EDA in the absence and presence of styrene can be attributed to carbene transfer activity. The 
chromatograms obtained from the assays also allow the carbene transferase activity of C45 to be 
quantified (figure 164, appendix 1). An average product yield of 80% (R,R), TTN of 802, 
diastereoselectivity of >99.9% (trans) and enantioselectivity of 77% (R,R) for the C45-catalysed 
reaction between EDA and styrene was calculated. 
In the literature, several carbene transferases, engineered from naturally occurring hemoproteins, 
have been reported.190 Figure 84 is a non-exhaustive list of data reported for various engineered 
hemoproteins catalysing the reaction between EDA and styrene presented as a scatter plot of TTN vs 
ee% (table 17, appendix 2).190–192,195,198,199 It is immediately observable that the reported values for the 
product yields, enantioselectivities and TTNs in figure 84 are relatively broad, with product yields 
ranging from 37% to >99.9%, enantioselectivities ranging from racemic to >99.9% and TTNs ranging 
from 186-3700.190–192,195,198,199 The two best mutants are the myoglobin variants Mb(F43V,V68F) and 
Mb(H64V,V68A), each with reported values of >99.9% product yields, >99.9% enantioselectivity, and 
TTNs of 500.195 In comparison to C45, the product yields and enantioselectivities are objectively better, 
but the dominant product of the reactions is the (S,S)-enantiomer, the opposite product to C45. 
Furthermore, C45 possess a higher TTN (802 vs 500), a consequence of the authors reporting catalytic 
loadings of 20 µM for each enzyme relative to 10 µM used in the C45 cyclopropanation assays. In 
terms of product yield, four additional mutants, Mb(F43V,V68A),195 Mb(L29T,H64V),199 
Mb(H64V,V68S)199 and T268-axH,193  have a higher yield (on average) relative to C45, with 91%, 93%, 
82% and 81% respectively relative to 80% (C45). However, three of the four mutants, Mb(F43V,V68A), 
Mb(L29T,H64V) and T268-axH, exhibit lower enantioselectivities, 67%, 59% and 42% respectively, 
relative to C45 (77%) as well as lower TTNs (455, 460, 710 vs 802).195,199 Mb(H64V,V68S) (in addition 
to Mb(F43V,V68F) and Mb(H64V,V68A)) has a superior product yield and enantioselectivity, 82% and 
99.9% respectively, relative to C45, but possess a TTN almost half that of C45 (410 vs 802).195,199 Only 
two mutants, P411BM3 and P411BM3-CIS, possess higher TTNs relative to C45 (2900 and 3700 
respectively vs 802), but present low product yields (50 and 55% respectively);191 in addition, these 
assays were conducted using whole cells expressing the mutants and so cannot be directly compared 
(and are excluded from figure 85).191 An assay conducted with purified P411BM3-CIS resulted in a 40% 
product yield and a 199 TTN, although a 94% enantioselectivity was reported.195 The data 
demonstrates that functionality can drastically vary among engineered hemoproteins, with C45, 





transferases. The data indicates the C45 maquette, in addition to displaying reasonable carbene 
transferase activity, is a suitable scaffold for further modification to manufacture more selective and 
efficient de novo carbene transferases. This will be explored in detail in chapter 7. 
 
Figure 84: A comparison of TTN vs enantioselectivity for several rationally designed carbene 
transferases relative to C45 (blue).190–192,195,198,199 
4.2.3.1 Substrate specificity – substituted diazo compounds and para-functionalised styrenes 
The C45-catalysed cyclopropanation assay was repeated using tBuDA and BnDA as the diazo 
precursors (the chiral-HPLC traces for the reaction products are presented in figure 85). As in the 
assays with EDA, the chromatograms for tBuDA and BnDA are dominant by a major peak with a 
retention time of 7.0-7.3, the known retention time for the (R,R)-cyclopropane product. Although 
activity can be detected for both tBuDA and BnDA, the product yields and TTNs of the assays are 
considerably lower (tBuDA = 18.45%, 189; BnDA = 19.6%, 196 respectively; table 3) while the 
enantioselectivities, although less affected, are also lower relative to EDA (tBuDA 40.64%; BnDA 





Table 3: The product yields, diastereoselectivities, enantioselectivities and TTN of the C45-catalysed 
cyclopropanation reaction between styrene and EDA, tBuDA and BnDA. 
 
The difference in activity towards tBuDA and BnDA relative to EDA can be partially accounted for by 
sterics, metallocarbenoid stability, and protein-carbene intermolecular interactions. The K1 values for 
C45-metallocarbenoid formation for each diazo precursor was presented in chapter 3, section 3.5.1.3. 
The values were calculated to be 74.36 113.16 and 219.43 µM for EDA, BnDA and tBuDA respectively 
(table 1, chapter 3, section 3.5.1.2). The rates of formation for C45-metallocarbenoid formation were 
also calculated as 0.498, 0.349 and 0.195 s-1 for EDA, BnDA and tBuDA, respectively. The single 
turnover kinetic data indicates that C45 preferentially forms a metallocarbenoid with EDA, but the 
kinetic data provides no information on the thermodynamic stability of the resultant complex. 
Computational studies have provided insight into metallocarbenoid stability and highlighted an 
increased steric bulk on the carbene carbon’s substituents decreases the rate of formation but also 
provides a stabilising effect on the resultant complex post-formation. The product yields acquired 
from the cyclopropanation assays support this claim, as the product yields negatively correlate with 
the K1 values for metallocarbenoid formation. The increase in K1 for metallocarbenoid formation is a 
consequence of the increased steric bulk of the carbene carbon’s substituents, which hinders 
accessibility into the active site and requires a reorganisation of the active site residues to 
accommodate the bulky ligand; however, upon formation, the bulkier ligand stabilises the 
metallocarbenoid, which hinders reactivity with a suitable substrate. The decrease in 
enantioselectivity for tBuDA and BnDA is probably a consequence of reorganisation of the active site 
residues to accommodate the bulkier substituents. However, additional C45-cataysed 
cyclopropanation assays employing a range of different functionalised diazo precursors would need 
to be conducted, and subsequently analysed, to corroborate the above hypothesis.  
The moderate enantioselectivity exhibited for BnDA could also be possibly accounted for by π-π 
interactions between the phenyl group of BnDA and nearby aromatic residues, an interaction that has 
been identified as important for governing the stereoselectivity in the literature. Any π-π interactions 
would facilitate the formation of the metallocarbenoid (K1(BnDA) < K1(tBuDA)) but would also stabilise 
the resultant conformation with the strongest π-π interactions. As the strength of π-π interactions is 





that can provide the strongest interactions would be energetically preferred and be the foremost 
conformer adopted. In terms of carbene transfer reactivity, the existence of a dominant 
conformation(s) would account for the observed stereoselectivity of BnDA relative to tBuDA. At 
present, however, it cannot be concluded whether sterics, electronics or both govern the observed 
stereoselectivity of the C45-catalysed cyclopropanation reaction. A combination of experimental 
techniques and computational analysis (DFT, MD, QM/MM) will be employed to elucidate these 
questions in the future. 
Having demonstrated that C45 can function as a stereoselective carbene transferase towards styrene 
the next line of investigation concerned substrate specificity. An assortment of para-functionalised 
styrenes were used to explore how the electronics/sterics of functionalised styrenes influenced the 
reaction yields and selectivity. The selected substrates are presented in table 4. EDA was employed as 
the diazo precursor substrate in all the assays. The reaction conditions employed for each substrate 
were identical to those employed in the aforementioned assays were styrene served as the substrate. 
All assays were subject to chiral-HPLC and LC-MS analysis to quantify product yields and 
stereoselectivities. All product yields were determined by reference to an external calibration, with 
each product synthesised by following a well-established protocol that uses Rh2(OAc)4 as the catalyst 






Figure 85: Chiral-HPLC chromatogram for the C45 (10 μM) catalyzed cyclopropanation assays. (top 
left) p-hydroxystyrene (30 mM) and EDA (10 mM); (top middle) p-chlorostyrene (30 mM) and EDA (10 
mM); (top right) p-trifluoromethylstyrene (30mM) and EDA (10 mM); (middle left) p-methoxystyrene 
(30 mM) and EDA (10 mM); (middle) p-cyanostyrene (30 mM) and EDA (10 mM); (middle right) p-tert-
butylstyrene (30 mM) and EDA (10 mM); (bottom left) p-fluorostyrene (30 mM) and EDA (10 mM); 
(bottom middle) styrene (30 mM) and tert-butyl diazoacetate (10 mM); (bottom right) styrene (30 
mM) and benzyl diazoacetate (10 mM). All assays were performed in CHES buffer (pH 8.6) with 10 μM 
C45 (0.1 % catalyst loading). A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) 






Figure 86: LC-MS spectra for the C45 (10 μM) catalyzed cyclopropanation assays. (top left) p-
hydroxystyrene (30 mM) and EDA (10 mM); (top middle) p-chlorostyrene (30 mM) and EDA (10 mM); 
(top right) p-trifluoromethylstyrene (30mM) and EDA (10 mM); (middle left) p-methoxystyrene (30 
mM) and EDA (10 mM); (middle) p-cyanostyrene (30 mM) and EDA (10 mM); (middle right) p-tert-
butylstyrene (30 mM) and EDA (10 mM); (bottom left) p-fluorostyrene (30 mM) and EDA (10 mM); 
(bottom middle) styrene (30 mM) and tert-butyl diazoacetate (10 mM); (bottom right) styrene (30 
mM) and benzyl diazoacetate (10 mM). All spectra were recorded in ES+ mode and monitored at 254 
and 280 nm. A C8 column was employed for the LC separation with a gradient mobile phase (95:5:0.1 








Figure 87: (top) Fragmentation pathways leading to the observed peaks in the mass spectra. (bottom) 
Fragmentation pathway for the product obtained using p-trifluoromethylstyrene as the starting 
substrate, resulting in the peaks observed in the product mass spectrum. 
The chiral-HPLC traces acquired for the C45-catalysed cyclopropanation assay for each para-
functionalised styrene are presented in figure 85 with yields, stereoselectivities and TTNs presented 
in table 4. The C45-catalysed cyclopropanation assay chromatograms for each respective para-
functionalised styrene is characterised by a dominant peak around retention time 7.0-7.5 minutes 
corresponding to the (R,R)-enantiomeric product, with many chromatograms exhibiting an additional 
peak with retention time 9.0-9.5 minutes corresponding to the (S,S)-enantiomeric product. The 





presented in table 4. From table 4 there is no consistency in the product yields across the substrate 
range. The lowest product yield is 36% for p-hydroxystyrene. The yields for p-chlorostyrene, p-
fluorostyrene, p-vinylphenol, p-methoxystyrene, and p-tert-butylstyrene all are mid-range, with 
reasonable product yields ranging from 46-57% respectively. The yield for p-(trifluoromethyl)styrene 
is very good, with an average product yield of 79%. From the product yields, there is no immediately 
apparent relationship between the electronics of the para-functionalised substituent and the product 
yields of the cyclopropanation assays. From electronics alone, it is expected that p-tert-butylstyrene 
and p-methoxystyrene would increase the reactivity by donating electron density towards the 
nucleophilic vinyl group of styrene, which is observed, but p-trifluoromethylstyrene should exhibit the 
opposite relationship, a decrease in the reactivity of the substrate as p-CF3 withdraws electron-density 
from the vinyl nucleophilic group. In addition to electronics, the range of product yields with respect 
to para-functionalisation cannot be immediately accounted for by sterics, although all the yields are 
lower than for styrene (80%). Irrespective of the ambiguous relationship between styrene 
functionalisation and product yield, what can be deduced is C45 exhibits good substrate specificity 
and is capable of turning over an assortment of differing styrene substrates. Figure 86 presents the 
LC-MS spectra acquired for each functionalised styrene substrate in addition to the molecular 
structure of the key fragments observed in each mass spectrum (figure 87). 
Table 4: The product yields, diastereoselectivities, enantioselectivities and TTN of the C45-catalysed 
cyclopropanation reaction between EDA and a selection of para-functionalised styrene substrates 
 
Table 4 also provides the calculated values for the enantioselectivities for each assay conducted. In 
direct contrast to product yield, the range of enantioselectivities are consistent and high. Only p-
chlorostyrene reports a lower enantioselectivity relative to styrene, but with an approximate deviation 





relative to styrene, with p-methoxy-, p-fluoro-, and p-trifluoromethyl- styrene each exhibiting 
exceptional enantioselectivities of >90% (93, 97, 99% respectively).  
The origin of the observed stereoselectivity for carbene transfer cyclopropanation has been explored 
in the literature.305 It was postulated by Fasan that two key factors govern the stereoselectivity: i) the 
conformation of the heme-localised metallocarbenoid, and ii) the geometry and orientation of the 
styrene-carbene transition state which is mediated through a combination of steric effects and various 
non-covalent intermolecular interactions between the active site residues and both the carbene and 
styrene substrates. In particular, π-π interactions between styrene and an aromatic residue on the 
protein were identified as key interactions governing the stereoselectivity (figure 88).305 MD 
simulations investigating the origin of stereoselectivity in C45-catalysed cyclopropanation reactions 
concluded that C45 is structurally homogenous, accommodating two possible orientations of the 
carbene in the active site. The simulations, however, revealed only a minor energetic preference for 
the enantioselective attack of the substrate on the pro-R face of the metallocarbenoid intermediate. 
It was reported that the orientation of the metallocarbenoid was influenced by the presence of a 
substrate, reinforcing the hypothesis that the stabilisation of the transition state is more important to 
the overall stereoselectivity. The simulations also revealed the majority of stabilising interactions 
between the substrate, carbene and active site are hydrophobic in nature, and demonstrated a lack 
of hydrogen bonds despite the existence of several hydrogen bonding donors/acceptors. The results 






Figure 88: The free energy diagram for the four possible optimised transition states for the 
Mb(H64V,V68A)-catalysed cyclopropanation reaction between EDA and styrene leading to the four 
possible stereoisomers: A) TS1S2S, B) TS1R2R, C) TS1S2R, and D) TS1R2S (figure taken from Tinoco et al).305 
As mentioned, Fasan highlighted the importance of π-π interactions between the styrene substrate 
and aromatic groups in the active site of the protein (figure 88).305 In C45, a tryptophan residue in 
close proximity to the heme cofactor (the tryptophan that the cationic radical of C45-compound I is 
localised) can provide the necessary π-π interactions with styrene and could account for the 
stereoselectivity observed. Interestingly, the two highest enantioselectivities observed in the C45-
cyclopropanation assays were with p-fluoro- and p-(trifluoromethyl)- styrene, with 
enantioselectivities of 99.64 and 96.62% respectively. It is possible the highly polarised and short C-F 
σ-bond provides stabilising electrostatic interactions and/or possible halogen bonds are provided 
from the substituents which can either stabilise the transition state and/or stabilise a particular 
trajectory of approach of the substrate towards the metallocarbenoid. However, the molecular origins 
of the stereoselectivity observed in the C45-catalysed cyclopropanation assays is currently unclear and 
therefore additional experiments are imperative. There are three possible experiments that would 
provide useful information on the parameters governing stereoselectivity: i) using site-directed 
mutagenesis to introduce select point mutations into C45’s active site to identify key amino acids 





styrenes to investigate the nature of the C-F bond in governing stereoselectivity, and iii) additional 
computational simulations (DFT, MD, QM/MM) to elucidate the key interactions that 1) govern the 
trajectory of approach of the styrene towards the metallocarbenoid intermediate, and 2) stabilise the 
metallocarbenoid-substrate transition state. 
4.2.4 Spectroscopic characterisation of Rma-TDE and Mb(H64V,V68A) metallocarbenoid formation 
in the presence of receptive olefins – a direct comparison with C45 
The UV-VIS spectra of the ferrous and ferric Rma-TDE and Mb(H64V,V68A) in the absence and 
presence of EDA were reported in chapter 3 section 3.5.1.4. The spectra for both enzymes were 
consistent with the formation of a stable, persistent, heme-localised metallocarbenoid species; which 
was consistent with the X-ray crystallographic structures reported in the literature for Rma-TDE and 
Mb(H64V,V68A) EDA-metallocarbenoid complexes.219,304 Having successfully demonstrated that C45 
i) forms a persistent, stable heme-localised metallocarbenoid complex when introduced to a suitable 
carbene precursor, and ii) exhibits proficient carbene transfer activity in the presence of suitable 
olefins, it would be prudent to investigate, spectroscopically, the carbene transfer activity of both 
Rma-TDE and Mb(H64V,V68A) metallocarbenoid complexes in the presence of styrene. A direct 
comparison between literature reported carbene transferases and C45 would provide a beneficial 
means of comparing de novo and re-engineered natural hemoproteins. The experimental conditions 
employed to investigate carbene transfer activity for Rma-TDE and Mb(H64V,V68A) were identical to 
the conditions used to investigate C45 activity in the presence of styrene. A solution containing ferrous 
enzyme (15 µM protein, stochiometric Na2S2O4, CHES buffer, pH 8.6) and a solution containing EDA 
and styrene (100 µM - 1 mM and 200 µM – 3 mM respectively, 20%:80% CHES:EtOH) was prepared in 
separate compartments (syringes) before a small volume (2x20 µl) of each were concurrently injected 
into a mixing chamber. The mixing chamber was monitored by UV-VIS spectroscopy over several 
timescales to monitor any reactions occurring over the duration of the experiment. Final 
concentrations were 7.5 µM enzyme, stochiometric Na2S2O4, 50 µM - 500 µM EDA, 100 µM - 1.5 mM 
styrene, and 40% EtOH. 
The time-course spectra for the stopped-flow experiments for Rma-TDE in the presence of EDA (500 
µM) and styrene (3 mM) at wavelengths 417 and 433 nm is presented in figure 89. 417 nm and 433 
nm correspond to ferrous Rma-TDE and the Rma-TDE-(EDA) metallocarbenoid complex, respectively. 
In the absence of styrene, after the initial 20 seconds post-mixing there is a gradual decrease in the 
417 nm absorbance accompanied by a concurrent increase in the 433 nm absorbance – corresponding 
to the formation of the Rma-TDE-(EDA) metallocarbenoid complex from the ferrous species (chapter 






Figure 89: (left) Single wavelength traces representing the time course absorbance of ferrous Rma-
TDE (417 nm, 7.5 μM protein, 10% EtOH) and the metallocarbenoid:Rma-TDE complex (433 nm) 
following rapid mixing of ferrous Rma-TDE with 500 μM ethyl diazoacetate at 5OC in the presence of 
3 mM styrene. (right) UV-VIS traces recorded at various time intervals following the rapid mixing of 
ferrous Rma-TDE with 500 μM ethyl diazoacetate at 5OC in the presence of 3 mM styrene. 
The time-dependent spectra in the presence of styrene is presented in figure 89. It is apparent that 
the formation of the Rma-TDE-(EDA) metallocarbenoid complex exhibits a lag phase, requiring a 
duration of approximately 100 seconds before reaching saturation. After 100 seconds, the absorbance 
at 433 nm begins to gradually decline and is accompanied by a paralleled increase in the absorbance 
at 417 nm. The observed changes post-100 seconds continue for up to 500 seconds, with no 
appreciable change in the linear profile of each wavelength. Figure 89 (right) is a collection of 
snapshots of the UV-VIS spectra, taken at various intervals, for the formation of the Rma-TDE-(EDA) 
metallocarbenoid complex in the presence of styrene. Figure 89 (right) shows a clear shift towards 
the metallocarbenoid species (433 nm) in the initial stages of the reaction, but over time the spectra 
is characterised by the re-emergence of the 417 nm ferrous Rma-TDE peak, shouldered by a 
continuously diminishing Rma-TDE-(EDA) metallocarbenoid peak at 433 nm. The data collected from 
the stopped-flow indicates that Rma-TDE is catalytically active towards styrene, catalysing a carbene 
transfer reaction and returning to the initial active ferrous state. The activity suggested by the UV-VIS 
spectra also accounts for the lag phase corresponding to the formation of the Rma-TDE-(EDA) 
metallocarbenoid complex. It should be noted that a 1:6 ratio of EDA:styrene was required to 
observed any spectroscopic activity, a much greater ratio required than for C45 (1:30), suggesting that, 
although Rma-TDE can catalyse the cyclopropanation of styrene, the affinity for EDA is considerably 
lower and requires elevated concentrations to reach saturation, an observation supported by the 
reported K1 values for Rma-TDE-(EDA) and C45 (for EDA) in chapter 3 (table 2, chapter 3, section 





metallocarbenoid peak suggests that Rma-TDE has a much lower affinity for styrene relative to C45. 
This observation will be returned to shortly. 
The time-course spectra for the stopped-flow experiments for Mb(H64V,V68A) in the presence of EDA 
(100 µM) and styrene (3 mM) at wavelengths 435 and 424 nm is presented in figure 90. 435 nm 
corresponds to the ferrous Mb(H64V,V68A) species and 424 nm corresponds to the Mb(H64V,V68A)-
EDA metallocarbenoid complex, respectively. In the absence of styrene the initial 20 seconds post-
mixing shows a rapid decrease in the 435 nm absorbance accompanied by a concurrent increase in 
the 424 nm absorbance – corresponding to the formation of the Mb(H64V,V68A)-EDA 
metallocarbenoid complex from the ferrous species (chapter 3, section 3.5.1.4). This is followed by a 
100 second phase marked by a gradual change in both respective absorbances. In the presence of 
styrene, the initial formation of the Mb(H64V,V68A)-EDA metallocarbenoid complex displays the same 
initial burst, followed by a major lag phase which persists for over 500 seconds; the 435 peak, 
corresponding to ferrous Mb(H64V,V68A) does not being to re-emerge over the duration of the 
experiment, and requiring a duration of approximately 100 seconds before reaching saturation. In 
contrast, the 424 nm peak, corresponding to the Mb(H64V,V68A)-EDA metallocarbenoid complex, 
also exhibits a lag phase in the initial formation, and begins to slowly diminish after approximately 200 
seconds, which continues for the remainder of the experiment.  
 
Figure 90: Single wavelength traces representing the time course absorbance of ferrous 
Mb(H64V,V68A) (417 nm, 7.5 μM protein, 10% EtOH) and the metallocarbenoid:Mb(H64V,V68A)  
complex (433 nm) following rapid mixing of ferrous Mb(H64V,V68A) with 500 μM ethyl diazoacetate 





The data collected from the stopped-flow indicates that Mb(H64V,V68A) is catalytically active towards 
carbene transfer and returns to the initial active ferrous state after reacting with substrate. It should 
be noted that a 1:6 ratio of EDA:styrene was required to observe any spectroscopic activity, an 
identical ratio required for C45. In addition, the absence of any re-emergence of the ferrous 
Mb(H64V,V68A) peak (435 nm) indicates that Mb(H64V,V68A) possesses a much higher affinity for 
EDA relative to either C45 or Rma-TDE, which is consistent with the reported K1 values for 
metallocarbenoid formation (table 2, chapter 3, section 3.5.1.5), but the much greater lag phase prior 
to the decline for the Mb(H64V,V68A)-EDA metallocarbenoid peak suggests that, while 
Mb(H64V,V68A) does exhibit carbene transfer activity towards styrene, Mb(H64V,V68A) has a much 
lower affinity for styrene relative to C45.  
4.2.5 Rma-TDE and Mb(H64V,V68A) catalysed cyclopropanation assays – a comparison with C45 
Having demonstrated carbene transferase activity for Rma-TDE and Mb(H64V,V68A) 
spectroscopically, both Rma-TDE and Mb(H64V,V68A) were subsequently employed as catalysts in the 
cyclopropanation assay to quantify reactions yields and stereoselectivities; the values were directly 
compared to the values acquired for C45. The same reagents and conditions used in the C45-catalysed 
cyclopropanation assays were employed for Rma-TDE and Mb(H64V,V68A). The assays were 
conducted in 1.5 mL seal-top reaction vials, which were purged with nitrogen prior to conducting the 
assays. The final reaction volumes were 400 µl, and consisted of 30 mM styrene, 10mM EDA, 10 mM 
sodium dithionite and 10 µM of Rma-TDE in CHES buffer (100 mM KCl, 20 mM CHES, pH 8.6) or 10 µM 
of Mb(H64V,V68A) in KPi buffer (100 mM phosphate, pH 7). The reactions were stirred for 2 hours, at 
room temperature, before being quenched (3M HCl) and the products extracted with ethyl acetate 
for analysis via chiral-HPLC and LC-MS. 
The normalised chromatogram acquired for the Rma-TDE-catalysed cyclopropanation reaction 
between styrene and EDA vs the normalised chromatogram acquired for commercially acquired 
enantiomerically-pure (R,R) is presented in figure 91 (top). Figure 91 (bottom) displays the average 
chromatogram for the Rma-TDE-catalysed cyclopropanation reaction between styrene and EDA, 






Figure 91: Chiral-HPLC chromatograms for the Rma-TDE-catalysed cyclopropanation assays. A polar 
organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and injection 
volumes were 2 μl. (top) normalised chiral-HPLC chromatograms for commercial (R,R)-ethyl 2-
phenylcyclopropane-1-carboxylate (280 nm, EtOH, red) and the Rma-TDE-catalysed cyclopropanation 
assays (280 nm, EtOH, blue). (bottom) Averaged chromatogram from the Rma-TDE (10 μM, 0.1 % 
catalyst loading) catalyzed cyclopropanation assay between styrene (30 mM) and EDA (10 mM) (CHES 
buffer, pH 8.6, 280 nm).  
The averaged and normalised chromatograms in figure 91 are both characterised by the presence of 
a dominant peak with a retention time of 7.1 minutes that is shortly followed by a minor peak with a 
retention time of 9.0 minutes. The normalised chromatogram (figure 91, top) demonstrates a good 
overlap between the Rma-TDE-catalysed cyclopropanation product and the commercially acquired 
enantiomerically-pure (R,R) sample, although there is a noticeable difference in the retention times. 
The molecular interactions between the stationary phase of the column and the eluting analyte are 
temperature dependent, and so small deviations in temperature are reflected in retention times;310–
312 because the chiral column is not thermally insulated, the observed shift for Rma-TDE-catalysed 
cyclopropanation product is accounted for by temperature fluctuations.310–312 Nonetheless, the 
chromatograms indicate that the peak at 7.1 minutes can be assigned to ethyl (1R,2R)-2-
phenylcyclopropane-1-carboxylate. From the averaged chromatogram in figure 91 (bottom), an 
average reaction yield of 73% and enantioselectivity of 70.6% was calculated. In order to 





was analysed by LC-MS (the acquired spectrum displayed in figure 94 (bottom right)). It can be seen 
that the spectrum possesses the dominant 145 m/z peak and the parent [M-H]+ at 191 m/z, and 
excluding relevant intensities is practically identical to the spectrum obtained for the commercial 
sample.  
 
Figure 92: Chiral-HPLC chromatograms for the Mb(H64V,V68A)-catalysed cyclopropanation assays. A 
polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and injection 
volumes were 2 μl. (top) normalised chiral-HPLC chromatograms for commercial (S,S)-ethyl 2-
phenylcyclopropane-1-carboxylate (280 nm, EtOH, red) and the Mb(H64V,V68A)-catalysed 
cyclopropanation assays (280 nm, EtOH, blue). (bottom) Averaged chromatogram from the 
Mb(H64V,V68A) (10 μM, 0.1 % catalyst loading) catalyzed cyclopropanation assay between styrene 
(30 mM) and EDA (10 mM) (CHES buffer, pH 8.6, 280 nm). 
The normalised chromatogram acquired for the Mb(H64V,V68A)-catalysed cyclopropanation reaction 
between styrene and EDA vs the normalised chromatogram acquired for commercially acquired 
enantiomerically-pure (S,S) is presented in figure 92 (top). Figure 92 (bottom) displays the average 
chromatogram for the Mb(H64V,V68A)-catalysed cyclopropanation reaction between styrene and 
EDA, obtained from triplicate repeats. The averaged and normalised chromatograms in figure 92 are 
both characterised by the presence of a single dominant peak with a retention time of 9.0 minutes. 
The normalised chromatogram (figure 92, top) demonstrates an excellent overlap between the 
Mb(H64V,V68A)-catalysed cyclopropanation product and the commercially obtained 





the peak at 9.0 minutes can be assigned to ethyl (1S,2S)-2-phenylcyclopropane-1-carboxylate, the 
anticipated product. From the averaged chromatogram in figure 92 (bottom), an average reaction 
yield of 96% and enantioselectivity of >99.9% was calculated, values identical to those reported in the 
literature.195 In order to unambiguously confirm the identity of the peak at 9.0 minutes, the 
Mb(H64V,V68A)-catalysed cyclopropanation product was analysed by LC-MS (the acquired spectrum 
is displayed in figure 94 (bottom left)). It can be seen that the spectrum possesses the dominant 145 
m/z peak and the parent [M-H]+ at 191 m/z, and excluding relevant intensities is practically identical 
to the spectrum obtained for the commercial sample.  
Figures 93 and 94 are comparative normalised chiral-HPLC chromatograms and LC-MS spectra for 
commercial ethyl (R,R)/(S,S)-2-phenylcyclopropane-1-carboxylate (top left), the C45-cataysed 
cyclopropanation product (top right), the Rma-TDE-catalysed cyclopropanation product (bottom left), 
and the Mb(H64V,V68A)-catalysed cyclopropanation product (bottom right) respectively; the 
respective product yields, enantioselectivities, diastereoselectivities, and TTNs for each enzyme are 
presented in table 5. 
Table 5: The yields, diastereoselectivities, enantioselectivities, and total turnover numbers for the 
cyclopropanation reaction between styrene and EDA catalysed by the de novo heme-containing 







Figure 93: The normalised chiral-HPLC chromatograms for commercial ethyl 2-phenylcyclopropane-1-
carboxylate, and the C45, Mb(H64V,V68A) and Rma-TDE catalyzed cyclopropanation assay products. 
(top left) commercial (R,R)-ethyl 2-phenylcyclopropane-1-carboxylate (in EtOH, red) and (S,S)-ethyl 2-
phenylcyclopropane-1-carboxylate (in EtOH, blue) (top right) C45-catalyzed cyclopropanation assay 
between styrene (30 mM) and EDA (10 mM). (bottom left) Mb(H64V,V68A)-catalyzed 
cyclopropanation assay between styrene (30 mM) and EDA (10 mM). (bottom right) Rma-TDE-
catalyzed cyclopropanation assay between styrene (30 mM) and EDA (10 mM). A polar organic mobile 






Figure 94: LC-MS spectra of commercial ethyl 2-phenylcyclopropane-1-carboxylate, C45, 
Mb(H64V,V68A) and Rma-TDE catalyzed cyclopropanation assay products. (top left) Commercial ethyl 
2-phenylcyclopropane-1-carboxylate (in EtOH) exhibiting the dominant oxonium ion fragment at 145 
m/z. (top right) C45-catalyzed cyclopropanation assay between styrene (30 mM) and EDA (10 mM). 
(bottom left) Mb(H64V,V68A)-catalyzed cyclopropanation assay between styrene (30 mM) and EDA 
(10 mM). (bottom right) Rma-TDE-catalyzed cyclopropanation assay between styrene (30 mM) and 
EDA (10 mM). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 column 
was employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v 
water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. 
4.2.6 Kinetic characterisation of C45, Rma-TDE and Mb(H64V,V68A) catalysed cyclopropanation 
The kinetic parameters for C45, Rma-TDE, and Mb(H64V,V68A) catalysed cyclopropanation assays 
between EDA and styrene were determined to gain insight into the differences between the three 
enzymes. The apparent kinetic parameters, Vmax, K1, klim, and the catalytic efficiencies of the 
cyclopropanation reaction for each enzyme were determined using stopped-flow spectroscopy. The 
concentration of EDA was kept constant through the experiments, with the concentration of styrene 
being varied; the apparent kinetic parameters were determined from the rate of change in absorbance 





the calculated curves acquired for each enzyme respectively, with each plot displaying concentration-
dependent Michaelis-Menten like curves. The apparent kinetic parameters, Vmax, K1, klim, and (klim/K1) 
are presented in table 6. The mechanism of cyclopropantion proceed via a heme-localised 
metallocarbenoid involves three distinct identities: i) free metallocarbenoid and substrate, ii) the 
formation of a three-membered cyclic intermediate, and iii) the elimination of the cyclopropane 
product to afford the starting ferrous enzyme. There are two underlining assumptions that have been 
made to assist in the analysis: i) the rate of decomposition of the three-membered cyclic intermediate 
to the product (klim) is first order, and ii) the reaction is irreversible (k2 >>> k-2). The overall process, 
with associated rate constants, is illustrated in figure 95 (bottom).   
 
 
Figure 95: (top) The concentration-dependent plots for the cyclopropanation reaction of the 
enzyme:EDA metallocarbenoid complex in the presence of styrene for the enzymes (left) C45 (7.5 µM, 
CHES buffer, pH 8.6, 40% (v/v) EtOH); (middle) Mb(H64,V68A) (7.5 µM, 0.1M KPi buffer, pH 7.0, 40% 
(v/v) EtOH); and (right) Rma-TDE (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) Initial rates were 
determined from the rate of change in absorbance for the enzyme:EDA adduct at 5oC in the presence 
of styrene. (bottom) the mechanism of metallocarbenoid degradation in the presence of styrene 
showing the respective rate constants. A mechanism involving a tricyclic intermediate/transition state 
has been postulated and computational studied by Cossio,313 Zhang,291 and Fasan.305 
The K1 values represent the affinity of the enzyme for the binding of styrene substrate, with lower K1 
values reflecting a higher affinity. The calculated K1(styrene) values for C45, Rma-TDE and 
Mb(H64V,V68A) are 482.51, 795.92, and 657.7 µM respectively (table 6). The K1 values indicate C45 
binds styrene with slightly higher affinity, and is possibility attributed to the simplicity of the maquette 





are evolutionarily complex scaffolds harbouring ambiguous interdependency between the amino 
acids which could hinder the binding of small hydrophobic molecules, such as a styrene. In particular, 
Rma-TDE was engineered to accept bulky silane substrates and is characterised by a dynamic flexibility 
in the loop region where the V75T, M100D and M103E mutations were introduced. In the absence of 
any carbene precursor, the amino acid residues Asp-100, Thr-101 and Asp-102 were unresolved in the 
crystal structure on account of the increase loop flexibility; this suggests the active binding site is also 
solvent exposed. Additionally, the three mutations introduce a threonine, an aspartic acid, and a 
glutamic acid, which would introduce electrostatics into the active site of Rma-TDE; electrostatic 
interactions would favour silane binding but would prove detrimental for binding small, hydrophobic 
molecules.  
In contrast, Mb(H64V,V68A) has five key residues in the active site: Leu-29, Phe-43, Val-64, Ala-68, 
and Ile-107. The leucine, isoleucine, and valine would provide a hydrophobic environment suitable for 
small molecule binding while the tryptophan, positioned in close proximity to the heme, could stabilise 
the binding of styrene through favourable π-π interactions. The authors reported the two mutations, 
H64V and V68A, creates a larger void above the solvent-exposed region of the heme cofactor, 
facilitating substrate accessibility. In C45, the introduction of three phenylalanine rings provides a 
stable, hydrophobic core suitable for accommodating small hydrophobic molecules. A tryptophan 
residue also residues in close proximity to the heme active site, which could provide a stabilising π-π 
interaction with styrene. The presence of several hydrophobic and aromatic residues in the core of 
C45 and Mb(H64,V68A) probably accounts for the higher binding affinity of styrene relative to Rma-
TDE. In addition to active site interactions, the dynamics of the protein scaffold and the degree of 
solvent exposed most likely play critical roles in determining the K1(styrene) values.       
Table 6: The kinetic parameters for the cyclopropanation reaction between styrene and EDA catalysed 
by the de novo heme-containing maquette C45 and the rationally designed heme-containing proteins 






The klim values for C45, Rma-TDE, and Mb(H64V,V68A) are 0.0011, 0.0104 and 0.021 s-1 respectively, 
which represent the relative rate of product formation following an interaction between styrene and 
the metallocarbenoid intermediate (table 6). The catalytic efficiencies (klim/K1) are therefore 2.23, 1.37 
and 31.93 µM s-1 for C45, Rma-TDE and Mb(H64V,V68A) respectively. The data suggests 
Mb(H64V,V68A) is the most efficient enzyme for cyclopropanation, with a klim 2-fold higher than Rma-
TDE and 20-fold higher than C45, respectively. This observation is unsurprising considering 
Mb(H64V,V68A) was selectively engineered for the cyclopropanation reaction, unlike C45 and Rma-
TDE. Rma-TDE was engineered for Si-H insertion chemistry, with the authors introducing key 
mutations into the distal loop region to facilitate silane binding and to provide stabilisation for the 
transition state. C45 was engineered as a simplified oxidoreductase, with an emphasis on oxygen 
binding, electron transfer, and peroxidase chemistry. The similarities between Rma-TDE and C45, such 
as dynamic flexibility, solvent exposed heme propionates, and a c-type heme cofactor, render the 
similarities in catalytic efficiency unsurprising, but the kinetic parameters suggest carbene-activated 
C45 binds styrene more efficiently whereas carbene-activated Rma-TDE turns over styrene more 
efficiently.  
At present, it is impossible to infer any conclusions concerning how the active site residues of each 
enzyme stabilise the transition state or the molecular/dynamic origin of the apparent kinetic 
parameters. A comparison between the three enzymes klim is rendered particularly impossible based 
on the lack of structural information for C45 with respect to metallocarbenoid binding, substrate 
binding, transition state stabilisation, and substrate turnover. It should also be noted the kinetic 
parameters discussed above are only apparent kinetic parameters and may not accurately represent 
the kinetics of the process. This is because the values are derived from the change in absorbance of 
the metallocarbenoid intermediate Soret peak. As the product does not absorb in the visible region, 
no new signal can be detected in the electronic spectra which can be followed to acquire the true 
kinetic parameters. This could be addressed in one of two ways. The first approach would be to 
develop a colourimetric assay that would allow the emergence of the product and/or disappearance 
of the substrate to be followed continuously. A rudimentary colourimetric assay was developed by 
employing indigo as the starting material. Indigo is a fully conjugated aromatic compound with the 
two fragments electronically connected via a C=C bridge. It was rationalised that disrupting that C=C 
π-bond, via the addition of a carbene, would destroy the conjugation and yield a product with no 
detectable trace in the electronic spectra. The employment of indigo as a substrate, however, proved 
more difficult than initially expected, and the assay was abandoned. A second approach would be to 
follow the progress of the reaction discontinuously using HPLC. Although a good idea in theory, 





comparisons between different enzymes problematic. For the purposes of acquiring a rough, 
rudimentary understanding of the cyclopropanation reaction catalysed by different enzymes, it was 
rationalised the approach outlined above (using stopped flow spectroscopy) was sufficient, providing 
the limitations of the approach are always remembered.   
4.3 CONCLUSION 
Having demonstrated in chapter 3 that C45 can form stable metallocarbenoid intermediates with 
three distinctive diazo precursors the question of whether the intermediate was reactive and could 
be employed in organic transformations was raised. The most established reaction in carbene 
chemistry is the [2+1] cycloaddition reaction between a reactive carbene and an olefin to yield a 
cyclopropane-containing product. In the presence of styrene, the spectroscopic profile observed for 
the C45:EDA metallocarbenoid complex exhibited a significant decay which was concurrent with the 
re-emergence of ferrous C45. It was subsequently demonstrated, via chiral-HPLC and LC-MS, that C45 
catalyses the cyclopropanation reaction between EDA and styrene with good product yields (80%), 
complete diastereoselectivity (99.9%), and good enantioselectivity (77%) in favour of the (R,R) 
product. The reaction was extended to the cyclopropanation reactions between EDA and a variety of 
para-functionalised styrene substrates and between styrene and two additional diazo substrates. 
Although the reactions mostly afforded lower reaction yields relative to EDA/styrene, the 
enantioselectivities of the reactions remained good, with C45 catalysing the cyclopropanation 
reaction between EDA and p-methoxystyrene, p-fluorostyrene, and p-trifluoromethylstyrene with 
enantioselectivities surpassing 90%. The carbene transferase activity of C45 was also compared 
against two carbene transferases reported in the literature: Rma-TDE and Mb(H64V,V68A). C45 
exhibited a similar reactivity to Rma-TDE (80% for C45 vs 73.5% for Rma-TDE) although which inverted 
stereoselectivity (77% in favour of the (R,R)-product for C45 vs 71% in favour of the (S,S)-product for 
Rma-TDE); C45 was, however, inferior to Mb(H64V/V68A) with respect to the cyclopropanation 
reaction between styrene and EDA (96% product yield and 99.9% enantioselectivity in favour of the 
(R,R)-product). Nonetheless, it has been demonstrated that C45 can form a stable heme-localised and 
catalytically active metallocarbenoid intermediate capable of reacting with olefins. C45 is a proficient 
carbene transferase, catalysing cyclopropanation reactions via an abiological mechanism (carbene 
transfer) with numbers equivalent to numbers reported for rationally designed carbene transferases 






CHAPTER 5: SUBSTRATE PROMISCUITY OF A DE NOVO CARBENE TRANSFERASE   
5.1 SUBSTRATE PROMISCUITY: X-H INSERTION, OLEFIN CARBONYLATION AND RING EXPANSION 
CHEMISTRY  
In chapter 1, section 1.4.2, the diverse chemistry of carbene reagents was introduced and included X-
H insertion reactions (X = C, N, B, S, Si).37,59,60,64–66 In organic synthesis, carbene X-H insertions are a 
versatile and important class of reactions often utilised in the synthesis of novel X-C σ-bonds. For 
example, N-H insertions allow complex synthetic pathways to be divided into multiple paths, allowing 
for a non-linear synthesis of complex molecules which can improve overall product yields. In addition 
to cyclopropanation reactions, several carbene transferases, designed from natural heme-containing 
protein scaffolds, have been reported in the literature as efficient catalysts in C-H, N-H, B-H, S-H, and 
Si-H insertions,17,210,215–217,220,221,288 as was discussed in detail in chapter 2 section 2.3.3. Although the 
reaction mechanism for a carbene transfer X-H insertion has key distinctive differences to the 
concerted olefin insertions,39,61 both mechanisms are postulated to proceed via an electrophilic 
metallocarbenoid which is susceptible to nucleophilic attack (e.g. an olefin in cyclopropanation, an 
amine in N-H insertion). Homologation reactions were also introduced in chapter 1, section 1.4.3, as 
reactions that proceed via carbene reagents. As of yet, no reported carbene transferase in the 
literature has been reported to perform a homologation reaction. Carbonyl olefination reactions, 
proceeding via a metallocarbenoid-phosphonium ylide intermediate, have also been reported in two 
cases.229,230   
Enzymes are renowned for exhibiting remarkable selectivity and substrate specificity. In biocatalysis, 
substrate specificity can be unfavourable because it demands individual biocatalysts be engineered 
for individual reactions. Enzyme promiscuity, the ability of an enzyme to catalyse multiple reactions, 
is therefore highly desirable from a synthetic perspective. In light of the activity of C45 towards 
cyclopropanation chemistry, the question of whether C45 could be employed as a carbene transferase 
in either X-H insertion, carbonyl olefination, or homologation reactions was raised. It was postulated 
the lack of any inherent specific substrate recognition sites (SRSs) (unlike the evolved SRSs in P450314 
and myoglobin scaffolds), structural heterogeneity, and flexibility of C45 would favour enzymatic 
promiscuity. For the X-H insertion, the N-H insertion reaction was initially selected for screening on 
account of the versatility and ubiquitous distribution of N-H and N-C σ-bonds in synthesis and 
biological chemistry.315 The carbonyl olefination reaction was explored using aromatic aldehyde 
substrates, as was reported in the literature,229,230 in an attempt to synthesise α,β-unsaturated 
carbonyl compounds. The homologation reaction was explored using a halogenated α-diazo precursor 





If successful, C45 would be the first ever enzyme, rationally designed or de novo, to catalyse a 
homologous ring expansion reaction. 
5.2 RESULTS AND DISCUSSION 
The C45-catalysed N-H insertion assays were conducted in an analogous way to the cyclopropanation 
assays, with the notable substitution of the olefin substrate for a suitable amine (figure 96). The two 
amines, piperidine, a secondary amine, and p-chloroaniline, a primary amine, were identified as 
suitable substrates to investigate N-H insertion activity. It is well established that secondary amines, 
the product of a mono-insertion reaction of a primary amine, can further react with another substrate 
to yield tertiary amines and ammonium salts. The employment of a primary amine, p-chloroaniline, 
therefore provides additional insight into the specificity of the enzyme towards amine 
functionalisation. The three diazo compounds employed in the cyclopropanation assays (EDA, BnDA 
and tBuDA) were also used in the N-H insertion assays, resulting in a total of six individual reactions to 
be screened. The reaction conditions employed were identical for the cyclopropanation assays. The 
reactions were conducted in 1.5 ml sealed, screw-top vials and were purged with nitrogen. The final 
concentrations of each constituent were 10 mM diazo precursor, 30 mM amine, 10 mM sodium 
dithionite, and 10 µM C45. The final volume for each reaction was 400 µl, and all reactions were 
performed in CHES buffer (20 mM CHES, 10 mM KCl, pH 8.6). The reaction mixture was quenched after 
2 hours, and the product mixture was subsequently extracted and analysed via HPLC (using a chiral-
HPLC column) and LC-MS. All reactions were performed in triplicate and the isolated products from 
each reaction were compared against commercially prepared or synthetically produced samples of 
the anticipated products.  
5.2.1 X-H insertion chemistry 
 
Figure 96: The general reaction scheme for an enzyme-catalysed N-H insertion reaction between a 
primary/secondary amine and a diazo compound. 
5.2.1.1 N-H insertion reaction in the presence and absence of hemin 
Initial assays were conducted in i) the absence of any catalyst, and ii) the presence of free hemin (10 





employed in the assays using C45. The reactions screened with no catalyst/hemin were the reactions 
between EDA and i) p-chloroaniline and ii) piperidine. The reaction mixtures were extracted with 1.25 
ml of n-hexane prior to analysis. The reaction mixtures were analysed via HPLC and the resultant 
chromatograms for all four reactions are presented in figure 97. The chromatograms for all four N-H 
insertion assays conducted with and without hemin present are all dominated by a single major peak 
with a retention time of 2.1 minutes which corresponds to the starting material EDA; no trace of any 
reaction product (or starting material) was detectable in any of the assays. The product mixtures were 
subsequently analysed via LC-MS and were also characterised by the lack of any detectable trace of 
the anticipated products. These assays indicate that no reaction occurs between EDA and 
piperidine/p-chloroaniline in the presence and absence of hemin. 
 
Figure 97: Chiral-HPLC chromatograms for the N-H insertion assays between p-
chloroaniline/piperidine (30 mM) and EDA (10 mM) (CHES buffer, pH 8.6, 254 nm) in the absence of 
any catalyst and in the presence of hemin (10 μM, 0.1 % catalyst loading). A polar organic mobile 





5.2.1.2 C45-catalysed N-H insertions: piperidine 
The anticipated product from the N-H insertion reaction between EDA and piperidine is ethyl-1-
piperidineacetate. The HPLC trace of a commercial sample of ethyl-1-piperidineacetate is dominated 
by a major peak in the retention time of 3.2 minutes (figure 98). The LC-MS spectrum of ethyl-1-
piperidineacetate is presented in figure 99 and is dominated by a major peak at m/z 98, corresponding 
to the fragmentation of the parent ion to an iminium species, a peak at m/z 144 corresponding to an 
iminium-acetate complex, and a peak at m/z 172, corresponding to the parent [M+H]+ peak. In 
addition, the chromatogram for the starting material, piperidine, was recorded (tR = 4.6 minutes). The 
external calibrations for ethyl-1-piperidineacetate, tert-butyl 2-(piperidin-1-yl)acetate and benzyl 2-
(piperidin-1-yl)acetate, used to calculate reaction yields, are provided in figure 165 (appendix 1).  
The average chiral-HPLC chromatograms acquired for the C45-catalysed N-H insertion reactions 
between EDA, BnDA, and tBuDA and piperidine are presented in figure 98 (bottom). In addition, the 
normalised average chromatograms acquired for each reaction vs the commercial sample of ethyl-1-
piperidineaceate are also presented in figure 98 (top). The average chromatogram for the C45-
catalysed N-H insertion reaction between EDA and piperidine is characterised by a retention time of 
approximately 3.1-3.2 minutes, resulting in a very good overlap between the reaction chromatogram 
and the commercial product. The average chromatogram for the C45-catalysed N-H insertion reaction 
between tBuDA and piperidine is characterised by a slight deviation with respect to the commercial 
product, with a retention time of approximately 3.4-3.5 minutes relative to 3.2 minutes respectively; 
a deviation that is expected considering the presence of the bulkier tert-butyl substituent. The average 
chromatogram for the C45-catalysed N-H insertion reaction between BnDA and piperidine is, 
analogous to EDA/piperidine, characterised by a very good overlap with respect to the commercial 
product, with a retention time of approximately 3.2 minutes relative to 3.2 minutes for the commercial 
sample. From the averaged chromatograms the average yields (accounting for dilutions) for each 







Figure 98: Chiral-HPLC chromatograms for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H 
insertion assays between piperidine (30 mM) and EDA (10 mM), tBuDA (10 mM), and BnDA (10 mM)  
in (CHES buffer, pH 8.6, 254 nm). (top row) The normalised chiral-HPLC chromatograms for the C45-
catalysed N-H insertion assays between piperidine and EDA (top left, blue), tBuDA (top middle, blue) 
and BnDA (top right, blue) vs the normalised chromatogram of commercial ethyl-1-piperidineacetate 
(red). (bottom row) The average chiral-HPLC chromatograms for the C45-catalysed N-H insertion 
assays between piperidine and EDA (bottom left), tBuDA (bottom middle) and BnDA (bottom right). 
A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and 
injection volumes were 2 μl. 
The LC-MS spectrum acquired for the N-H insertion assay between i) EDA, ii) tBuDA, and iii) BnDA and 
piperidine are all presented in figure 99 alongside the LC-MS spectrum acquired for a commercial 
sample of ethyl-1-piperidineacetate. The mass spectrum for ethyl-1-piperidineacetate presents a 
fragmentation pattern with dominant peaks at 98, 144 and 172 m/z. The C45-catalysed N-H insertion 
reaction between EDA and piperidine is dominated by major peaks at 98, 144 and 172 m/z, presenting 
an identical fragmentation profile to the spectrum acquired for ethyl-1-piperidineacetate. The LC-MS 
spectrum acquired for the C45-catalysed N-H insertion reaction between tBuDA and piperidine is 
characterised by a similar fragmentation profile recorded for the commercial sample, with dominant 
peaks at 98, 144 m/z, corresponding to the iminium fragment, and the iminium-acetate complex 





catalysed N-H insertion reaction between BnDA and piperidine is distinctively different from the 
EDA/tBuDA-pieridine mass spectrum, and is characterised by a dominant peak at 91 m/z. This peak 
corresponds to the mass of a tropylium fragment and is produced via fragmentation of the benzyl 
ester. A peak at 234 m/z was detected though, which corresponds to the expected mass of the [M+H]+ 
parent ion. The emergence of a tropylium ion, at 91 m/z, in the mass spectrum for the C45-catalysed 
N-H insertion reaction between BnDA and piperidine parallels the fragmentation pattern observed for 







Figure 99: (top) LC-MS mass spectra for commercial ethyl-1-piperidineacetate (top left) and the C45-
catalysed (10 μM, 0.1 % catalyst loading) N-H insertion assays between piperidine (30 mM) and (top 
left) EDA (10 mM), (bottom left) tBuDA (10 mM), (bottom right) and BnDA (10 mM) in (CHES buffer, 
pH 8.6, 254 nm). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 
column was employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v 
water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. (bottom) 
Fragmentation pathway leading to the dominant iminium (98/144) and tropylium (91) ions observed 





5.2.1.3 C45-catalysed N-H insertions: p-chloroaniline 
The anticipated product from the N-H insertion reaction between EDA and aniline is N-phenylglycine  
ethyl ester. The HPLC trace of a commercial sample of N-phenylglycine  ethyl ester is dominated by a 
major peak in the retention time of range 3.2-3.5 minutes (figure 100). The LC-MS spectrum of N-
phenylglycine ethyl ester is presented in figure 101 and is dominated by a major peak at 106.8 m/z, 
corresponding to the fragmentation of the parent ion to an iminium species. The LC-MS spectrum of 
ethyl (4-chlorophenyl)glycinate is presented in figure 101 and is dominated by a major peak at 140 
m/z, corresponding to the fragmentation of the parent ion to an iminium species with the addition of 
a chlorine. The peak 140 m/z is followed by a peak at 142 m/z with an approximate ratio of 3:1 in 
intensity for the two peaks on account of the chlorine. The external calibrations ethyl (4-
chlorophenyl)glycinate, tert-butyl (4-chlorophenyl)glycinate, and benzyl (4-chlorophenyl)glycinate, 
used to calculate reaction yields, are provided in figure 166 (appendix 1). 
The chiral-HPLC chromatograms acquired for the C45-catalysed N-H insertion reactions between EDA, 
BnDA, and tBuDA and p-chloroaniline are presented in figure 100 (bottom). In addition, the normalised 
average chromatograms acquired for each reaction vs a commercial sample of N-phenylglycine  ethyl 
ester are also presented in figure 100 (top). The average chromatogram for the C45-catalysed N-H 
insertion reaction between EDA and p-chloroaniline is characterised by a slight deviation of the 
reaction mixture peak relative to the commercial product, with a retention time of approximately 3.7 
minutes relative to 3.2-3.5 minutes. This deviation is accounted for by the chlorine atom in the 
reaction mixture product, which is absent in the commercial sample. In addition to the single insertion 
product, a small amount of the double insertion product could be detected. The average 
chromatogram for the C45-catalysed N-H insertion reaction between tBuDA and p-chloroaniline is also 
characterised by a very good overlap with respect to the commercial product, with a retention time 
of approximately 3.2-3.5 minutes relative to 3.2-3.5 minutes. Unlike the assay conducted with EDA, 
only the single insertion product was detected for tBuDA. The average chromatogram for the C45-
catalysed N-H insertion reaction between BnDA and p-chloroaniline is, analogous to tBuDA/p-
chloroaniline, characterised by a very good overlap with respect to the commercial product, with a 
retention time of approximately 3.2-3.5 minutes relative to 3.2-3.5 minutes for the commercial 
sample. Unlike the assay conducted with EDA, only the single insertion product was detected for 
BnDA. From the averaged chromatograms (and accounting for dilutions), the average yields for each 
assay (table 16, appendix 2) were calculated to be 67.59, 72.50, and 89.44% for EDA, tBuDA, and BnDA, 
respectively. For the assay conducted with EDA, an average yield for the double product was 5.29%, 






Figure 100: Chiral-HPLC chromatograms for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H 
insertion assays between p-chloroaniline (30 mM) and EDA (10 mM), tBuDA (10 mM), and BnDA (10 
mM)  in (CHES buffer, pH 8.6, 254 nm). (top row) The normalised chiral-HPLC chromatograms for the 
C45-catalysed N-H insertion assays between p-chloroaniline and EDA (top left, blue), tBuDA (top 
middle, blue) and BnDA (top right, blue) vs the normalised chromatogram of commercial ethyl 
phenylglycine ester (red). (bottom row) The average chiral-HPLC chromatograms for the C45-
catalysed N-H insertion assays between p-chloroaniline and EDA (bottom left), tBuDA (bottom middle) 
and BnDA (bottom right). A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) 
was employed and injection volumes were 2 μl. 
After analysis via chiral-HPLC, the product mixtures were investigated using LC-MS. The LC-MS 
spectrum acquired for the N-H insertion assay between i) EDA, ii) tBuDA, and iii) BnDA and p-
chloroaniline are all presented in figure 101 alongside an LC-MS spectrum acquired for commercially 
prepared N-phenylglycine ethyl ester. The mass spectrum for the C45-catalysed N-H insertion reaction 
between EDA and p-chloroaniline is characterised by a dominant peak at 140 m/z corresponding to 
the mass of the iminium fragment observed in the commercial sample (+ chlorine). The presence of a 
1:0.33 ratio between 140:142 m/z corroborates the HPLC chromatogram, indicating a N-H insertion 
reaction has taken place. In addition, a peak at 214 m/z corresponds to the expected [M+H]+ of the 
anticipated product of an N-H insertion between EDA and p-chloroaniline. A closer inspection of the 





the parent ion mass. The LC-MS spectrum acquired for the C45-catalysed N-H insertion reaction 
between tBuDA and p-chloroaniline is characterised by a dominant peak at 140 m/z corresponding to 
the mass of the iminium fragment observed in the commercial sample (+ chlorine) and in the 
EDA/piperidine mass spectrum. The presence of a 1:0.33 ratio between 140:142 m/z corroborates the 
HPLC chromatogram, indicating a N-H insertion reaction has taken place. In addition, a peak at 242 
m/z corresponds to the expected [M+H]+ of the anticipated product of an N-H insertion between 
tBuDA and p-chloroaniline. A closer inspection of the parent ion reveals the same 1:0.33 ratio between 
242/244 m/z, the expected isotopic distribution for the parent ion mass. The LC-MS spectrum acquired 
for the C45-catalysed N-H insertion reaction between BnDA and p-chloroaniline is distinctively 
different from the EDA-tBuDA/p-chloroaniline mass spectrum, and is characterised by a dominant 
peak at 91 m/z. This peak corresponds to the mass of a tropylium fragment and is produced via 
fragmentation of the benzyl ester. The characteristic 140:142 m/z peaks, characterised by a 1:0.33 
isotropic ratio, are also observable in the BnDA/p-chloroaniline spectrum, but at a significantly 
reduced intensity relative to the EDA-tBuDA/p-chloroaniline mass spectra. The acquired data indicates 









Figure 101: (top) LC-MS mass spectra for commercial ethyl phenylglycine ester (top left) and the C45-
catalysed (10 μM, 0.1 % catalyst loading) N-H insertion assays between p-chloroaniline (30 mM) and 
(top left) EDA (10 mM), (bottom left) tBuDA (10 mM), (bottom right) and BnDA (10 mM) in (CHES 
buffer, pH 8.6, 254 nm). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A 
C8 column was employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v 
water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. (bottom) 
Fragmentation pathway leading to the dominant iminium (104/140) and tropylium (91) ions observed 





5.2.1.4 C45-catalysed chemoselective N-H vs O-H insertion: aminophenol regioisomers 
Large, complex organic molecules often contain more than one type of functional group. The most 
common heteroatoms in organic molecules are nitrogen and oxygen, with the functional groups 
containing nitrogen or oxygen typically being structurally and functionally similar. For example, two 
extremely common functional groups are the hydroxy (-OH) and primary amine (-NH2) groups, both 
of which are characterised by a polarised C-X σ-bond in favour of the heteroatom. These differences 
in electronegativity imparts nucleophilicity to hydroxy and amine groups. A significant problem 
frequently encountered in organic synthesis is when a molecule possesses two functional groups with 
similar reactivity, such as a molecule containing both an amine and a hydroxy group. As an example, 
consider the reaction between bromomethane and 3-amino-1-propanol; seven products are possible 
from this reaction (figure 102). If only one product is desired, say 3-methoxypropan-1-amine, it would 
first be necessary to protect the amine group with a suitable protecting group, such as Fmoc-Cl.316,317 
The synthesis of 3-methoxypropan-1-amine now requires three steps, the initial protection of the 
amine group, the O-methylation step, and the subsequent deprotection of the Fmoc-amine group to 
afford the desired product (figure 102).  
 
Figure 102: The problem of chemoselectivity. (top) the unprotected starting material contains two 
reactive groups which results in a possible seven products (two possible ammonium salts not shown), 
and (bottom) the amine is protected to afford a single product but requires two additional steps in 
the synthesis: i) the protection of the amine with Fmoc-chloride, and ii) the deprotection of the Fmoc 





The problem with the above reaction is a lack of chemoselectivity, defined as a preferential reaction 
with one functional group over another functional group with similar reactivity. The ability to 
transform substrates chemoselectivity is of high importance both biologically and technologically in 
order to avoid complex purification steps and minimize product contamination.318,319 In addition to 
stereoselectivity, enzymes often exhibit significant chemoselectivity during biosynthesis,320–322 
selectively transforming one particular functional group in the presence of multiple others. As C45 has 
already demonstrated proficient N-H carbene insertion chemistry, the question of whether C45 would 
catalyze the X-H carbene insertion reaction when alkanolamines are employed as substrates was 
raised. The three regioisomers of aminophenol, 2-aminophenol (2AP), 3-aminophenol (3AP), and 4-
aminophenol (4AP) were identified as suitable substrates for exploring the chemoselectivity of X-H 
insertions (figure 103).  
 
Figure 103: The three possible reaction products following the C45-catalysed O/N-H insertion reaction 
between a regioisomer of aminophenol and EDA. 
Initial reactions were conducted with phenol as the substrate to examine the proficiency of C45 
towards catalyzing O-H insertion reactions. The normalized C18-HPLC chromatogram for phenol (red) 
and for the C45 O-H insertion assay product mixture (blue) are presented in figure 104. From the 
chromatogram, it can be readily identified that no reactivity has occurred when phenol is employed 
as a substrate, with an almost perfect overlap between the two traces which are dominated by a single 
major peak with a retention time in the range of 15.2-15.7 minutes. Analysis of the product mixture 
via LC-MS revealed no appreciable O-H insertion product. From the assay it is concluded that C45 does 






Figure 104: C18-HPLC chromatograms for phenol (red) and the C45-catalysed (10 μM, 0.1 % catalyst 
loading) O-H insertion assay between phenol (30 mM) and EDA (10 mM) (blue). An isocratic mobile 
phase (100% CH3OH: 0.1% w/v NH4AcO) was employed and injection volumes were 20 μl. 
Figure 105 displays the C18-HPLC chromatograms obtained for N-phenylglycine  ethyl ester, 2AP, 3AP, 
and 4AP, respectively. N-phenylglycine  ethyl ester is the product obtained from the reaction between 
aniline and EDA, and, although structurally different, is similar enough to the anticipated reaction 
product obtained for the reaction between EDA and xAP (where x = 2,3,4) that is functions as a 
convenient and suitable comparison. From the chromatograms, at can be readily seen that all three 
aminophenol regioisomers elute before N-phenylglycine ethyl ester, as would be expected given the 






Figure 105: C18-HPLC chromatograms for (top left) N-phenylglycine  ethyl ester, (top right) 2-
aminophenol, (bottom left) 3-aminophenol, and (bottom right) 4-aminophenol. An isocratic mobile 
phase (100% CH3OH: 0.1% w/v NH4AcO) was employed and injection volumes were 20 μl. 
Figure 106 (top) presents the C18-HPLC chromatograms and the LC-MS mass spectra acquired for the 
C45-catalysed reaction between 2-aminophenol and EDA, tBuDA, and BnDA. The chromatogram for 
the reaction between EDA and 2AP is dominated by a major peak at retention time 16.25 minutes, 
preluded by a split peak in the range 15.1-15.5 minutes. The split peak preluding the dominant peak 
is attributed to unreacted 2AP, with the splitting a consequence of the various ionization states 
accessible by the substrate. The emergence of the new peak at 16.25 minutes corresponds 
exceedingly well to the retention time reported for N-phenylglycine ethyl ester (16.6 minutes), with 
the deviations probably accounted for by the introduction of a hydroxy group in the ortho-position of 
the product. Subsequent LC-MS analysis of the peak at 16.25 minutes generated a mass spectrum 
dominated by a peak at 122 m/z, which corresponds to the exact mass expected for the iminium 
fragment of the 2-AP/EDA single-insertion product ethyl (2-hydroxyphenyl)glycinate. The mass 
spectrum also possesses a small peak at 195 m/z, corresponding to the expected mass of the [M+H]+ 
parent ion. The chromatogram for the reaction between tBuDA and 2AP exhibits a single peak at 
retention time 15.70 minutes, preluded by a dominant single peak at 15.1 minutes which corresponds 
to unreacted 2AP. The subsequent LC-MS analysis of the peak at 15.70 minutes generated a mass 





iminium fragment of the 2-AP/tBuDA single-insertion product tert-butyl (2-hydroxyphenyl)glycinate. 
No parent ion could be detected for tert-butyl (2-hydroxyphenyl)glycinate, probably on account of the 
increased probability of fragmentation of a tert-butyl group relative to an ethyl group. The 
chromatogram for the reaction between BnDA and 2AP exhibits a dominant single peak at retention 
time 16.01 minutes, preluded by a single smaller peak at 15.1 minutes which corresponds to unreacted 
2AP. Subsequent LC-MS analysis of the peak at 16.01 minutes generated a mass spectrum dominated 
by three peaks: i) a peak at 91 m/z corresponding to the tropylium ion fragment previously observed 
for ESI-MS analysis of benzyl substituents, ii) a peak at 212 m/z, and iii) a peak at 258 m/z which 
corresponds to the exact mass of the [M+H]+ parent ion for benzyl (2-hydroxyphenyl)glycinate.  
 
Figure 106: (top) C18-HPLC chromatograms for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H 
insertion assays between 2-aminophenol (30 mM) and (top left) EDA (10 mM), (top middle) tBuDA (10 
mM), and (top right) BnDA (10 mM) in (CHES buffer, pH 8.6, 254 nm). An isocratic mobile phase (100% 
CH3OH: 0.1% w/v NH4AcO) was employed and injection volumes were 20 μl. (bottom) LC-MS spectra 
for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H insertion assays between 2-aminophenol 
(30 mM) and (bottom left) EDA (10 mM), (bottom middle) tBuDA (10 mM), and (bottom right) BnDA 
(10 mM). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 column was 
employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v water/MeCN/formate 





The C18-HPLC chromatograms acquired for the C45-catalysed X-H insertion assays employing 2-
aminophenol as the substrate revealed the presence of a new, single species being formed in the 
reaction. The di-insertion product was not detected in the LC-MS analysis, and the fragmentation 
patterns for all three diazo substrates are consistent with the patterns observed for aniline insertion. 
The data suggests that C45 is catalyzing the carbene insertion reaction of 2-aminophenol 
chemoselectively, inserting the carbene exclusively into a N-H bond even in the presence of 
unprotected O-H groups, a conclusion corroborated by the lack of reactivity exhibited in the phenol 
O-H insertion assays. From the chromatograms, products yields of 88.17, 66.63, and 70.85% and 
(Ninsertion/Oinsertion) ratios of >99.9% were calculated for ethyl (2-hydroxyphenyl)glycinate, tert-butyl (2-
hydroxyphenyl)glycinate, and benzyl (2-hydroxyphenyl)glycinate respectively (table 7). It should be 
noted that the relative trends observed for product yields previously (EDA > BnDA > tBuDA) is also 
observed for 2-aminophenol.  
Table 7: The retention times, product yields, and nitrogen/oxygen insertion ratios for the C45-
catalysed N-H insertion reactions between the three regioisomers of aminophenol and the diazo 
compounds EDA, tBuDA, and BnDA. 
 
The figures 107 and 108 present the C18-HPLC chromatograms and the LC-MS mass spectra acquired 
for the C45-catalysed reaction between 3-aminophenol/4-aminophenol and EDA, tBuDA, and BnDA, 
respectively. The trend of chemoselective mono-N-H-insertion is continued across all six reactions. 
The chromatogram for the reaction between EDA and 3AP is dominated by a major peak at retention 
time 15.60 minutes, accompanied by a shadowing peak in the range 14.7 minutes corresponding to 
unreacted 3AP. The subsequent LC-MS analysis of the peak at 16.25 minutes generated a mass 
spectrum dominated by a peak at 122 m/z, which corresponds to the exact mass expected for the 
iminium fragment of the 3-AP/EDA single-insertion product ethyl (3-hydroxyphenyl)glycinate. The 
chromatogram for the reaction between tBuDA and 3AP exhibits a single peak at retention time 15.10 
minutes, with no peak corresponding to 3AP observed (reaction yield >99.9%). Subsequent LC-MS 





mass expected for the iminium fragment of tert-butyl (3-hydroxyphenyl)glycinate. The chromatogram 
for the reaction between BnDA and 3AP exhibits a dominant single peak at retention time 15.41 
minutes, preluded by a single smaller peak at 14.7 minutes which corresponds to unreacted 3AP. 
Subsequent LC-MS analysis generated a mass spectrum dominated by two peaks: i) a peak at 91 m/z 
corresponding to the tropylium ion fragment previously observed for ESI-MS analysis of benzyl 
substituents, and iii) a peak at 258 m/z which corresponds to the exact mass of the [M+H]+ parent ion 
for benzyl (3-hydroxyphenyl)glycinate. From the chromatograms, products yields of 73.50, >99.9, and 
53.14% and (Ninsertion/Oinsertion) ratios of >99.9% were calculated for ethyl (3-hydroxyphenyl)glycinate, 
tert-butyl (3-hydroxyphenyl)glycinate, and benzyl (3-hydroxyphenyl)glycinate respectively (table 7). 
The chromatogram for the reaction between EDA and 4AP is dominated by a major peak at retention 
time 15.10 minutes, with no unreacted 4AP peak detectable (it should be noted that 3M HCl was 
employed in the purification of assays conducted with 4AP instead of acetic acid. The increased acidity 
of HCl probably converted most of the unreacted 4-aminophenol to the hydrochloride salt, enhancing 
its removal from the product mixture upon aqueous-organic work up). Subsequent LC-MS analysis of 
the peak at 15.10 minutes generated a mass spectrum dominated by a peak at 122 m/z, which 
corresponds to the exact mass expected for the iminium fragment of the 4-AP/EDA single-insertion 
product ethyl (4-hydroxyphenyl)glycinate. The chromatogram for the reaction between tBuDA and 
4AP exhibits a single peak at retention time 15.42 minutes, and subsequent LC-MS analysis generated 
a mass spectrum dominated by a peak at 122 m/z, which corresponds to the exact mass expected for 
the iminium fragment of tert-butyl (4-hydroxyphenyl)glycinate. The chromatogram for the reaction 
between BnDA and 4AP exhibits a dominant single peak at retention time 15.50 minutes and 
Subsequent LC-MS analysis generated a mass spectrum dominated by two peaks: i) a peak at 91 m/z 
corresponding to the tropylium ion fragment previously observed for ESI-MS analysis of benzyl 
substituents, and iii) a peak at 258 m/z which corresponds to the exact mass of the [M+H]+ parent ion 
for benzyl (4-hydroxyphenyl)glycinate. The mass spectrum was, however, reasonably unresolved, 
probably on account of the low reaction yield (10.4%). From the chromatograms, product yields of 
58.12, 10.40, and 31.36% and (Ninsertion/Oinsertion) ratios of >99.9% were calculated for ethyl (4-
hydroxyphenyl)glycinate, tert-butyl (4-hydroxyphenyl)glycinate and benzyl (4-






Figure 107: (top) C18-HPLC chromatograms for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H 
insertion assays between 3-aminophenol (30 mM) and (top left) EDA (10 mM), (top middle) tBuDA (10 
mM), and (top right) BnDA (10 mM) in (CHES buffer, pH 8.6, 254 nm). An isocratic mobile phase (100% 
CH3OH: 0.1% w/v NH4AcO) was employed and injection volumes were 20 μl. (bottom) LC-MS spectra 
for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H insertion assays between 3-aminophenol 
(30 mM) and (bottom left) EDA (10 mM), (bottom middle) tBuDA (10 mM), and (bottom right) BnDA 
(10 mM). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 column was 
employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v water/MeCN/formate 






Figure 108: (top) C18-HPLC chromatograms for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H 
insertion assays between 4-aminophenol (30 mM) and (top left) EDA (10 mM), (top middle) tBuDA (10 
mM), and (top right) BnDA (10 mM) in (CHES buffer, pH 8.6, 254 nm). An isocratic mobile phase (100% 
CH3OH: 0.1% w/v NH4ACO) was employed and injection volumes were 20 μl. (bottom) LC-MS spectra 
for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H insertion assays between 4-aminophenol 
(30 mM) and (bottom left) EDA (10 mM), (bottom middle) tBuDA (10 mM), and (bottom right) BnDA 
(10 mM). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 column was 
employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v water/MeCN/formate 
10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. 
From the data, it can be concluded that C45 is a proficient and remarkably chemoselective enzyme for 
catalyzing the N-H carbene insertion of unprotected alkanolamines. Furthermore, two trends can be 
identified with respect to product yield: i) the reaction yields follow the trend EDA > BnDA > tBuDA, 
and ii) the reaction yields increase with decreasing molecular volume of the substrate (1.38, 1.51 and 
1.61 x10-22 cm3 for 2AP, 3AP and 4AP respectively). The first trend has been observed previously for 
styrene cyclopropanation and p-chloroaniline insertion and has been rationalized by the sterics of the 
three substituents, and possible π-π interactions between the phenyl group of benzyl diazoacetate 
and aromatic residues in the active site of C45. The increase in product yield with respect to decreasing 
molecular volume suggests a key factor governing C45’s functionality is diffusion and accommodation 





in product yields (ortho > meta > para; 2AP > 3AP > 4AP) can therefore be accounted for, at least 
partially, by the molecular volume of the substrate (ortho < meta < para; 2AP < 3AP < 4AP), an 
observation paralleled by the observed rate of diffusion of the three regioisomers of xylene through 
a zeolitic imidazolate framework: the decreasing size of the molecule (o-xylene < m-xylene < p-xylene) 
decreases its rate of absorption.323 No observable relationship was discerned between product yields 
and the pKa(NH) of the substrates (pKa(NH) = 4.37 (3AP) < 4.78 (2AP) < 5.48 (4AP)), indicating diffusion 
into the active site, and not the nucleophilicity of the amine, plays a more important role in governing 
enzymatic activity. One remarkable anomaly, however, is the C45-catalysed N-H insertion reaction 
between tBuDA and 3-aminophenol which affords the product with yields consistently >99.9%. The 
remarkable enzymatic activity exhibited by C45 towards this reaction is likely accounted for by a 
combination of sterics and electronics. The bulky tert-butyl group perhaps disrupts the active-site of 
C45 upon metallocarbenoid formation, causing select amino acids in the active site to adopt a 
temporary deviation in conformation. The distortion of the active site could possibly result in a 
thermodynamic and kinetic effect which accounts for the observed catalytic efficiency. First, a 
distortion of the active site, by tert-butyl, could facilitate the diffusion of a substrate (X-aminophenol) 
into the active site which would enhance catalysis; however, if the only contributing factor to catalysis 
was a general distortion of the active site, it would be expected that such a phenomena would 
translate over to all reactions concerning tert-butyl diazoacetate. Therefore, it is conceivable that any 
deviations away from ideal confirmations to accommodate the bulky tert-butyl-substituted 
metallocarbenoid intermediate could engender an active site topology perfectly arranged to provide 
selective stabilizing interactions to 3-aminophenol, and/or interactions which modify the pKa of the -
NH group, rendering the amine significantly more nucleophilic. Alternatively, it is also possible that 
such interactions could orientate the 3-aminophenol amine group perfectly for nucleophilic attack on 
the metallocarbenoid carbon, thus facilitating catalysis. The exact dynamics and electronics governing 
the reaction between tBuDA and 3-aminophenol remain unelucidated and requires additional 
experiments in the future to be fully understood. One possible experiment would involve isotopically 
labelling 3-aminophenol with 18O and observing any changes in the reaction kinetics. A change in 
kinetics would indicate the meta-hydroxy group plays an important role in the mechanism, probably 
through an orientating interaction with an active-site amino acids, whereas no appreciable change 
would eliminate the meta-hydroxy groups involvement and would suggest the reason for the 





5.2.1.5 phenylenediamines: the building blocks for chelating ligands and heteropolymers 
In addition to the chemoselective N-H insertion of alkanolamines, another reaction of interest 
concerns the di-insertion reaction of diamine substrates. The bifunctionality of diamines means this 
class of molecules are often utilised as cross-linking agents and/or as precursors in heteropolymer 
synthesis; one prominent example being the aliphatic diamine 1,6-diaminohexane, a precursor in the 
synthesis of Nylon.324 The three regioisomers of phenylenediamine are industrially relevant diamines, 
with all three regioisomers finding applications as precursors to an assortment of industrial useful 
chemicals.324 Ortho-phenylenediamine is used in the synthesis of chelating ligands and commercial 
dyes, meta--phenylenediamine is employed in the preparation of aramid fibres, epoxy resins and 
polyurea elastomers and commercial dyes, and para-phenylenediamine is employed in the synthesis 
of Kevlar and Tawron.324 The proficiency of C45 towards mono N-H carbene insertion reactions raised 
the question of whether C45 could be used as a catalyst for di-N-H insertions of phenylenediamine 
regioisomers. If successful, it would afford a new biosynthetic methodology for manufacturing a large 
variety of novel bifunctional monomers which could find applications in the synthesis of new 
phenylenediamine-containing heteropolymers. 
 
Figure 109: The general reaction scheme for a di-NH-insertion reaction. The di-NH-insertion reaction 
ortho-phenylenediamine and excess EDA catalysed by C45. 
Initial small-scale experiments were conducted using ortho-phenylenediamine (figure 109). In all the 
N-H insertion assays conducted so far, the ratio of substrate:diazo compound has been 3:1 to 
encourage mono-insertion and disfavour di-insertion. As the di-insertion product was desired from 
the C45-catalysed N-H insertion reactive between EDA and ortho-phenylenediamine the diamine:EDA 
ratio was modified to 1:5 to encourage di-insertion. After approximately two hours, the reaction 
mixture was extracted and analysed via LC-MS. The acquired LC-MS mass spectrum for the C45-
catalysed reaction between EDA and o-phenylenediamine is presented in figure 110 and is 
characterised by a dominant peak at 281 m/z, which corresponds to the exact mass of the [M+H]+ 
parent ion of the double insertion product. The mass spectrum also contains a major peak at 207 m/z, 





fragment detected ubiquitously across all N-H insertion assays and diagnostic of a successful N-H 
insertion reaction. A negligible quantity of the single insertion product was detected by LC-MS.  
 
Figure 110: LC-MS spectra for the C45-catalysed (10 μM, 0.1 % catalyst loading) N-H insertion assay 
between ortho-phenylenediamine (10 mM) and EDA (30 mM). The spectrum was recorded in ES+ 
mode and monitored at 254 and 280 nm. A C8 column was employed for the LC separation with a 
gradient mobile phase (95:5:0.1 % v/v water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). 
The Injection volume was 20 μl. 
The initial assays revealed two interesting points. Firstly, C45 remains catalytically active following an 
initial carbene insertion, and is capable of reforming the metallocarbenoid intermediate and 
conducting another round of catalysis. Secondly, C45 can accommodate the single-insertion product 
into the active site to catalyse the second-insertion reaction. This work will be extended to meta-
phenylenediamine and para-phenylenediamine at a later date. If successfully, the di-insertion 
products would provide suitable monomers for the synthesis of copolymers via a condensation 
reaction with a diol or peptide bond formation with a diamine.  
5.2.1.6 C45-catalysed Si-H insertion – a comparison with Rma-TDE 
The success of the C45-catalysed N-H insertions for a variety of different substrates raised the question 
of whether C45 could be used to catalyse a different X-H insertion reaction. The cytochrome c mutant 
Rma-TDE, a variant generated in the Arnold lab that is three mutations away from a WT cytochrome 





bonds to form new Si-C σ-bonds.217,219 This work expand the reaction scope of biocatalysis towards 
the synthesis of novel organosilicon compounds.217,219 As Rma-TDE was employed as a suitable 
comparison for metallocarbenoid formation and cyclopropanation activity against C45, it was 
rationalised that the propensity of C45 to also catalyse the carbene insertion reaction of Si-H 
containing molecules should be investigated and compared to the activity reported for Rma-TDE. In 
the literature, the Arnold lab investigated the catalytic activity of Rma-TDE towards Si-H insertion by 
employing ethyl 2-diazopropanoate (Me-EDA) and dimethylphenylsilane (DMPS). The formation of a 
new Si-C σ-bond using Me-EDA and DMPS as substrates also results in the emergence of a new 
stereogenic centre, meaning two possible stereoisomers are possible from this reaction. In the assays 
conducted using C45, DMPS was employed as the silane substrate, but EDA was employed as the 
diazo-compound. The selection of EDA as the carbene precursor means that no stereogenic centre 
arises from the reaction, and hence only the activity, and not the stereoselectivity, of C45 towards Si-
H insertion can be compared to Rma-TDE (figure 111). 
 
Figure 111: The general C45/Rma-TDE-catalysed Si-H insertion assay between EDA and DMPS. 
The Si-H insertion assays were conducted according to the protocol established for investigating 
carbene transferase activity. The protocol involves a small-scale (400 µl) reaction between EDA and 
dimethylphenylsilane (DMPS) catalysed by the enzyme of interest (C45 and Rma-TDE) under anaerobic 
conditions. The reaction is left to mix for 2 hours at room temperature before the product is extracted 
into an organic solvent and analysed. The analysis of the product mixture was conducted via HPLC, 
employing a C18 Column as the stationary phase. LC-MS was then used to assist in product 
identification. A C18-HPLC chromatogram of the starting substrate, DMPS (in CH3CN), and a Si-
insertion assay conducted in the absence of any enzyme were acquired initially. The assay was 
conducted in 1.5 mL seal-top reaction vials, which was purged with nitrogen prior to conducting the 
assay. The final reaction volume was 400 µl, and consisted of 10 mM DMPS, 10mM EDA and 10 mM 
sodium dithionite in CHES buffer (100 mM KCl, 20mM CHES, pH 8.6). The reaction vial was allowed to 
stir for 2 hours, at room temperature, before the reaction was extracted with n-hexane for analysis. 
The chromatogram for the starting substrate, DMPS, and the Si-H insertion assay conducted in the 






Figure 112: C18-HPLC chromatograms for (top) the Si-H insertion reaction between 
dimethylphenylsilane (30 mM) and EDA (10 mM) in the absence of any catalyst, (bottom) of 
dimethylphenylsilane alone (1 mM, EtOH, 220 nm). An isocratic mobile phase (100% CH3OH: 0.1% w/v 
NH4AcO) was employed and injection volumes were 20 μL. 
It is clearly seen in figure 112 that the chromatogram for DMPS is dominated by a single symmetric 
peak with a retention time of 5.4 minutes. The chromatogram for the Si-H insertion assay conducted 
in the absence of any enzyme is dominated by two symmetrical peaks with retention times of 4.9 and 
5.4 minutes, which corresponds to EDA and DMPS respectively; no Si-H insertion product was 
identified in the assays conducted in the absence of any enzyme. The assay was then repeated under 
identical conditions employed in the controls but in the presence of either Rma-TDE or C45. The 
normalised average chromatograms acquired for the C45-cataysed and Rma-TDE-catalysed assays are 






Figure 113: (top) C18-HPLC chromatograms for the Si-H insertion assays between 
dimethylphenylsilane (30 mM) and  EDA (10 mM) catalysed by (top left) C45 (10 μM, 0.1 % catalyst 
loading) and (top right)  Rma-TDE (10 μM, 0.1 % catalyst loading). An isocratic mobile phase (100% 
CH3OH: 0.1% w/v NH4AcO) was employed and injection volumes were 20 μL. (bottom) LC-MS spectra 
for the Si-H insertion assays between dimethylphenylsilane (30 mM) and  EDA (10 mM) catalysed by 
(bottom left) C45 (10 μM, 0.1 % catalyst loading) and (bottom right)  Rma-TDE (10 μM, 0.1 % catalyst 
loading). All spectra were recorded in ES+ mode and monitored at 254 and 280 nm. A C8 column was 
employed for the LC separation with a gradient mobile phase (95:5:0.1 % v/v water/MeCN/formate 
10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. 
The chromatograms for both the C45- and Rma-TDE-catalysed Si-H reaction between DMPS and EDA 
both contain the two major peaks observed in the control assays (EDA, 4.9 minutes; DMPS, 5.4 
minutes), but also both contain the emergence of a new peak with a retention time of 4.2 minutes. It 
has already been reported in the literature that Rma-TDE catalyses Si-H insertion reactions with 
reasonably proficiency, therefore the new peak at 4.2 minutes could be attributed to the Si-H insertion 
product. In order to confirm the identity of the new peak, the C45- and Rma-TDE-catalysed assay 
mixtures was subsequently analysed by LC-MS; the acquired normalised spectra for both enzymes are 
displayed in figure 113 (bottom). It can be readily seen that both mass spectra contain a dominant 
peak at 135 m/z, which corresponds to the PhMe2Si+ fragment generated from the protonation of the 





neutral enolate (which most probably tautomerizes) and the observed fragment. The mass spectrum 
for C45 (and very marginally in the Rma-TDE spectrum) contains an additional peak at 177 m/z, which 
corresponds to the oxonium ion generated from the elimination of EtOH following the protonation of 
the parent ion; the diagnostic fragmentation observed in the mass spectra for cyclopropanation assays 
conducted using EDA. The mass spectrum for Rma-TDE also contains a very small peak at 223 m/z, 
which corresponds to the mass of the protonated parent ion [M+H]+.  
The data acquired from the C45- and Rma-TDE-catalysed Si-H insertion reactions indicate the new 
peak can be attributed to the expected Si-H insertion product ethyl 2-(dimethyl(phenyl)silyl)acetate, 
and is consistent with the literature reports of the assays conducted with Rma-TDE. Therefore, it can 
be reasonably inferred that C45 is also proficient at catalysing carbene insertion reactions into Si-H σ-
bonds, opening up the possibility for de novo enzymatic synthesis of novel organosilicon compounds.  
Average product yields of 57.66 (± 4.14) and 62.86 (± 1.95) % were calculated from the chromatograms 
for the reactions catalysed by Rma-TDE and C45 respectively (table 19, appendix 2).  
5.2.2 C45 catalysed carbonyl olefination  
One of the most challenging, yet pertinent, reactions in organic chemistry concerns the synthesis of 
new C-C σ/π-bonds. One prominent example of a C-C bond forming reaction is the Wittig reaction – 
the reaction between a carbonyl group and a phosphonium ylide to form a new C=C π-bond, with the 
stereoselectivity of the new C=C bond controlled by the electronics of the phosphonium ylide (figure 
114). Although the Wittig reaction is a renowned reaction in organic chemistry, there are several 
limitations concerning stereoselectivity and functional group tolerability which need to be addressed.  
 
Figure 114: The general reaction scheme for the Wittig reaction. 
Following the success described in the C45-catalysed cyclopropanation and N-H insertion assays, and 
the activity reported by Fasan and Weissenborn, enzymatic carbonyl olefination was identified as 
another possible reaction to be investigated. The mechanism for enzymatic carbonyl olefination 
proceeds first via the nucleophilic attack of the phosphine (or arsine) species on the electrophilic 
metallocarbenoid intermediate to yield a reactive ylide (figure 115). The ylide subsequently attacks 





membered cyclic oxaphosphetane intermediate. A concentred rearrangement of the oxaphosphetane 
intermediate’s C-O and P-C σ-bonds results in the expulsion of a phosphine oxide side product and the 
desired α,β-unsaturated carbonyl product (figure 115). Although the mechanism of hemoprotein-
catalysed olefin carbonylation does not proceed via a direct carbene transfer, the formation of a 
heme-localised metallocarbenoid intermediate is a prerequisite for ylide formation. It is therefore 
conceivable that C45 could exhibit carbonyl olefination activity when presented with a suitable 
phosphine species. 
 
Figure 115: The mechanism for the hemoprotein-catalysed carbonyl olefination between EDA and a 
carbonyl substrate in the presence of triphenylphosphine. 
The C45-catalysed carbonyl olefinations assays were conducted in an analogous way to the previous 
assays, with two notable modifications: i) an aldehyde-containing substrate was employed, and ii) 
PPh3 was introduced. Benzaldehyde was identified as a suitable substrate for the initial assay, and 
three additional functionalised benzaldehydes were employed to examine substrate promiscuity: i) p-
cyano, ii) p-nitro, and 3,4,5-trimethoxy- benzaldehyde. EDA was employed as the diazo compound. 
The reaction conditions employed were identical to the previously detailed assays. The reactions were 
performed in 1.5 ml sealed, screw-top vials and were purged with nitrogen. The final concentration of 
each constituent was 10 mM diazo precursor, 30 mM aldehyde, 10 mM sodium dithionite, 10 mM 
PPh3 and 10 µM C45. The final volume for each reaction was 400 µl, and all reactions were performed 
in CHES buffer (20 mM CHES, 10 mM KCl, pH 8.6). The reaction mixture was quenched after 2 hours, 
and the product mixture was extracted and analysed via HPLC (using an achiral C18 column) and LC-






The anticipated reaction product arising from the carbonyl olefination reaction between EDA and 
benzaldehyde is ethyl cinnamate. The C18-HPLC trace of a commercial sample of (E)-ethyl cinnamate 
is dominated by a major peak with a retention time of 4.9 minutes. The LC-MS spectrum of (E)-ethyl 
cinnamate is dominated by major peaks at m/z 104, 131, and 177 corresponding the loss of EtOH and 
CO, EtOH only, and the [M+H]+ parent ion, respectively. An external calibration for (E)-ethyl cinnamate, 
showing a linear relationship between sample concentration and the peak height response in the 
chromatogram, is presented in figure 167 appendix 1.  
Initial assays were conducted in i) the absence of any catalyst, and ii) the presence of free hemin (10 
µM) for reaction between benzaldehyde and EDA in the presence of PPh3. The reaction mixtures were 
quenched and then extracted with 1 ml of ethyl acetate prior to analysis. The reaction mixtures were 
analysed via HPLC and the resultant chromatograms for all reactions are presented in figure 116. The 
chromatograms for the assays conducted with and without hemin are both dominated by two major 
peaks with retention times of 6.5-6.8 and 8.1-8.3 minutes which corresponds to PPh3 and 
benzaldehyde respectively; no reaction product was detectable in either assay. The product mixtures 
were subsequently analysed via LC-MS and also lacked any detectable trace of the anticipated 
product. These assays indicate that no reaction occurs between EDA, PPh3, and benzaldehyde in the 
presence/absence of hemin. 
 
Figure 116: The C18-HPLC chromatogram for the carbonyl olefination reaction between PPh3 (10 mM), 
EDA (10 mM) and benzaldehyde (30 mM) in the absence (red) and presence (blue) of hemin. An 
isocratic mobile phase was employed (100% CH3CN: 0.1% v/v TFA: 0.1% v/v: Et3N) and injection 





The C18-HPLC chromatogram obtained from the C45-catalysed carbonyl olefination reaction between 
EDA and benzaldehyde is presented in figure 117. The chromatogram is dominated by a split peak 
ranging from 4.7-5.3 minutes, with apexes at retention times 4.9 minutes and 5.1 minutes. In 
comparison to the chromatogram obtained for commercial (E)-ethyl cinnamate, a good overlap can 
be deduced for the peak at 4.9 minutes; however, the presence of another apex 5.1 requires 
identification. The LC-MS for the assay is presented in figure 118 and possesses the same 
fragmentation profile observed for the commercial (E)-ethyl cinnamate, indicating a reaction has 
occurred. The peak at 5.1 minutes could correspond to either i) (Z)-ethyl cinnamate, or ii) the 
dimerization product. From the LC-MS, no dimerization product could be deducted, nor could the 
presence of any additional impurities; therefore, the peak at 5.1 minutes has been attributed to (Z)-
ethyl cinnamate. From the chromatogram, the yields for the (E)- and (Z)- products were calculated to 
be 2.57% and 3.7% respectively, translating to TTNs of 26 (cis) and 24 (trans) and a cis/trans ratio of 
1.1 (table 8). The C18-HPLC chromatograms obtained from the C45-catalysed carbonyl olefination 
reaction between EDA and i) para-nitro, ii) para-cyano, and iii) 3,4,5-trimethoxy- benzaldehyde are 
also presented in figure 117. All three chromatograms exhibit the same pattern observed in the 
chromatogram for benzaldehyde, characterised by split peak ranging from 4.7-5.2 minutes, with 
apexes at retention times 4.9 minutes and 5.1 minutes. From the chromatograms, the yields, TTNs 
and cis/trans ratios were calculated to be 4.21% (cis) and 4.21% (trans), 42 (cis and trans), and 1 for 
para-nitrobenzaldehyde, 3.16% (cis) and 3.19% (trans), 32 (cis) and 32 (trans), and 0.99 for para-
cyanobenzaldehyde, and 5.47% (cis) and 5.53% (trans), 55 (cis) and 55 (trans), and 1 for 3,4,5-
trimethoxybenzaldehyde respectively (table 8).  
Table 8: The product yields, total turnover numbers, and cis/trans ratios for the C45-catalysed 








Figure 117: The C18-HPLC chromatogram for the C45-catalsyed (10 μM, 0.1 % catalyst loading) 
carbonyl olefination reaction between EDA (10 mM) and (top left) benzaldehyde (30 mM), (top right) 
p-nitrobenzaldehyde (30 mM), (bottom left) p-cyanobenzaldehyde (30 mM), and (bottom right) 3,4,5-
trimethoxybenzaldehyde (30 mM) in the presence of PPh3 (10 mM) (CHES buffer, pH 8.6). An isocratic 
mobile phase was employed (100% CH3CN: 0.1% v/v TFA: 0.1% v/v: Et3N) and injection volumes were 
20 μl. 
 
Figure 118: LC-MS spectrum of the reaction product obtained from the C45 catalyzed carbonyl 
olefination assay between benzaldehyde and EDA in the presence of PPh3. LC-MS spectrum of the C45 
catalyzed carbonyl olefination assay products. The mass spectrum was recorded in ES+ mode and 
monitored at 245 nm. A C8 column was employed for the LC separation with a gradient mobile phase 





Although C45 exhibited activity towards carbonyl olefination, the reactions are consistently 
characterised by poor product yields and zero-to-negligible selectivity. The poor product yields are 
undoubtedly a consequence of the need to form an ylide intermediate with the large, bulky PPh3 prior 
to reacting with the carbonyl substrate. The binding pocket of C45 would be expected to perform a 
significant, and energetically expensive, reorganisation to accommodate PPh3 and the resultant ylide, 
although favourable π-π interactions between the phosphine phenyl groups and nearby aromatic 
residues and/or the porphyrin ring could provide some energetic compensation for the reorganisation 
process. The formation of the ylide is, therefore, most probably the rate-limiting step of the reaction 
and accounts for the poor yields observed. The poor reaction yields reported in the literature, even 
after letting the reaction proceed for upwards of 16 hours, supports this conjecture. The absence of 
any appreciable stereoselectivity can be accounted for in two ways, i) such a significant reorganisation 
of C45’s binding pocket resulting in the lack of any energetically favourable diffusion trajectory for the 
carbonyl substrate, or ii) dissociation, and expulsion from the binding picket, of the ylide intermediate 
prior to interacting with the carbonyl substrate. The dissociation and expulsion of the ylide into 
solution would also result in unwanted side-reactions (i.e. solvent hydrolysis) which would also 
negatively affect the product yields. 
From the above experiments it can be concluded that C45 does exhibit some catalytic activity towards 
carbonyl olefination, but offers no advantage, in terms of yields or selectivity, over established 
synthetic methodologies. It would be helpful to investigate, in future experiments, if certain key 
modifications could improve the catalytic performance. For example, employing a less-bulky 
phosphine substituent (i.e. PMe3), or by mutating large residues to smaller residues (i.e. valine to 
glycine) in the binding pocket surrounding the heme to increase the active site volume.  
5.2.3 C45 catalysed nitrogen-containing heteroaromatic homologous ring expansion 
Nitrogen-containing-heterocycles (NHCs) constitute an enormous class of molecules ubiquitously 
distributed across all kingdoms of life (figure 119). From a biological perspective, the most noteworthy 
subclass of NHCs are the alkaloids, a diverse group of secondary metabolites that serve an assortment 
of biologically important functions.315,325–328 From a technological perspective, the alkaloids are 
renowned for their various functions, including several important pharmaceutical and therapeutic 
properties, ranging from antibacterial, antimalarial (i.e. quinine), anticancer (i.e. vinblastine) to 
vasodilatory (i.e. vincamine), analgesic (i.e. codeine) and antihyperglycemic properties. In addition to 
direct medical applications, many alkaloids function as molecular blueprints, or starting scaffolds, 
from which semi-synthetic NHC drugs are developed.329–333 The application of alkaloids extends 





or as stimulants (i.e. caffeine, nicotine). Many alkaloids are also rather infamous for their psychoactive 
properties, including stimulants (i.e. cocaine), hallucinogens (i.e. psilocybin, ibogaine), although some 
psychoactive properties have direct medical applications, such as the painkillers morphine and 
codeine.  
 
Figure 119: Some important nitrogen-containing heterocycles  
The ubiquitous distribution of alkaloids, and the assortment of technologically relevant properties, 
has naturally resulted in the isolation, extraction and synthesis of alkaloids, semi-alkaloids and other 
NHCs semi-related to alkaloids becoming pertinent areas of scientific research.325–331,333 Although 
many different synthetic methodologies are employed in the synthesis of NHCs, ring expansion 
reactions are exceptionally useful as they provide a reliable and facile method for acquiring large, 
expanded ring systems.334,335 Though currently underused, the homologous ring expansion of 
nitrogen-containing heteroaromatics (NHAs) could be of considerable use in the synthesis of naturally 
occurring or semi-synthetic products. One of the most well-established ring expansion reactions is the 
Buchner ring expansion (figure 120): a homologous expansion of a benzene ring to a seven-membered 
cyclohepta-1,3,5-triene by the insertion of a reactive carbene species.336,337 Although the reaction does 
not contain any NHCs or NHAs, it serves as a good introduction to ring expansion chemistry. The 
reaction proceeds in two steps: i) the initial decomposition of a diazo compound, expelling nitrogen 
and generating a reactive carbene intermediate. The decomposition of the diazo precursor can be 





carbene then undergoes a concerted [2+1] cycloaddition to one of the benzene π-π bonds to yield a 
bicyclo[4.1.0]heptadiene.336,337 
 
Figure 120: The Buchner ring expansion 
The product of the Buchner reaction is a bicyclo[4.1.0]heptadiene species. The cyclopropane fragment 
of the products is susceptible to ring opening via an electrocyclic reaction to yield a cyclohepta-1,3,5-
triene, the 7-membered ring expansion product. In solution, the bicyclo[4.1.0]heptadiene and 
cyclohepta-1,3,5-triene species form a chemical equilibrium, with the position of the equilibrium 
dependent on steric, electronic, and conformational effects. The equilibrium can be destabilised in 
favour of the bicyclo[4.1.0]heptadiene by the inclusion of bulky substituents and/or electron-donating 
groups, while small and/or electron-withdrawing groups stabilise the cyclohepta-1,3,5-triene product 
and shift the equilibrium towards the ring expansion product. One major limitation of the Buchner 
ring expansion is the lack of control over the regioselectivity process, meaning multiple regioisomers 
can feasibly exist in solution at any given time.336,337 
While the Buchner ring expansion reaction is a good example of a homologous ring expansion, the 
starting substrate is not an NHC or NHA. The Ciamician-Dennstedt rearrangement, though not as well 
known, is a good example of a ring expansion reaction involving an NHA species (figure 123).338–340 The 
original reaction is between the 5-membered NHA pyrrole and chloroform to yield a 6-membered NHA 
3-halopyridine product. The reaction is activated by a strong base (i.e. KOH), thermolysis and/or 
photolysis, which decomposes chloroform to yield the highly reactive carbene species 
dichlorocarbene. The dichlorocarbene then undergoes a concerted [2+1] cycloaddition reaction with 
one of pyrrole’s π-π double bonds to yield a cyclopropane-containing-bicyclic species, analogous to 
the mechanism for the Buchner ring expansion reaction.338–340  If chloroform is used as the carbene 
precursor, the cyclopropane-moiety of the bicyclic intermediate is functionalised with two chlorine 
substituents, which are good leaving groups. The cyclopropane-containing-bicyclic species is 
susceptible to a spontaneous concerted ring opening reaction, which results in the elimination of HCl 
to yield 3-chloropyridine. The expulsion of HCl from the cyclopropane-containing-bicyclic species to 





unlike the Buchner ring expansion reaction, the Ciamician-Dennstedt reaction gives a single product 
and is not an equilibrium in solution.338–340  The molecular symmetry of pyrrole also renders the 
reaction regiospecific, yielding the 3-functionalised pyridine (the regiospecificity disappears if an 
asymmetric pyrrole substrate is employed in the reaction).  
 
Figure 121: The mechanism of the Ciamician-Dennstedt rearrangement following the [2+1] 
cycloaddition of a carbene to a nitrogen-containing heteroaromatic molecule (i.e. pyrrole). 
It has been demonstrated that C45 can catalyse cyclopropanation reactions between olefins and diazo 
compounds. It was therefore hypothesised that C45 could catalyse the cyclopropanation of a nitrogen-
containing heteroaromatic to produce a cyclopropane-containing bicyclic system. If a suitable  
halogen-substituted carbene precursor was employed to incorporate a leaving group into the 
cyclopropane-containing bicyclic compound it would render the product susceptible to spontaneous 
rearrangement to yield a 3-functionalised pyridine product. If demonstratable, this would be the first 
enzymatically catalysed homologous ring expansion of an NHA species. The carbene precursor ethyl-
2-bromo-2-diazoacetate (Br-EDA) was identified as a suitable substrate, on account of Br-EDA being 
straightforward to synthesise from EDA (chapter 9, section 9.7.7.1) and because the bromine atom 
would function as a good leaving group, which would hopefully facilitate the spontaneous 
rearrangement of the cyclopropane-containing-bicyclic intermediate.  
Initial assays were conducted in i) the absence of any catalyst, and ii) the presence of free hemin (10 
µM) for the ring expansion reaction between pyrrole (10 mM) and Br-EDA (1 mM). The reaction 
mixtures were quenched and then extracted with ethyl acetate prior to analysis. The reaction mixtures 
were analysed via C18-HPLC and the resultant chromatograms for both reactions are presented in 
figure 122. The chromatograms for the ring expansion assays conducted with and without hemin are 
both dominated by a single major peak, with a retention time of 2.2-2.5 minutes, which corresponds 
to Br-EDA respectively; no reaction product was detected. The product mixtures were subsequently 
analysed via LC-MS and were also characterised by the lack of any detectable trace of the anticipated 
product. These assays indicate that no reaction occurs between pyrrole and Br-EDA in the presence 






Figure 122: The C18-HPLC chromatogram for the ring expansions reaction between pyrrole (10 mM) 
and ethyl 2-bromo-2-diazoacetate (1 mM) in the presence (top, black, 10 μM, 0.1 % catalyst loading) 
and absence (bottom, blue) of hemin . A gradient mobile phase was employed (70:30% H2O:CH3CN to 
10:90% H2O:CH3CN) and injection volumes were 20 μl. 
The anticipated product arising from the homologous ring expansion between Br-EDA and pyrrole is 
ethyl nicotinate. The C18-HPLC trace of a commercial sample of ethyl nicotinate is dominated by a 
major peak with a retention time of 8.3-8.6 minutes (figure 123, bottom). The LC-MS spectrum of 
ethyl nicotinate is presented in figure 124 (bottom) and is dominated by major peaks at m/z 106, 124, 
and 152 corresponding the loss of EtOH, hydrolysis of the ester group, and the [M+H]+ parent ion 
respectively. An external calibration for ethyl nicotinate is presented in appendix 1. Using the same 
reaction conditions as those described for C45-catalyzed styrene cyclopropanation, it was investigated 
whether C45 could catalyse the ring expansion of pyrrole with ethyl-2-bromo-2-diazoacetate as the 
carbene precursor. The C18-HPLC chromatogram obtained from the C45-catalysed ring expansion 
reaction between pyrrole and Br-EDA is presented in figure 123 (top) alongside the C18-
chromatogram obtained for commercial ethyl nicotinate under the same conditions figure 123 
(bottom). The chromatogram obtained for the C45-catalysed ring expansion reaction between pyrrole 
and Br-EDA is dominated by a single major peak with a retention time of 8.6 minutes, which overlaps 






Figure 123: The C18-HPLC chromatogram for the (top, black) C45-catalysed (10 μM, 0.1 % catalyst 
loading)  ring expansion reaction between pyrrole (10 mM) and ethyl 2-bromo-2-diazoacetate (1 mM) 
and (bottom, blue) commercial ethyl nicotinate (1 Mm, EtOH). A gradient mobile phase was employed 
(70:30% H2O:CH3CN to 10:90% H2O:CH3CN) and injection volumes were 20 μl. 
The LC-MS spectrum acquired for the C45-catalysed ring expansion reaction between pyrrole and Br-
EDA, is presented in figure 124 (top) alongside an LC-MS spectrum acquired for a commercial sample 
of ethyl nicotinate figure 124 (bottom). The mass spectrum for ethyl nicotinate presents a 
fragmentation pattern with dominant peaks at m/z 106, 124, and 152 respectively, corresponding the 
loss of EtOH, hydrolysis of the ester group, and the [M+H]+ parent ion, respectively.  The C45-catalysed 
ring expansion assay is also dominated by major peaks at 106, 124, and 152 m/z respectively, 
presenting an identical fragmentation profile to the spectrum acquired for commercial ethyl 
nicotinate. The HPLC chromatogram and LC-MS spectrum acquired for the C45-catalysed ring 
expansion reaction between pyrrole and Br-EDA strongly suggest that C45 is catalysing the 
cyclopropanation of pyrrole leading to the bicyclic intermediate, followed by a spontaneous 
rearrangement reaction, facilitated by the expulsion of HBr, to yield the final product: ethyl nicotinate. 







Figure 124: LC-MS spectra for the (top) C45-catalysed (10 μM, 0.1 % catalyst loading) ring expansion 
reaction between pyrrole (10 mM) and ethyl 2-bromo-2-diazoacetate (1 mM) and (bottom) 
commercial ethyl nicotinate (1 Mm, EtOH). All spectra were recorded in ES+ mode and monitored at 
254 and 280 nm. A C8 column was employed for the LC separation with a gradient mobile phase 
(95:5:0.1 % v/v water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 
20 μl. 
The C45-catalysed ring expansion of pyrrole to ethyl nicotinate is the first example of an enzyme - 
natural, engineered or de novo - capable of catalysing a homologous ring expansion reaction via a 
carbene transfer mechanism. Interestingly, the product of the reaction, ethyl nicotinate, is an ethyl 
ester of nicotinic acid (3-pyridinoic acid), biochemically known as niacin, the nicotinamide and 
NAD(P)H precursor. Subsequent base hydrolysis of ethyl nicotinate was accomplished under basic 
conditions, with a new trace, corresponding to niacin, appearing in the C18-HPLC chromatogram after 
30 minutes of incubation (figure 125, B, trace 1). The ability to synthesise ethyl nicotinate using C45, 
and subsequently hydrolysing ethyl nicotinate to niacin, raises the possibility of engineering a life 
sustaining, artificial biochemical pathway from pyrrole to nicotinamide that is reliant on the in vivo 
activity of C45. To further explore the possibility of employing C45 in a new, essential, and life-





nicotinate in living E. coli cells was examined. Using a well-established procedure for carbene 
transferase activity under such conditions, the ability of E. coli bearing the C45-expression plasmid and 
pEC86 (harbouring the c-type cytochrome maturation apparatus) to perform the ring expansion 
reaction of pyrrole with ethyl-2-bromo-2-diazoacetate under anaerobic conditions was investigated. 
Since the maturation apparatus is constitutively expressed and results in the production of several 
heme containing membrane proteins (CcmC, CcmE & CcmF),270 it was vital to establish whether any 
intrinsic ring expansion activity was detectable in the presence of these proteins. Whole cells that had 
been grown for 3 and 6 hours in the absence of the inducer, IPTG, had barely detectable ring-
expansion activity (figure 125, B, traces 3 and 4). In contrast, cells that were grown for 3 hours, 
induced with IPTG and grown for a further 3 hours displayed significant ethyl nicotinate formation 
with a total yield of 76 % (table 9), indicating that under these conditions and in vivo, C45 exhibits the 
catalytic ring expansion activity (figure 125, B, trace 5). It also indicates that both pyrrole and ethyl-2-
bromo-2-diazoacetate can cross the outer membrane and access the periplasmically-located C45.  
 
Figure 125: A. Reaction scheme for the ring expansion strategy using ethyl 2-bromo-2-diazoacetate, 
pyrrole and ferrous C45. Following carbene transfer to the pyrrole, spontaneous rearrangement of the 
bicyclic ring system leads to elimination of HBr and formation of a 6-membered pyridine ring. B. C18 
reversed phase HPLC traces of the C45-catalyzed ring expansion of pyrrole to ethyl nicotinate (1% 
catalyst loading (10 μM C45), 10 mM sodium dithionite, 1 mM ethyl 2-bromo-2-diazoacetate, 10 mM 





expansion compared to a partially hydrolysed commercial standard of ethyl nicotinate. The ring 
expansion was carried out with Traces 3,4 & 5 show the results of incubating whole cells containing 
the C45 expression vector and pEC86 harbouring the E. coli cytochrome c maturation apparatus. 
Traces 3 & 4 represent reactions between whole cells, pyrrole, and ethyl 2-bromo-2-diazoacetate at 
3 and 6 hours after inoculation and in the absence of the inducer, IPTG. Trace 5 represents the reaction 
with C45-expressing whole cells, pyrrole, and ethyl 2-bromo-2-diazoacetate. In this case, the cells 
were grown for 3 hours, induced with 1 mM IPTG and C45 was expressed for a further 3 hours prior 
to use in the whole cell transformation. 
Table 9: The product yields, total turnover numbers, reaction time, and ITPG parameter for the C45-
catalysed ring expansion reaction between pyrrole and Br-EDA in vivo and in vitro. 
 
Interestingly, despite the production of ethyl nicotinate by the cells overexpressing C45, there was no 
observable increase in the concentration of niacin in the extract, indicating that E. coli possibly lacks - 
or does not produce an appreciable quantity of - an endogenous periplasmic esterase capable of 
efficiently hydrolysing the product. In order to determine whether esterase activity could be 
accomplished in E.coli post-ring expansion, a recombinant esterase, Bacillus subtilis, that had been 
expressed in, and purified from E. coli, was identified as a suitable candidate for screening for ethyl 
nicotinate hydrolysis activity.341 Incubation of this esterase with ethyl nicotinate under near-
physiological conditions results in the production of niacin (figure 126, left), highlighting another 
functional part in a potential novel biosynthetic pathway to pyridine nucleotides from pyrrole through 






Figure 126: C18-HPLC chromatograms of ethyl nicotinate and esterase-hydrolysed ethyl nicotinate. 
(top left) commercial ethyl nicotinate (200 μl of 5 M stock in DMSO, 19.8 ml CHES buffer, pH 8.6) in 
the absence of esterase and (bottom left) 1 hour after the addition of 2 mg esterase (final esterase 
concentration is 100 μg/ml, 19.8ml CHES buffer, pH 8.6). The mixture was analysed directly after 
precipitating the esterase with 3 M trichloroacetic acid. A reverse phase gradient mobile phase 
(70:30% H2O:MeCN to 10:90% H2O:MeCN) was employed and injection volumes were 20 μl; traces 
were recorded at 265 nm. (right) Michaelis-Menten plot and kinetic parameters for the B subtilis 
esterase catalysed hydrolysis of 4-nitrophenylacetate; initial rates were calculated from the change in 
absorbance of the 4-nitrophenyl acetate anion. 
It was speculated that it is possible to make C45 and the Bacillus esterase essential to NAD+ 
biosynthesis. E. coli synthesises NAD+ through two pathways that both involve the production of 
NaMN, then NaAD prior to NAD+ formation (figure 127):342–345 i) the de novo pathway, using L-
aspartate as a starting material to produce quinolate which is a NaMN precursor,343 and ii) the pyridine 
ring salvage pathway where exogenous niacin or nicotinamide is utilised instead as NaMN precursors, 
representing the favoured pathway when niacin and nicotinamide are abundant in the 
environment.345 Knocking out a key enzyme in the aspartate pathway - e.g. nicotinate-nucleotide 
diphosphorylase (NadC) - would engender an auxotrophic strain of E. coli that, when expressing both 
C45 and a suitable periplasmically-directed esterase (using a signal sequence such as malE as for 
C45)234 in nicotinamide and niacin-lacking media, could harbour the potential for converting pyrrole 
and ethyl-2-bromo-2-diazoacetate to niacin and ultimately NAD+, recovering the deleterious 
phenotype. Currently, production of such an E. coli strain has not been properly investigated, but this 
strategy highlights the mechanism by which a novel and rationally designed metabolic pathway, 
reliant on a de novo enzyme, to sustain an essential pathway could be engineered in a bacterium 






Figure 127: Natural and engineered biosynthetic pathways to NAD+. Steps catalyzed by the de novo-
designed enzyme C45 and the non-native esterase from B. subtilis are displayed in the red box, 
showing an alternative route from pyrrole to nicotinate. It is hypothesised that deleting the E. coli 
nicotinate nucleotide diphosphorylase and growing esterase- and C45-expressing cells under 
nicotinate starved conditions with added 2-bromo-2-diazoacetate would result in the life-sustaining 
biosynthesis of NAD+. Data and annotations in the figure were obtained from the KEGG database 
(https://www.genome.jp/kegg/ kegg1.html) and the NC-IUBMB database 
(http://www.sbcs.qmul.ac.uk/iubmb/enzyme/). 
5.3 CONCLUSION 
It was demonstrated in chapter 3 that C45 can form stable, heme-localised metallocarbenoid 
intermediates and it was subsequently demonstrated in chapter 4 that C45 can catalyse the carbene 
transfer reaction to receptive olefins to yield cyclopropane products. It has been demonstrated that 
the carbene transferase enzymatic activity of C45 extends beyond cyclopropanation and includes X-H 
insertion (X = N, Si), chemoselective aromatic N-H insertion, carbonyl olefination (when combined with 
PPh3) and the in vitro and in vivo homologous ring expansion of nitrogen-containing heteroaromatics, 
the latter being the first enzymatic ring expansion – natural, designed or de novo – that proceeds via 
a carbene transfer mechanism. The homologous ring expansion of pyrrole to ethyl nicotinate, 
catalysed by E.coli overexpressing C45, opens up the possibility of engineering a novel biosynthetic 





transferase. C45 is not only promiscuous with respect to substrates and reactions, but is also 
remarkably proficient at the reactions investigated, producing products with up to 90% yields. In 
addition, unlike what was observed in the cyclopropanation assays, C45 appears to be more 
accommodating towards bulkier diazo precursors, such as tBuDA and BnDA, in the N-H insertion 
reactions; in fact, C45 catalysed the chemoselective N-H insertion reaction between 3-aminophenol 
and tBuDA with a product yield of >99%. Overall, the inherent simplicity underpinning the maquette 
approach to enzyme design, compared to its naturally designed counterparts, renders C45 a versatile, 
catalytically proficient, and promiscuous enzyme capable of performing an assortment of difficult 






CHAPTER 6: NON-AQUEOUS ENZYMOLOGY - ALGINATE-ENCAPSULATED DE NOVO HEME-
CONTAINING MAQUETTE CATALYSED CARBENE TRANSFERASE CHEMISTRY  
Industrial biotechnology is the utilisation of biocatalysts in chemical transformations of industrial 
importance. Several enzymes have well established reputations as industrial biocatalysts, being used 
in food processing, pharmaceutical synthesis, biofuel synthesis and materials manufacturing.83,346–350 
Some noteworthy examples include i) xylose isomerase, an isomerase that catalyses the 
interconversion of D-xylose and D-xylulose and is used in the production of high fructose corn syrup,85 
ii) cellulase, an enzyme that decomposes cellulose to glucose monomers and is used in biofuel 
production,346 and iii) penicillin amidase, an enzyme that catalyses the hydrolysis of the amide bond 
in natural penicillins and is used in the synthesis of semi-synthetic penicillins.346,351 Enzymes offer 
several advantages to the production processes when compared to organometallic-based catalysts. A 
major advantage is the gentle operating conditions required for enzymes to adequately function.83,346 
Most enzymes function best in aqueous conditions at standard atmospheric temperature and 
pressures, accounting for optimal pH and the inclusion of any necessary cofactors/coenzymes. 
Although considered an advantage from an environmental and biotechnological perspective, the 
gentle operating conditions of most enzymes is also limiting the widespread adoption of  biocatalysts 
because slight deviations away from optimal conditions is often detrimental to enzymatic function.83 
This is a severe hinderance in industrial biotechnology as many industrial processes use reaction 
conditions inhospitable to enzymes, such as high temperatures or high organic solvent contents. A 
wealth of research has been devoted to engineering enzymes with enhanced thermal stability, 
inspired by the discovery of several thermostable enzymes from extremophilic microorganisms.352,353 
However, efforts to engineer enzymes with enhanced stability towards organic solvents is still lacking. 
Several proteins, mainly lipases and select enzymes isolated for extremophiles,354–357 have remarkable 
activity in organic solvents, but the vast majority of enzymes are either too insoluble, catalytically 
inadequate, or both, in organic solvents and exhibit poor catalytic activities compared to aqueous 
systems. 
From a biotechnological perspective, the advantages of non-aqueous enzymology include i) the 
increased solubility of organic compounds in organic solvents, ii) the suppression of unwanted side 
reactions, such as hydrolysis, and shifts in chemical equilibriums in favour of desired products, iii) the 
ease of product extraction and isolation, and iv) the ease of catalyst recoverability relative to water.356–
359 Interestingly, some counterintuitive advantages have also been reported including i) the enhanced 
thermostability of enzymes in organic solvents, ii) the emergence of novel reactivity unobserved in 





the solvent medium, and iv) the lack of pH dependence in organic solvents.356–360 These advantages, 
combined with most industrial reactions using solvents inhospitable to enzymes, means it is pertinent 
to understand how organic solvents perturb an enzyme’s structure, dynamics and function, and to 
developed chemical strategies to counteract such perturbations in order to stabilise enzymes in 
organic solvents, and elevate the catalytic activities towards industrially useful numbers.  
6.1 ENZYMATIC DEACTIVATION IN ORGANIC SOLVENTS 
The majority of enzymes have drastically reduced catalytic activities in organic solvents relative to 
water.361 Despite this, the aforementioned advantages of non-aqueous enzymology mean overcoming 
such barriers are of practical importance. To develop novel methodologies for stabilising enzymes in 
organic solvents it is necessary to understand how organic solvents interact with enzymes. From a 
molecular perspective, this question concerns how organic solvents influence protein-protein and 
protein-water interactions, how organic solvents stabilise/destabilise protein conformations, and how 
these factors translate to a loss of enzymatic activity. Numerous factors have been identified in 
governing enzyme functionality in organic solvents, including conformational changes,356,359–362 
protein rigidification,356,359,360 perturbation of essential noncovalent protein-water 
interactions,360,362,363 changes in protein-protein noncovalent interactions,360 substrate solvation 
thermodynamics,356,361 substrate partitioning,361 solvent penetration into the active site,356 and the 
modification of activation energy barriers.356,361  
A tertiary structure of a protein is stabilised by an intricate network of intraprotein noncovalent-
interactions and intermolecular noncovalent-interactions with water molecules. The network of 
noncovalent hydrogen bonds is essential to the structure, confirmation, and functionality of a protein. 
It is suggested that water provides a ‘’lubricating’’ effect to enzymes, affording conformational 
flexibility for optimal catalysis;356,360 in addition, water molecules also play crucial roles in reaction 
mechanisms, either directly (e.g. lipases, hydrolases)364 or indirectly as an acid/base catalyst (e.g. 
cytochrome P450 compound I formation).101 Furthermore, water molecules can also provide stability 
to transition states and reaction intermediates which can lower the effective activation barrier to 
catalysis.356,361 Given the importance of water to protein dynamics and catalysis, it is hardly surprising 
that enzymes are extremely sensitive to any changes in the external environment which perturb its 
hydrogen bonding network. This includes deviations from optimal pH, elevated temperatures and, in 
particular, the introduction of organic solvents.  
The nature of protein-solvent interactions, and their role in enzymatic function and structure, has 





water/formamide solvent systems found that enzymatic activity was unaffected by the presence of 
organic cosolvents until a critical concentration was reached, after which even minute additions of the 
cosolvent proved catastrophic to enzymatic activity.365 The authors reported a relationship between 
the critical concentration of residual water (where enzyme inactivation occurs) and the 
hydrophobicity of a given alcohol solvent.365 Interestingly, the loss of activity for α-chymotrypsin after 
surpassing the critical concentration of organic solvent was reversible, with a complete regeneration 
of activity reported for α-chymotrypsin suspended in alcohol, diol and formamide solvent systems.365 
A similar observation was reported for the hydrolytic activities of three different β-galactosidases 
dissolved in various 50% (v/v) organic solvent–buffer mixtures.366 These observations are attributed 
to a conformational change in the protein, proposing that protein-solvent interactions perturb the 
solvation shell of enzymes, strip essential water molecules from the active site and strengthen 
intraprotein noncovalent-interactions; the relationship between the hydrophobicity of a solvent and 
enzymatic activity supports these claims.366 It is thought that hydrophilic solvents ‘’strip’’ water 
molecules from the protein’s interior to a greater extent than hydrophobic solvents, while also 
strengthening the intraprotein hydrophobic interactions.356,360 Furthermore, the lower dielectric 
constant of most organic solvents compared to water strengthens the intraprotein electrostatic 
interactions.360 The two phenomena result in a rigid, non-flexible protein with less conformational 
stability. As conformational flexibility is essential for catalysis, the rigidification of an enzyme impairs 
its function and is one factor accounting for the observed decrease in enzymatic activity in organic 
solvents. This conclusion is reinforced from reports that additions of small quantities of water to a 
deactivated enzyme in organic solvents results in a drastic recovery of the catalytic activity and from 
the elevated thermostability of proteins in organic solvents. A study of moisture content and catalytic 
activity (kcat/KM) for α-chymotrypsin hydrolysis revealed a direct correlation between the two factors, 
in the order octane > toluene > THF > acetone >> pyridine.367 The addition of 1.5% of water to acetone 
(v/v) elevated the moisture content of α-chymotrypsin from 1.2 to 2.4% and was accompanied by a 
1000-fold recovery in enzymatic activity.367 The authors concluded that solvent-water interactions 
were more important to overall catalytic function than protein-solvent interactions. In another study 
of three different lipases (porcine pancreatic, yeast, and mold) it was shown that all three lipases could 
efficiency catalyst the transesterification reaction between tributyrin and heptanol in a host of organic 
solvents.359 All three lipases obeyed Michaelis-Menten kinetics in the presence of only 0.02 % (v/v) of 
water.359  
The conformational changes caused by protein-solvent and solvent-water interactions play an 
important role in the catalytic activities of enzymes in organic solvents. A governing factor is the 





pronounced effect on catalytic activities compared to hydrophobic solvents.356,360 Another factor is 
solvation thermodynamics, in particular the solvation of the substrate, transition states, and reactive 
intermediates.356,361 In an aqueous solution, the substrate is solvated by water molecules to form a 
solvation shell; the enthalpy of solution, ΔHsol(substrate), is the thermodynamic property that 
accounts for the change in internal energy of a system following the dissolution of a substrate into a 
solution, at constant pressure and infinite dilution. The enthalpy of solution can be broken down into 
the sum of three separate components, the endothermic breaking of solute-solute bonds, the 
endothermic breaking of solvent-solvent bonds, and the exothermic formation of new solute-solvent 
bonds (solvation). For organic substrates, diffusion into the active site of an enzyme is accompanied 
by a breaking of the substrate-solute bonds and the establishment of substrate-enzyme bonds in the 
hydrophobic core.368,369 The more hydrophobic the substrate is, the greater the enthalpy change 
associated with desolvation and diffusion into the active site. The desolvation of hydrophobic 
solvents/substrates is accompanied by a large entropic change, as the removal of a hydrophobic 
substrate from an aqueous network liberates the water molecules that were restricted to the solvation 
sphere of the hydrophobic substrate.368,369 The net result is that diffusion of the substrate into the 
hydrophobic cavity of the enzyme is a thermodynamically favourable process, which facilitates 
catalysis.369 In organic solvents, both the enthalpy and entropy associated with an organic substrate 
diffusing into the active site is significantly lower as the perturbation to the solvent-solvent bonds 
caused by the presence of the organic substrate is significantly lower compared to water. The solute-
solvent interactions are also stronger, resulting in a less positive enthalpy of solution for the process. 
The decrease in both the entropic and enthalpic incentive for substrate diffusion into the active 
impairs catalysis, and is a factor accounting for the decreased catalytic activities observed by enzymes 
in organic solvents.  Finally, water molecules often establish stabilising noncovalent interactions with 
transient transition states and reaction intermediates.368 These interactions lower the overall 
activation energy of catalysis by reducing the energetic gap between the ground state and the 
transition state/reaction intermediate. The removal of crucial water molecules in the presence of 
organic solvents elevates the activation barrier and impairs enzymatic function.356,360   
The molecular origins of enzyme instability in organic solvents are associated with conformational 
changes, protein rigidification, and solvation thermodynamics. These phenomena all present unique 
challenges to performing biocatalysis in non-aqueous systems. To address these problems, research 





6.1.2 Methods for stabilising enzymes in organic solvents: immobilisation 
The methods for stabilising enzymes in organic solvents can be separated into three categories: i) 
enhanced solvent stability through genetic modification, ii) the chemical modification of the solvent 
environment to lessen the deleterious effects on the protein, and iii) immobilisation techniques.370 
Methods i) and ii) are important areas of research; however, the remainder of this chapter will be 
exclusively dedicated to method iii). Immobilisation of an enzyme can be broken down into two 
separate approaches: i) immobilisation of an enzyme onto an inert surface, or ii) encapsulation of an 
enzyme within an inert matrix (figure 128).370–372  
 
Figure 128: The two major methods of enzyme immobilisation. A) The tethering of an enzyme to an 
inert surface, and B) the encapsulation of an enzyme inside an inert matrix. 
Immobilisation of an enzyme onto an inert surface can be achieved either via non-covalent 
interactions (adsorption) or covalent binding. Physical adsorption is the simplest strategy for attaching 
an enzyme to an inert supporting material and can be accomplished by mixing the enzyme with a 
suitable inert support.370 For example, several lipases non-covalently immobilised on celite were 
proficient at the enzymatic interesterification of phosphatidylcholine when suspended in toluene.373 
The authors reported the immobilised enzyme resulted in a 50% regioselective conversion of various 
fatty acids in the presence of heptadecanoic acid.373 In another study, immobilised lipase B (from 
Candida antarctica) was employed as the catalyst in the synthesis of (R)-α-monobenzoyl glycerol. 





different solvents with reaction yields and enantioselectivities of up to 80 and 50% respectively.374 
Lipase type B, immobilised on a microporous acrylic resin, was also used in the synthesis of 2-
substituted-1,3-propanediols.375 The synthesis was later scaled-up, and afforded kilogram quantities 
of SCH51048 to be acquired using immobilised lipase type B in pure acetonitrile.375 A nanoporous sol-
gel glass structure was investigated by Wang and Davison as a possible support structure for covalently 
immobilising enzymes.376 The authors covalently attached α-chymotrypsin to the glass using a 
bifunctional trimethoxysilylpropanal ligand; the advantage of the bifunctional ligand is the enzyme 
can be immobilised via multiple covalent linkages instead of the mono-attachment typical of flat 
surfaces.  The transesterification of N-acetyl-L-phenylalanine ethyl ester and n-propanol, catalysed by 
immobilised α-chymotrypsin, was conducted in several organic solvents; a 110-fold enhancement in 
catalytic activity was reported when the reaction was conducted in hexane.376  
Another common method for immobilising enzymes is entrapment.370,377,378 In entrapment, the 
enzyme is encapsulated inside a polymeric network. The encapsulation of an enzyme inside a 
polymeric network protects the enzyme from the harmful effects of an organic solvent, although 
problems with mass transfer and substrate/product diffusion can impair overall catalytic rates. Alcohol 
dehydrogenase, isolated from Lactobacillus kefir, was encapsulated inside a polyvinyl alcohol gel bead 
and employed as the catalyst in the stereoselective reduction of prochiral ketones in pure hexane.379 
The authors reported the entrapped enzyme exhibited higher thermal stability and converted an 
assortment of prochiral ketones with product yields ranging from 30-100%. In another report, glucose 
oxidase was encapsulated within polymeric nanocapsules via inverse miniemuslion periphery RAFT 
polymerisation.380 The encapsulated glucose oxidase retained high activities (71-100%) relative to free 
glucose oxidase, retaining its activity even when dispersed in toluene and toluene/tBuOH.380 In 
another report, it was demonstrated that glucose oxidase follows Michaelis-Menten kinetics for the 
oxidation of glucose to gluconic acid when encapsulated inside calcium alginate beads; although with 
a lower Vmax and higher KM relative to free glucose oxidase.381  
6.2 STRUCTURE OF CALCIUM ALGINATE GELS 
From all the possible immobilisation strategies, encapsulating an enzyme inside a calcium alginate 
polymeric network is the simplest and most cost-effective method. The preparation of alginate-
encapsulated (AE) enzymes simply involves dissolving the enzyme of interest in a solution of sodium 
alginate (3% (w/v)) and pipetting the solution dropwise into a stirring mixture of aqueous calcium 
chloride (100-500 mM). The sodium and calcium instantaneously exchange and result in the 
spontaneously polymerisation of calcium alginate into spherical gel beads, encapsulating the enzyme 





beads are resistant to the vast majority of organic solvents, rendering them versatile heterogeneous 
platforms for non-aqueous enzymology applications.  
Alginates are polysaccharides isolated from brown algae. The polymeric network consists of a linear 
chain of D-mannuronic acid and L-guluronic acid monomers connected via a (1-4) glycosidic linkage 
(figure 129). The (1-4)-linkage between the monomers results in guluronic monomers adopting a 
‘buckled’ confirmation.382,383 Alginate gels are water-swollen cross-linked polymeric networks and can, 
therefore, be classified as hydrogels.383 Hydrogels can be divided into homogenous and 
heterogeneous hydrogels depending on the degree chain mobility.384 In homogenous gels, the 
backbone chains have a large degree of flexibility.384 In heterogeneous hydrogels, intermolecular 
cross-linking between chains results in the formation of junction zones, which provide structural 
integrity to the hydrogel at the expense of flexibility.384–386 The buckled conformation of the guluronic 
acid monomers in the polymeric backbone provides suitable binding sites for divalent cations.383 The 
introduction of divalent ions to a solution of alginate results in the formation of junction zones (figure 
129).383 Junction zones are structural features of a gel resulting from the interpolymer interactions 
between two polymer chains.385,386 In alginate gels, the junction zones are formed from the cross-
linking of two alginate chains via coordination to a divalent ion.383 The number of junction zones is, 
therefore, a function of the concentration of the cross-linking divalent ion and the relative strength of 
the interactions between an alginate chain and divalent cation. 
 
 
Figure 129: (top) Molecular structure of the repeating monomeric unit of the polysaccharide alginate 
(figure taken from Wikipedia, https://en.wikipedia.org/wiki/Alginic_acid#/media/File:Algins%C3%A4ure.svg), 
(bottom) A cartoon representation of a junction zone in a calcium alginate hydrogel (black lines = 





The defining structural features of hydrogels are the relative pore size and fractional volume of water 
of the gel.383 The pore size and fractional volume of water are determined predominantly by the 
number of junction zones formed by interpolymer interactions, which in alginate hydrogels is 
governed by the cross-linking divalent ion.382,383 Homogenous hydrogels naturally have fluctuating 
pore sizes and water fractions on account of their greater backbone flexibility. In heterogeneous 
hydrogels, such as calcium alginate, the pore size and fractional volume of water remain constant.303 
In heterogeneous hydrogels, increasing the cross-linking between chains (by increasing Ca2+ 
concentration) reduces the average pore size and fractional volume of water.303 How changes in pore 
size and fractional volume of water affect the stability and catalytic activity of an encapsulated enzyme 
is an important question to consider when preparing encapsulated enzymes for catalytic applications.  
In addition, the density of interpolymer interactions also governs the transport of solutes from the 
bulk solvent phase into and out of the hydrogel.382,383,387 The magnitude of solute transport is a 
significant parameter governing the enzymatic activity of encapsulated enzymes; it was reported 
above that glucose oxidase encapsulated inside calcium alginate retained its catalytic activity, 
although with significantly reduced catalytic efficiency because of substrate diffusion.381 It is therefore 
also imperative to establish methods for quantifying the relationship between solute transport and 
the observed enzymatic activity of an encapsulated enzyme.  
6.3 MASS TRANSFER AND DIFFUSION OF SUBSTRATES THROUGH GELS 
In homogenous catalysis, the catalyst (enzyme) and substrate(s) are in the same phase. The 
encapsulation of the enzyme inside a calcium alginate bead and subsequent suspension of the 
insoluble beads in a solvent creates a heterogeneous system, where the enzyme and substrates 
occupy different phases (at t = 0). In the alginate catalyst system, the two phases are the bulk-organic-
phase (BOP) and the aqueous-alginate-phase (AAP) (figure 130); the two phases being separated by 
the bulk-alginate-interface (BAI) (figure 130). The substrate is initially dissolved in the BOP, and 
therefore for catalysis to occur the substrate must transfer across the BAI and enter the AAP (figure 
130). This net movement of molecules across a biphasic interface is described as mass transfer and is 






Figure 130: Illustration of substrate diffusion in a heterogeneous system; SBOP = a substrate molecule 
localised in the bulk organic phase, SAAP = a substrate molecule localised in the aqueous alginate phase, 
E = an alginate encapsulated enzyme, r = the radius of an alginate bead 
In the heterogeneous system described above, the BOP can be labelled phase 1 (P1) and the AAP 
system 2 (P2). At a given time, t, the concentration of substrate, S, in P1 and P2 is CS1 and CS2 (when t = 
0, CS2 = 0). When the system is in a state such that CS1 =/= CS2 is true a concentration gradient across 
P1 and P2 exists, with the interface located at the BAI; under such conditions the system is in a state of 
non-equilibrium. The chemical potential, µ, is defined as the energy that can be absorbed or realised 
by a species due to a change in the particle number, Ni, of that given species in the system. 
Thermodynamically, the chemical potential is the rate of change of the Gibb’s free energy of the 
system, ΔG, with respect to the rate of change of particle number, ΔNi. Because the chemical potential 







Eq  1 
And the rate of change of the Gibb’s free energy of the entire system consisting of more than one 









Eq  2 
A system out of equilibrium will tend towards equilibrium, defined thermodynamically as a dynamic 
system where the Gibb’s free energy is at a minimum and is unchanging over time (dG = 0). For the 
heterogeneous alginate system at time zero the concentration gradient present is thermodynamically 
defined as µP1 > µP2, where µP1 is the chemical potential of the BOP and µP2 is the chemical potential of 
the AAP. As systems tend towards energetic minima, a diffusion of substrate A across the BAI will 
occur until such a point where µP1 = µP2 and the system is in thermodynamic equilibrium.388 At this 
point the concentration of substrate (S) in the BOP and AAP, defined as CS1 and CS2, remains 
unchanging, with the ratio of the two mathematically defined by the partition coefficient, K;388  







Eq  3 
From a thermodynamic perspective, the partition coefficient contains information on the strength of 
the solvent(1)-substrate (n1s) and solvent(2)-substrate (n2S) interactions, when solvent(1) and 
solvent(2) are separated by a well-defined boundary. The rate of mass transport of substrate, S, from 
P1 into P2 as a function of time is expressed by the diffusion equation 
𝜕∅(𝐫, 𝑡)
𝜕𝑡
= ∇ ∙ [𝐷(∅, 𝐫)∇∅(𝐫, 𝑡)] 
Eq  4 
Where Φ(r,t) is the density of the diffusing material at location r and time t and D(Φ,t) is the diffusion 
coefficient for density Φ at location r; ∇ represents the partial differential operator del. If D is constant 
the equation reduces to 
𝜕∅(𝐫, 𝑡)
𝜕𝑡
= 𝐷∇2∅(𝐫, 𝑡) 
Eq  5 
The diffusion coefficient for a substrate, D, is a proportionality constant relating the rate of molecular 





molecular flux, J, defined as the rate at which a molecule crosses a boundary, is mathematically related 





Eq  6 
Where J is the diffusional flux (quantity of substrate per time), D is the diffusion coefficient (m2 s-1), C 
is the concentration (mol dm-3) and x is the position (m2).388,389 Equation (6) is known as Fick’s first law 
of diffusion and provides a mathematical description for the driving force of diffusion by relating the 
rate of diffusion to the concentration gradient (−
𝑑𝐶
𝑑𝑥
). From equation (6), it can be deduced that a 
substrate S will transfer from regions of high concentration into regions of low concentration, until a 
point where µP1 = µP2 is satisfied. The rate of diffusion is a function of a concentration gradient, and so 
as the concentration gradient is minimised it would be expected that the rate of diffusional flux 
decreases accordingly. This postulation forms the basis of Fick’s second law of diffusion, and is 







Eq  7 
In two or more dimensions, equations (6) and (7) are expressed by equations (8) and (9) 
𝐽 = −𝐷∇𝐶 




Eq  9 
The equations presented above are derived for a system under ideal conditions. The diffusion of a 
substrate into a gel is a deviation away from ideal conditions, and as such the equations must be 
modified accordingly. A few considerations need to be discussed to understand why such 
modifications are justified. Firstly, one way a gel may influence diffusion is by the binding of a 
substrate, resulting in a situation where the diffusivity of the substrate is characterised by two 
distinctively different diffusion coefficients, Dbound and Dfree. In such a case, the molecular flux would 





𝐽 = −𝐷𝑏𝑜𝑢𝑛𝑑 (
𝜕𝐶𝑏𝑜𝑢𝑛𝑑
𝜕𝑥




Eq  10 
Were Cbound and Cfree are the concentrations of bound and free substrate, respectively. In the simplest 
situations, it is assumed that Dbound = 0 and equation (10) reduces to the standard equation for Fick’s 
first law. An additional assumption is typically made where the rate of swelling is independent of the 
diffusion of a substrate into and out of the bead.389  
The concentration of the substrate can also be defined in two possible ways: i) The concentration of 
solute per unit volume of gel (CG), or ii) The concentration of solute per unit void of gel (CV). However, 
the concentration of a solution in equilibrium with the gel (CE), is independent of CV and CG. For non-
absorbed solutes, CE is related to CG through the partition coefficient, K, expressed as388,389 
𝐶𝐺 = (1 − 𝛷)𝐶𝐸 
Eq  11 
The geometric exclusion effect states the fractional void volume available for the centres of large 
solute molecules (1 – ø) is less than the fractional void volume available for the centres of smaller 
solvent molecules (1 – β).389 The porosity of the gel, ε, in terms of the geometric exclusion effect, is 
defined as (1 – ø); therefore, the porosity of the gel is the constant of proportionality connecting the 
concentration of solute per unit volume of gel, CG, to the concentration of the solution in equilibrium 
with the gel, CE.387,389 The molar flux, defined by Fick’s first law, can be written as 










Eq  12 
where J is the flux per unit area of gel of thickness ΔX, which separates solutions differing in 
concentration by amount ΔCE, ε is the porosity of the gel (which is dependent on the number of 
junction zones in the gel), and Deff is the effective diffusion coefficient387 
𝐷𝑒𝑓𝑓 = 𝜀𝐷 
Eq  13 











Eq  14 
If the diffusion of a substrate into the spherical bead follows Fickian diffusion, the concentration of 
substrate inside the bead, CS2, at time, t, can be mathematically expressed as387 
 


















Eq  15 
Where Cp,∞ is the substrate concentration inside the bead after an infinite time, rp is the radial position 





Eq  16 





Eq  17 
Where  Vb is the total volume of the bulk solvent, Vp is the total volume of the alginate beads and Kp is 
the partition coefficient.387 If external mas resistance is negligible, equation (15) reduces to the non-
steady state equation387 
𝐶𝑆2(𝑡) =  
𝛼𝐶𝑆2(0)
1 + 𝛼

















Where Cs2(t) is the concentration of substrate, S, in the bulk at time t, Cs2(0) is the concentration of 
substrate, S, in the bulk at t = 0, R is the radius of the alginate beads, qn is the position non-zero root 
of equation (16), t is time, and D is the diffusion coefficient. Equation (18) affords a method for readily 
calculating the diffusion coefficient.  
6.4 RESULTS AND DISCUSSION 
6.4.1 Chemophysical characterisation of calcium-alginate beads 
The synthesis of calcium alginate beads involves the dropwise addition of a 3% (w/v) aqueous sodium 
alginate solution into an aqueous calcium chloride solution. An ion-exchange between sodium and 
calcium occurs almost instantaneously, and the calcium alginate chains undergo a spontaneous 
gelation event to yield spherical, hydrogels. Any substrate dissolved in the sodium alginate solution, 
such as an enzyme, is entrapped within the newly formed hydrogel, as the rate of gelation upon 
contact with calcium chloride far exceeds the rate of diffusion through the aqueous calcium chloride 
solution. It was mentioned above that the physical properties of calcium alginate beads, including the 
pore size, water retention and strength, are a function of the number of junction zones formed within 
the alginate polymeric network. In calcium alginate, the number of junction zones is a function of the 
concentration of calcium chloride, and so the chemophysical properties of a calcium alginate hydrogel 
can be reasonably tuned by controlling the concentration of calcium chloride.382,383 
The chemophysical characteristics of calcium alginate beads were first determined prior to conducting 
any biophysical or catalytic characterisation on C45 encapsulated within an alginate hydrogel (figure 
131). In particular, the water content and enzyme retention of the calcium alginate beads, as a 
function of calcium chloride concentration, was investigated. The sodium alginate concentration was 
chosen to be 3% (w/v), as it was observed that beads made below this concentration were susceptible 
to degradation in organic media; because calcium ions govern the formation and strength of junction 






Figure 131: C45 encapsulated inside calcium alginate beads (3% (w/v) alginate, 0.3M CaCl2, CHES 
buffer, pH 8.6). 
The water content and enzyme retention properties of 3% (w/v) alginate hydrogel beads as a function 
of calcium chloride concentration was initially investigated, with the results tabulated in table 10. The 
water retention was determined by preparing the beads as delineated in chapter 9, section 9.12. The 
beads were then oven-dried at 37OC for 2 hours and the diameter was re-measured to determine the 
change in volume. It can be readily seen from table 10 that, as expected, the water content of a 3% 
(w/v) sodium alginate bead decreases linearly with increasing calcium chloride concentration. The 
overall volume of the bead prior to dehydration is independent of calcium chloride concentration, and 
so the decreased water content is accounted for by the increased volume occupied by calcium ions 
inside the alginate beads. As the calcium ions function as the molecular adhesive that establishes 
junction zones it is probable that a greater proportion of junction zones are formed inside the bead at 
higher calcium chloride concentrations; an increase in the number of junction zones would reduce the 
fractional free volume available for water molecules to occupy. Interestingly, although the densities 
of the calcium alginate beads as a function of calcium chloride were not determined, it was observed 
experimentally that at values < 0.3M the beads floated to the top of the solvent, whereas for beads  > 
0.3M the beads sank to the bottom of the suspension. This change in behaviour as a function of 
calcium chloride concentration indicates that above 0.3M calcium chloride the density of the beads 
surpasses the density of water, indicative of lower water content inside the alginate beads. The 
quantity of enzyme retained inside the alginate bead after a certain duration was also measured for 
two haemoproteins: HRP and cytochrome c. As can be seen in table 10, the quantity of enzyme 





with increasing calcium chloride concentration, again accounted for by a decrease in pore space and 
fractional free volume in the bead at higher calcium concentrations.  
A calcium chloride concentration of 0.3M was selected to determine the spectroscopic and catalytic 
properties of C45 encapsulated inside alginate beads (figure 131). The rationale is based on two 
principles: i) the water content of 0.3M CaCl2 is sufficient to provide a hospitable environment to the 
enzyme while also possessing a sufficient quantity of free volume to accommodate the enzyme, the 
substrates and the products, ii) at 0.3M calcium chloride, the alginate beads were homogenously 
distributed when suspended in an aqueous solution (density not measured).  
Table 10: The (de)hydrated particle volume, water content/volume, and enzyme retention factors of 
calcium alginate beads formed from 3% (w/v) sodium alginate (in CHES buffer, pH 8.6) as function of 
calcium chloride concentration (0.1-0.5M CaCl2(aq). 
 
6.4.2 Spectroscopic characterisation of alginate-encapsulated hemoproteins/maquettes  
Initial experiments were concerned with spectroscopically characterising hemoproteins entrapped in 
alginate beads suspended in several organic solvents. In order to achieve this, thin sheets of protein-
encapsulated alginate samples were prepared in a petri dish. A sample of protein was mixed into 3% 
sodium alginate until fully dispersed and was allowed to sit until all the bubbles had disappeared. Then 
a thin sheet of enzyme-loaded sodium alginate was loaded into a petri dish. The sodium alginate was 
submerged in a solution of 0.3M CaCl2 and the samples were left for 1 hour to fully mature. After 1 
hour, a scalpel was used to cut out thin strips of the enzyme-encapsulated alginate layers in 
accordance with the dimensions of the UV-VIS cuvette. In order to optimise this process, initial 
characterisations were performed with equine cytochrome c.  
The normalised UV-VIS spectra acquired for cytochrome c in CHES buffer, alginate-encapsulated 
cytochrome c in CHES buffer, and alginate-encapsulated cytochrome c in anhydrous hexane are 
presented in figure 132. It is immediately apparent that the Soret peak for cytochrome c, at 406 nm, 
remains completely unaffected when cytochrome c is encapsulated inside an alginate bead, and when 





resolved, remains observable in the 500-550 nm region for all samples. The poor resolution of the Q-
band is probably a consequence of scattering from the alginate beads; nonetheless, the UV-VIS spectra 
indicate cytochrome c remains unperturbed in pure hexane when encapsulated inside an alginate 
bead. 
 
Figure 132: The normalised UV-VIS spectra of cytochrome c in CHES buffer (black) and alginate-
encapsulated (0.3M CaCl2, 3% (w/v) sodium alginate) cytochrome c suspended in CHES (red) and n-
hexane (blue). 
Having acquired sufficient data for cytochrome c, the C45-encapsulated alginate sheets were 
subsequently investigated spectroscopically. Applying the same protocol for cytochrome c, C45-
alginate sheets were prepared and examined spectroscopically. The normalised UV-VIS spectra for 
C45-encapsulated alginate sheets in CHES, MeOH, EtOH, acetone, ethyl acetate, and hexane are 
presented in figure 133 (top left). The UV-VIS spectra acquired for all solvents systems are all 
dominated by a Soret peak at 406 nm, as is observed under aqueous conditions. The resolution of the 
Q-band, however, is poor, probably a consequence of scattering by the alginate bead. All the recorded 
spectra so far have been for ferric-C45; as it is necessary to reduce ferric-C45 to ferrous-C45 in order 
to access carbene transferase chemistry, C45-encapsulated alginate sheets were prepared in CHES 
buffer prior to the addition of excess sodium dithionite. The time-course UV-VIS spectra presented in 
figure 133 (top right) shows that over the course of 90 seconds the ferric-C45 Soret peak at 406 nm 





corresponding to the ferrous-C45 peak. The long duration before appreciable quantities of ferrous-
C45 can be detected is a consequence of the slow diffusion rate across the alginate-solvent interface; 
however, it would be anticipated that reduction would occur more rapidly in the presence of pure 
hexane, in which sodium dithionite is insoluble. For comparison, the experiment was repeated using 
Rma-TDE. The normalised UV-VIS spectra for Rma-TDE in CHES, MeOH, EtOH, acetone, ethyl acetate, 
and hexane are presented in figure 133 (bottom left), alongside the UV-VIS spectra for the alginate-
encapsulated Rma-TDE in the presence and absence of sodium dithionite figure 133 (bottom right). 
The UV-VIS spectra acquired for all the solvent systems are dominated by a Soret peak at 406 nm, as 
is observed under aqueous conditions. In addition, the UV-VIS spectra recorded in the absence of 
sodium dithionite is dominated by a Soret peak at 406 nm, correspond to ferric Rma-TDE. The UV-VIS 
spectra in the presence of sodium dithionite, however, is dominated by a Soret peak at 417 nm, 
corresponding to ferrous Rma-TDE. Interestingly, the UV-VIS spectra recorded for alginate-
encapsulated ferrous Rma-TDE also displays a reasonable well resolved split Q-band with peaks at 525 
nm and 551 nm. Overall, the UV-VIS spectra for alginate-encapsulated C45 and Rma-TDE 
demonstrates the enzymes remain spectroscopically distinct and unaffected by the presence of 
organic solvents, and that reduction from the ferric to the ferrous state is possible and is only impacted 






Figure 133: UV-VIS spectra of (top left) alginate encapsulated C45 in various organic solvents, (top 
right) alginate encapsulated C45 in the presence of Na2S2O4, (bottom left) alginate encapsulated Rma-
TDE in various organic solvents, (bottom right) alginate encapsulated Rma-TDE in the presence of 
Na2S2O4.  
Having demonstrated that C45 retains its spectroscopic profile when encapsulated in calcium alginate 
beads and can be successfully reduced from the ferric to the ferrous state, the question of whether 
the formation of the metallocarbenoid intermediate could be identified spectroscopically was raised. 
Applying the same protocol delineated above, a thin sheet of C45-encapsulated calcium alginate was 
prepared. The sheet was transferred to a UV-VIS cuvette and submerged in CHES buffer for 
subsequently UV-VIS analysis. The acquired UV-VIS spectra for ferric C45, ferrous C45, and ferrous C45 
in the presence of EDA are presented in figure 134 (left). The UV-VIS of alginate-encapsulated ferric 
C45 (figure 134 (left); black) is characterised by a large Soret peak at 407 nm, accompanied by a 
relatively low-intensity, but detectable, Q-band in the 500-600 nm region. After the addition of 
Na2S2O4 a new spectrum emerged (figure 134 (left); red) characterised by an intense Soret peak at 





with an intensity profile of β > α. The acquired UV-VIS for alginate encapsulated ferrous C45 is 
consistent with the UV-VIS spectra acquired free ferrous C45. After the addition of EDA to the cuvette, 
a new red-shifted spectrum emerges (figure 134 (left); blue) which is dominated by an intense Soret 
peak at 426 nm which is accompanied by Q-band consisting of two red-shifted peaks at 542 nm (α 
peak) and 584 nm (β peak), with an intensity profile of β > α. Figure 134 (right) presents the normalised 
UV-VIS spectrum acquired for alginate encapsulated ferrous C45 in the presence of EDA (figure 134 
(right); blue) compared with the normalised UV-VIS spectra acquired for the C45-EDA 
metallocarbenoid intermediate in solution (figure 134 (right); red). The two spectra are affectively 
identical, with both spectra characterised by an intense Soret peak at 426 nm which is accompanied 
by a Q-band consisting of two peaks at 541 nm (α peak) and 582 nm (β peak), with an intensity profile 
of β > α. The spectroscopic data acquired clearly indicates that encapsulating C45 inside calcium 
alginate beads does not impact its ability to form a stable, metallocarbenoid intermediate. The 
formation of the intermediate is, however, slower when C45 is encapsulated, but this is to be expected 
on account of partitioning dynamics of EDA across the alginate-solution barrier, and diffusion of EDA 
through the polymeric network of the alginate bead towards C45.  
 
Figure 134: Alginate encapsulated C45 metallocarbenoid formation 
6.4.3 Alginate encapsulated-C45/HRP catalysed peroxidase activity and functional recoverability  
Having spectroscopically demonstrated that encapsulated hemoproteins remain stable and can be 
reduced in the presence of suitable reductants, the next question concerned catalytic activity. 
Although C45 has been demonstrated to be an efficient carbene transferase, C45 was originally 
designed with the intention of mimicking natural oxidoreductases. C45 is an established de novo 





encapsulated C45 were focused on its peroxidase chemistry. The reasons for investigating peroxidase 
chemistry prior to investigating carbene transfer chemistry was because i) peroxidase chemistry can 
be conducted under aerobic conditions, ii) peroxidase assays do not require C45 to be reduced to the 
ferrous state, and iii) a well-established and colourimetric assay involving ABTS and hydrogen peroxide 
exists allowing for the peroxidase kinetics to readily obtained much easier compared to carbene 
transfer chemistry. For comparative purposes, the peroxidase assay between ABTS and hydrogen 
peroxidase, catalysed by alginate-encapsulated C45, was benchmarked against alginate-encapsulated 
horseradish peroxidase (HRP), as the kinetics of the peroxidation of ABTS, in aqueous solution, has 
been previously reported for C45 and was compared against HRP.235 
6.4.3.1 Horseradish peroxidase and C45 – peroxidase kinetics and recoverability 
Horseradish peroxidase is a large monomeric α-helical heme-containing enzymes that catalyses the 
oxidation of various organic compounds using hydrogen peroxide as a substrate.101,136 One particular 
substrate, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) is a common reagent used 
to determine the reaction kinetics of peroxidases. ABTS exists as a colourless dianionic species in 
solution but can function as a reductant in the presence of a peroxidase, supplying the electrons in 
the reduction of hydrogen peroxide. The first reduction step generates a green-blue radical cation 
whose production can be continuously monitored spectroscopically.235         
Alginate-encapsulated HRP beads were prepared according to the protocol outlined in chapter 9, 
section 9.12. The final beads had an average diameter of 1.4 mm (± 0.1 mm) and an average HRP 
concentration of 100 µM. A 100 mM solution of ABTS and 1 mM solution of H2O2 were prepared in 
CHES buffer (20 mM CHES, 100 mM KCl, pH – 8.6). All reactions were performed in triplicates, in a 1 
ml UV-VIS cuvette with one bead per reaction and a final concentration of 1 mM ABTS. The 
concentration of hydrogen peroxide was varied across a 1-100 µM range and the reaction progress 
was monitored using a single-wavelength spectrophotometer set at 680 nm. Figure 135 shows that 
the alginate-encapsulated HRP catalysed peroxidation of ABTS at select concentrations of H2O2 obeys 
Michaelis-Menten kinetics, and from figure 135 values of 8.83 µM and 0.054 s-1 were calculated for 
KM and kcat respectively, resulting in a calculated catalytic efficiency of kcat/Km = 6.12 x 103 M-1 s-1. For 
reference, the catalytic efficiency for HRP towards in the peroxide activation step in aqueous solutions 
has been reported as kcat/Km = 4.6 × 106 M−1 s−1,235 meaning encapsulating HRP inside an alginate bead 
results in a 1000-fold decrease in catalytic efficiency towards the peroxide activation step. For 
reference, the values for kcat and KM(H2O2) for HRP (100 nM) in solution have been reported as 4100 






Figure 135: The Michaelis-Menten plot of the AE-HRP catalysed peroxidation of ABTS as a function of 
hydrogen peroxide concentration. Initial rates were calculated from the rate of change in absorbance 
of the ABTS cation radical. 
Having demonstrated that HRP remains active towards ABTS peroxidation when encapsulated inside 
an alginate bead, albeit with lower catalytic activity, it was of subsequent interest to whether C45 
would also remain catalytically active towards the same chemistry when encapsulated inside alginate 
beads. Alginate-encapsulated C45 beads were prepared according to the protocol provided in section 
9, and the experimental conditions paralleled the ones described for HRP, with exceptions being a 
greater hydrogen peroxide concentration range (100 – 2500 µM) and C45 concentration. The final 
beads had an average diameter of 1.4 mm (± 0.1 mm) and an average C45 concentration of 10 µM 
Figure 136 shows, as with HRP, that the alginate-encapsulated C45 catalysed peroxidation of ABTS at 
select concentrations of H2O2 obeys Michaelis-Menten kinetics, and values of 686.15 µM and 0.081 s-
1 were calculated for KM and kcat respectively, resulting in a calculated catalytic efficiency of kcat/Km = 
1.24 x 102 M-1 s-1. For reference, the catalytic efficiency for C45 towards the peroxide activation step 
in aqueous solutions has been reported as kcat/Km = 1.3 × 104 M−1 s−1,235 meaning encapsulating C45 
inside an alginate bead results in a 100-fold decrease in its catalytic efficiency towards the peroxide 
activation step. The values for kcat and KM(H2O2) for C45 (100 nM) in solution are 1200 s−1 and 94 mM 







Figure 136: The Michaelis-Menten plot of the AE-C45 catalysed peroxidation of ABTS as a function of 
hydrogen peroxide concentration. Initial rates were calculated from the rate of change in absorbance 
of the ABTS cation radical. 
The reaction of H2O2 and ABTS follows a steady-state ping-pong mechanism typical of peroxidase 
enzymes.235 The overall mechanism is broken into two step-wise processes: the initial binding and 
activation of peroxide followed by the subsequent binding of ABTS prior to an electron transfer. It was 
previously reported that C45 exhibits a catalytic efficiency of kcat/KM(ABTS) = 3.2 × 106 M−1 s−1 for the 
electron transfer between peroxide-activated C45 and ABTS, which is purported to be one of the 
highest catalytic efficiencies observed for a de novo enzyme, possessing a value very close to that for 
HRP (kcat/KM(ABTS) = 5.13 × 106 M−1 s−1).235 In contrast to the high efficiency of the electron transfer 
step, the activation of peroxide by C45 is less catalytically efficient than in HRP (C45 kcat/KM = 1.3 × 104 
M−1 s−1; HRP kcat/KM = 4.6 × 106 M−1 s−1), which is attributed to the lack of peroxide-activating amino 
acid side chains in the vicinity of the heme in C45 relative to HRP, which is reflected in the KM(H2O2) 
values reported in solution (C45 = 94 mM; HRP = 900 µM).235  However, when encapsulated inside an 
alginate bead, HRP exhibits a 1000-fold decrease in catalytic efficiency towards the peroxide step, in 
contrast to a 100-fold decrease for C45. In order to account for this observation, it is necessary to 
consider how encapsulating an enzyme inside an alginate bead would affect the dynamics and activity 
of enzymes which would be reflected in the values of kcat and KM. The first consideration concerns 
partitioning of substrates across the bead/solvent interface. As enzymatic processes are dependent 
on the diffusion of the necessary substrates, the introduction of additional diffusion processes would 





alginate-encapsulated glucose oxidase activity.381 The effect of substrate diffusion has already been 
observable in the reduction of ferric alginate-encapsulated C45 and Rma-TDE, a process requiring 120 
seconds before appreciable quantities of the ferrous species could be detected spectroscopically. The 
diffusion of substrate(s) across the alginate-solvent barrier is therefore accredited as a major factor 
contributing to the observed reduction in kcat for both C45 and HRP ABTS peroxidation. The second 
major consideration concerns the relative sizes, and confirmations, of the enzymes inside the alginate 
beads.    
One major limitation of homogenous biocatalysts is the difficulty associated with recovering the 
catalyst post-reaction. An enzyme immobilised in an alginate bead creates a heterogeneous 
biocatalyst that can be readily recovered at the end of the reaction and reused in another catalytic 
cycle. Therefore, having demonstrated that C45 remains catalytically active towards ATBS 
peroxidation when encapsulated inside alginate beads, subsequent investigations were concerned 
with whether C45 would remain catalytically active once recovered after one round of peroxidation 
chemistry. For comparative purposes, a recoverability assay was initially optimised using HRP. 
Alginate-encapsulated HRP beads were prepared according to the protocol provided in chapter 9, 
section 9.12. The final beads had an average diameter of 1.4 mm (± 0.1 mm) and an average HRP 
concentration of 100 µM. A 100 mM solution of ABTS and a 100 mM solution of H2O2 were both 
prepared in CHES buffer (20 mM CHES, 100 mM KCl, pH – 8.6). All the reactions were conducted in a 
1 ml UV-VIS cuvette with one bead per reaction and the final concentrations were 1 mM ABTS and 1 
mM H2O2. The reaction progress was monitored using a single-wavelength spectrophotometer set at 
680 nm. After 2 minutes, the bead was recovered from the cuvette, both the cuvette and the bead 
were washed with 1 ml CHES buffer and another reaction was prepared using the same bead and 
identical reaction conditions. For the C45 recoverability assays, an identical protocol was followed, 
with the only exception being the final enzyme concentration was 10 µM. The normalised conversion 
rates for alginate-encapsulated HRP and C45 ABTS peroxidation recoverability are presented in figure 
137. For HRP, the enzyme retained 79% and 24% of its initial activity during the 2nd and 3rd runs, 
respectively. C45 could be recovered and reused three additional times before any lack of appreciable 
activity could be detected, retaining 52%, 23% and 12.5% of its initial catalytic activity during the 2nd, 






Figure 137: The normalised conversion rate of AE-C45 (red) and AE-HRP (blue) towards the 
peroxidation of ABTS over successive catalytic cycles (all values are within a 10% error margin). 
6.4.4 Alginate encapsulated-C45 catalysed carbene transfer chemistry  
Having demonstrated that C45 encapsulated in calcium alginate beads retains both its peroxidase 
activity and its ability to form a stable metallocarbenoid intermediate, the following step was to 
explore the carbene transferase activity of alginate-encapsulated C45 (AE-C45) when the loaded beads 
were submerged in a variety of non-aqueous solvents. As the alginate-encapsulated C45 beads 
function as a heterogeneous catalyst, coupled with the aforementioned observation that 
heterogeneous C45 retains its peroxidase activity, it was also of interest to investigate the 
recoverability of C45 and its carbene transferase proficiency when utilised in subsequent rounds of 
catalysis.  
The cyclopropanation reaction between styrene and EDA, and the N-H insertion reaction between 
piperidine and EDA were selected as the reactions to investigate the catalytic activity of 
heterogeneous AE-C45. A selection of 12 varying solvents were used, ranging from polar protic, polar 
aprotic, and non-polar solvents, and included CHES buffer (20 mM CHES, 100 mM KCl, pH 8.6), 
methanol, ethanol, isopropanol, acetone, acetonitrile, ethyl acetate, THF, dichloromethane, hexane, 
petroleum ether, and toluene. All the reactions were performed in 1.5 ml glass vials sealed with an 
air-tight septum lid. The reaction volumes were 1 ml of neat solvent and each reaction vial contained 
three C45-containing alginate beads. Stock solutions of Na2S2O4 (1 mM in dH2O), EDA (1 mM in EtOH) 





a nitrogen atmosphere, to initiate the reactions. The final concentrations of the substrates were 10 
mM EDA, 30 mM styrene/piperidine and 10 mM Na2S2O4. All the reactions were performed under a 
nitrogen atmosphere.    
6.4.4.1 Styrene cyclopropanation 
After leaving the reactions to mix for 2 hours, the reactions were quenched by the addition of 25 µl of 
a 3M HCl solution. The alginate beads were removed from the vials, and then 1 ml of ethyl acetate 
was added to each vial before each reaction mixture was transferred to an individual 15 ml falcon 
tube, vortexed and centrifuged (14,500 rpm; 2 minutes). The organic layer for each reaction mixture 
was subsequently transferred to a separate 15 ml falcon tube containing 1 ml of 3M NaOH, and the 
mixture was left stirring for another 2 hours, and TLC was used to monitor the progress of the 
hydrolysis reaction (7:3 ethyl acetate:hexane, 254 nm). Once no progress could be detected for the 
hydrolysis reaction, the aqueous layer was extracted and analysed via chiral-HPLC and LC-MS.  
 
Figure 138: The chiral-HPLC chromatogram for the alginate-encapsulated C45 catalyzed 
cyclopropanation reaction between styrene (30 mM) and EDA (10 mM) (CHES buffer, pH 8.6, 280 nm). 
A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and 
injection volumes were 2 μl.). 
Initial assays were conducted using CHES buffer to check for any activity and, if detected, as a suitable 
comparison to free C45. Figure 138 presents the chiral-chromatogram for the alginate-encapsulated 
C45-catalysed cyclopropanation reaction between styrene and EDA in CHES buffer. The chromatogram 
is dominated by a peak with a retention time of 7.2 minutes, the known retention time of the 
anticipated (R,R)-cyclopropane-product, followed shortly by a small, additional peak with a retention 
time of 9.2 minutes, the known retention time of the (S,S)-cyclopropane-product. The peak at 7.2 
minutes was collected and analysed via LC-MS to confirm the identity of the compound, with the 





phenylcyclopropane-1-carboxylate. A reaction yield of 55.30% and enantiomeric excess of 82.81% 
were calculated from the peak heights. For comparison, the percentage yield and enantiomeric excess 
for the assays conducted with free C45 are 80.20% and 77.00% respectively. It was previously 
demonstrated that encapsulating C45 inside an alginate bead does not impair its ability to form a 
stable metallocarbenoid intermediate, so it is unsurprising that C45’s encapsulation does not impair 
its proficiency towards carbene transfer chemistry; however, the encapsulation does results in an 
approximate 31% decrease in product yield, which is marginally compensated for by a 7% increase in 
enantiomeric excess.  
The catalytic activity and selectivity of AE-C45 was next investigated using an assortment of diverse 
organic solvents. The acquired values for product yields and (R,R)-enantioselectivity for each solvent 
is tabulated in table 11 and presented in figure 139. The cyclopropanation reaction catalysed by AE-
C45 submerged in the polar protic solvents MeOH, EtOH, and IPA afforded average reaction yields of 
59.60, 38.00, and 79.00% and enantiomeric excesses of 69.20, 91.80, and 95.80% respectively. The 
values reported for MeOH are similar to the values reported for CHES buffer and is probably accounted 
for by the similarities between the two solvents. For EtOH, the reaction yield is significantly affected, 
exhibiting a 31.4% decrease, relative to CHES buffer. Isopropanol, however, resulted in an 
approximate 30% increase in the product yield. The cyclopropanation reaction catalysed by AE-C45 
submerged in the polar aprotic solvents CH3CN, EtOAc, THF, acetone, and DCM afforded average 
reaction yields of 92, 18.60, 91.00, 91.10, and 49.50% and enantiomeric excesses of 89.40, 74.60, 
96.50, 94.80, and 92.70% respectively. The solvents EtOAc and DCM negatively affected the reaction 
yield, exhibiting a 66.40 and 10.30% decrease in product yield relative to CHES, CH3CN, THF, and 
acetone; however, both drastically enhanced the product yields, with an average 39% increase in 
product yield relative to CHES. The cyclopropanation reaction catalysed by AE-C45 submerged in the 
two non-polar solvents hexane and pether afforded average reaction yields of 9.40 and 6.50% and 
enantiomeric excesses of 62.40 and 53.00% respectively. The non-polar solvents most negatively 
affected the reaction, affording an average 85.70% decrease in product yield and 30.30% decrease in 






Figure 139: The product yields (red bars) and enantioselectivities (blue bars) of AE-C45 catalysed 
cyclopropanation reaction between EDA and styrene in various organic solvent. 
Table 11: The product yields of the (R,R)-cyclopropane product and enantioselectivities for the 
alginate encapsulated C45 catalysed cyclopropanation reaction between styrene and EDA in an 






6.4.4.1.1 Product yields and substrate diffusion 
Figure 139 presents the product yields (red) and enantioselectivities (blue) for ethyl (1R,2R)-2-
phenylcyclopropane-1-carboxylate acquired from each AE-C45 solvent assay. From figure 139, it can 
be readily seen that changing the solvent system of the assays affects the enantioselectivity of the 
reaction, but the solvent induces a much greater influence over the product yields. Unlike the reaction 
catalysed by free enzyme, the encapsulation of the enzyme inside an insoluble bead introduces 
additional factors to the overall reaction. The partition of the substrate(s) between the bulk phase and 
the bead, and the rate of diffusion of both the substrate(s) and product(s) across the bulk-bead 
interface and through the bead itself introduce novel dynamic process which are intricately entwined 
with the overall reaction rate. The partition coefficient, as discussed in section 6.3, represents the 
preferential solvation of a substrate molecule across two separate, distinct phases when the system 
is in equilibrium. In the heterogeneous alginate systems, the two phases are the bulk organic phase 
(BOP) and the aqueous alginate phase (AAP), which are separated by the bulk-alginate interface (BAI). 
The partition coefficient is the ratio of the substrate concentration in the AAP relative to the BOP and 
is a function of the physical and chemical properties of organic solvent constituting the BOP. One 
important property to consider is the polarity of a solvent, which can be quantified by a solvent’s 
dielectric constant (ɛ; Farad m-1); the higher the dielectric constant the more polar the solvent. 
Styrene, being composed exclusively of non-/marginally polar C-C and C-H bonds, is a non-polar 
molecule with a dielectric constant of approximately 2 F m-1. The dielectric constants of water, being 
composed of extremely polar O-H bonds, and hexane, being composed of non-polar C-C and C-H 
bonds, are approximately 80 and 1.68 F m-1, respectively. In a biphasic system where hexane 
constitutes the BOP it would be anticipated that the partition coefficient ([styrene]hexane/[styrene]bead) 
would be exceedingly high, indicating that styrene overwhelmingly is preferentially solvated by 
hexane compared to water, resulting in a very low flux of styrene diffusing into the bead to become 
available for catalysis. Figure 140 presents the dielectric constant of the various solvents screened in 
the AE-C45 cyclopropanation assays vs the respective (R,R)-product yields for each assay. From figure 
140, a very tenuous relationship can be inferred between the respective product yield for each AE-
C45 cyclopropanation assay and the dielectric constant of the solvent used. This can be accounted for 
by consideration of the precise information containing in the dielectric constant. The dielectric 
constant represents the capacitance of a system, the ability of a system to store electrical energy when 
subject to an electric field. The dielectric constant is a physical quantity and contains no relevant 
information regarding the solute-solvent molecular interactions, and therefore cannot account for 
differences observed between separate solvents. For example, DCM, ethyl acetate, and THF all have 





water, whereas THF is highly miscible. The differences in the solubilities of THF, ethyl acetate, and 
DCM are a function of the molecular interactions established between solute-solvent molecules. The 
oxygen in THF can establish a hydrogen-bond with a water molecule which significantly enhances the 
miscibility of the two solvents; DCM and ethyl acetate, despite being polar molecules, are incapable 
of establishing hydrogen-bonds with water which significantly impairs their miscibility. The lack of any 
molecular information contained with the dielectric constant accounts for the lack of any relationship 
in figure 140. 
 
Figure 140: The product yields for the (R,R)-cyclopropane product obtained from the AE-C45 catalysed 
cyclopropanation reaction between EDA and styrene as a function of the dielectric constant of the 
solvent employed in the reaction. 
Unlike the dielectric constant, a partition coefficient is a thermodynamic quantity and contains 
information on the solute-solvent interactions. The partition coefficient was demonstrated in section 
6.3 to be mathematically and molecularly related to the diffusion coefficient of a substrate and 
provides information on the rate of flux of a molecule across a permeable barrier which separates two 
distinct phases. The partition coefficients for styrene in each solvent were determined by C18-HPLC. 





the introduction of 10 µl of styrene from a 1M stock. The vials were allowed to stir for 2 hours until 
equilibrium had been achieved, then the BOP was extracted and quantitatively analysed by C18-HPLC. 
The remaining concentration of styrene in the BOP was calculated with reference to an external 
calibration of styrene across a concentration range of 500 µM – 10 mM (figure 167, appendix 1). The 
partition coefficient for each solvent was calculated using equation (3), which were subsequently used 
to calculate the parameter ‘’α’’ using equation (17). The diffusion coefficients for styrene in each 
solvent were calculated using equation (18)and the effective diffusion coefficients were calculated 
using equation (13) (table 12; see chapter 9, sections 9.18 and 9.19 for further details). 
 
Figure 141: The product yields for the (R,R)-cyclopropane product obtained from the AE-C45 catalysed 
cyclopropanation reaction between EDA and styrene as a function of the effective diffusion coefficient 









Table 12: Partition coefficient and diffusion coefficients for styrene in various organic solvents 
suspended in alginate beads prepared from 3% (w/v) sodium alginate and 0.3M CaCl2; R = radius of 
the alginate beads; alpha parameter is defined by equation (17); all values are within a 10% error 
margin. 
 
Figure 141 presents the (R,R)-product yield acquired from the AE-C45 catalysed cyclopropanation 
assays as a function of the calculated effective diffusion coefficient for styrene with respect to the bulk 
organic solvent. The figure demonstrates a reasonably good linear relationship between the two 
parameters, indicating that the diffusion rate of styrene across the bulk-alginate interface (BAI) is a 
key factor governing catalysis. The diffusion coefficient for styrene, with respect to the solvent system, 
corresponds to the amount of styrene localised inside the alginate bead with respect to time; the 
higher the diffusion coefficient the greater the general flux of styrene across the BAI from the BOP 
into the bead. Styrene is highly miscible with n-hexane, pether, ethyl acetate, and ethanol and the 
favourable solute-solvent interactions established in the bulk phase impairs styrene’s diffusion into 
the bead, as can be induced from figure 141. The fact that ethanol would impair styrene’s diffusion 
into the bead is not immediately obvious from the differences in the dielectric constants of the two 
systems (ethanol is a high outliner in figure 141), because it would be anticipated that the high polarity 
of EtOH, and ethanol’s ability to establish hydrogen bonds, would disfavour the dissolution of styrene. 
However, computational studies of aromatic-water interactions in water-benzene clusters have 
highlighted the possibility for the formation π-HB interactions.390 In 2011 Gierszal et al combined 
Raman multivariate curve resolution spectroscopy (Raman-MCR) with quantum and classical 
computational calculations to investigate the nature of π-hydrogen bond (π-HB) interactions in liquid 
water.390 The report indicates that π-HB interactions are enthalpically unfavourable (ΔH > 0) but are 
entropically favourable (ΔS > 0) as the formation of a π-HB interaction liberates a water molecule.390 





diffusion coefficients of EtOH, MeOH, and CHES, coupled with the modest reaction yields, indicate 
that styrene-solvent solute-solvent interactions when the solvent possess hydrogen bonding donors 
are stronger than otherwise anticipated merely from polarity considerations. It is also interesting to 
note that when isopropyl alcohol (IPA) is employed as the solvent both the diffusion coefficient of 
styrene and the reaction yield increase, a relationship that would not be expected when solely 
considering dielectric constants (ɛIPA < ɛEtOH < ɛMeOH). The observation that alcoholic solvents can 
stabilise aromatic solutes is supported by the modest changes in the enthalpy of solution (ΔHsol; kcal 
mol-1) accompanying the dissolution of various aromatic solutes in MeOH, tBuOH, and 1-octanol, 
reported by Stephenson and Fuchs, where the magnitude of the enthalpy change upon dissolution 
increased when a benzene core was functionalised with electron-donating substituents.391  
The catalytic proficiency of AE-C45 towards cyclopropanation of styrene is significantly enhanced 
when the assays are conducted in the polar aprotic solvents THF, acetone, and ACN, with all three 
solvents affording product yields and enantioselectivities of >89%. In contrast, the two other polar 
aprotic solvents employed, DCM and ethyl acetate impaired the catalytic efficiency of the reaction 
(although without any significant decrease in enantioselectivity), reporting product yields of 
approximately 50 and 20% respectively. From figure 140, it is clear that absolutely no relationship can 
be established between the solvent’s dielectric constant or the acquired product yield, meanwhile 
figure 141 exhibits a clear linear relationship between the diffusion coefficient of styrene in the 
respective solvent and the acquired product yield: EtOAc < DCM < THF, acetone and ACN. One possible 
factor influencing this trend is the relative solubilities of the solvents in water; THF, acetone, and ACN 
are highly miscible with water, whereas DCM and ethyl acetate are highly immiscible. The miscibility 
of THF, acetone, and ACN could facilitate the diffusion of styrene across the alginate-solvent interface 
by provide a stabilising ‘solvation shell’ which encapsulates styrene from the aqueous internal 
environment of the alginate bead and visa-versa. In addition, THF, acetone, and ACN possess 
hydrogen-bonding acceptors which would provide stabilising solute-solvent interactions. DCM and 
ethyl acetate would be incapable of providing a stabilising solvation shell to styrene to facilitate the 
solvent-alginate interface and assist in catalysis. Ethyl acetate does contain a carbonyl oxygen which 
is capable of forming hydrogen bonds with water molecules, however, such an interaction is 
considerably weaker, relative to THF, acetone, and ACN, on account of the hydrophobic alkyl 
substituents flanked on either side of the carbonyl group (and accounts for the immiscibility of ethyl 
acetate in water). The bulky hydrophobic chains would favourably solvate styrene (in addition to some 
possible dipole-π interactions) resulting in styrene preferentially remaining in the bulk organic phase. 





establish weakly stabilising π-halogen bonds (π-HaloB) with styrene, in a fashion analogous to π-HBs, 
which may partially account for the position of DCM in figure 141.  
6.4.4.1.2 Enantioselectivity: protein rigidification vs denaturation 
The enantioselectivity of the AE-C45 assays fall within a range of 53-95%, six solvents (acetone, CH3CN, 
DCM, EtOH, IPA, and THF) have higher enantioselectivities (>89%) relative to CHES buffer. 
Interestingly, the four solvents (EtOAc, MeOH, n-hexane, and pether) with lower enantioselectivities 
compared to AE-C45 catalysed cyclopropanation in CHES buffer do exhibit lower product yields, but 
DCM and EtOH have enhanced enantioselectivities when compared to CHES buffer despite the 
appreciable decrease in catalytic efficiency. There is no relationship between the product yield and 
the enantioselectivity of the AE-C45 catalysed cyclopropanations, indicating the observed alterations 
of the stereoselectivity is a function of protein dynamics and not substrate diffusion.  
It is established in the literature that organic solvents alter protein dynamics either by destabilising 
the tertiary structure of the protein and encouraging denaturation or by stripping essential water 
molecules from the internal structure of the protein and causing a rigidification effect (chapter 6, 
section 6.1).361,363,370 If an organic solvent destabilises the tertiary structure of a protein and facilitates 
denaturation the chiral environment provided by the coordination sphere of the heme cofactor will 
also be disrupted. In such a situation, any energetic preference associated with the trajectory of 
approach of a substrate, such as styrene, to the reactive intermediate will also be disrupted. In 
addition, additional conformations of the metallocarbenoid intermediate that are energetically 
inaccessible in a well-folded protein will be permitted in the absence of a well-defined active site. In 
such a case, the changes in the protein flexibility, dynamics, and conformational ensemble caused by 
the organic solvent would translate to a decrease in observed enantioselectivity, with the magnitude 
of the decrease being a function of the magnitude of disruption the solvent causes. If the solvent 
causes a rigidification of the protein, then two scenarios are possible.363,367,370 The first is that 
rigidification causes a ‘shrinking’ effect which enhances the selectivity but decreases the overall 
activity as a consequence of the active site shrinking, as is observed for EtOH and DCM. The second is 
the protein preferentially adopts a particular conformation (over all possible conformations adopted 
in equilibrium in solution) with a well-defined active site. The rigidification causes a ‘stiffening effect’ 
which results in a well-defined, less conformationally dynamic active site which translates to 
enhanced/decreased activity and or enantioselectivity. At present, the relationship between the 
enantioselectivity observed in the AE-C45 catalysed cyclopropanation reaction and the solvent the 
reaction is conducted in remains ambiguous. Additional experiments into how different organic 





results. In particular, CD and NMR spectroscopy of C45 in various organic solvents could provide some 
valuable insights.  
6.4.5 Piperidine N-H insertion 
The cyclopropanation assays addressed above demonstrated that  AE-C45 remains catalytically active 
and proficient toward not only towards metallocarbenoid formation but also carbene transferase 
chemistry. In addition, a relationship between the effective diffusion coefficient for a substrate in a 
given solvent correlates reasonably well with the observed product yield. To further investigate the 
catalytic activity and relationship between substrate diffusion and product yield, AE-C45 was 
employed as the catalyst for the N-H insertion reaction between piperidine and EDA; the reaction was 
chosen because it has already been demonstrated that free C45 can efficiently catalyst the reaction 
(chapter 5, section 5.2.1.2), and because piperidine possess drastically different properties to styrene. 
The reaction yields for the N-H insertion assays (determined from C18-HPLC) between piperidine and 
EDA catalysed by AE-C45, and performed in a variety of different solvents, are presented in figure 142 
and tabulated in table 13. It can be readily seen that, for the vast majority of solvent systems, most 
the product yields are >50%, showing a decrease in overall catalytic activity relative to the activity 
observed when free C45 is employed as the catalyst. It can also be seen that the best solvents for the 
styrene cyclopropanation reaction (THF, IPA, CH3CN) are poor solvents for the N-H insertion reaction 
(acetone was not used as a solvent for the piperidine N-H insertion assays on account of the favourable 
formation of the Schiff base intermediate between the two substrates).392 In direct contrast to the 
cyclopropanation assays, the product yields acquired for the N-H insertion assays conducted in 
toluene, pether, and n-hexane are remarkably high, with all three assays consistently exceeding 90% 






Figure 142: The product yields for the ethyl-1-piperidineacetate product obtained from the AE-C45 
catalysed N-H insertion reaction between EDA and piperidine as a function of the dielectric constant 
of the solvent employed in the reaction. 
The calculated effective diffusion coefficient for piperidine in each solvent is tabulated in table 13 and 
figure 142 presents the effective diffusion coefficients vs product yield for each solvent. It can be 
readily seen that figure 142 demonstrates a reasonable linear relationship between product yield and 
Deff, paralleling the observations made in the styrene cyclopropanation assays; however, there are 
some noticeable differences. For piperidine, the values for the Deff  extend across a much broader 
range (1.0-8.0 x1010 m2 s-1) relative to styrene (0.1-3 x1010 m2 s-1), and is probably a consequence of 
the N-H groups present in piperidine as multiple ionisation states of piperidine are possible in addition 
to a hydrogen-bonding acceptor and donor; a conjecture supported by the location of CHES in figure 
142. The presence of the hydrogen-bonding acceptor and donor in piperidine also provides a possible 
account for the high yields observed in apolar solvents. The unfavourable interactions between 





more thermodynamically favourable and would increase the rate of diffusion. Overall, the AE-C45 
catalysed N-H insertion assays support the postulation that substrate-solvent interactions in both the 
organic and aqueous phases (which is translated into the partition and diffusion coefficient) play a 
significant role in heterogeneous enzymatic processes.  
Table 13: Reactions yields for the alginate-encapsulated C45 catalysed reaction between piperidine 
and EDA in various organic solvents, partition coefficient and diffusion coefficients for piperidine in 
various organic solvents containing in alginate beads prepared from 3% (w/v) sodium alginate and 
0.3M CaCl2; R = radius of the alginate beads; alpha parameter is defined by equation (18); all values 
are within a 10% error margin. 
 
6.4.6 Enzyme recoverability 
The differences observed between the AE-C45 cyclopropanation and N-H insertions also highlight the 
possibility of affording a degree of control over the observed reactivity. In a multi-step synthesis, 
which uses the same alginate-encapsulated enzyme for two individual steps, the reaction system could 
be intelligently engineered to circumvent possible issues associated with chemoselectivity, or to 
preferentially react with one substrate out of many possible substrates, by carefully selecting a 
suitable solvent for each reaction step. Although two batches of identical alginate-encapsulated 
enzymes could feasibly be employed, it would be highly beneficial if the enzyme could be recovered 
after the first round of catalysis and recycled for a second round of catalysis. This process is called 
catalyst/enzyme recoverability and is highly desirable from a biotechnological and industrial 
perspective. One of the major advantages of heterogeneous catalysts vs homogenous catalysts is the 
ease at which heterogeneous catalysts can be recovered on account of occupying a separate phase. 
In the case of AE-C45, the alginate-beads are insoluble and a wide range of solvents, and recoverability 
simply entails decanting the reaction mixture after a reaction to isolate/wash/prepare/store/preserve 





peroxidase assays, in which AE-C45 could be reused a total of four times, it was particularly pertinent 
to see whether AE-C45 could be recovered, washed and reused as a carbene transfer heterogeneous 
catalyst.  
The cyclopropanation reaction between EDA and styrene, catalysed by AE-C45, was selected as the 
initial reaction to screen for AE-C45 recoverability. The three best solvents (acetone, ACN, and THF) 
were selected for the assays. The reactions were conducted in accordance with the AE-C45 
cyclopropanation assays as detailed in chapter 9, section 9.12.2. Briefly, the reactions were conducted 
in 2 ml sealed-top vials. 970 µl of solvent (acetone, ACN, or THF) was added, followed by three alginate 
beads containing C45. The vials were purged under nitrogen, before 10 µl of Na2S2O4 (1M stock in 
ddH2O) and 10 µl of styrene (3M stock in EtOH) was added. The mixture was allowed to stir for 1 
minute before 10 µl of EDA (1M stock in EtOH) was added to initiate the reaction. After two hours of 
stirring on a roller, the vials were unscrewed (under a nitrogen atmosphere) and the product mixture 
was pipetted into a 1.5 ml Eppendorf for purification/analysis. The three alginate beads containing 
C45 were washed three times with the respective solvent (acetone, ACN, or THF) before the 
second/third round of catalysis was prepared.  
Figure 143 displays the enantioselectivities and product yields for all three runs, for each solvent as a 
bar chart to facilitate comparison. As anticipated, the first run for each respective solvent afforded 
decent-to-high product yields (80-90%) and enantioselectivities of >90% determined, in each solvent, 
for the (R,R)-cyclopropane product. In terms of product yields, the second and third runs for each 
solvent predictably decreased, with yields between 45-65% observed for the second runs and 18-55% 
for the third runs. Acetonitrile delivered the best performance out of the three systems screened, 
exhibiting only an approximate 40% decrease in product yield across the three screens. Although the 
second reactions conducted in THF and acetone resulted in moderate product yields (40-50% 
respectively), attempts to recover and reuse a third time resulted in low-to-poor yields (15-30%). 
However, despite the general loss in activity, the initial screens show that AE-C45 remains catalytically 
active after its initial use and can be easily recovered and successfully redeployed as a carbene transfer 
catalyst multiple times, allowing 1.5-1.8 times of the desired cyclopropane product to be prepared 
from the same catalyst relative to a single use catalyst. For the assays conducted in ACN, the 
enantioselectivity of the reaction was only marginally affected, with an approximate 10% decrease 
observed after the third reaction. The second and third assays conducted in THF and acetone, 
however, were characterised by a drastic decrease in enantioselectivity, with moderate values 
between 50-60% observed during the second runs followed by remarkably low values of ≥20% 





unknown. It is possible that swelling of the beads, caused by the diffusion of solvent into the bead, 
results in the aqueous environment of the bead becoming gradually more organic over time, which 
could provide an environment more accommodating to hydrophobic solutes and incidentally 
destabilise the maquette by causing moderate changes to its conformation. Why this would result in 
such pronounced effects for THF and acetone, but not for ACN, currently remains a mystery. It is also 
well known that proteins become more rigid in the presence of organic solvents, which would account 
for the decreasing reactivity observed in each successive run, but does not provide a satisfactory 
answer for the decrease in enantioselectivity, as it would be expected that protein rigidification would 
increase the observed enantioselectivity. It is possible a combination of rigidification and 
conformational changes in the active site result in the observed enzymatic activity and selectivity in 
each successive run. It is also possible that modification to the alginate structure over time, either via 
swelling, binding of substrate(s), and reacting with substrates, could impart conformational changes 
to the protein. It is unfortunately absolutely clear that additional experiments are essential before a 
molecular level explanation can be provided to account for the above observations. 
 
Figure 143: The product yields and enantioselectivities for the successive AE-C45 encapsulated 
cyclopropanation reactions between styrene and EDA in acetone, acetonitrile and tetrahydrofuran (all 





After the above assays were performed, a concern to whether the data could be accounted for by 
‘’product leaking’’ was raised. It is possible that the diffusion of the cyclopropane product out of the 
alginate bead is remarkably slow, and in the second/third runs the observed peak corresponds to 
(R,R)-product, which had accumulated inside the bead after the initial run, leaking out of the bead and 
producing a false positive observation. An additional experiment was conducted, in the same three 
solvents, in which the first reaction catalysed was the cyclopropanation reaction reported above, 
followed by the subsequent recovery and re-deployment of the same AE-C45 beads to catalyse the N-
H insertion reaction between piperidine and EDA. The reactions were conducted under identical 
conditions to those previously reported, with the only modification being the reactions were left 
mixing for one hour instead of two.  
 
Figure 144: The normalised chiral-HPLC chromatograms for the AE-C45 catalysed cyclopropanation 
reaction between styrene and EDA (red) followed by the recovery and subsequent use of the same 
bead in the AE-C45 catalysed N-H insertion reaction between piperidine and EDA (blue) in (top left) 
CHES buffer (pH 8.6), (top right) acetone, (bottom left) acetonitrile, and (bottom right) 
tetrahydrofuran. A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was 





The normalised chromatograms for the AE-C45 cyclopropanation reaction between EDA and styrene 
followed by the recovered AE-C45 catalysed N-H insertion reaction between EDA and piperidine, for 
four solvent systems (CHES, acetone, ACN, THF), are presented in figure 144. The calculated yields for 
both the cyclopropanation and N-H insertion reactions, and the enantioselectivities of the 
cyclopropanation reaction, in each solvent system are tabulated in table 20 (appendix 2). It can be 
seen from table 20 (appendix 2) that all four cyclopropanation assays proceeded with moderately high 
yields (62-79%) and enantioselectivity (86->99%). After isolating, washing and re-deploying the AE-
C45 beads used in the cyclopropanation reaction, a peak in each respective chromatogram, with a 
retention time similar to the anticipated N-H insertion product, ethyl-1-piperidine acetate, can be 
readily detected. From the chromatograms, it was calculated that reusing the AE-C45 beads resulted 
in an average 10% yield of ethyl-1-piperidine acetate across all four solvent systems. No 
cyclopropanation product was detected in any of the N-H insertion product mixture chromatograms. 
The ability to detect the N-H insertion product in the second run, although in poor yields, highlights 
two important things: i) the initial results acquired from the aforementioned cyclopropanation 
recoverability screens were not a false positive caused by the leaking of cyclopropane product, and ii) 
conclusively confirms that AE-C45 remains active towards carbene transferase chemistry in successive 
reactions after being recovered from an initial application.   
6.5 CONCLUSION 
Throughout chapters 3-5 the catalytical proficiency of C45 towards abiological chemistry, proceeding 
via a metallocarbenoid intermediate, was explored. C45 was demonstrated to be proficient towards 
cyclopropanation, chemoselective N-H insertions, Si-H insertions, carbonyl olefinations, and ring 
expansions reactions. In this chapter, the focus was on developing a methodology for expanding the 
biocatalytic potential of C45 to include reactions conducted in neat organic solvents. The method of 
entrapment was employed to prepare heterogeneous catalysts for biocatalytic applications. The 
hydrogel calcium alginate, which is resistant to degradation in organic solvents, was identified as a 
suitable medium for encapsulating C45. Alginate-encapsulated (AE) C45 was initially subjected to 
spectroscopic characterisation, in a variety of organic solvents, which revealed the spectroscopic 
profile of ferric and ferrous C45 remains unperturbed once encapsulated inside calcium alginate 
hydrogels, or when AE-C45 is suspended in pure organic solvents such as MeOH and n-hexane. In 
addition, it was demonstrated that AE-C45 retains its ability to form a stable metallocarbenoid 
intermediate, yielding an electronic spectrum identical to the C45:EDA metallocarbenoid spectrum 
observed in aqueous solution. It was subsequently demonstrated that AE-C45 remains catalytically 





chemistry, catalysing the cyclopropanation of styrene and the N-H insertion of piperidine in an 
assortment of organic solvents. Although the reaction yields were affected by the encapsulation of 
C45, a relationship between substrate diffusion and product yield was observed, indicating the 
changes in catalytic performance of AE-C45 relative to C45 can be account for by the inclusion of a 
substrate/product diffusion process across the solvent:hydrogel interface. It was also demonstrated 
that AE-C45 can be recovered after one catalytic cycle, and re-employed as the catalyst in subsequent 
reactions, although at the cost of product yield and enantioselectivity. Overall, in addition to 
demonstrating the catalytic versatility of C45, it has been demonstrated that AE-C45 can be employed 
(and recovered for future use) as a biocatalyst to perform important chemical reactions, via an 






CHAPTER 7: EVOLUTION OF C45 TOWARDS IMPROVED AND STEREODIVERGENT CARBENE 
TRANSFERASE ACTIVITY (In collaboration with Jack Steventon) 
7.1 INTRODUCTION 
In chapter 2 section 2.3.1 a general outline of a technique used in molecular biology called 
mutagenesis was introduced. A few mutagenesis methods, including random mutagenesis, site-
directed mutagenesis, and saturation mutagenesis, were also introduced and briefly outlined. The 
technique of direct evolution (DE) was then introduced as a method for generating large numbers of 
mutant libraries. It was explained that DE mimics natural evolution, with the selective pressure being 
defined by the desired functionality. DE involves iterative rounds of mutagenesis to create mutant 
libraries that are screened to identify variants that exhibit the desired functionality. The best variant(s) 
are then amplified to serve as a/the template(s) in subsequent rounds of mutagenesis. The successful 
redesign of naturally occurring hemoproteins towards carbene transferase activity via mutagenesis 
and DE was subsequently introduced in chapter 2 section 2.3.1. 
The heme-containing tetra-α-helical maquettes are characterised by a simplified and easily evolvable 
protein scaffold. In the Anderson lab, Jack Steventon had been using DE to generate novel libraries of 
tetra-α-helical maquettes in attempts to improve on the peroxidase activity exhibited by C45. This 
work occurred concurrently alongside research into the carbene transferase activity of C45. Inspired 
by the success of Arnold, Fasan, Hartwig, and others in redesigned naturally occurring hemoproteins 
towards a broad range of carbene transferase activities, the carbene transferase activity exhibited by 
C45, and the pre-existing methodology for generating large libraries of C45 mutants (established by 
Jack Steventon and Peter Wilson) the first question raised concerned whether the carbene transferase 
activity (and/or stereoselectivity) of C45 could be enhanced through mutagenesis and/or DE. 
Alongside using DE to enhance the stereoselectivity of a given reaction, it has also been demonstrated 
in the literature that select, key mutations can actually change the stereoselectivity exhibited by an 
enzyme towards a certain reaction. Therefore, whether a novel mutant with differing stereoselectivity 
towards the cyclopropanation reaction (compared to C45) could be engineered and isolated was the 
second question raised. 
7.2 RESULTS AND DISCUSSION 
7.2.1 Carbene transferase screening the first library – JR1 
A library of C45 mutants was generated from error-prone PCR by Jack Steventon and were 





particular, JR1, DH6, and AG5 all reported decrease peroxidase activity relative to C45. As peroxidase 
activity was the primary functional target influencing the design of C45, and oxygen binding inhibits 
metallocarbenoid formation, it was rationalised that the three poorest mutants could exhibit 
enhanced cyclopropanation activity relative to C45. The sequences of the three mutants compared to 
the sequence of C45 are presented in figure 145. JR1 has 2 mutations relative to C45: G67S and G92S. 
The mutation G67S occurs in the loop region connecting helix B to helix C and the mutation G92S 
occurs in the loop region connecting helix C to helix B. It was of interest to determine how mutations 
to the loop region influenced the overall flexibility and conformational dynamics of JR1 and whether 
the mutations would influence the enantioselectivity of the cyclopropantion reaction. The mutants 
DH6 and AG5 each possess a single mutation in helix A; The mutation in DH6 is F25Y and the mutation 
in AG5 is Q5H; both mutations introduce a new hydrogen bonding residue into helix A. 
 
Figure 145: The primary sequences of the four mono-heme containing tetra-α-helical maquettes C45, 
JR1, DH6, and AG5 and the labelling of the four helices A-D (mono-histidine ligated heme cofactor 
appended to helix D). 
The three mutants were each initially screened for carbene transferase activity using the protocol 
previously reported in chapter 4 for cyclopropanation, with the average respective yields and 
enantioselectivities (for the (R,R)-cyclopropane product) being tabulated in table 14. It can be 
immediately concluded that neither AG5 or DH6 possess any activity towards cyclopropanation, with 
reaction yields consistently >10% and negligible to poor enantioselectivities. The exact reason for the 
lack of activity in AG5 and DH6 still needs to be addressed, but it is possible that the introduction of a 





both mutants, negatively alters the dynamics of the heme active site or impairs substrate diffusion. 
The double mutant, JR1, however, exhibits a slightly elevated reaction yield relative to C45 (85.6% vs 
80.20%) without any change to the observed enantioselectivity (78% vs 77%).  
Table 14: Average product yields, diastereoselectivities, and enantioselectivities for the 
cyclopropanation reaction between EDA and styrene catalysed by the C45 mutants JR1, AG5, and DH6 
 
 
Figure 146: (left) Chiral-HPLC chromatograms for the JR1-catalysed (10 μM, 0.1 % catalyst loading) 
cyclopropanation assays between styrene (30 mM) and EDA (10 mM) (CHES buffer, pH 8.6, 280 nm). 
A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and 
injection volumes were 2 μl. (top left) normalised chiral-HPLC chromatograms for commercial (R,R)-
ethyl 2-phenylcyclopropane-1-carboxylate (280 nm, EtOH, red) vs JR1-catalysed cyclopropanation 
(280 nm, blue); (bottom left) Averaged chromatogram from the JR1-catalyzed cyclopropanation assay. 
(right) LC-MS spectra of JR1-catalyzed cyclopropanation assay products exhibiting the dominant 
oxonium ion fragment at 145 m/z. The spectrum was recorded in ES+ mode and monitored at 254 and 
280 nm. A C8 column was employed for the LC separation with a gradient mobile phase (95:5:0.1 % 
v/v water/MeCN/formate 10:90:0.1 % v/v water/MeCN/formate). Injection volumes were 20 μl. 
The ESI-MS of the product extracted from the JR1-characterised cyclopropanation reaction between 
styrene and EDA is presented in figure 146 and exhibits the characteristic and well-defined 





yield is small, analysis of JR1 may still prove useful in providing information on how the structure of 
the maquette influences the carbene transferase activity, which will undoubtedly aid future 
engineering efforts. JR1 was therefore subsequently biophysically characterised and the 
metallocarbenoid formation and cyclopropanation reaction was kinetically characterised.   
7.2.1.1 Biophysical characterisation of JR1 
JR1 (figure 147) was characterised by UV-VIS spectroscopy, redox potentiometry and circular 
dichroism to determine its UV-VIS absorption profile, standard reduction potential and thermal 
stability. The information determined was compared against C45. In addition, an MD simulation of JR1 
was acquired (figure 147). 
 
Figure 147: The structure of JR1 acquired after MD (ABMER) simulations. 
The UV-VIS spectrum for ferric and ferrous JR1 is presented in figure 148. The UV-VIS spectrum for 
ferric JR1 was dominated by the characteristic Soret peak at 406 nm and was accompanied by a Q-
band series of less intense peaks in the range 500-550 nm. Upon the addition of sodium dithionite, a 
new spectroscopic profile emerged and is attributed to ferrous JR1. The reduced spectrum was 
dominated by a red-shifted intense Soret peak at 418 nm which is accompanied by a Q-band with two 
less-intense but well-resolved peaks, the α and β peaks, with the intensity ratio β > α. The UV-VIS 
spectra for JR1 is consistent with that of c-type mono-histidine ligated tetra-α-helical maquettes, with 
a spectroscopic profile that parallels the spectra observed for C45 and for Rma-TDE. The redox 
potentiometry for JR1 results in a calculated mid-point potential of -197 mV (vs SEP), meaning JR1 is 
more reducing than C45 (-176 mV vs SEP)235 and is possibly a reflection of minor conformational 





in the relative distances of the heme cofactor and the first-coordination sphere amino acids, with a 21 
mV decrease suggesting either a lengthening and/or weakening of key bonds governing the reduction 
potential of JR1 relative to C45. This postulation is corroborated by the 6 OC decrease in the melting 
temperature for JR1 relative to C45 (80OC vs 86OC respectively)235 calculated from circular dichroism 
figure 148. The information extracted from the biophysical analysis of JR1 indicates the combination 
of glycine to serine mutations in the loops connecting helices A-B and B-C engenders a maquette, JR1, 
with a slightly increased backbone flexibility. 
 
Figure 148: Biophysical characterisation of JR1. (top left) The UV-VIS spectrum for ferric (red) and 
ferrous (blue) JR1, (top right) Redox potentiometry of JR1 (100 mM KCl, 50 mM CHES, 10% glycerol, 
pH 8.6) collected with redox mediators as described in the methods, (bottom left) Far-UV circular 
dichroism spectra of JR1 with varying temperature (100 mM KCl, 20 mM CHES, pH 8.6), (bottom right) 
Temperature dependence of the CD signal monitored at 222 nm during the thermal denaturation of 
JR1. The inset shows a smoothed second derivative of the thermal melt trace indicating a melting 





7.2.1.2 Spectroscopic and kinetic characterisation of JR1 metallocarbenoid formation  
Having demonstrated a 6.25% percentage increase in product yield relative to C45 in the 
cyclopropanation assay, and after biophysical examination, the formation of the metallocarbenoid 
intermediate in JR1 was subsequently investigated. Under identical conditions to those employed for 
C45 (5OC, 40% EtOH, CHES buffer, pH 8.6), in the presence of EDA the expected shifts in the UV-VIS 
spectrum corresponding to the formation of a terminal metallocarbenoid complex were observed: the 
emergence of a red-shifted Soret peak at 428-433 nm accompanied by red-shifting and broadening of 
the Q-band profile (figure 149). The time-dependent spectra for the change in absorbance at 417 and 
433 nm, corresponding to ferrous JR1 and the JR1-EDA metallocarbenoid intermediate respectively, 
exhibited a profile analogous to the spectroscopic changes observed for C45 - a rapid decrease in the 
ferrous peak (417 nm) concurrent with an increase in the metallocarbenoid peak (433 nm) punctuated 
by a plateauing of both spectroscopic changes upon achieving saturation. The time-course spectra 
indicate that, analogous to C45, once formed the metallocarbenoid intermediate is stable and persists, 
exhibiting no appreciable decay over time. The spectra also indicate that JR1 achieves saturation on a 
time scale similar to C45 (10 s) (figure 149). 
 
Figure 149: (Left) Metallocarbenoid formation and stability in the absence of styrene substrate. The 
UV-VIS spectra of JR1 (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) after 0 (red) and 60 (blue) seconds 
following rapid mixing of ferrous JR1 with 500 μM ethyl diazoacetate at 5oC. (Right) Single wavelength 
traces represent the time course of ferrous JR1 (417 nm, red, 7.5 μM protein, 10% EtOH) and 
metallocarbenoid:JR1 adduct (433 nm, blue) following rapid mixing of ferrous JR1 with 500 μM ethyl 
diazoacetate at 5OC. Once formed, the metallocarbenoid:JR1 adduct persists for the duration of the 
experiment (1000 seconds). 
In order to properly compare metallocarbenoid formation in JR1 to C45, the single turnover kinetic 
parameters, K1 and kobs (and the ratio (kobs/K1)), for the formation of the JR1-metallocarbenoid 





determined using stopped-flow spectroscopy by adopting the protocol used for C45, Rma-TDE and 
Mb(H64V,V68A), which was outlined in chapter 3, section 3.5.1.3. Figure 150 exhibits the calculated 
curve acquired for EDA.  As for C45, the analysis of the formation of a metallocarbenoid involves three 
distinct identities: i) free enzyme and substrate, ii) a tetrahedral transition state, and iii) the 
metallocarbenoid intermediate. There are three underlining assumptions that have been made to 
assist in the analysis: i) the rate of decomposition of the tetrahedral transition state to the 
metallocarbenoid intermediate (k2) is first-order, ii) the reaction is irreversible (k2 >>> k-2), and iii) a 
steady-state equilibrium is established between the free enzyme and the tetrahedral transition state. 
The values for the single turnover kinetic parameters for JR1-metallocarbenoid formation are 
tabulated, against the same values acquired for C45, in table 22 (appendix 2).  
 
Figure 150: The concentration-dependent kinetic plots of JR1 (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) 
EtOH) with varying concentrations of EDA. Initial rates were determined from the rate of change in 
absorbance for the C45:metallocarbenoid adduct at 5oC. 
The kobs, K1, and kobs/K1 values for JR1 are 0.553 s-1, 21.68 µM and 2.55 x 104 s-1 M-1 respectively, relative 
to 0.498 s-1, 74.36 µM and 6.70 x 103 s-1 M-1 for C45. The K1 for JR1 is significantly smaller than for C45, 
indicating that JR1 possess a binding affinity three-times higher than for C45. Upon reflecting on the 
biophysical data acquired for JR1, the increased binding affinity is possibly related to a minor increase 





and would also assist in accommodating the resultant metallocarbenoid intermediate. In addition, the 
increase in standard electrode potential (-176 vs -196 mV)235 would make the heme more electron 
rich relative to C45, which would assist in the hypothesised electron transfer step proceeding 
metallocarbenoid formation. This is supported by the larger kobs for JR1 metallocarbenoid formation 
relative to C45 (0.553 vs 0.498 s-1 respectively, table 22 (appendix 2)). The change in K1 and kobs for JR1 
alludes to an increased efficiency for the formation of the metallocarbenoid intermediate relative to 
C45. Although the increase can be partly rationalised with the biophysical data, additional experiments 
need to be conducted to elucidate the entire picture. 
7.2.1.3 Kinetic characterisation of JR1-catalysed cyclopropanation 
The formation of the metallocarbenoid intermediate in JR1 is seemingly more efficient relative to C45; 
however, the single turnover kinetic parameters are limited to the formation of the intermediate and 
provide no insights or information into the stability and reactivity of the resultant complex. It has 
already been demonstrated that JR1 catalyses the cyclopropanation reaction between styrene and 
EDA with a 6.25% increase in reaction yield relative to C45, and so to comprehensively compare the 
carbene transfer activity of the two maquettes the kinetics of the reaction was studied for JR1. As with 
metallocarbenoid formation, the kinetic parameters for the JR1-catalysed cyclopropanation reaction 
were investigated using stopped-flow spectroscopy, adopting the protocol used to determine the 
analogous C45 kinetic parameters and outlined in chapter 4 section 4.2.5.  
The experimental conditions employed to investigate carbene transfer activity paralleled the 
conditions used to investigate metallocarbenoid formation, with a single modification being the 
introduction of a suitable substrate, styrene. A solution containing ferrous JR1 (15 µM protein, 10 mM 
Na2S2O4, CHES buffer, pH 8.6) and a solution containing ethyl diazoacetate (EDA) and styrene (100 µM 
-10 mM and 200 µM - 3mM respectively, 20%:80% CHES:EtOH) were prepared in separate 
compartments (syringes) before a small volume (2x20 µl) of each were injected concurrently into a 
mixing chamber. The mixing chamber was monitored by UV-VIS spectroscopy over several timescales 
to monitor any reactions occurring over the duration of the experiment. Final concentrations were 7.5 






Figure 151: (left) Single wavelength traces representing the time course absorbance of ferrous JR1 
(417 nm, 7.5 μM protein, 10% EtOH) and the metallocarbenoid:JR1 complex (433 nm) following rapid 
mixing of ferrous JR1 with 500 μM ethyl diazoacetate at 5OC in the presence of 3 mM styrene. (right) 
UV-VIS traces recorded at various time intervals following the rapid mixing of ferrous JR1 with 500 μM 
ethyl diazoacetate at 5OC in the presence of 3 mM styrene. 
Figure 151 displays the time-course spectra obtained from the stopped-flow experiments for JR1 in 
the presence of EDA and styrene at wavelengths 417 and 433 nm. 417 nm corresponds to the ferrous 
JR1 species and 433 nm corresponds to the JR1-EDA metallocarbenoid complex, respectively. The data 
indicates that in the initial 20 seconds post-mixing there is a drastic decrease in the 417 nm absorbance 
that is accompanied by a concurrent increase in the 433 nm absorbance – corresponding to the 
formation of the JR1-EDA metallocarbenoid complex.  
It was demonstrated in figure 149 that the JR1-EDA metallocarbenoid complex is stable and persists 
over a duration of 600 seconds without any appreciable decay. In the presence of styrene, the initial 
spectra acquired resembles the spectra acquired in the absence of styrene, corresponding to the 
formation of the metallocarbenoid intermediate. After approximately 40 seconds, however, the 
absorbance at 433 nm plateaus and is accompanied by a sharp linear increase in absorbance at 417 
nm – indicating the decay of the metallocarbenoid species and the return to the starting ferrous 
complex. Figure 151 clearly demonstrates the plateauing of the absorbance changes at 417 and 433 
nm in the absence of styrene, corresponding to saturation, is never accomplished in the presence of 
styrene. UV-VIS traces captured at numerous timepoints over 300 seconds are presented in figure 
151. In the initial stages of the reaction (1-20 seconds) the UV-VIS exhibits a red-shift corresponding 
to the formation of the metallocarbenoid intermediate, alongside the concurrent shift and broadening 
of the Q-band profile. In the UV-VIS spectra acquired in the absence of styrene the red-shift from 





disappears alongside the emergence of a Soret peak at 428-433 nm. In the presence of styrene, the 
emergence of the 433 nm peak appears as a shoulder alongside the 417 nm, resulting in a broad, split 
Soret peak, without either the 417 nm or 433 nm peak dominating the spectra. After 20 seconds, the 
maximum absorbance begins to shift towards the 417 nm peak and is accompanied by the gradual re-
emergence of the ferrous Q-band profile. The spectroscopic profile for JR1-metallocarbenoid 
formation in the presence of styrene parallels the profile exhibited by C45. The analogous 
spectroscopic profiles mean the kinetic parameters klim, K1, and klim/K1 for the JR1-catalysed 
cyclopropanation reaction can be calculated under conditions identical to those employed for C45 
(figure 152), allowing for comparisons between the two maquettes to be investigated. 
 
Figure 152: The Michaelis-Menten plots for the cyclopropanation reaction of the JR1:EDA 
metallocarbenoid complex in the presence of styrene (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH). 
Initial rates were determined from the rate of change in absorbance for the JR1:EDA adduct at 5oC in 
the presence of styrene. 
The kinetic parameters klim, K1, and klim/K1 for the JR1-catalysed cyclopropanation reaction between 
EDA and styrene are 0.048 s-1, 352,1 µM and 136.32 s-1 M-1 respectively, relative to 0.001 s-1, 482.51 
µM and 2.23 s-1 M-1 for C45 (table 23, appendix 2). From the acquired data, it can be calculated that 
JR1 exhibits at 60-fold increase in cyclopropanation efficiency relative to C45 for the reaction between 





and accommodation of styrene in the active site is more favourable with JR1 compared to C45, 
possibly another reflection of the increased flexibility of JR1 as indicated by the biophysical data. In 
addition, the flexibility of JR1 relative to C45 could possibly weaken any stabilising interactions 
afforded to the metallocarbenoid intermediate for the protein backbone. This would decrease the 
thermodynamic stability of the metallocarbenoid and increase its reactivity, a hypothesis supported 
by the significantly higher klim for JR1 (0.048 s-1) vs C45 (0.001 s-1). The kinetic analysis of JR1 indicates 
the formation of the metallocarbenoid intermediate is enhanced relative to C45, but the rate of 
decomposition of the metallocarbenoid intermediate when presented with a suitable substrate is also 
enhanced; both observations can be accounted for partly by an increase in the backbone flexibility.  
7.2.2 The second library carbene transferase screening – AP3.2 
C45 was initially designed as a simple, heme-containing oxidoreductase and revealed functionality 
towards peroxidase enzymology. In the Anderson group, C45 was employed as the primary scaffold 
for robot-assisted directed evolution studies in efforts to generate new maquettes with enhanced 
peroxidase activity. A novel library of mutants was generated by Jack Steventon, using error-prone 
PCR, and were classified as APx, (Artificial peroxidase x, where x reflects the generation the mutant 
was identified in). The best mutants from the first generation were taken forward into the second 
generation of direct evolution. The process resulted in three generational libraries, AP1, AP2 and AP3. 
It was decided that a random selection of mutants, across all three generations, would be taken from 
the peroxidase assays and screened for carbene transferase activity. The designated reaction was the 
cyclopropanation between EDA and styrene so that any modifications in stereoselectivity could be 
identified alongside any relative changes in enzymatic activity. A total of 17 mutants were expressed 
and screened for cyclopropanation activity using the standard cyclopropanation protocol (chapter 9, 
section 9.7.1), with the only modification being cell lysate containing the overexpressed mutant was 
used as the reaction medium (table 15). The reaction mixtures were allowed to react overnight, 
quenched with 3M HCl, and extracted with EtOAc; each reaction mixture was analysed via chiral-HPLC 
to identify and quantify any cyclopropanation activity. The results of the initial screen are tabulated in 





Table 15: Average product yields, diastereoselectivities, and enantioselectivities for the 
cyclopropanation reaction between EDA and styrene catalysed by a library of C45 mutants generated 
via direct evolution. The reactions were catalysed using lysate containing the mutant.  
 
From table 15, it is readily seen that seven mutants, F18R, F46S, L50R, AP2, AP3.2, DF5, and FG1, 
catalysed the reaction with >25% product yield. However, more importantly is that all the screened 
mutants, with the exception of AP2, were stereoselective for the (S,S)-cyclopropane product, an 
inversion to the selectivity exhibited by C45 and JR1; AP3.2, DF5, and FG1 each exhibited an 
enantioselectivity of >99.9% for the (S,S)-product. From the six (S,S)-selective mutants, three mutants 
were selected for additional screening on account of exhibiting the highest stereoselectivities in 
combination with the highest product yields. AP3.2 and FG1 were selected as both mutants exhibited 
product yields and (S,S)-enantioselectivity of >30% and >99.9% respectively; L50R was chosen over 
DF5 on account of L50R exhibiting the highest product yield (>40%) from all the initial screens, despite 
a significantly lower (S,S)-enantioselectivity (58%). The sequences of the three mutants, L50R, AP3.2, 
and FG1, relative to C45 are presented in figure 153. FG1 and L50R, both first-generation mutants, are 
each one mutation away from WT-C45. In FG1, the mutation is a lysine to asparagine (K9N) at position 
9, located in helix A. In L50R, the mutation is a leucine to arginine (L50R) at position 50, located in helix 
B. AP3.2, however, is a third-generation variant and deviates from WT-C45 by eight mutations. The 
mutations are F11Y in helix A, G39S in the A-B loop, D48Y and F52S in helix B, F83S in helix C, and 






Figure 153: The primary sequences of the four mono-heme containing tetra-α-helical maquettes C45, 
AP3.2 FG1, and L50R and the labelling of the four helices A-D (the mono-histidine ligated heme 
cofactor is bound to helix D). 
The three selected mutants were expressed and purified and the cyclopropanation assays were 
repeated with the purified enzyme, using the protocol outlined in chapter 9 section 9.7.1. The average 
product yields and enantioselectivities for the L50R-, AP3.2-, and FG1-catalysed cyclopropanation 
assays are tabulated in table 16. From the table, it can be readily seen that AP3.2 is the best variant, 
catalysing the reaction with on average 46.6% reaction yield but, more importantly, with a >99.9% 
enantioselectivity towards the (S,S)-cyclopropane product. The resultant normalised chromatogram 
for the AP3.2-catalysed cyclopropanation reaction and the normalised average chromatogram for the 
AP3.2-catalysed cyclopropanation reaction plotted against a commercial sample of enantiomerically-
pure ethyl (1S,2S)-2-phenylcyclopropane-1-carboxylate is presented in figure 154. Although the 
reactivity of AP3.2 is notably lower relative to C45, the absolute inversion in stereochemistry is of 
significant interest, and therefore AP3.2 was subsequently subjected to biophysical characterisation, 
alongside the spectroscopic and kinetic characterisation of AP3.2 metallocarbenoid formation and 
cyclopropanation, in attempts to elucidate the functionality, activity and selectivity of AP3.2 compared 





Table 16: Average product yields, diastereoselectivities and enantioselectivities for the 
cyclopropanation reaction between EDA and styrene catalysed by the C45 mutants FG1, L50R, and 
AP3.2. The reactions were repeated in triplicate and were catalysed by purified enzyme.  
 
 
Figure 154: Chiral-HPLC chromatograms for the AP3.2-catalysed (10 μM, 0.1 % catalyst loading) 
cyclopropanation assays between styrene (30 mM) and EDA (10 mM) (CHES buffer, pH 8.6, 280 nm). 
A polar organic mobile phase (100% MeCN: 0.1% (v/v) TFA:0.1% (v/v) Et3N) was employed and 
injection volumes were 2 μl. (top) normalised chiral-HPLC chromatograms for commercial (S,S)-ethyl 
2-phenylcyclopropane-1-carboxylate (280 nm, EtOH, red) vs AP3.2-catalysed cyclopropanation (280 





7.2.2.1 Biophysical characterisation of AP3.2 
AP3.2 (figure 155) was characterised by UV-VIS spectroscopy, redox potentiometry and circular 
dichroism to determine its UV-VIS absorption profile, standard reduction potential and thermal 
stability. The information determined was compared against C45. In addition, an MD simulation of 
AP3.2 was acquired (figure 155). 
 
Figure 155: The structure of AP3.2 acquired after MD (ABMER) simulations. 
The UV-VIS spectra for ferric and ferrous AP3.2 are presented in figure 156. The UV-VIS spectrum for 
ferric AP3.2 is dominated by the characteristic Soret peak at 408 nm and is accompanied by a Q-band 
series of less intense peaks in the range 500-550 nm. Upon the addition of sodium dithionite, a new 
spectroscopic profile emerged and is attributed to ferrous AP3.2. The reduced spectrum is dominated 
by a red-shifted intense Soret peak at 419 nm which is accompanied by a Q-band with two less-intense 
but well-resolved peaks, the α and β peaks, with the intensity ratio β > α. The UV-VIS spectra for ferric 
and ferrous AP3.2 is consistent with that of c-type mono-histidine ligated tetra-α-helical maquettes, 






Figure 156: (left) The UV-VIS spectrum for ferric (red) and ferrous (blue) JR1, (right) Redox 
potentiometry of AP3.2 (100 mM KCl, 50 mM CHES, 10% glycerol, pH 8.6) collected with redox 
mediators as described in the methods section. 
Redox potentiometry for AP3.2 gives a calculated mid-point potential of -203 mV (vs SEP) relative to 
C45 (-176 mV vs SEP),235 indicating a slight stabilization of ferric AP3.2 possibly due to increased 
solvent accessibility at the iron. AP3.2, however, has a melting temperature (TM) of 49OC, a substantial 
31OC and 37OC decrease in the melting temperature relative to JR1 (TM = 80OC) and C45 (86OC) 
respectively,235 as determined by circular dichroism (figure 157), and indicates the maquette scaffold 
of AP3.2 is significantly destabilised relative to C45/JR1. The significant decrease in TM for AP3.2 can 
be largely accounted for by the substitution of three hydrophobic phenylanilines to hydrophilic serines 
at the helical positions 53, 83 and 132. In C45 and JR1 the residues Phe-53, Phe-83, and Phe-132 all 
point towards the core of the maquette, providing π-groups which can participate in stabilising inter-
residual interactions in addition to enhancing the hydrophobicity of the core; the mutations to serine 
remove these stabilising interactions and, consequently, facilitate the thermal denaturation of AP3.2 
relative to C45/JR1. The introduction of the D48Y mutation in AP3.2 does introduce another aromatic 
residue, but from the MD simulation of AP3.2 it can be seen the tyrosine is pointing away from the 
protein, and is orientated above the entrance of the active site parallel to the solvent-exposed 






Figure 157: (left) Far-UV circular dichroism spectra of AP3.2 with varying temperature (100 mM KCl, 
20 mM CHES, pH 8.6) (right) Temperature dependence of the CD signal monitored at 222 nm during 
thermal denaturation of AP3.2. The inset shows a smoothed second derivative of the thermal melt 
trace indicating a melting transition (Tm) of 49oC. 
7.2.2.2 Spectroscopic and kinetic characterisation of AP3.2 metallocarbenoid formation  
The formation of the metallocarbenoid intermediate in AP3.2 was investigated under identical 
conditions to those employed for C45 (5OC, 40% EtOH, CHES buffer, pH 8.6). In the presence of EDA, 
the expected shifts in the UV-VIS spectra corresponding to the formation of a terminal 
metallocarbenoid complex where observed (figure 158): the emergence of a red-shifted Soret peak at 
430-436 nm accompanied by a red-shifted and broadened Q-band profile. The time-dependent 
spectra for the change in absorbance at 417 and 433 nm, corresponding to ferrous AP3.2 and the 
AP3.2-EDA metallocarbenoid intermediate respectively, exhibited a profile analogous to the 
spectroscopic changes observed for C45 - a rapid decrease in the ferrous peak (417 nm) with a 
concurrent increase in the metallocarbenoid peak (433 nm) punctuated by a plateauing of both 
absorbances upon saturation. The time-course spectra indicate that once formed the 
metallocarbenoid intermediate is stable and persists, exhibiting no appreciable decay over time, 
analogous to C45. The spectra also indicate that AP3.2 achieves saturation on a time scale similar to 






Figure 158: (left) Single wavelength traces representing the time course absorbance of ferrous AP3.2 
(417 nm, 7.5 μM protein, 10% EtOH) and the metallocarbenoid:AP3.2complex (433 nm) following 
rapid mixing of ferrous AP3.2 with 500 μM ethyl diazoacetate at 5OC in the presence of 3 mM styrene. 
(right) UV-VIS traces recorded at various time intervals following the rapid mixing of ferrous AP3.2 
with 500 μM ethyl diazoacetate at 5OC in the presence of 3 mM styrene. 
In order to properly compare metallocarbenoid formation in AP3.2 to JR1 and C45, the single turnover 
kinetic parameters, K1 and kobs (and the ratio (kobs/K1)) for the formation of the AP3.2-
metallocarbenoid intermediate were determined. The kinetics of metallocarbenoid formation in 
AP3.2 were determined using stopped-flow spectroscopy by adopting the protocol used for C45, JR1, 
Rma-TDE, and Mb(H64V,V68A). Figure 159 exhibits the calculated curve acquired for EDA. As for C45, 
the analysis of the formation of a metallocarbenoid involves three distinct identities: i) free enzyme 
and substrate, ii) a tetrahedral transition state, and iii) the metallocarbenoid intermediate. There are 
three underlining assumptions that have been made to assist in the analysis: i) the rate of 
decomposition of the tetrahedral transition state to the metallocarbenoid intermediate (k2) is first-
order, ii) the reaction is irreversible (k2 >>> k-2) and iii) a steady-state equilibrium is established 
between the free enzyme and the tetrahedral transition state. The values for the single turnover 
kinetic parameters, K1, kobs, and (kobs/K1) for AP3.2-metallocarbenoid formation are tabulated, against 






Figure 159: The Michaelis-Menten plots of AP3.2 (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH) with 
varying concentration of EDA. Initial rates were determined from the rate of change in absorbance for 
the AP3.2:metallocarbenoid adduct at 5oC. 
The kobs, K1, and kobs/K1 values for AP3.2 are 0.82 s-1, 69.26 µM, and 1.18 x 104 s-1 M-1 respectively, 
relative to 0.498 s-1, 74.36 µM and 6.70 x 103 s-1 M-1 for C45 (table 22 (appendix 2)). The K1 for AP3.2 
is essentially identical to the value for C45, indicating that AP3.2 possesses a binding affinity similar to 
C45. More importantly, the kobs for the formation of the AP3.2-EDA metallocarbenoid intermediate is 
the highest value reported across all the enzymes screened (C45, JR1, Rma-TDE and Mb(H64V,V68A)). 
In order to understand the values for K1 and kobs for AP3.2 it is necessary to understand how the 
mutations to AP3.2 effect the resultant structure of the maquette scaffold relative to C45. Figure 160 
shows an overlap diagram of the MD generated structures of C45 and AP3.2. The F52S mutation is the 
only substitution that occurs in the proximity of the heme active site. In conjunction with the 
decreased secondary structure of the maquette scaffold, the switch from a hydrophobic phenylaniline 
to a hydrophilic serine would create a cavity in the active site that would facilitate the accommodation 
of a substrate. In addition, the hydroxy group of serine could possibly participate in a hydrogen bond 
with the carbonyl group of EDA. The combination of an increase in backbone flexibility and active site 






Figure 160: Overlapping MD simulations of the two maquettes C45 (cyan; heme shown in yellow) and 
AP3.2 (magenta; heme shown in blue), (left) overlay of C45 and AP3.2, and (right) close up view of the 
overlap of active sites of C45 and AP3.2 (the D48Y mutation is shown).  
7.2.2.3 Kinetic characterisation AP3.2-catalysed cyclopropanation 
The experimental conditions employed to investigate carbene transfer activity paralleled the 
conditions initially used to investigate metallocarbenoid formation, with a single modification being 
the introduction of a suitable substrate, styrene. A solution containing ferrous AP3.2 (15 µM protein, 
10 mM Na2S2O4, CHES buffer, pH 8.6) and a solution containing ethyl diazoacetate (EDA) and styrene 
(100 µM -10 mM and 200 µM - 3mM respectively, 20:80% CHES:EtOH) were prepared in separate 
compartments (syringes) before a small volume (2x20 µl) of each were injected concurrently into a 
mixing chamber. The mixing chamber was monitored by UV-VIS spectroscopy over several timescales 
to monitor any reactions occurring over the duration of the experiment. Final concentrations were 7.5 










Figure 161: (left) Single wavelength traces representing the time course absorbance of ferrous AP3.2 
(417 nm, 7.5 μM protein, 10% EtOH) and the metallocarbenoid:AP3.2 complex (433 nm) following 
rapid mixing of ferrous AP3.2 with 500 μM ethyl diazoacetate at 5OC in the presence of 3 mM styrene. 
(right) UV-VIS traces recorded at various time intervals following the rapid mixing of ferrous AP3.2 
with 500 μM ethyl diazoacetate at 5OC in the presence of 3 mM styrene. 
Figure 161 displays the time-course spectra obtained from the stopped-flow experiments for AP3.2 in 
the presence of EDA and styrene at wavelengths 417 and 433 nm. 417 nm corresponds to the ferrous 
AP3.2 species and 433 nm corresponds to the AP3.2-EDA metallocarbenoid complex, respectively. The 
data shows that in the initial 20 seconds post-mixing there is a gradual decrease in the 417 nm 
absorbance which is accompanied by a concurrent increase in the 433 nm absorbance – corresponding 
to the formation of the AP3.2-EDA metallocarbenoid complex. It was demonstrated above that once 
formed the AP3.2-EDA metallocarbenoid complex is stable and persists over a duration of 600 seconds 
without any appreciable decay. In the presence of styrene, the initial spectra acquired for AP3.2 
resembles the spectra acquired in the absence of styrene, corresponding to the formation of the 
metallocarbenoid intermediate. After approximately 30 seconds, however, the absorbance at 433 nm 
starts linearly decreasing and is accompanied by a concurrent linear increase in absorbance at 417 nm 
– indicating the decay of the metallocarbenoid species and the return to the starting ferrous complex. 
UV-VIS traces captured at numerous timepoints over 600 seconds are also presented in figure 161. In 
the initial stages of the reaction (1-60 seconds) the UV-VIS exhibits the red-shift corresponding to the 
formation of the metallocarbenoid intermediate, alongside the concurrent shift and broadening of the 
Q-band profile. In the UV-VIS spectra acquired in the absence of styrene the red-shift from ferrous to 
metallocarbenoid intermediate is characterised by sharp Soret peaks as the 417 nm peak disappears 
alongside the emergence of a Soret peak at 428-433 nm. In the presence of styrene, the emergence 
of the 433 nm peak appears as a shoulder alongside the 417 nm peak, resulting in a broad, split Soret 





maximum absorbance begins to shift towards the 417 nm peak and is accompanied by the gradual re-
emergence of the ferrous Q-band profile. The spectroscopic profile for AP3.2-metallocarbenoid 
formation in the presence of styrene parallels the profile exhibited by C45 and JR1. The analogous 
spectroscopic profiles mean the kinetic parameters klim, K1, and klim/K1 for the AP3.2-catalysed 
cyclopropanation reaction can be calculated under conditions identical to those employed for C45 and 
JR1, allowing for comparisons between the maquettes to be investigated (figure 162). The kinetic 
parameters klim, K1, and klim/K1 for the AP3.2-catalysed cyclopropanation reaction between EDA and 
styrene are 0.067 s-1, 141.23 µM, and 474.4 s-1 M-1 respectively, relative to 0.001 s-1, 482.51 µM, and 
2.23 s-1 M-1 for C45 (table 23, appendix 2). From the acquired data, it can be inferred that AP3.2 possess 
is a more efficient cyclopropanation carbene transferase relative to C45 for the reaction between EDA 
and styrene. The kinetic parameters for the AP3.2-catalysed cyclopropanation reaction eclipse all the 
other enzymes screened thus far, including (in order of decreasing klim/K1) JR1, Mb(H64V,V68A), C45, 
and Rma-TDE respectively (table 23, appendix 2).  
 
Figure 162: The Michaelis-Menten plots for the cyclopropanation reaction of the AP3.2:EDA 
metallocarbenoid complex in the presence of styrene (7.5 µM, CHES buffer, pH 8.6, 40% (v/v) EtOH). 
Initial rates were determined from the rate of change in absorbance for the AP3.2:EDA adduct at 5oC 
in the presence of styrene. 
From the computationally generated C45 and AP3.2 models no immediate explanation can be 
deduced to account for i) the pronounced change in the observed stereoselectivity, ii) the significantly 
enhanced cyclopropanation kinetics relative to all other enzymes screened thus far, or iii) the 





to serine mutations at key helical positions result in a more destabilised protein scaffold for AP3.2, 
which was reflected in the drastic decrease in the melting temperature of AP3.2 relative to C45 and 
JR1 (39OC vs 86OC and 81OC respectively).235 The destabilisation of the maquette core would engender 
a more molten globular like structure for AP3.2 which would exist, in solution, in an ensemble of ill-
defined tertiary conformations. The F53S is the only mutation that is positioned close to the carbene 
binding site at the distal face of the heme, and the replacement of a bulky hydrophobic phenylalanine 
residue for a small hydrophilic serine residue would create a cavity capable of accommodating bulkier 
substrates, transitions states or intermediates; furthermore, the hydroxy group of serine can function 
as a hydrogen-bond acceptor/donator, possibly providing some compensatory stabilisation to the 
substrates and/or enzymatic transitions states/intermediates; the combination of the four 
phenylalanine to serine mutations in AP3.2 could account for the enhanced kinetic parameters for 
both the metallocarbenoid formation and its subsequent reaction with styrene. The D48Y mutation in 
AP3.2 results in a tyrosine positioned above the entrance to the active site, orientated parallel to the 
solvent-exposed propionate groups of the heme cofactor. The tyrosine residue could possibly provide 
stabilising π-π interactions to the incoming styrene substrate, functioning to provide a favourable 
trajectory into the active site, perhaps directing styrene into the cavity generated by the F53S 
mutation. The directional guiding of styrene by tyrosine, through favourable π-π interactions, into an 
accommodating space would engender an energetically preferable trajectory of approach towards the 
metallocarbenoid intermediate and would provide a reasonable account for the inverted and 
remarkably high stereoselectivity exhibited by AP3.2.  
7.3 CONCLUSION 
The simplicity and malleability of the four-helix bundle renders maquettes suitable scaffolds for 
mutagenesis and directed evolution. Error-prone PCR afforded a C45-variant, JR1, which exhibited 
slightly improved activity towards the cyclopropanation of styrene and EDA. JR1 is only two mutations 
away from WT-C45 but has a K1 for the binding of EDA three times lower compared to C45. In addition, 
despite minor improvements in product yield, JR1 exhibited a klim for the cyclopropanation of styrene 
that was almost 50 times higher than C45 (0.048 vs 0.0011 s-1 respectively), and twice that of the 
rationally designed carbene transferase Mb(H64V,V68A) (0.048 vs 0.021 s-1 respectively). The 
biophysical properties of JR1 were largely unaffected by the mutations, exhibiting a UV-VIS profile and 
possessing values for Tm and EM that are similar to C45. Another variant, AP3.2 (8 mutations away from 
C45), was produced using directed evolution. The UV-VIS profile of AP3.2 was consistent with a mono-
heme-containing four-helix bundle, but the biophysical data revealed a significant decrease in Tm 





catalysing the cyclopropanation reaction between EDA and styrene, although less catalytically active 
than its counterparts C45 and JR1 (47% for AP3.2 vs 80/85% for C45/JR1 respectively). Interestingly, 
AP3.2 exhibited a complete inversion of stereoselectivity towards the reaction, with only the (S,S)-
cyclopropane product being isolated, in direct contrast to the (R,R)-selective maquettes C45 and JR1. 
Kinetically, AP3.2 outperformed all over variants, reporting the highest kobs for the formation of the 
metallocarbenoid intermediate (0.820 s-1). AP3.2 also exhibited remarkable kinetic parameters for the 
cyclopropanation reaction, with a K1 for styrene of 141.23 µM (relative to 428.51 µM and 657.7 µM 
for C45 and Mb(H64V,V68A) respectively) and a klim three times higher than that for Mb(H64V,V68A) 
(0.067 s-1 vs 0.021 s-1  respectively). The experiments discussed in this chapter highlight not only the 
powerful technique of direct evolution, but also how introducing key mutations can have pronounced 
effects on the kinetics and stereoselectivity of a reaction. At present, it is difficult to elucidate the 
relationships between the mutations and the observed changes, but nonetheless the maquette 
scaffold offers a facile platform for engineering novel biocatalysts with tailored functionality, 






CHAPTER 8: CONCLUSION 
In chapter 3, the metallocarbenoid formation propensity of the de novo tetra-α-helical c-type heme-
containing maquette C45 was explored and compared against two artificial carbene transferases 
reported in the literature: a cytochrome c variant engineered in the Arnold lab, Rma-TDE, and a sperm 
whale myoglobin mutant engineered in the Fasan lab, Mb(H64V,V68A). The electronic spectra of C45, 
Rma-TDE, and Mb(H64V,V68A) all exhibited similar profiles. Further spectroscopic characterisation 
revealed that C45, Rma-TDE, and Mb(H64V,V68A) can form stable metallocarbenoid intermediates 
under the conditions investigated. A metallocarbenoid intermediate of Rma-TDE and Mb(H64V,V68A) 
has been successfully crystallised and reported in the literature, so the similarities between the 
electronic spectra provides good evidence that C45 is forming stable, terminally bound, heme-
localised metallocarbenoid intermediates. This was further supported by experiments conducted 
using ESI-MS which revealed the new intermediates each had a shifted mass corresponding exactly to 
the respective carbene precursor (diazo) compound. The kinetics of metallocarbenoid formation 
revealed that C45 is intermediate between Rma-TDE and Mb(H64V,V68A), which supports the notion 
that de novo proteins can compete with rationally redesigned enzymes. In chapter 7, the 
metallocarbenoid formation of two C45 variants JR1 (2 mutations from WT-C45) and AP3.2 (8 
mutations from WT-C45) exhibited superior kinetics relative to C45 (AP3.2 reported a catalytic 
efficiency superior to Mb(H64V,V68A)) which demonstrates the versatility and evolvability of the C45 
tetra-α-helical maquette. 
Chapter 4 and 5 explored the catalytic versatility of the C45 maquette towards carbene transfer 
chemistry. The cyclopropanation of olefins was initially explored in chapter 4, and it was demonstrated 
that C45 is a proficient, stereoselective carbene transferase, catalysing the reaction between styrene 
and ethyl diazoacetate with a product yield, diastereoselectivity, and enantioselectivity of 80%, 99% 
and 77% for the (R,R)-cyclopropane product respectively. Investigating the substrate promiscuity of 
C45 revealed its cyclopropanation activity extended to functionalised diazo esters and para-
functionalised styrenes, with enantioselectivities surpassing 90% for the cyclopropantion reaction 
between EDA and  p-methoxystyrene, p-fluorostyrene, and p-trifluoromethylstyrene. The kinetics of 
C45-catalysed cyclopropanation was explored spectroscopically. The catalytically efficiency of C45 was 
similar to Rma-TDE, but inferior to Mb(H64V,V68A). In chapter 7, the cyclopropanation kinetics of JR1 
and AP3.2 were also investigated spectroscopically, and it was demonstrated the C45-variants 
possessed catalytic efficiencies approximately 4-times (136 s-1 M-1) and 12-times (474 s-1 M-1) higher 
than Mb(H64V,V68A) (32 s-1 M-1) respectively. It was also shown that mutations to the maquette 





between EDA and styrene with an enantioselectivity surprising 99% in favour of the (S,S)-cyclopropane 
product, directly contrasting the (R,R)-selectivity exhibited by C45 and JR1. 
In chapter 5, the enzymatic promiscuity of C45 was investigated, and it was demonstrated that C45’s 
carbene transferase activity extends to chemoselective N-H insertions, Si-H insertions, carbonyl 
olefinations, and in vivo and in vitro homologous ring expansions. The in vivo and in vitro homologous 
ring expansion of pyrrole, catalysed by C45, is the first reported enzymatic ring expansion – natural, 
designed or de novo- –  that proceeds via a carbene transfer mechanism. With the exception of the 
carbonyl olefinations, C45 was demonstrated to catalyse the aforementioned reactions with 
remarkable yields and selectivity; in particular, the C45-catalysed reaction between tert-butyl 
diazoacetate and 3-aminophenol afforded product yields surpassing 99%. Overall, chapters 4 and 5 
demonstrated the synthetic utility of small tetra-α-helical maquettes as biocatalysts in a range of 
important abiological reactions. The synthetic utility of C45 was further expanded in chapter 6, in 
which it was demonstrated that encapsulating C45 inside an organic-solvent resistant calcium alginate 
hydrogel afforded a heterogeneous biocatalyst. The spectroscopic profile of alginate-encapsulated 
C45 (AE-C45) was unperturbed by the encapsulation process, even when the AE-C45 beads were 
suspended in pure organic solvents such as MeOH and n-hexane. It was demonstrated that AE-C45 
also retains its metallocarbenoid formation ability, as the electronic spectra of the AE-C45-EDA 
complex is identical to the electronic spectra of the C45-EDA complex in aqueous solution. AE-C45 not 
only retained its ability to form a metallocarbenoid intermediate, but it also retained its catalytic 
proficiency as AE-C45 was demonstrated to be a proficient catalyst in the i) cyclopropanation reaction 
between EDA and styrene, and ii) N-H insertion reaction between piperidine and EDA, when the AE-
C45 beads were suspended in a range of organic solvents. The product yields of the AE-C45 carbene 
transfer assays were demonstrated to be dependent on the diffusion of the reacting substrate across 
the solvent-alginate bead interface. In addition, AE-C45 could be recovered after one round of 
catalysis and could be successfully re-employed as a carbene transferase in subsequent rounds of 
catalysis.  
The importance of this work is it demonstrates that large and/or complex protein scaffolds are not a 
prerequisite for engineering novel biocatalytic enzymes towards synthetically and technologically 
useful chemical reactions. It was demonstrated that C45, a simple, evolutionary naïve tetra-α-helical 
protein scaffold can catalyse carbene transfer reactions, with a variety of substrates, with yields and 
selectivities that rival, and even surpass, the carbene transferases, engineered from naturally-
occurring heme-containing protein scaffolds reported in the literature.184,187,288,393 Furthermore, it was 





The introduction of small changes often proves sufficient for altering a maquette’s functionality, which 
was elegantly highlighted by the aforementioned variant AP3.2. AP3.2 demonstrated a complete 
inversion of stereochemistry towards the cyclopropanation reaction, has the highest kobs for the 
formation of the metallocarbenoid intermediate (0.820 s-1), and exhibited remarkable parameters 
towards the cyclopropanation reaction, with a K1 for styrene of 141.23 µM (relative to 428.51 µM and 
657.7 µM for C45 and Mb(H64V,V68A) respectively) and a klim three times higher than that for 
Mb(H64V,V68A) (0.067 s-1 vs 0.021 s-1  respectively). Overall, a simple, highly engineerable, de novo c-
type heme-containing protein proficient at i) forming a number of stable, bioorganometallic 
intermediates that are spectroscopically consistent with the metallocarbenoid intermediates reported 
for rationally designed carbene transferases, ii) catalysing a wide range of abiological chemical 
reactions, via a metallocarbenoid intermediate, with remarkable chemoselectivity and 
stereoselectivity, and iii) performing biocatalytic conversions under conditions typically inhospitable 
to solvents (i.e. neat organic solvents), was reported. These observations collectively reinforce the 
postulation that re-engineering naturally occurring proteins is unnecessary to achieve abiological 






CHAPTER 9: MATERIALS AND METHODS 
All chemicals were purchased from either Sigma or Fisher Scientific, and T7 Express competent cells 
and Q5 polymerase were purchased from NEB. Cloned synthetic genes for Rma-TDE and 
Mb(H64V/V68A) were purchased from Eurofins Genomics. Error-prone PCR (epPCR) libraries of 
C45were produced using the GeneMorph II EZClone Domain Mutagenesis Kit. All UV-visible spectra 
were recorded on an Agilent Cary-60 UV-visible spectrophotometer. OTTLE potentiometry was used 
to measure heme redox potentials. A JASCO J-815 CD polarimeter was used to measure circular 
dichroism spectra. All stopped-flow data an SX20 Stopped Flow was acquired using an SX20 Stopped 
Flow spectrophotometer (Applied Photophysics) housed in an anaerobic glove box under N2 ([O2] <5 
p.p.m.; Belle Technology). All LC-MS mass spectra were acquired using positive electron-spray-
ionization (ESI) mass spectrometry (Waters Xevo G2-XS QTof) attached to a C8 reverse column (Grace 
Vydac, 100 x 21 mm, 5 μm. All High Performance Liquid Chromatography (HPLC) chromatograms were 
acquired using a Agilent waters HPLC and two separate columns were employed for quantification: a 
chiral column using either a  C18 HPLC reverse phase column (Phenomenex, 150 x 15 mm, 5 μm) or a 
chiral-HPLC column (Astec CHIROBIOTIC® V, 250 x 21 mm, 5 μm). 
9.1 GENERAL & MOLECULAR BIOLOGY, PROTEIN EXPRESSION AND PURIFICATION 
All chemicals were purchased from either Sigma or Fisher Scientific and cloned synthetic genes for 
Rma-TDE and Mb(H64V/V68A) were purchased from Eurofins Genomics. All transformations were 
performed using E. coli T7 Express competent cells (NEB) and by following a standard protocol.234 For 
C45, JR1, and AP3.2 a modified pMaI-p4x+ plasmid (the maltose-binding protein (MBP) sequence is 
deleted, leaving the MBP Sec translocon recognition sequence (MKIKTGARILALSALTTMDFSASALAK) 
that enables the periplasmic translocation of the artificial c-type cytochrome) containing the sequence 
for C45/JR1/AP3.2 with a C-terminal His6 tag and a Tobacco Etch Virus (TEV) recognition sequence 
(ENLYFQ/G) between the His6 tag and the protein sequence (to allow the removal of the purification 
tag) and Pec86+ (containing the ccm machinery required for incorporation of the c-type heme into 
C45) expression vectors were used. The vectors pSHT (for periplasmic expression) or pET45b(+) (for 
cytoplasmic expression) were used for the enzymes Rma-TDE (co-expressed with Pec86+) and 
Mb(H64V,V68A). Error-prone PCR (epPCR) libraries of C45, with a mutation rate of 2-3 amino acid 
mutations, were produced using the GeneMorph II EZClone Domain Mutagenesis Kit. The mutation 
rate was determined by randomly selecting and sequencing 10 colonies after transforming the PCR 
products into E. coli T7 Express cells. This mutation rate was achieved with 18.7 ng of target DNA (C45 





variant was expressed and purified as described below. 50% glycerol stocks for each cell-line were 
prepared and frozen for all proteins. 
9.2 EXPRESSION PROTOCOL  
All of the proteins were expressed and purified via the following protocol. All steps were performed 
under sterile conditions.  Overnight starter cultures were prepared by adding 100 µl carbenicillin (50 
mg/ml), and 100 µl chloramphenicol (50 mg/ml, Pec86+ containing vectors only), to 100 ml of LB 
before inoculating the solution with the appropriate glycerol stock. Starter cultures were then 
incubated overnight at 37OC and 180 rpm. To 1L of LB was added 1ml of the appropriate antibiotics 
(50 mg/ml) before 50ml of an overnight starter culture was added. Litre cultures were then left to 
grow until an OD600 value between 0.6-0.8 was obtained (usually after 3 hours), at which point 1 ml 
IPTG (1M stock, 1 mM induction concentration) was added per litre to induce protein expression; the 
induced solutions were left to express for an addition three hours. After three hours the cultures were 
collected, centrifuged (4000 rpm, 4oC, 30 mins) and the resultant cell pellets were isolated from the 
supernatant, resuspended in 10ml lysis buffer (300 mM NaCl, 50 mM sodium phosphate, 20 mM 
imidazole, pH-8) and stored at -20OC until purification. 
9.3 PURIFICATION PROTOCOL  
The lysis suspensions were defrosted at room temperature prior to purification. Once thawed, the 
suspensions were sonicated multiple times in increments of 20 seconds (stored on ice for 20 seconds 
between increments) to lyse the cells. After sonication, the suspensions were transferred to 50 ml 
SS34 centrifuge tubes and centrifuged (SS34 centrifuge) at 4OC and a rate of 18000 rpm for 30 minutes. 
After centrifugation, the supernatant was transferred to a 50 ml Eppendorf tube and the cell pellets 
discarded. The supernatant was filtered via 45 µm and 20 µm membrane filters and transferred onto 
a nickel column under lysis buffer (300 mM NaCl, 50 mM Sodium phosphate (dibasic), 20 mM 
imidazole, pH 8). The protein of interest contains a HIS6-tag, which exhibits a high affinity for nickel; 
therefore, the HIS6-tagged protein remained attached to the nickel column as the undesirable 
contents of the solution (proteins, cell debris etc) was filtered off. After running approximately 25 ml 
of lysis buffer through the column, the column lines were switched to elution buffer (300 mM NaCl, 
50 mM Sodium phosphate (dibasic), 250 mM imidazole, pH 8) which passed through the column, 
displacing the HIS-tagged protein and eluting it off the column. *The HIS-tagged protein was collected, 
and subsequently subject to overnight dialysis to re-suspend the protein in TEV protease buffer (0.5 
mM EDTA, 50 mM Tris, 5L Milli-Q, pH 8). Once in TEV buffer, excess DDT and TEV protease were added 





mixture was then filtered again (45 and 20um membrane filters) and transferred back onto a nickel 
column under lysis buffer. If the HIS6-tag had been cleaved successfully, the protein of interest eluted 
off the nickel column under lysis buffer and can be collected immediately. The remaining HIS-tag was 
subsequently washed off the column and discarded. If the HIS-tag failed to cleave, the dialysis and TEV 
protease steps were repeated, but the mixture allowed to mix for longer durations (overnights). After 
cleaving the HIS-tag, the protein was concentrated down to 5ml using a 10,000-spin-membrane 
Eppendorf and centrifuging at 4500 rpm and 4OC for as long as necessary. The protein was then 
purified using an AKTA PURE S75 gel filtration column employing CHES buffer (20 mM CHES, 100 mM 
KCl, pH 8.6) or KPi buffer (100 mM phosphate, pH 7.5, used for Mb(H64V,V68A) only) as the mobile 
phase. The progress of the protein along the column was monitored spectroscopically, at 280 nm, and 
the collected fractions containing the desired protein were characterised via UV-spectroscopy and an 
SDS-PAGE gel to examine purity. The desirable fractions were then combined, and the final solution 
was concentrated (if necessary) and divided into 500 µL aliquots which were stored at -80OC until 
required.      
9.4 UV-VIS SPECTROSCOPY 
All UV-VIS spectra were recorded on an Agilent Cary-60 UV-visible spectrophotometer using a 1 mm 
pathlength quartz cuvette. Reduced spectra for each sample were acquired by the addition of 10 µl of 
Na2S2O4 (1 mM in de-ionised water). All UV-VIS spectra were recorded across a wavelength range of 
300-750 nm. The concentrations were determined using the extinction coefficients for the ferric and 
ferrous samples, respectively. C45: ɛ406 = 147,433 M-1 cm-1 and ɛ417 = 119,900 M-1 cm-1; JR1: ɛ406 = 
191,000 M-1 cm-1 and ɛ417 = 172,000 M-1 cm-1; AP3.2: ɛ406 = 62,000 M-1 cm-1 and ɛ417 = 68,000 M-1 cm-1; 
Rma-TDE: ɛ406 = 138,200 M-1 cm-1 and ɛ417 = 128,000 M-1 cm-1; Mb(H64V,V68A): ɛ409 = 156,700 M-1 cm-
1 and ɛ435 = 96,000 M-1 cm-1. 
9.5 STOPPED-FLOW SPECTROPHOTOMETRY 
Stopped-flow kinetics were conducted using an SX20 stopped-flow spectrophotometer (Applied 
Photophysics) housed in an anaerobic glovebox under N2 ([O2] < 5 ppm; Belle Technology). In the initial 
experiments, a solution containing a known concentration of a reduced enzyme (15 μM, 100 mM KCl, 
20 mM CHES, pH 8.6, reduced with Na2S2O4 for C45, AP3.2, JR1, and Rma-TDE; 0.1M phosphate, pH 
7.5, reduced with Na2S2O4 for Mb(H64V,V68A)) was placed in one syringe and a 5 mM solution of a 
carbene precursor (either EDA, tBuDA or BnDA) in ethanol (20-100%) was placed in the second syringe. 
50 μL from each syringe was simultaneously injected into a mixing chamber and the progression of 





to examine the metallocarbenoid formation and porphyrin degradation pathway, respectively. The 
formation of the metallocarbenoid was monitored by following the time-course profiles at 417 nm 
and 428-437 nm, the Soret peak for reduced C45/AP3.2/JR1/Rma-TDE and the metallocarbenoid 
intermediate respectively, and 435 nm and 424 nm, the Soret peak and the metallocarbenoid 
intermediate for reduced Mb(H64V,V68A). Final concentrations were 7.5 μM ferrous C4 enzyme and 
2.5 mM EDA/tBuDA/BnDA (10-50% ethanol). The kinetics of the formation of the metallocarbenoid for 
each enzyme were determined using the same conditions outlined above but using varying 
concentrations of EDA (50 μM – 3 mM). The rate constants were calculated at varying substrate 
concentrations by plotting to a single exponential and then fitting the data to a hyperbolic function 
(equation 19). 
rate = kobs[S]/K1+[S] 
Eq  19 
Additional experiments using stopped-flow spectrophotometry were conducted to study the 
degradation of the metallocarbenoid intermediates in the presence of a suitable substrate. A solution 
containing a known concentration of ferrous enzyme (15 μM, 100 mM KCl, 20 mM CHES, pH 8.6, 
reduced with stoichiometric Na2S2O4 for C45, AP3.2, JR1, and Rma-TDE; 0.1M phosphate, pH 7.5, 
reduced with stoichiometric Na2S2O4 for Mb(H64V,V68A)) was placed in one syringe and an 80:20% 
ethanol:water solution containing 1 mM of a carbene precursor (either EDA, tBuDA or BnDA) and 6 
mM of styrene was placed in the second syringe. 50 μL from each syringe was simultaneously injected 
into a mixing chamber and the progression of the reaction was monitored spectroscopically, at 5 oC 
and 25 oC, over the course of 180-1000 seconds to examine carbene transfer activity. The reaction 
progressed was monitored by following the time-course profiles at 428-437 nm and 417 nm for 
reduced C45/AP3.2/JR1/Rma-TDE, and 424 nm and 435 nm for reduced Mb(H64V,V68A). Final 
concentrations were 7.5 μM reduced enzyme, 500 μM EDA/tBuDA/BnDA, 3 mM styrene (40% 
ethanol). The kinetics of the degradation of the metallocarbenoid species for each enzyme were 
determined using the same conditions outlined above but using varying concentrations of styrene (50 
μM – 3 mM). The rate constants were calculated at varying substrate concentrations, plotted and then 
the data were fitted using equation (20). 
kobs = klim[S]/K1+[S]. where K1 = (k-1 + k2)/k1 





9.6 PROTEIN MASS SPECTROMETRY FOR C45 
The formation of the C45-metallocarbenoid intermediate was further examined using positive 
electron-spray-ionisation (ESI) mass spectrometry (Waters Xevo G2-XS QTof). A 1 ml solution of 350 
μM C45 in CHES buffer (100 mM KCl, 20 mM CHES, pH 8.6), in a 1.5 ml sealed-top vial containing a 
silicon septum, was flushed under scrubbed nitrogen inside an anaerobic glovebox ([O2] < 5 ppm; Belle 
Technology) before being sealed, removed from the glovebox and placed on ice for 10 minutes. The 
sample was then immediately loaded directly into the mass spectrometer, where an isocratic 100 mM 
ammonium acetate solution was employed as the mobile phase (0.25 ml min-1). 20 μl injections were 
employed and the progression of the sample into the chamber was monitored spectroscopically at 
280 nm. The mass spectrum contained peaks screened across a m/z range of 1500-2700. The dominant 
peaks were identified, and the charges of the fragments were calculated using the molecular mass of 
C45 (15168 Da). 
A 1 ml solution of 350 μM C45 in CHES buffer (100 mM KCl, 20 mM CHES, pH 8.6), in 1.5 ml sealed-top 
vials, was then flushed under scrubbed nitrogen inside an anaerobic glovebox ([O2] < 5 ppm; Belle 
Technology) followed by the addition of 25 μl of Na2S2O4 (400 mM stock in CHES buffer). A separate 
vial containing the selected diazo compound (EDA, tBuDA, BnDA, 400 mM stock in EtOH) was 
deoxygenated alongside the vial containing reduced C45. The vials were sealed, transported out of 
the glovebox, and cooled in an ice bath for 10 minutes. Once cooled, 50 μl of the selected diazo 
compound was added via a gastight syringe into the vial containing reduced C45 to initiate the 
reaction. The sample was kept on ice for 1 minute to allow for the formation of the metallocarbenoid 
intermediate before being directly loaded onto the mass spectrometer. Final reaction concentrations 
were 350 μM enzyme, 10 mM sodium dithionite, and 20 mM diazo compound. Identical conditions to 
the experiment with only C45, mentioned above, were employed for each carbene precursor studied 
9.7 CARBENE TRANSFER CHEMISTRY 
Unless stated otherwise, all assays were conducted under scrubbed nitrogen inside an anaerobic 
glovebox ([O2] < 5 ppm; Belle Technology). The assays were conducted inside 1.5 mL screw top vials 
sealed with a silicone-septum containing cap. All assays were conducted in CHES buffer (100 mM KCl, 
20 mM CHES, pH 8.6) except for the assays conducted with Mb(H64V,V68A) which were performed in 
KPi buffer (100 mM potassium phosphate, pH 7). The final reaction volumes for all assays were 400 μL 





9.7.1 cyclopropanation assays 
To 370 μL of a 10 μM C45/AP3.2/Rma-TDE/JR1/Mb(H64V,V68A) solution was added 10 μL of Na2S2O4 
(400 mM stock; de-ionized water) and the mixture was left to stir for 1 minute, ensuring complete 
reduction of the enzyme from Fe3+ to Fe2+. 10 μL of the selected styrene (1.2 M stock in EtOH) was 
added and the reaction left to mix for 30 seconds. A separate vial containing the selected diazo 
compound (400 mM stock in EtOH) was deoxygenated alongside the reaction vessel. The vials were 
sealed, transported out of the glovebox, and cooled in an ice bath. Once cooled, 10 μL of the diazo 
compound was added via a gastight syringe into the reaction vials to initiate the reaction. Final 
reaction concentrations were 10 μM enzyme (0.1% mol%), 10 mM sodium dithionite, 10 mM diazo 
compound, and 30 mM styrene. Once mixed, the reactions were stirred on a roller at room 
temperature. After 2 hours, the reaction was quenched by the addition of 20 μL of 3 M HCl. The vials 
were subsequently unscrewed, and 1 mL of ethyl acetate was added to the vial. The solution was 
transferred to a 1.5 mL microcentrifuge tube, vortexed and centrifuged for 1 minute at 13,500 rpm. 
The upper organic layer was extracted, dried over MgSO4 if necessary, and subsequently used for 
analysis. Where base hydrolysis of the resultant ester was necessary, 400 μL of 3 M NaOH was 
introduced to the organic layer and the mixture was left to stir at room temperature for 30 minutes 
(the progress of the ester hydrolysis was monitored using TLC (7:3 ethyl acetate:hexane)). Products 
were analysed by chiral-HPLC and LC-MS as described below. The product yields, enantiomeric 
excesses, and total turnover numbers (TTN; concentration of product formed/concentration of 
enzyme) were calculated via external calibration with commercial ethyl 2-phenylcyclopropane-1-
carboxylate, 2-phenylcyclopropane-1-carboxylic acid, and synthesised standards. 
9.7.2 carbonyl olefination assays 
Carbonyl olefination assays were conducted under the same reaction conditions as the 
cyclopropanation assays, with the following alterations: alkene substrates were substituted for 
selected benzaldehyde substrates; 10 mM of PPh3 was included as an additional reagent in the 
reaction (10 μL of a 400 mM stock in acetone). The reactions were carried out overnight and the 
products extracted with 1 mL of dichloromethane. The products were analysed by C18 reverse-phase 
HPLC and LC-MS as described below. The product yields, cis/trans ratios, and total turnover numbers 
were calculated via an external calibration with commercial ethyl cinnamate and cinnamic acid. 
9.7.3 N-H insertion assays 
N-H insertion assays were conducted under the same reaction conditions as the cyclopropanation 





amines; the reactions were carried out overnight and the products were extracted with 1.25 mL of n-
hexane (1.25 mL of hexane as required for sufficient extraction of the product into the organic phase 
[monitored by TLC]); the products were subsequently analysed by chiral-HPLC and LC-MS as described 
below. The product yields and total turnover numbers were calculated via an external calibration with 
commercial N-phenylglycine ethyl ester and ethyl-1-piperidine acetate (and including a 1.25 
multiplication factor to account for product dilutions) and synthesised standards. 
9.7.4 Chemoselective N-H insertion assays 
Chemoselective N-H insertion assays were conducted under the similar reaction conditions as the N-
H insertion assays using ortho-, meta-, and para-aminophenol; the reactions were stirred for2 hours 
and quenched with 20 µl 10% (w/v) acetic acid (2-aminophenol and 3-aminophenol) or 3M HCl (4-
aminophenol). After quenching the products were extracted with 1 mL of ethyl acetate and the 
products were subsequently analysed by C18-HPLC and LC-MS as described below. The product yield 
and total turnover numbers were calculated via an external calibration with commercial N-
phenylglycine ethyl ester. 
9.7.5 Phenylenediamine N-H insertion assays 
Phenylenediamine N-H insertion assays were conducted similarly to the chemoselective N-H insertion 
assays, with two differences: i) substitution of ortho-, meta-, para-aminophenol for ortho-, meta- and 
para-phenylenediamine, and ii) final substrate concentrations were 10 mM phenylenediamine and 30 
mM EDA. 
9.7.6 Si-H insertion assays  
Si-H insertion assays were conducted similarly to the N-H insertions assays, with a few notable 
differences: i) dimethylphenylsilane (DMPS) was used as the substrate in place of an amine, ii) the 
reactions were quenched by the addition of 1 ml n-hexane, and iii) final substrate concentrations were 
20 mM EDA and 20 mM DMPS. The product mixtures were analysed using C18-HPLC and LC-MS 
9.7.7 Ring expansion assays 
Ring expansion assays were conducted under similar reaction conditions as the cyclopropanation 
assays described above, but with the following alterations: styrene was substituted for pyrrole (400 
mM stock in ethanol); ethyl 2-bromo-2-diazoacetate was used as the carbene precursor (40 mM stock 
in CH2Cl2). The products were extracted with 1 mL of ethyl acetate and subsequently analysed by C18 





(1% mol%), 10 mM sodium dithionite, 1 mM diazo compound, and 10 mM pyrrole. The product yields 
and total turnover numbers were calculated via an external calibration with commercial ethyl 
nicotinate and niacin. 
9.7.7.1 Synthesis of ethyl 2-bromo-2-diazoacetate 
Ethyl 2-bromo-2-diazoacetate was synthesised as previously reported. Briefly, N-bromosuccinimide 
(26 mmol) was added to a solution of EDA (20 mmol) and 1,8-Diazabicyclo(5.4.0)undec-7-ene (28 
mmol) in CH2Cl2 (5.0 ml) at 0 °C, and the reaction mixture was stirred for 10 mins. The crude reaction 
mixture was washed with cold Na2S2O3 (aqueous, 3 x 5 ml) and quickly filtered through a silica column 
(cold CH2Cl2). Cold CH2Cl2 was added to bring the final volume up to 2.5 ml (~40 mM) 
9.8 WHOLE CELL C45-CATALYSED RING EXPANSION EXPERIMENTS 
Overnight starter cultures were prepared by adding 100 μl carbenicillin (50 mg/ml) and 100 μl 
chloramphenicol (50 mg/ml, C45 only) to 100 ml of LB before inoculating the media with a C45-
expressing E. coli glycerol stock. Starter cultures were then incubated overnight at 37 oC and 180 rpm. 
50 ml of the overnight starter culture was then used to inoculate 1 L of LB containing the same 
concentrations of antibiotics (see above). The 1 L cultures were grown in a shaking incubator at 37 oC 
and 180 rpm until an OD600 between 0.6-0.8 was obtained (usually after 3 hours), at which point 980 
μl was extracted from both vessels, placed inside separate 1.5 ml screw-top vials and placed on ice. 1 
ml of IPTG solution (1 M stock, 1 mM final concentration at induction) was added to specific cultures 
to induce protein expression; induced and non-induced cultures were left in the incubator for an 
additional four hours (37 oC and 180 rpm). After four hours, 980 μl was extracted from the vessels and 
transferred to separate 1.5 ml screw-top vials. The samples were then degassed inside an anaerobic 
glove-box (Belle Technology) for 30 minutes before 10 μl of pyrrole (1 M stock in EtOH) was added 
and the vials sealed and removed from the glovebox. The vials were cooled on ice before 25 μl of ethyl 
2-bromo-2-diazoacetate (40 mM stock in DCM, nitrogen flushed) was added via a gastight needle; the 
final concentration of the reagents was 1 mM ethyl 2-bromo-2-diazoacetate and 10 mM pyrrole. The 
products were extracted with 1 ml ethyl acetate and analysis was conducted as reported above in the 
“Ring expansion assays’’ section. 
9.9 HYDROLYSIS OF ETHYL NICOTINATE BY A BACILLUS SUBTILIS ESTERASE 
To a 100 ml round-bottom flask equipped with a small magnetic stirrer bar was added 19.8 ml of CHES 
buffer (pH 8.6) and 200 μl of commercial ethyl nicotinate (5 M stock in DMSO). The final concentration 





for HPLC analysis. 2 mg of esterase from Bacillus subtilis (Sigma Aldrich) was added to the mixture, 
then the round-bottom flask was closed with a stopper and the solution was left to stir for 1 hour. 
After 1 hour, a 1 ml aliquot of the solution was extracted into a 1.5 ml Eppendorf tube, and 100 μl of 
3 M trichloroacetate was added to precipitate the protein. The mixture was vortexed, centrifuged (30 
seconds, 13000 rpm) and the resulting solution analysed directly via HPLC. The HPLC protocol for the 
analysis was identical to the procedure outlined in the ‘’ring expansion assays’’ section above. 
9.10 PRODUCT CHARACTERIZATION BY REVERSE PHASE AND CHIRAL HPLC 
All the reactions performed were quantified by High Performance Liquid Chromatography (HPLC). Two 
separate columns were employed for quantification: a chiral column and a reverse phase C18 column. 
A chiral-HPLC column (Astec CHIROBIOTIC® V, 250 x 21 mm, 5 μm) was used to analytically quantify 
the cyclopropanation and N-H insertion assays, employing an isocratic mobile phase (100% CH3CN: 
0.1% v/v TFA: 0.1% v/v: Et3N; 0.1 mL min-1 flow rate and 2 μL injection volume for the cyclopropanation 
assays; 0.2 mL.min-1 flow rate and 5 μL injection volume for the N-H insertion assays). Injection 
volumes of the N-H insertion assay products were 5 μL to account for the 2.5:1 dilution in the 
extraction step. All elution traces were monitored spectroscopically at 245, 254 and 280 nm. The 
chiral-HPLC column allowed the retention times of the starting materials and the reaction products to 
be determined, and to quantify, where necessary, the enantioselectivity of a given reaction. A C18 
HPLC reverse phase column (Phenomenex, 150 x 15 mm, 5 μm) was used to analytically quantify the 
ring expansion and carbonyl olefination assays, employing a gradient as the mobile phase for ring 
expansion assays (70:30% H2O:CH3CN to 10:90% H2O:CH3CN; 2 mL min-1 flow rate and 20 μL injection 
volume) and an isocratic mobile phase for the carbonyl olefination assays (100% CH3CN: 0.1% v/v TFA: 
0.1% v/v: Et3N; 2 mL min-1 flow rate and 20 μL injection volume). Injection volumes of the sample 
mixture were 20 μL to account for the 2.5:1 dilution in the extraction step. All elution traces were 
monitored spectroscopically at 245, 254, 265 and 280 nm. The C18 column allowed the retention 
times of the starting materials and the reaction products to be determined, and, where necessary, to 
quantify the diastereoselectivity of a given reaction. A C18 HPLC reverse phase column (Phenomenex, 
150 x 15 mm, 5 μm) was used to analytically quantify the chemoselective N-H insertion and Si-H 
insertions assays, employing an isocratic mobile phase (100% CH3OH: 0.1% w/v NH4AcO, 0.5 mL min-1 
flow rate and 20 μL injection volume for chemoselective N-H insertion assays; 100% CH3OH: 0.1% w/v 
NH4AcO; 2 mL min-1 flow rate and 20 μL injection volume for the Si-H insertion assays). All elution 
traces were monitored spectroscopically at 220, 254 and 280 nm. The C18 column allowed the 
retention times of the starting materials and the reaction products to be determined and allowed the 





initial HPLC experiments, the products were subsequently analysed using Liquid chromatography-
Mass spectrometry (LC-MS) to assist in product identification (described below). 
9.10.1 External calibrations 
External calibrations of the anticipated reaction products were conducted using HPLC with 
commercially available standards or with synthesised standards (see section 9.10.2 for details). The 
conditions and mobile phases employed in the product analysis for each assay were employed for the 
calibrations. Each substrate was prepared at multiple concentrations (i.e. 50-500 μM, 1 mM, 2 mM, 5 
mM, 7.5 mM, 10 mM, and 20 mM) and the peak height response in the chromatogram was recorded 
as a function of concentration. A plot of [substrate] vs peak height engendered a straight line which 
could be used to determine the product yields and TTNs for each assay. Injection volumes for the 
external calibrations were 2 μL and 8 μL for the chiral-HPLC and C18 columns, respectively. The 
following equations were subsequently used to calculate total turnover numbers (TTN), enantiomeric 
excesses (ee %), and cis/trans ratios: 




Eq  21 
𝑒𝑒 % = ( 
[𝑅, 𝑅] − [𝑆, 𝑆]
[𝑅, 𝑅] + [𝑆, 𝑆]
) × 100 
Eq  22 




Eq  23 
9.10.2 Synthesis of external standards 
External standards for every reaction (excluding carbonyl olefinations) were synthesised using the 
following methods. 
9.10.2.1 Cyclopropanation synthesis 
A 100 ml oven-dried round-bottom flask was purged with nitrogen and 7 ml of DCM, Rh2(OAc)4 (5% 
mol) and the appropriate reagent (olefin or amine, 5 equivalents) was added. A 3 ml solution 





over a 30-minute period. Final concentrations were 250 mM olefin, 50 mM diazo compound and 5% 
mol catalyst; the final volume was 10 ml. The reaction was left stirring for 1 hour before the solvent 
was removed under vacuum. The crude mixture was purified by flash column chromatography (9:1 n-
hexane:diethyl ether) to yield the pure product. The product identify was confirmed via ESI-MS and 
chiral-HPLC; ethyl 2-(4-hydroxyphenyl)cyclopropane-1-carboxylate: synthesised following the 
outlined protocol, colourless oil, % yield (56), LC-MS m/z (% relative intensity): 133.06 (42.48), 207.1 
(100); ethyl 2-(4-methoxyphenyl)cyclopropane-1-carboxylate: synthesised following the outlined 
protocol, white needle-like crystals, % yield (90), LC-MS m/z (% relative intensity): 147.07 (74.03), 
160.05 (63.11), 175.07 (100); ethyl 2-(4-fluorophenyl)cyclopropane-1-carboxylate: synthesised 
following the outlined protocol, colourless oil, % yield (67), LC-MS m/z (% relative intensity): 135.05 
(40.75), 145.04 (45.70), 163.05 (100), 209.09 (1.14); ethyl 2-(4-chlorophenyl)cyclopropane-1-
carboxylate: synthesised following the outlined protocol, colourless oil, % yield (69), LC-MS m/z (% 
relative intensity): 144.05 (100), 179.02 (51.04), 225.06 (1.47); ethyl 2-(4-
(trifluoromethyl)phenyl)cyclopropane-1-carboxylate: synthesised following the outlined protocol, 
colourless oil, % yield (61), LC-MS m/z (% relative intensity): 165.01 (100), 183.03 (91.54), 211.06 
(57.11), 239.09 (62.33); ethyl 2-(4-(tert-butyl)phenyl)cyclopropane-1-carboxylate: synthesised 
following the outlined protocol, colourless oil, % yield (79), LC-MS m/z (% relative intensity): 127.05 
(86.37), 145.06 (100), 168.08 (72.42), 191.10 (5.15), 247.16 (9.87); ethyl 2-(4-
cyanophenyl)cyclopropane-1-carboxylate: synthesised following the outlined protocol, colourless oil, 
% yield (47), LC-MS m/z (% relative intensity): 131.05 (42.81), 188.07 (100), 216.1 (10.98); tert-butyl 
2-phenylcyclopropane-1-carboxylate: synthesised following the outlined protocol, colourless oil, % 
yield (62.00), LC-MS m/z (% relative intensity): 127.05 (100), 145.06 (87.13), 168.07 (52.34), 247.16 
(16.22); benzyl 2-phenylcyclopropane-1-carboxylate: synthesised following the outlined protocol, 
colourless oil, % yield (56.00), LC-MS m/z (% relative intensity): 91.05 (100), 165.05 (44.34), 181.09 
(75.77). 
9.10.2.2 N-H insertion synthesis 
A 100 ml oven-dried round-bottom flask was purged with nitrogen and 7 ml of DCM, Rh2(OAc)4 (5% 
mol) and the appropriate reagent (amine, 5 equivalents) was added. A 3 ml solution containing the 
diazo compound (DCM, 1 equivalent) was added dropwise to the solution while stirring over a 30-
minute period. Final concentrations were 250 mM olefin, 50 mM diazo compound and 5% mol 
catalyst; the final volume was 10 ml. The reaction was left stirring for 4 hours before the solvent was 
removed under vacuum. The crude mixture was purified by flash column chromatography (8:2 pet 





chiral-HPLC; ethyl (4-chlorophenyl)glycinate: synthesised following the outlined protocol, white 
crystals, % yield (45), LC-MS m/z (% relative intensity): 140.11 (100), 142.09 (39.56), 214.06 (3.41); 
tert-butyl (4-chlorophenyl)glycinate: synthesised following the outlined protocol, yellow oil, % yield 
(26), LC-MS m/z (% relative intensity): 140.04 (100), 142.04 (31), 226.05 (10.48), 228.05 (3.45); benzyl 
(4-chlorophenyl)glycinate: synthesised following the outlined protocol, yellow oil, % yield (38), LC-MS 
m/z (% relative intensity): 91.06 (100), 276.01 (14.9), 278.13 (4.3); tert-butyl 2-(piperidin-1-yl)acetate: 
synthesised following the outlined protocol, yellow oil, % yield (47), LC-MS m/z (% relative intensity): 
98.10 (100), 144.10 (57.93); benzyl 2-(piperidin-1-yl)acetate: synthesised following the outlined 
protocol, yellow oil, % yield (48), LC-MS m/z (% relative intensity): 91.05 (100), 142.08 (17.05), 234.14 
(69.87). 
 9.11 PRODUCT CHARACTERIZATION BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY 
Liquid chromatography-Mass spectrometry (LC-MS, C8) was employed to identify the products formed 
in each assay. A C8 reverse column (Grace Vydac, 100 x 21 mm, 5 μm) was used with a 10-minute 
gradient mobile phase (95:5% H2O:CH3CN to 10:90% H2O:CH3CN; 0.1% v/v formic acid, 0.25 mL min-1). 
Injection volumes of 20 μL were employed and the chromatogram was screened across a wavelength 
range of 240-300 nm. After eluting from the column, the mixture entered an isocratic solvent chamber 
where a 1:100 dilution was performed prior to injecting the sample into a positive electron-spray-
ionization (ESI) mass spectrometer (Waters Xevo G2-XS QTof). The mass spectrum contained peaks 
screened across a m/z range of 70-350 (depending on the molecular mass of the product being 
screened). Retention times and fragmentation patterns were initially determined using commercial 
samples of the anticipated products. 
9.12 PREPARATION OF AN ALGINATE-ENCAPSULATED ENZYME 
9.12.1 For UV-VIS spectroscopy  
A solution of 3% (w/v) sodium alginate was prepared by mixing 3 g of sodium alginate with 100 ml of 
CHES buffer (20 mM CHES, 100 mM KCl, pH 8.6). The mixture was left stirring for 1 hour to ensure 
complete dissolution and homogeneity. Once ready, to 9 ml of the 3% (w/v) sodium alginate solutions 
were added 1 ml of C45/Rma-TDE (100 µM) or cytochrome c (1 mM). The mixture was adequately 
mixed to ensure homogeneity. A thin film of 0.2 M CaCl2(aq) was prepared in a petri dish and the 
alginate mixture was slowly pipetted over the surface to generate a thin sheet. The sheet was allowed 
to cure for 30 minutes before the residual CaCl2(aq) was discarded. The sheets were left on the bench 





cm) which was transferred into a cuvette for UV-VIS analysis. The UV-VIS trace was then compared to 
the free enzyme UV-VIS trace.  
9.12.2 For non-aqueous enzymology 
A solution of 3% (w/v) sodium alginate was prepared by mixing 3 g of sodium alginate with 100 ml of 
CHES buffer (20 mM CHES, 100 mM KCl, pH 8.6). The mixture was left stirring for 1 hour to ensure 
complete dissolution and homogeneity. Once ready, to 9 ml of the 3% (w/v) sodium alginate solutions 
were added 1 ml of C45/Rma-TDE (100 µM) or HRP (1 mM). The mixture was adequately mixed to 
ensure homogeneity, and then pipetted dropwise, from an elevation of approximately 30 cm, into a 
conical flask equipped with a stirrer bar and containing an excess of 0.2 M CaCl2(aq) solution. The beads 
formed spontaneously and were allowed to cure for 30 minutes before being collected by vacuum 
filtration. The beads were allowed to dry for an additional 30 minutes before being collected and 
stored at 4OC.  
9.13 UV-VIS SPECTROSCOPY OF AN ALGINATE-ENCAPSULATED ENZYME 
All UV-VIS spectra were recorded on an Agilent Cary-60 UV-visible spectrophotometer. To a 1 mm 
pathlength UV-VIS quartz cuvette was added a thin-sheet of alginate-encapsulated C45/Rma-
TDE/cytochrome c. 1 ml of the appropriate solvent was added to the cuvette (CHES buffer, MeOH, 
EtOH, acetone, ethyl acetate or hexane) and a UV-VIS spectrum was recorded across a wavelength 
range of 300-750 nm. An initial baseline was acquired using an alginate sheet without any enzyme 
encapsulated within it. For the reduced spectrum, 10 µl of a 100 mM sodium alginate solution (in de-
ionized water) was pipetted into the cuvette containing the solvent/alginate-encapsulated enzyme 
sheet, and mixing was assisted with the pipette. A UV-VIS spectrum was then recorded every 30 
seconds across a wavelength range of 300-750 nm.  
9.14 UV-VIS SPECTROSCOPIC IDENTIFICATION OF THE FORMATION OF A METALLOCARBENOID 
INTERMEDIATE IN AN ALGINATE-ENCAPSULATED ENZYME 
All UV-VIS spectra were recorded on an Agilent Cary-60 UV-visible spectrophotometer. To a 1 mm 
pathlength UV-VIS quartz cuvette was added a thin-sheet of alginate-encapsulated C45. 1 ml CHES 
buffer (20 mM CHES, 100 mM KCl, pH – 8.6) was added to the cuvette and a UV-VIS spectrum was 
recorded across a wavelength range of 300-750 nm. An initial baseline was acquired using an alginate 
sheet without any enzyme encapsulated within it. The cuvette was subsequently sealed with a silicon 
septum and flushed with N2 for a nitrogen cylinder. The reduced spectrum was acquired by adding 10 





solvent/alginate-encapsulated C45 sheet via an airtight syringe. A UV-VIS spectrum was then recorded 
every 30 seconds across a wavelength range of 300-750 nm. After sufficient reduction could be 
detected, 10 µl of a stock solution of ethyl diazoacetate (EDA, 400 mM in EtOH) was added into the 
sealed cuvette via an airtight syringe. The solution was left to mix for 1 minute before a UV-VIS 
spectrum was recorded, across a wavelength range of 300-750 nm, every 30 seconds for 10 minutes. 
9.15 CHEMOPHYSICAL CHARACTERISATION OF CALCIUM ALGINATE BEADS 
9.15.1 Volumetric analysis 
An assortment of varying alginate beads were prepared by pipetting a 1ml of a solution of sodium 
alginate (3% (w/v) sodium alginate, 20 mM CHES, 100 mM KCl, pH 8.6), dropwise and from a 
suspension of approximately 30 cm, into varying concentrations of CaCl2(aq) solutions (0.1 – 0.5M). All 
the beads that prepared were matured for 1 hour in the respective CaCl2 solution and were prepared 
without any enzyme encapsulated. Once matured, the beads were collected via vacuum filtration and 
subsequently weighted and measured. The beads were placed in a labelled tray and left in an oven set 
at 37 OC for 3 hours. After 3 hours, the beads were collected, reweighed and remeasured. The 
differences in the values pre- and post-oven were used to calculate the water content of each bead 
(µl and %).  
9.15.2 Retention analysis 
All UV-VIS spectra were recorded on an Agilent Cary-60 UV-visible spectrophotometer. 10 mg of a 
select enzyme (horseradish peroxidase, cytochrome c, and C45) was dissolved in 10 ml of a sodium 
alginate solution (3% (w/v) sodium alginate, 20 mM CHES, 100 mM KCl, pH 8.6) and left to stir on a 
roller to achieve homogeneity. 1 ml of the resultant mixture was added, dropwise and from a 
suspension of approximately 30 cm, to varying concentrations of CaCl2(aq) solutions (0.1 - 0.5M), 
resulting in a total of 15 different samples (final enzyme concentration in each sample was 1 mg ml-1). 
The beads were allowed to mature for 1 hour, before being collected via vacuum filtration and 
resuspended in 50 ml of CHES buffer (20 mM CHES, 100 KCl, pH 8.6). The samples were left mixing on 
a roller overnight and were analysed the following morning. 1 ml from each respective sample was 
collected and analysed via UV-VIS spectroscopy. The concentration of each protein leaked into the 
aqueous phase has called from the Soret peak for each respective protein (C45, ɛ406 nm = 147,344 M-1 





9.15.3 Determination of alginate porosity 
The porosity (ɛ) of the alginate beads was determined following the procedure outlined by Ha.387 200 
alginate beads (14 µl bead-1) were suspended in a 50 ml solution of 100 mM indigo carmine (C1) and 
allowed to stir for 20 minutes. After two hours the beads were collected via vacuum filtration and the 
concentration of indigo carmine remaining in the 50 ml solution was determined via UV-VIS 
spectroscopy (ɛ667 nm = 34145 M-1 cm-1). The collected beads were then resuspended in another 
solution of indigo carmine (17 mM; C2) and left mixing for 20 minutes, before the beads were collected 
via vacuum filtration and the concentration of indigo carmine in the second solution was determined 










Eq  24 
• Vb = the total volume of the bulk solvent (ml) 
• Vp = the total volume of the alginate beads (ml) 
• C = the bulk concentration of indigo carmine at the end of the experiment (mM) 
• C2 = the concentration of indigo carmine in the second solution (mM) 
• C1 = the concentration of indigo carmine in the first solution (mM) 
• r = the radius a single alginate bead (mm) 
• N = the total number of alginate beads 
9.16 ALGINATE-ENCAPSULATED ABTS PEROXIDATION KINETICS AND RECOVERABILITY 
C45 and HRP alginate beads were prepared according to the protocol outlined above. The following 
protocol was used to measure the peroxidase kinetics of each encapsulated enzyme. To a quartz 
cuvette was added 980 µl of CHES buffer (20 mM CHES, 100 mM KCl, pH 8.6) and a single alginate 
bead (r = 1.5 mm). 10 µl of ABTS (100 mM stock in CHES buffer) was added to the cuvette and the 
mixture was allowed to stir for 1 minute. 10 µl of hydrogen peroxide (250 - 1 mM stocks in CHES) was 
pipetted into the cuvette to initiate the reaction. The progress of the reaction was monitored using a 
UV-VIS spectroscopy set to a single wavelength (607 nm). The initial rates were calculated from the 
slope. The final volume was 1 ml and the kinetics were collected by varying the concentration of 
hydrogen peroxidase. All reactions were repeated in triplicates, with a fresh bead employed every 





HRP and C45 in the alginate beads were 100 µM and 10 µM, respectively. The recoverability assays 
were conducted by using the same bead in multiple runs, with ABTS and hydrogen peroxide 
concentrations of 1 mM, respectively. 
9.17 ALGINATE-ENCAPSULATED CARBENE TRANSFERASE ASSAYS  
9.17.1 Styrene cyclopropanation 
To 970 µl of solvent (CHES buffer, MeOH, EtOH, isopropanol, acetone, acetonitrile, ethyl acetate, 
dichloromethane, THF, n-hexane, pet ether) ) in a 1.5 ml glass vial was added 3 alginate-enzyme (10 
µM, 1.4 mm3) beads and 10 µl of Na2S2O4 (1M stock; de-ionised water) and the mixture was left to stir 
for 1 minute (complete reduction of C45 from Fe3+ to Fe2+ could be verified via UV/VIS spectroscopy if 
necessary). 10 µl of a styrene (3M stock; EtOH) was added and the reaction left to mix for 30 seconds. 
After 30 seconds 10 µl of EDA (1M stock; EtOH) was added into the reaction vials to initiate the 
reaction. Final concentrations were 30 µM enzyme, 10 mM sodium dithionite, 10 mM diazo 
compound, and 30 mM styrene. Once mixed, the reactions were stirred on a roller at room 
temperature.  After 2 hours, the reaction was quenched by the addition of 20 µl of 3M HCl. The vials 
were unscrewed, the beads were removed, and the resultant mixture was transferred to a 15 ml falcon 
tube containing 1 ml of ethyl acetate, vortexed and then centrifuged (14,500 rpm; 2 minutes). The 
organic layer was collected and was then slowly added to a 15 ml falcon tube containing 1 ml of an 
aqueous 3M NaOH solution. The resulting biphasic mixture was left to stir, at room temperature, for 
2 hours; the progress of the hydrolysis reaction was monitored by TLC (7:3 ethyl acetate:hexane, 254 
nm). After 2 hours, the aqueous layer was isolated analysed by chiral-HPLC and LC-MS. The product 
yields, enantiomeric excesses, and total turnover numbers (TTN; concentration of product 
formed/concentration of enzyme) where calculated via an external calibration with commercial ethyl 
2-phenylcyclopropane-1-carboxylate and 2-phenylcyclopropane-1-carboxylic acid.  
9.17.2 Piperidine N-H insertion 
To 970 µl of solvent (CHES buffer, MeOH, EtOH, isopropanol, acetone, acetonitrile, ethyl acetate, 
dichloromethane, THF, n-hexane, pet ether, toluene) in a 1.5 ml glass vial was added 3 alginate-
enzyme (10 µM, 1.4 mm3) beads and 10 µl of Na2S2O4 (1M stock; de-ionised water) and the mixture 
was left to stir for 1 minute (complete reduction of C45 from Fe3+ to Fe2+ could be verified via UV/VIS 
spectroscopy if necessary). 10 µl of a piperidine (3M stock; EtOH) was added and the reaction left to 
mix for 30 seconds. After 30 seconds 10 µl of EDA (1M stock; EtOH) was added into the reaction vials 
to initiate the reaction. Final concentrations were 30 µM enzyme, 10 mM sodium dithionite, 10 mM 





temperature.  After 2 hours, the reaction vials were unscrewed, the beads were removed, and the 
mixture was transferred to a 15 ml falcon tube containing 2 ml of a 1:1 water:ethyl acetate mixture, 
vortexed and then centrifuged (14,500 rpm; 2 minutes). The organic layer was isolated and 
subsequently analysed by chiral-HPLC and LC-MS. The product yields and total turnover numbers (TTN; 
concentration of product formed/concentration of enzyme) where calculated via an external 
calibration with commercial ethyl-1-piperidineacetate. 
9.18 DETERMINATION OF SUBSTRATE BULK VS BEADS PARTITION COEFFICIENTS 





Eq  25 
Where [Substrate]bead is the concentration of a substrate in the alginate-bead and [Substrate]bulk is the 
concentration of a substrate in the bulk solution. C18-HPLC was used to determine the partition 
coefficient for styrene and piperidine in a variety of solvents as follows. An external calibration for 
styrene/piperidine was performed by injecting various concentrations of the sample and recording 
the peak height in the chromatogram at 280 nm (styrene) or 254 nm (piperidine; the concentration 
range was 500 µM – 10 mM. A batch of fresh beads were prepared according to the protocol provided 
in section 9.12 (without the encapsulation of any enzyme). The beads were collected and dried via 
vacuum filtration prior to use. The volume of the beads was determined according to the protocol 
provided in section 9.15. To a 2 ml screw-top vial was added 990 µl of the respective solvent (CHES, 
MeOH, EtOH, IPA, ACN, EtOAc, THF, acetone, DCM, n-hexane, pether, toluene), 10 µl of a 3M stock of 
piperidine/styrene (in EtOH) and three alginate beads; the final concentration of the 
styrene/piperidine was 10 mM. The vials were left to mix on a roller for 2 hours before the beads were 
removed from the vials prior to loading onto the HPLC. The concentration of the substrate remaining 
in the bulk solution was calculated from the peak height and was subsequently used to determine the 
partition coefficient of the substrate in each respective solvent.   
The value, α, was calculated using equation (26), and was utilised in the calculations to determine the 











• Vb = the total volume of the bulk solvent (ml) 
• Vp = the total volume of the alginate beads (ml) 
• Kp = the partition coefficient  
9.19 DETERMINATION OF SUBSTRATE DIFFUSION COEFFICIENTS AS A FUNCTION OF SOLVENT 
The protocol to determine the substrate diffusion coefficients in each respective solvent was identical 
to the protocol outlined in 9.20. The partition coefficients were calculated using the non-steady state 
equation (27). 
𝑆𝑏(𝑡) =  
𝛼𝑆𝑏(0)
1 + 𝛼












Eq  27 
Where 
• Sb(t) = The concentration of substrate, S, in the bulk at time t (mM) 
• Sb(0) = The concentration of substrate, S, in the bulk at time 0 (mM) 
• R = the radius of the alginate beads (m3) 
• qn = the position non-zero roots of equation (28) 
• t = time (s) 
• D = the diffusion coefficient (m2 s-1) 




Eq  28 
The non-positive roots for equation 26, and the value of qn, was solved using the Secant method 
(equation (29)) and by setting the initial guess as x0 = 0 and x1 = 1. 









The effective diffusion coefficient, Deff (m2 s-1), for a substrate each solvent was calculated using 
equation (30). 
𝐷𝑒𝑓𝑓 = 𝜀𝐷 
Eq  30 
Where ε is the porosity. For alginate beads prepared from 0.3M CaCl2 and 3% (w/v) sodium alginate 
the porosity was calculated to be 0.889 (following the method delineated in section 9.15.3). 
9.20 ALGINATE-ENCAPSULATED CARBENE TRANSFER RECOVERABILITY ASSAYS 
The recoverability assays were conducted identically to the protocol outlined in section 9.17. After 
each reaction, the sealed vials were transported into an anaerobic glove box (Belle technology, [O2] < 
5 ppm), the lids were removed, and the product mixture extracted was decanted into an Eppendorf 
for analysis. The remaining beads were washed with twice with respective solvent before the 
subsequent reaction.  
9.21 CIRCULAR DICHROISM SPECTROSCOPY 
Circular Dichroism spectra were collected using a JASCO J-815 CD polarimeter. The enzyme was loaded 
into a 1 mm pathlength quartz cell at 0.01 mg mL-1 in mM KCl, 20 mM CHES, pH 8.58, and far-UV CD 
spectra were recorded at 100 nm/min with a sensitivity of 50 mdeg. Thermal stability of an enzyme 
was assessed by monitoring ellipticity at 222 nm while increasing the temperature at a ramp rate of 
40 °C/hour with 1 °C intervals. All the raw data was converted to mean residue ellipticity (MRE) and 
the thermal denaturation transition midpoint (Tm) was assessed by plotting the second derivatives of 
a smoothed thermal denaturation trace where the x-axis intercept corresponds to the Tm. 
9.22 REDOX POTENTIOMETRY 
The redox potential of an enzyme was measured as previously described for C45. Briefly, an enzyme 
(50 μM) was loaded into a spectroelectrochemical cell in 100 mM KCl, 50 mM CHES, pH 8.6, 10% 
glycerol with the following redox mediators: 20 μM benzyl viologen, 20 μM anthroquinone-2-
sulfonate, 20 μM phenazine, 25 μM 2-hydroxy-1,4-napthoquinone. Potential was applied to the 
spectroelectrochemical cell (platinum working and counter electrodes, Ag/AgCl reference electrode) 
using a Biologic SP-150 potentiostat in both reductive and oxidative directions to confirm 





reduced protein versus the applied potential, and the data were fitted using the following single 
electron Nernst function (equation (31)): 
f(x) = (A+B*10^((Em-x)/59))/(1+10^((Em-x)/59)) 
Eq  31 
In equation (31), A and B are y-axis values at 100% oxidized and reduced heme respectively; Em is the 







APPENDIX 1: EXTERNAL CALIBRATIONS 
 
Figure 163: Chiral-HPLC external calibrations for ethyl 2-phenylcyclopropane-1- carboxylate at 280 nm 
(upper panel) and 254 nm (lower panel). A polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 






Figure 164: Chiral-HPLC external calibrations for (top left) ethyl 2-(4-hydroxyphenyl)cyclopropane-1-
carboxylate at 280 nm, (top middle) ethyl 2-(4-chlorophenyl)cyclopropane-1-carboxylate  recorded at 
280 nm, (top right) ethyl 2-(4-(trifluoromethyl)phenyl)cyclopropane-1-carboxylate recorded at 280 
nm, (middle left) ethyl 2-(4-methoxyphenyl)cyclopropane-1-carboxylate recorded at 280 nm, (middle) 
ethyl 2-(4-cyanophenyl)cyclopropane-1-carboxylate recorded at 280 nm, (middle right) ethyl 2-(4-
(tert-butyl)phenyl)cyclopropane-1-carboxylate recorded at 280 nm, (bottom left) ethyl 2-(4-
fluorophenyl)cyclopropane-1-carboxylate recorded at 280 nm, (bottom middle) tert-butyl 2-
phenylcyclopropane-1-carboxylate recorded at 254 nm, and (bottom right) benzyl 2-
phenylcyclopropane-1-carboxylate recorded at 254 nm. A polar ionic mobile phase (100 % CH3CN: 0.1 








Figure 165: Chiral-HPLC external calibration (left) for ethyl (4-chlorophenyl)glycinate at 254 nm, 
(middle) tert-butyl (4-chlorophenyl)glycinate at 254 nm, and (right) benzyl (4-chlorophenyl)glycinate 
at 254 nm. A polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N) was employed 




Figure 166: Chiral-HPLC external calibration (left) for ethyl-1-piperidineacetate at 254 nm, (middle) 
tert-butyl 2-(piperidin-1-yl)acetate at 254 nm, and (right) benzyl 2-(piperidin-1-yl)acetate at 254 nm. 
A polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N) was employed and injection 







Figure 167: C18-HPLC external calibrations for (top left) ethyl cinnamate at 245 nm (a polar ionic 
mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N) was employed), (top middle) ethyl 
nicotinate at 265 nm (a gradient mobile phase (70:30% H2O:CH3CN to 10:90% H2O:CH3CN) was 
employed), (top right dimethylphenylsilane at 220 nm (a gradient mobile phase (70:30% H2O:CH3CN 
to 10:90% H2O:CH3CN) was employed), (bottom left) styrene at 254 nm (a polar ionic mobile phase 
(100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N) was employed), (bottom middle) styrene at 280 nm (a 
polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N) was employed), and (bottom 
right) piperidine at 254 nm (a polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N) 






APPENDIX 2: TABLES 
Table 17: A non-exhaustive list of rationally designed carbene transferases reported in the literature, 
including reaction conditions, product yields, enantioselectivities and total turnover numbers for the 
cyclopropanation reaction between EDA and styrene. 
 
Table 18: The product yields, total turnover numbers, and single/double insertion ratios for the C45-
catalysed N-H insertion reactions between piperidine/p-chloroaniline and the diazo compounds EDA, 







Table 19: The reaction yields and total turnover numbers for the Si-H insertion reaction between EDA 
and DMPS catalysed by C45 and Rma-TDE. 
 
Table 20: The product yields and enantioselectivities of the AE-C45 catalysed cyclopropanation 
reaction between EDA and styrene in various organic solvents, followed by the recovery and re-
employment of the same AE-C45 catalyst in the N-H insertion reaction between EDA and piperidine in 
various organic solvents. 
 
Table 21: The yields, diastereoselectivities, enantioselectivities, and total turnover numbers for the 
cyclopropanation reaction between styrene and EDA catalysed by the de novo heme-containing 







Table 22: The kinetic parameters for the metallocarbenoid formation between EDA and the de novo 
heme-containing maquettes C45, JR1, AP3.2, and the rationally designed heme-containing proteins 
Mb(H64V,V68A), and Rma-TDE. 
 
Table 23: The kinetic parameters for the cyclopropanation reaction between styrene and EDA 
catalysed by the de novo heme-containing maquettes C45, JR1, AP3.2, and the rationally designed 
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